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 A single synthetic method rarely is sufficient to provide universal access to a 
chemical structure class. This realization forces organic chemists to devise and 
develop new methods. The copper catalyzed ring expansion of vinylaziridines 
produces nitrogen containing heterocycles commonly found in pharmaceuticals and 
natural products. This reaction is described from its initial discovery, through 
optimization, to application. Many substitution patterns and functional groups were 
tested and the reaction was found to be quite tolerant. By controlling the aziridine 
and olefin stereochemistry the selective synthesis of either cis or trans 2,5-
dihydropyrroles was achieved. Likewise, vinyloxiranes were stereoselectively 
converted to cis- or trans-2,5-dihydrofurans. Furthermore, the asymmetric synthesis 
of 2-substituted-2,5-dihydrofurans was achieved using chirality transfer 
characteristic of a [1,3]- sigmatropic rearrangement. This method was further tested 
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1.1 Heterocycle Containing Natural Products, and Pharmaceuticals  
 The field of organic synthesis has experienced tremendous growth over the last 
century enabling scientists to construct increasingly complex molecules. This growth 
has been realized because of the intricate interplay between synthetic methodology 
and total synthesis. Whereby, the discovery and development of new reactions enables 
more efficient, shorter syntheses. Alternatively, the pursuit of natural products offers 
an opportunity to test methodologies and discover new ones. Table 1.1 summarizes the  
Nobel Prizes received in the area of organic synthesis and demonstrates that scientists 
Table 1.1: Nobel Prizes in Organic Synthesis (1901-2010) 
Year Recipient Prize Motivation Specialty 
1902 Emil Fischer Sugar and purine syntheses Total Synthesis 
1905 Adolf von Baeyer Organic dyes and hydroaromatic compounds Total Synthesis 
1910 Otto Wallach Alicyclic compounds Total Synthesis 
Victor Grignard Grignard reagents Methodology 
1912 
Paul Sabatier Metal catalyzed hydrogenations Methodology 
1930 Hans Fischer Haemin Total Synthesis 
Norman Haworth Carbohydrates and vitamin C Total Synthesis 
1937 
Paul Karrer Carotenoids, flavins and vitamins A and B2 Total Synthesis 
1938 Richard Kuhn Carotenoids and vitamins Total Synthesis 
Adolf Butenandt Sex hormones Total Synthesis 
1939 
Leopold Ruzicka Polymethylenes and higher terpenes Total Synthesis 
1947 Sir Robert Robinson Alkaloids Total Synthesis 
1950 Otto Diels, Kurt Alder Diels-Alder reaction Methodology 
1955 Vincent du Vigneaud Polypeptide hormones and sulfur compounds Total Synthesis 
1957 Lord Alexander Todd Nucleotides and nucleotide co-enzymes Total Synthesis 
1965 Robert B. Woodward Art of organic synthesis Total Synthesis 
1969 Derek H. R. Barton, Odd Hassel Conformations of molecules Structure and Theory
1975 John Cornforth, Vladimir Prelog Stereochemistry of molecules Structure and Theory
Herbert C. Brown Boron containing compounds Methodology 
1979 
Georg Wittig Phosphorus containing compounds Methodology 
1981 Kenichi Fukui, Roald Hoffmann Course of chemical reactions Structure and Theory
1984 R. Bruce Merrifield Chemical synthesis on a solid matrix Methodology 
1990 Elias J. Corey Theory and methodology of organic synthesis Methodology Total Synthesis 
1994 George A. Olah Carbocation chemistry Structure and Theory
William S. Knowles, Ryoji Noyori Asymmetric hydrogenation Methodology 
2001 
K. Barry Sharpless Asymmetric oxidation reactions Methodology 
2005 Robert Grubbs, Richard Schrock, Yves Chauvin Metathesis Methodology 
3 
in both areas of expertise have been recognized for their advancements.1 In the realm 
of synthetic methodology one can argue that the discovery of a truly “new” synthetic 
method is quite difficult. Many new reactions are actually new protocols of existing 
reactions or creating a cascade of known reactivity.2 However, improvements of these 
types can have profound impact allowing broader substrate scope, diastereocontrol, or 
asymmetric variants. Therefore synthetic methodology and total synthesis will 
continue to grow in technique and art for the foreseeable future. 
 Representative natural products that are considered “classics” in our discipline 
are shown in Figure 1.1.3 The synthesis of these molecules represented a significant 
advancement in the field of total synthesis at the time of their completion. Common to 
a plethora of natural products are heterocycles and more specifically 5-membered 
heterocyclic rings containing oxygen, nitrogen, and sulfur. These rings can be 
aromatic (furan, pyrrole, thiophene), partially reduced, or saturated (tetrahydrofuran, 
pyrrolidine, tetrahydrothiophene). Many diverse and creative approaches to construct 
these motifs have been developed, but no single method provides ready access to this 
entire substrate class.  
 
Figure 1.1: Classic Natural Product Architectures with 5-Membered Heterocycles  
4 
 Pharmaceuticals also contain 5-membered heterocycles and several of the top 
selling drugs in 2008 that contain this motif are shown in Figure 1.2. The synthesis of 
pharmaceuticals is of equal if not superior importance to that of natural products. 
Although the structural complexity is often lower, the necessity for efficiency, 
enantiopurity, and scaleability can make the synthesis of pharmaceuticals more 
challenging. These requirements mandate an influx of new methods and protocols for 
the synthesis of approved compounds, but also access to new architectures for drug 
discovery.    
 
 
Figure 1.2: Important Pharmaceuticals with 5-Membered Heterocycles 
5 
 Lipinski’s rules (Lipinski’s Rule of Five)4 are used to evaluate drug likeness, 
but these rules can be expanded by analysis of the top selling pharmaceuticals over the 
last few years. Some of these startling trends and statistics are shown in Table 1.2. The 
top 200 brand-name and generic pharmaceuticals by sales are comprised 
predominantly of small organic molecules (~407 g/mol) and a few inorganic, polymer, 
and biological molecules. These small organic molecules on average have 21 carbon, 
27 hydrogen, 4 oxygen, and 3 nitrogen atoms. Also, these pharmaceuticals sometimes 
contain sulfur, fluorine, chlorine, and phosphorous, but rarely any other elements. 
Further analysis reveals that most of these molecules are cyclic and in particular the 
ring contains a heteroatom such as nitrogen oxygen, or sulfur. These vast 
generalizations to the structure of the top selling pharmaceuticals allows one to 
conclude that small heterocyclic structures are prevalent in the pharmaceutical space 
explored to date. 
Table 1.2: Characteristics of the Top 200 Selling Pharmaceuticals 




(g/mol) C H O N S F Cyclic Heterocyclic
Biological Inorganic Polymers
2006 Generic 376.4 19.1 24.5 4.0 2.3 0.3 0.1 190 134 1 3 2 
2006 Brand-Name 441.8 22.9 29.1 4.2 2.7 0.4 0.3 172 130 18 1 3 
2007 Generic 371.1 18.9 24.2 3.8 2.4 0.3 0.1 188 127 2 4 2 
2007 Brand-Name 439.4 23.0 29.0 4.0 2.8 0.4 0.3 171 134 18 1 4 
2008 Generic 374.6 19.1 24.7 3.9 2.4 0.3 0.1 185 128 3 3 0 
2008 Brand-Name 436.8 22.8 28.9 4.0 2.8 0.3 0.4 168 128 17 2 4 
 More in-depth analysis of the heterocycles present in pharmaceuticals reveals 
several trends displayed in Table 1.3. The presence of each heterocycle has been 
quantified with respect to launched drugs, ones in clinical trials, and all those which 
have been tested for biological activity and deposited in the MDL drug database.5 The 
presence of small rings (3,4), regardless of the heteroatom, are very rare in 
pharmaceuticals except for the plethora of -lactams. Next, five-membered rings, not 
surprisingly, are quite common for nitrogen and oxygen while sulfur containing 
heterocycles make their only contribution to launched drugs here. Lastly, nitrogen 
6 
overwhelms oxygen with respect to 6-membered rings. From these trends we conclude 
that nitrogen and oxygen containing 5- and 6- membered heterocycles are common 
motifs found in pharmaceuticals of a wide variety of biological modes of action. 
Therefore, new methods that facilitate the construction of these motifs will enable the 
synthesis of new structures yet to be tested or enable the more efficient synthesis of 
existing structures.  
 
Table 1.3: Analysis of Heterocycles Found in Pharmaceuticals 
Heterocycle Launched Clinical  Trials All 
 2 9 241 
 69 64 5415 
 
220 614 38298 
 
327 916 66599 
 12 86 1045 
 3 18 682 
 
77 438 10695 
 
85 153 8916 
 0 0 3 
 0 0 19 
 
34 101 9855 
 
0 9 313 
 
1.2 [1,3]-Sigmatropic Rearrangements  
 Sigmatropic rearrangements have proved to be a valuable tool for organic 
chemists in the synthesis of complex molecules. The value of these transformations is 
based on the precise regio- and stereo-control offered by many pericyclic reactions.6 
The [1,3] sigmatropic rearrangement, in particular the isomerization of 
vinylcyclopropanes to cyclopentenes, has been utilized numerous times in the 
7 
synthesis of natural products.7 The first vinylcyclopropane isomerization to a 
cyclopentene was observed by Neureiter in 1959 with 1,1-dichloro-2-
vinylcyclopropane (1.11h).8 This reaction prompted thorough study and discussion of 
the parent, unbiased vinylcyclopropane rearrangement. Utilizing a wide variety of 
physical organic experiments and calculations the mechanism is best explained in 
terms of a concerted rearrangement that has a biradical like transition state (Scheme 
1.1). The transition state is located on a very flat surface which leads to several 
products arising from the orbital symmetry allowed (suprafacial inversion, antarafacial 
retention) and the forbidden (suprafacial retention, antarafacial inversion) pathways. 
The energy of activation was determined to be 52 kcal/mol using several different 
methods.  
 
Scheme 1.1: Stereochemical Outcome of Vinylcyclopropane Rearrangement 
 Selected examples of the perturbation of the vinylcyclopropane rearrangement 
are displayed in Table 1.4. The changes in reactivity are readily explained by 
stabilization of the biradical like transition state. It is clear that adding substituents to 
the parent systems dramatically alters the energetics and stereochemical outcome. In 
light of this, it is not surprising that involving a heteroatom in the strained ring 
(oxirane, thiirane, aziridine, phosphirane, silyrene, etc.) will result in fundamentally 
different reactivity. For example the thermal rearrangement of the vinylphosphirane 
8 
(1.11k, 1.11l) to the phospholene 1.12k, 1.12l) was studied and found to most likely 
proceed by a biradical. The reaction can be catalyzed by transition metals and the 
energies of activation for both the catalyzed and non-catalyzed processes were 
calculated. The large effect of a Lewis acid catalyst bodes well for utilizing transition 
metals to catalyze variants of this rearrangement with lone pairs. The vinylsilyrene 
(1.11m) was studied and the barrier to rearrangement was prohibitively high such that 
extrusion and 1,4 insertion was found to be a more accessible pathway. Together these 
results show that future attempts to ring expand strained rings will be challenging 
because of the high activation energy and the surface around the transition state.  
Table: 1.4: [1,3]-Rearrangement of Vinylcyclopropanes 








































150 37*   (21)** 
l15 
  




ND = Not Determined, * = Calculated Energy, ** = Cr(CO)5 catalyzed Calculated Energy 
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 The development of a [1,3] rearrangement of a strained heterocycle would be 
of great value to synthetic chemists. Scheme 1.2 shows the orbital symmetry allowed 
pathway for a true, concerted rearrangement. Analysis of the bond dissociation 
energies and ring strain suggest that this reaction should be feasible. A thorough study 
of the literature for [1,3] rearrangements of vinyl-thiiranes, -oxiranes, and -aziridines 
teaches us that this is non-trivial. 
 
Scheme 1.2: Stereochemical Rationale and Energetics for [1,3] Sigmatropic 
Rearrangement of Various Three-Membered Heterocycles 
 The first publication of a formal [1,3] rearrangement of a vinylthiirane was not 
performed until Quin in 1985 (Scheme 1.3).17 The oxidation of the mono-thiirane of 
cyclooctadiene results in the isolation of both sulfoxide diastereomers of the [4.2.1] 
bicycle (1.19, 1.20) in modest yield. Likewise, attempted oxidation of a vinylthiirane 
by Bader produced sulfolene 1.22.18 The true ring expansion of a vinylthiirane was not 
realized until 2007 by Njardarson et. al.19 Vinylthiiranes (1.23) with varying 
substitution patterns and functional groups could be treated with copper (II) 
bishexafluoroacetylacetonate (Cu(hfacac)2) and the dihydrothiophenes (1.24) were 
isolated in good yield. This catalytic reaction, with appropriate choice of temperature 
and catalyst loading, was able to overcome the extrusion of sulfur which was known 





































(1.23k) 1 mol. % cat.
0.5 h, 80oC, 93%
(1.23l) 1 mol. % cat.
1 h, 100oC, 95%
(1.23j) 5 mol. % cat.
1 h, 120oC, 85%
(1.23b) 5 mol. % cat.
1.5 h, 120oC, 78%
S Ph
(1.23h) 10 mol. % cat.
2 h, 110oC, 91%
S
p-MeC6H4
(1.23e) 2 mol. % cat.
2 h, 80oC, 85%
S
C6H13
(1.23f) 10 mol. % cat.
20 h, 80oC, 75%
S
C5H11
(1.23i) 10 mol. % cat.
20 h, 80oC, 92%
S
(1.23g) 30 mol. % cat.




(1.23c) 10 mol. % cat.
4.5 h, 80oC, 65%
S
CO2Et
(1.23a) 5 mol. % cat.




(1.23d) 5 mol. % cat.






















Scheme 1.3: Ring Expansion of Vinylthiiranes 
 Garnering significant more attention is the ring expansion of vinyloxiranes 
(Scheme 1.4). The acid catalyzed expansion by Whitam in 1969 represents the first 
example and one of the highest yields reported.22 The results of Jeger23 are 
representative of Bronsted/Lewis acid catalyzed ring expansion of vinyloxiranes 
despite the use the photochemical conditions in this example. Low yield and no 
control of the stereochemistry is observed, but more limiting is the [1,2] hydride shift 
that is often the major product when a hydrogen is present adjacent to the vinyl group 
on the oxirane.24  These shortcomings were present until 2006 when Njardarson et. al. 
published a copper (II) bishexafluoroacetylacetonate catalyzed ring expansion of 
vinyloxiranes.25 Once again the metal catalyzed reaction was able to overcome known 




Scheme 1.4: Ring Expansion of Vinyloxiranes 
 The formal [1,3] rearrangement of a vinylaziridine to a 3-pyrroline was first 
observed by Rees and Scheiner independently in 1967 (Scheme 1.5).28,29 The 
rearrangement can be performed using thermal conditions when appropriate groups 
are present on the nitrogen of the aziridine or done in an SN2’ fashion with soft 
nucleophiles. In each case, severe limitations were observed with respect to functional 
group compatibility and the substitution patterns tolerated. A major advance was made 
by Oshima who found the process could be catalyzed by Pd0, but only for 
dienylaziridines.30 Also, the stereochemical outcome resulted in what appears to be a 
thermodynamic mixtures of products. This technology facilitated the synthesis of 
numerous pyrrolines, but a general method was still lacking.31 The typical reactivity 
that was known for vinylaziridines with carbonyl groups on the nitrogen was to 
undergo the Heine reaction to form an oxazolidine.32 Secondly, the thermolysis of aryl 
vinylaziridines is known to produce azepines by an amino-Claisen rearrangement. 
Lastly, divinylaziridines were shown to undergo strain assisted Cope rearrangements 
12 
also to azepines.33 These competing thermal reactions may limit the groups present on 
the nitrogen in the [1,3] rearrangement. We hope to achieve another milestone in the 
history of this process by facilitating the reaction with broad functional group 
compatibility, tolerance of various substitution patterns, and control of 
stereochemistry. 
12 References, 34 Examples (38-95%), (Avg. = 82%)



































































Scheme 1.5: Ring Expansion of Vinylaziridines 
1.3 Synthesis of Dihydrofurans, Dihydrothiophenes, and Dihydropyrroles 
 It is clear that the need for operationally simple, atom-efficient methods with 
as broad substrate scope as possible will always be great. It is important to emphasize 
that one type of chemical transformation can rarely provide universal access to all 
substrate permutations of a given class. Efforts should be devoted to developing a 
series of complementary practical synthetic methods that together can provide access 
to every member of a given substrate class. Such practical new synthetic methods can 
have a significant impact since a large number of research areas rely on building new 
molecular architecture either for fundamental or industrial applications 
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 Five membered heterocycles are essential building blocks that are frequently 
used in the pharmaceutical and commodity chemical industry. For example, more than 
65% of pharmaceuticals contain at least one heterocyclic fragment. Our group has 
dedicated substantial efforts to developing a useful synthetic approach that can afford 
access to a broad range of 2,5-dihydro- furan, thiophene, and pyrrole products. These 
products are very attractive building blocks en route to natural products, 
pharmaceuticals, materials, and commodity chemicals. The 3,4-unsaturation of these 
heterocycles is a particularly attractive feature as it enables straightforward access to 
reduced, oxidized, and further functionalized members of these three important 
structural families. Members of the furan family can be found in thousands of natural 
products, bulk commodity chemicals, and pharmaceutical agents.34 Thiophenes are 
used for a number of practical applications such as pharmaceuticals and materials.35 A 
significant number of marketed and approved drugs contain a pyrrolidine core, with 
the most commonly employed derivatives being proline or azabicyclics.36 The tropane 
core ([3.2.1]-azabicyclic), for example, is the structural backbone of many very 
successful therapeutics.37   
 The eight distinct 2,5-dihydro- furan, thiophene, and pyrrole retrosynthetic 
approaches are highlighted in Figure 1.3. In this discussion we have chosen not to 
cover any synthetic methods that form either fused aromatic products or those that are 
sp2-hybridized at either the 2- or 5-positions, which also excludes lactones, lactams, 
and such derivatives. Finally, the only methods discussed are considered “general” in 
that they allow access to all three heterocycle classes. Although this stipulation seems 
very restrictive only a few notable methods are not discussed. Each synthetic approach 
is discussed in the following sections. A brief outline is followed by reaction 
comments and literature examples highlighting their strengths. Whenever possible we 




























Figure 1.3:  Eight Retrosynthetic Approaches for 2,5-Dihydro- Furans, Thiophenes, 
and Pyrroles 
1.3.1 Ring Closing Metathesis 
 Metathesis reactions, and ring closing metathesis (RCM) in particular, have in 
the last fifteen years revolutionized how organic chemists design and assemble 
molecules.38 Not surprisingly this new synthetic approach was quickly applied to the 
construction of 2,5-dihydro- furan, thiophene, and pyrrole products (Scheme 1.6, 
1.48).  Early efforts utilized tungsten (1.49),39 ruthenium, and molybdenum catalysts, 
with Grubbs (1.50)40 and Schrock (1.51)41 catalysts being featured most prominently. 
In accessing simple heterocyclic products the primary challenges that were 
encountered were catalyst inhibition by sulfide42 and free amine substrates43 as well as 
unwanted olefin isomerization of dihydrofuran products.44 Many of these challenges 
have since been overcome. Second generation ruthenium catalysts such as 1.5245 and 
1.5346 have led the way because of their attractive air stability and functional group 
compatibility. For example, by utilizing suitably protected diallylamines, 3-pyrrolines 
can now be readily accessed.47 Diallyl sulfides are now manageable substrates48 
although challenges still exist and in many cases sulfones49 are used as substitutes. 
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The dihydrofuran olefin isomerization challenge has been addressed by using a 
benzoquinone additive.50 Tetrasubstituted and strained bicyclic substrates continue to 
be very challenging for ring closing metathesis, although recent new catalyst 
developments indicate that the tetrasubstituted products will soon be more 
accessible.51 From a retrosynthetic point of view, metathesis is less appealing for 2,5-
substituted substrates as synthesis of the requisite starting materials can be challenging 
at times. Additionally, the fact that a large amount of solvent is usually needed 
coupled with high catalyst cost, non-trivial catalyst removal, and toxicity challenges 
often make the scale-up less attractive.           
 
Scheme 1.6:  Synthesis of 2,5-Dihydro- Furans, Thiophenes, and Pyrroles Using 
Metathesis 
 This new synthetic approach has been utilized for natural product synthesis 
with great success (Scheme 1.7).  Most examples reported to date have employed this 
strategy to access 3-pyrrolines en route to a target natural product. Lack of dihydro- or 
tetrahydrothiophene containing natural products probably accounts for the fact that no 
such 2,5-dihydrothiophene examples exist. Aryl furan natural product 1.56 was easily 
assembled from benzylic allyl ether 1.54 using Grubbs first generation catalyst.52  
Blechert has taken advantage of ring closing metathesis to access azasugar 1.5953 and 
the natural product (-)-trans-dendrochrysine 1.6254 from trienes 1.57 and 1.60 
respectively. The second example is a particularly attractive application of this 




























































1.60 1.61  
Scheme 1.7:  Natural Product Total Synthesis Using Ring Closing Metathesis 
1.3.2 [3+2] Dipolar Cycloadditions 
 Dipolar cycloadditions are an important class of reactions within the field of 
organic chemistry.55 Prominently featured as a member of this class are [3+2] dipolar 
cycloadditions. Dipoles such as 1.67 (Scheme 1.8, X = O, S, N), when coupled with an 
alkyne (1.68) provide ready access to 2,5-dihydro- furan, thiophene, and pyrrole 
products (1.69).56 Although most reported examples are on generating and using 
azomethine ylides for constructing 2,5-dihydropyrroles. Generating the requisite 1,3-
dipole (1.67) is one of the main challenges for this approach. Summarized in Scheme 
1.8 are the three most commonly used strategies for generating the dipole. Thermal or 
Lewis acid catalyzed opening of oxiranes or aziridines (1.63) have been reported 
extensively.57  This approach is not very general and requires very specific 
functionalization to proceed favorably. Imines, carbonyl, and thiocarbonyl groups 
(1.64) can be converted in a single step to 1.67 upon treatment with the appropriate 
metalcarbene, which in most cases originates from a diazo precursor (1.65).58  This 
strategy is most commonly employed for carbonyl starting materials. The third 
approach, which relies on precursors such as 1.66 (Lg = leaving group) is the preferred 
method for accessing azomethine ylides. Another major challenge of this approach is 
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reactivity and regioselectivity. In most cases symmetrical activated alkynes such as 
acetylene dicarboxylates or diphenylacetylenes are needed. In general, this synthetic 
strategy is almost exclusively used to synthesize 2,5-dihydropyrroles, although 
intramolecular oxonium ylide variants have been popularized by Padwa and 
coworkers.59 If the above conditions are met functional group compatibility tends to be 
good.   
 
Scheme 1.8:  Synthesis of 2,5-Dihydro- Furans, Thiophenes, and Pyrroles Using [3+2] 
Cycloadditions 
 This synthetic approach has found its place in natural product synthesis, but as 
is evident from the three examples in Scheme 1.9 these cases have been primarily 
limited to alkaloid synthesis. The natural product retronecine has been assembled in 
two steps from a trisilylated pyrrolidine (1.70). The intermediate azomethine ylide was 
generated using silver fluoride and then trapped with methyl propiolate to form 
pyrrolizidine core 1.71.60 In an interesting approach, the core of carbapenam 
antibiotics (1.74) was assembled from oxazolidone 1.73.  The dipole was generated by 
thermolysis of 1.73, which released carbon dioxide and allowed trapping of the ylide 
with an alkyne.61 As part of a vigorous research program, which recently resulted in 
the approval of varenicline (Chantix®), researchers at Pfizer have used an azomethine 
ylide approach to rapidly assembly a novel cytisine inspired structure (cyfusine 1.78).  
Ynoate 1.75 and silyl aminal 1.76 were coupled under acidic conditions to form 1.77, 
which was then converted in four additional steps to cyfusine.62   
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Scheme 1.9:  Natural Product Total Synthesis Using [3+2] Cycloadditions 
1.3.3 Birch Reductions 
 The dissolving metal reduction (Birch reduction) of furans, pyrroles, and 
thiophenes is one of the earlier reported strategies for accessing the target building 
blocks (Scheme 1.10).63 Classically these dissolving metal reductions are performed in 
the presence of sodium or lithium in ammonia, although now lithium di-tert-
butylbiphenyl (DBB) or similar reagents are more likely to be used. Many of these 
aromatic compounds can also be reduced without using dissolving metals. In such 
cases, the reagents of choice are commonly zinc or sodium cyanoborohydride. The 
nature of substituents tends to be critical for success. For all practical purposes this 
otherwise attractive approach tends to be mostly limited to substrates having at least 
one electron withdrawing group in the 2- position of the aromatic ring. What is 
particularly attractive about this approach is that the in situ generated carbanion can be 
trapped with useful electrophiles. This reductive strategy can be accomplished 
asymmetrically using either a chiral proton source or chiral auxiliary. When these 
promising asymmetric solutions are coupled with an in situ alkylation it seems clear 
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that this strategy can hold its own against other methods for a range of useful 
substrates.   
 
Scheme 1.10:  Birch Reduction of Aromatic Building Blocks 
 Donohoe and coworkers have led the way in this area for some time now, 
which is reflected by the fact that all the examples detailed in Scheme 1.11 are the 
work of his research group. Showcasing the strengths of this strategy, Donohoe has 
demonstrated that symmetrical pyrrole substrates (1.81) can be reduced to either the 
2,5-cis (1.82) or 2,5-trans (1.83) products by using the appropriate reducing agent and 
proton source.64 The trans-pyrroline (1.83) has been advanced to the natural product 
epi-australine.65 In his synthetic approach towards the lactacystin -lactone the 
intermediate anion generated during the reduction process is coupled in situ with 
isobutyraldehyde to afford 1.86 as a single diastereomer.66 In his synthetic approach 
towards the natural product nemorensic acid Donohoe uses a C2-symmetrical 
pyrrolidine chiral auxiliary (1.88) to very effectively (30:1 dr) control the methylation 
of the anion generated during the Birch reduction.67 Intermediate 1.89 was then 
advanced to the natural product in seven additional steps. Although these are all very 
impressive applications of this synthetic strategy they also very clearly highlight the 
fact that this approach is not yet very practical for aromatic precursors lacking an 




Scheme 1.11:  Natural Product Total Synthesis Using Birch Reductions 
1.3.4 Vinyl- Oxirane, Thiirane, and Aziridine Rearrangements 
 Our research group has recently demonstrated that a wide range of vinyl- 
oxirane,68 thiirane69 and aziridine70 substrates (Scheme 1.12, 1.91) can be rearranged 
efficiently to the corresponding 2,5-dihydro- furan, thiophene, and pyrroline products 
(1.92) by using copper(II) hexafluoroacetylacetonate as a catalyst. Prior to our work in 
this area there were scattered reports of success for a narrow range of vinyl- oxirane 
and aziridine substrates, but there were no reports of a vinyl thiirane rearrangement. 
For example, it has been known since the 1960’s that certain simple vinyl aziridines 
can be rearranged thermally71 under very forcing conditions and in the 1980’s Oshima 
showed that triene monoaziridines can be rearranged in the presence of a palladium 
catalyst,72 while simple vinyl aziridines did not. Acid catalyzed vinyl oxirane 
rearrangements have been known for a long time. Most of these examples are rigged 
for success in that the detrimental competing hydride shift cannot occur. Our copper 
catalyzed rearrangement is the optimal approach for all substrate categories and again 
the only approach that can be applied to vinyl thiiranes. 
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Scheme 1.12:  Rearrangement of Vinyl- Oxiranes, Thiiranes, and Aziridines 
 This powerful synthetic strategy has also found its place in the field of natural 
product total synthesis (Scheme 1.13). Our group has recently completed the total 
synthesis of goniothalesdiol by stereoselectively rearranging vinyl oxirane 1.93 to 2,5-
dihydrofuran 1.94, which could be converted to the natural product in four additional 
steps.73 Sarpong and coworkers used trifluoroacetic acid to ring expand 1.96 to 
oxabicyclic product 1.97 in their synthetic approach towards salviasperanol.74 Yields 
are high for this substrate since the competing hydride shift is not possible. Majetich 
used the same conditions for a similar substrate in his approach towards 
salviasperanol.75 We showcased our novel copper catalyzed vinyl thiirane 
rearrangement by converting 1.99 to 2,5-dihydrothiophene 1.100 en route to a formal 
synthesis of biotin.36 Somfai has shown that vinyl aziridine 1.102 can be rearranged 
under microwave conditions to pyrroline 1.103 in the presence of lithium iodide.76  He 
then advanced this product to an intermediate in Hall’s total synthesis of anisomycin.77   
 
Scheme 1.13:  Natural Product Total Synthesis Using Vinyl- Oxiranes, Thiiranes, and 
Aziridines 
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1.3.5 [4+2] and [4+3] Cycloadditions 
 Although [4+2] and [4+3] cycloadditions of furans, thiophenes and pyrroles 
provide access to a very narrow spectrum of 2,5-dihydro- furan, thiophene, and 
pyrrole products, we have included these two cycloaddition approaches in our survey 
because the resulting oxa-, aza, and thiabicyclic products are hard to access using 
other methods (Scheme 1.14). These two approaches do not work very well for 
thiophenes,78 although this limitation can be partly remedied by using sulfone 
derivatives.79 The Diels-Alder reaction of furans and pyrroles require in most cases 
very active dienophiles for the reaction to succeed.80 The oxyallyl cations classically 
used for [4+3] cycloadditions can be generated in many different ways, but originate 
in most cases from halo ketones or similary activated ketone precursors.81 These halo 
ketones are converted to the oxyallyl cation by treatment with zinc metal. This 
approach is in most cases limited to simple substitution patterns and many functional 

















Scheme 1.14:  [4+2] and [4+3] Cycloadditions of Furans, Thiophenes, and Pyrroles 
 These cycloadditions have been used for the total synthesis of a number of 
natural products (Scheme 1.15). Epibatidine has served as a favored playground for 
evaluating different synthetic methods and strategies. Azabicyclic product 1.112 was 
nicely assembled by fusing chiral allene 1.111 to pyrrole 1.110 in the presence of 
aluminum trichloride.82 This intermediate was then advanced to a known ketone that 
had previously been converted to epibatidine by Trudell and coworkers.83 Kishi 
employed furan 1.114 as a dienophile in an intramolecular Diels-Alder reaction with 
an in situ generated methacrolein moiety. The resulting product (1.115) was then 
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eventually converted to batrachotoxinin A.84  The anti-cancer agent pervilleine C was 
recently synthesized. Its tropane core (1.119) was constructed by coupling pyrrole 
1.117 with tetrabromoketone 1.118 and the resulting cycloadduct was debrominated.85 
By reacting the oxyallyl cation generated from 1.122 with furan 1.121 the natural 
product imerubrine was efficiently assembled. The oxabicyclic cycloadduct (1.123) 
was then converted in a single step to the natural product.86 
 
Scheme 1.15:  Natural Product Total Synthesis Using [4+2] and [4+3] Cycloadditions 
1.3.6 Vinyl Phosphonium Cascade 
 In the 1960’s Schweizer demonstrated that various nucleophiles, including 
R2NH, RSH, ROH, and R2PH could be added to vinyl phosphonium salts (1.126, 
Scheme 1.16). When a carbonyl (1.125) was tethered to these nucleophiles the ylide 
generated in situ underwent a Wittig olefination, thus allowing ready access to all 
three heterocycle families (1.128) in a single operation.87 This is an attractive two 
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component coupling reaction using readily available starting materials. When amines 
and alcohols are used as nucleophiles the vinylphosphonium salt is often activated by 
an additional stabilizing group such as arylsulfones and arylsulfoxides to ensure a 
successful Michael addition step. This coupling strategy suffers when the vinyl 
phophonium salt is substituted in the -postion, although thiols are in most cases 
sufficiently nucleophilic to be successful. The phosphonium salt in certain situations 
can be replaced by the phosphoryl ester with comparable results. Amine nucleophiles, 
in order to be competent, must be electron deficient such as amides or sulfonamides. 
This method is one of the better methods discussed to construct 2,5-
dihydrothiophenes.   
 
Scheme 1.16:  Vinyl Phosphonium Cascade 
 This exciting synthetic approach has also found its place in natural product 
synthesis (Scheme 1.17). Hewson nicely demonstrated that the pyrrolizidine alkaloid 
supinidine can be rapidly assembled in two steps from lactam 1.129.88  
Dihydrothiophenes 1.135 and 1.138 were both accessed in a single step from 1,4-
dithiane-2,5-diol (1.133) upon treatment with vinyl phosphonates 1.134 and 1.137 
respectively. Enone 1.135 was advanced to elaeokanine A89 while enoate 1.138 was 
further functionalized to isopenicillin analogue 1.139.90 
25 
 
Scheme 1.17:  Natural Product Total Synthesis Using a Vinyl Phosphonium Cascades 
1.3.7 Nucleophilic Displacements 
 One of the oldest approaches to 2,5-dihydrofurans, thiophenes, and pyrroles is 
a simple nucleophilic displacement using either an internal or external nucleophile 
(Scheme 1.18). By using an appropriately functionalized Z-olefin with two leaving 
groups (Y and Z, 1.140) a sulfur or nitrogen based nucleophile (X, 1.141) can be used 
to form the product (1.142) directly. In practice, this method is rarely used and those 
few literature examples are mostly limited to the unsubstituted case. More commonly 
Y or Z is the desired heteroatom and the other is the leaving group such as a halide, 
sulfonate ester, or a hydroxy group. What makes this synthetic approach most 
unattractive is the need for a multistep route for constructing a highly functionalized 
Z-olefin (1.140). Once precursors like 1.140 are accessed the cyclization tends to 
occur without problems.   
 
Scheme 1.18:  Nucleophilic Displacements 
 Three natural product examples utilizing this strategy are presented in Scheme 
1.19. Swainsonine’s fused bicyclic core was completed by in situ activation and 
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cyclization of allylic alcohol 1.143 to 1.144.91 Substrate controlled dihydroxylation 
and protecting group manipulations then afforded the natural product. A similar core 
(1.147) was stitched together by cyclizing a lithiolactam onto an allylic sulfonate ester 
(1.146). White and coworkers then advanced this intermediate to the bridged bicyclic 
alkaloid (+)-loline.92 In his approach towards the guanacastepene family of natural 
products, Sorensen cyclized a triene triol (1.149) to a fused 2,5-dihydrofuran (1.150).93    
 
Scheme 1.19:  Natural Product Total Synthesis Using Nucleophilic Displacements 
1.3.8 Allene Cyclizations 
 The cyclization of an allenic alcohol (1.152, Scheme 1.20) to a 2,5-
dihydrofuran (1.153) in the presence of either a base94 or mercury salts95 was first 
reported forty years ago. In 1979 Claesson demonstrated that pyrrolines could be 
accessed similarly upon treatment with Ag(I) catalysts.96 In the late 1980’s Liebeskind 
and coworkers reported that palladium catalyzed this cyclization and that the resulting 
vinyl palladate could be cross-coupled in situ with an olefin (Y = vinyl).97 Since then a 
number of halide, selenium, and sulfur electrophiles have also been shown to aid this 
cyclization while at the same time incorporating a functional handle (Y = Cl, Br, I, 
PhS, PhSe).98 This powerful transformation has been revisited in the last eight years as 
part of what could only be described as a gold99 and silver100 catalyst rush. For 
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example, Krause has shown Au(I) and Au(III) catalysts to be ideally suited for 2,5-
dihydrothiophene formation.101 These efforts have greatly expanded the scope of this 
transformation, which in our minds firmly ranks as one of the best current methods to 
access 2,5-dihydro- furans, thiophenes, and pyrroles.   
 
Scheme 1.20:  Cyclizations of Allenic Alcohols, Amines, and Thiols 
 The allene precious metal rush has not surprisingly found its way to natural 
product total synthesis. Shown in Scheme 1.21 are three nice applications of this 
useful cyclization approach. Krause has used a gold(III) catalyst to cyclize allene 
1.154 in high yield and stereoselectivity to dihydrofuran 1.155 en route to the natural 
product (-)-isochrysotricine.102 Fürstner and colleagues have used the classic silver 
nitrate cyclization conditions to advance allenic alcohol 1.157 to dihydrofuran 1.158.  
This key intermediate was then utilized to complete the first total synthesis of 
amphidinolide X.103 Although 1.162 has not been converted to FR 901493, Reissig has 
showcased an efficient cyclization of amino allene 1.160 to pyrrolidine 1.161 that 
could then be converted in five additional steps to 1.162.104 
 
Scheme 1.21:  Total Synthesis of Natural Products Using Allene Cyclizations 
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1.3.9 Conclusions 
 For a chemist planning to use any of these methods in a synthesis, perhaps one 
of the best ways to summarize the strengths and weaknesses of the eight synthetic 
approaches discussed in this section is to graphically tabulate this information. We 
have chosen the five product classes shown in Table 1.5 as indicators of the 
effectiveness of these methods. Our ranking system uses (++), (+), and (–) as grades of 
a very good, fair, and no match of the reaction of interest for a given substrate class.  
This graphic presentation also serves very well to highlight the need for further 
improving existing methods and to develop new approaches. For many of these 
substrate classes there are no good choices. For example, when one considers the 
bridged bicyclic substrate class there are not many choices. We are particularly proud 
of the fact that our contributions to this area, the copper catalyzed rearrangement of 
vinyl- oxiranes, thiiranes and aziridines allows access to all five product classes. It is 
important to note that this table does not factor in the difficulty of preparing the 
synthetic precursors or factors such as cost, toxicity, scaleability, or solvent use. 
Inclusion of these factors would be quite complex and would undoubtedly further 
highlight just how much need there is for better methods.   
Table 1.5:  Comparison of the Eight Synthetic Approaches 
Synthetic 
Approaches   
X
n   X
EWG  
Ring Closing Metathesis (RCM) 
++ ++ - - + 
[3+2] Cycloaddition - + - + ++ 
Birch Reduction - + - - ++ 
[1,3]-Rearrangement ++ + + ++ + 
[4+2]/[4+3] Cycloadditions 
- - ++ - - 
Vinylphosphine Cyclization Cascade 
+ - - + + 
Nucleophilic Substitution + - - + + 
Allene Cyclization + + - + + 
(++) = very good, (+) = fair, (–) = no match 
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1.4 Copper (II) bishexafluoroacetylacetone 
 Copper has been a popular metal for a number of metal catalyzed reactions in 
both the +1 and +2 oxidation states.105 For example the copper catalyzed conjugate 
addition of Grignard reagents, Huisgen alkyne-azide cycloaddition, decomposition of 
diazo-alkanes, Sonogashira cross-coupling, and the activation of aryl halides are some 
of the most popular.106 Copper (II) bis-hexalfuoroacetylacetonate is a commercially 
available compound that contains an electrophilic metal center. The crystal structure 
of anhydrous Cu(hfacac)2 (Figure 1.4) reveals that it is a square planar complex with a 
great affinity for donor ligands as exemplified by close intermolecular interaction with 
fluorine on another ligand.107 However, it is usually sold as a hydrate (5g for $41 from 
Aldrich), with the mono-hydrate existing as a square pyramidal complex with an 
apical water molecule.  
 
Figure 1.4: Crystal Structure of anhydrous Cu(hfacac)2 
 It has been known for a long time that Cu(hfacac)2 binds a second nitrogenous 
ligand with great ease, where most other copper (II) centers will not.108 Upon 
treatment with excess of such ligands usually trans- or cis-octahedral Cu(hfacac)2L2 
complexes are formed.  The ligand-complex outcome is dependent on the nature of the 
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added ligand. Pyridine and chelating diamines prefer to form cis-octahedral 
complexes,109 while pyrazine prefers to form an oligomeric network of trans-
octrahedral units.110 Interestingly, when ammonia or t-butyl amine are mixed with 
Cu(hfacac)2 a trigonal bipyramidal complex is formed with the amine ligand at the 
basal position.111 When 2-ethynyl pyridine is used it acts as a bidentate ligand with a 
slightly distorted trigonal bipyramidal complex with the nitrogen occupying the apical 
site thus bringing the alkyne substitutent in close proximity to the metal center.112 
Although there are no crystal structures of copper(II) olefin complexes they can be 
observed using a number of spectroscopic techniques.113 With the knowledge 
presented in this paragraph we can expect that addition of a vinyloxirane, 
vinylazridine, or vinylthiirane to exist in a complex equilibrium. Scheme 1.22 shows 
the possible geometries that the Cu (II) catalyst may adopt in the presence of these. 
 
Scheme 1.22: Structurally Relevant Substrate-Catalyst Complex Scenarios for 
Cu(hfacac)2 
 Despite the intensive study of the structure and reactivity of Cu(hfacac)2 it has 
not been used as a catalyst extensively. Shown in Scheme 1.23 are the two modes of 
catalysis known for Cu(hfacac)2 prior to investigation by the Njardarson group. 
Alonso first discovered that Cu(hfacac)2 was effective at decomposing stabilized diazo 
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compounds to the metal associated carbenoid intermediate.114 These carbenoids have 
subsequently been shown to undergo cyclopropanations, insertions into X-H bonds (X 
= C, N, O, S), and 1,3-dipolar cycloadditions. A second catalytic mode of reactivity 
was discovered by Yamada where a dehydrogenative coupling of alcohols and 
phenylsilane was observed.115 The primary use of Cu(hfacac)2 has been for chemical 
vapor deposition of metallic copper.116  
 
Scheme 1.23:  Known Reactions Catalyzed by Cu(hfacac)2 
 As mentioned above Cu(hfacac)2 readily binds additional ligands and several 
methods have been used to measure the binding constants and enthalpy associated 
with these interactions. Table 1.6 displays the results of several Lewis bases binding to 
Cu(hfacac)2 which may be relevant to the subsequent chapters of this thesis. We 
observe that increased fluorination of the ligands on copper increases the equilibrium 
constant with only a modest enthalpy effect. We observe that Cu(hfacac)2 is unique in 
its ability to bind a second base (entry d) and the ability to bind very week donor 
groups like olefins (entry e). Hard nucleophiles (entry g) are preferred to soft 







Table 1.6: Binding of Lewis Bases to Copper (II) Acetylacetonate Complexes





a117 Cu(acac)2 Benzene 4.7 6.5 
b117 Cu(tfacac)2 Benzene 701 7.4 
c117 Cu(hfacac)2 Benzene >105 9.1 
d117 Cu(hfacac)2.py  Benzene 780 9.4 
e118 Cu(hfacac)2 
 
Chloroform 1.2 ND 
f119 Cu(hfacac)2 
 
o-Dichlorobenzene 99 4.6 
g119 Cu(hfacac)2 
 
o-Dichlorobenzene 3500 7.2 
h119 Cu(hfacac)2 
 
CCl4 >107 15.5 
i119 Cu(hfacac)2 EtOAc CCl4 190 5.9 
j119 Cu(hfacac)2 P(OEt)3 o-Dichlorobenzene 420 5.5 
k117 Cu(hfacac)2 
 
Benzene ND 19.1 
ND = Not Determined, Cu(acac)2 = Copper (II) bisacetylacetonate, Cu(tfacac)2 = Copper (II)  
bistrifluoroacetylacetonate, Cu(hfacac)2 = Copper (II) bishexafluoroacetylacetonate, Py =  
Pyridine 
 
 Based on these structural and reactivity characteristics, Cu(hfacac)2 seems 
ideally suited for the ring expansion of vinyloxiranes, aziridines, and thiiranes. By 
investigating and developing this method, heterocycles containing oxygen, nitrogen, 
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Chapter 2   
 
Lewis Acid Catalyzed [1,3]-
















2.1 Background and Significance 
 3-Pyrrolines (2,5-dihydropyrroles), while important in their own right, are 
versatile intermediates for the synthesis of pyrrolidines and pyrroles.1 Collectively 
these ring systems occur in countless natural products and pharmaceuticals.2 Not 
surprisingly, several different synthetic approaches toward pyrrolines have been 
developed, the most popular of which are Birch reduction of pyrroles,3 [3+2] 
cyclization,4 and ring closing metathesis.5 Despite these and other creative approaches, 
a need exists for a simple and selective method which allows access to structurally 
complex 3-pyrrolines. Herein, we demonstrate that vinyl aziridines can be efficiently 
converted to 3-pyrrolines using commercially available copper(II) catalysts. 
 
Scheme 2.1:  General Scheme for 3-Pyrroline Synthesis 
 Analogous to the vinylcyclopropane rearrangement,6 the thermolysis of vinyl 
aziridines to 3-pyrrolines was first observed in the late 1960’s.7 Harsh thermal 
conditions were employed and little substrate scope was observed. Since these initial 
experiments, several attempts have been made to investigate the reaction further, but 
limitations such as competing side reactions and the necessity of additional 
functionality were found.8 Therefore, applications of this rearrangement to the 
synthesis of complex molecules have been lacking.9,10 Clearly, there is a need to 
develop conditions that expand the scope of the rearrangement and allow functional 
group compatibility.  
 Vinyl aziridines are most easily synthesized by one of three methods: the 
addition of a nitrene to a diene, the addition of an allylic ylide to an imine, or the 
47 
cyclization of unsaturated amino alcohols.11 Each method has limitations often directly 
related to the nitrogen protecting group. Our efforts focus on the p-toluenesulfonyl 
(Ts) and phthalimido (PhthN) protecting groups. Tosyl aziridines are easily accessed 
by employing an aziridination protocol developed by Sharpless12 or by catalytic 
decomposition of N-phenyliodinanes.13 Although phthalimide substituted aziridines 
are less commonly used, they offer an attractive option based on their ease of synthesis 
utilizing a stabilized singlet nitrene and broader substrate scope.14  
2.2 Results and Discussion 
 Vinyl aziridine 2.1 was chosen as a model substrate due to the growing interest 
in dehydroprolines.15 Based on previous work by our group on the catalytic ring 
expansion of vinyl oxiranes and vinyl thiiranes,16 copper catalysts were tested (Table 
2.1). The more electrophilic copper(II) hexafluoroacetylacetonate (entries 14-18) 
proved far superior to other commercially available and synthetic catalysts. 
Interestingly, the reaction proceeds faster and with a higher yield when the 
Cu(hfacac)2 hydrate is dried prior to use. Optimized reaction conditions were found to 





















entry catalyst time (h) yielda 
1 none 16 0%b 
2 CuI 16 0% 
3 Cu[(S,S)-Ph-box]Cl2 16 0% 
4 Cu[(S,S)-Ph-box]OTf2 16 0% 
5 Cu(acac)2 16 0% 
6 Cu(tfacac)2 16 0% 
7 Cu(dbm)2 16 10% 
8 Cu(ptfm)2 16 0% 
9 Cu(accy)2 16 35% 
10 Cu(tfaccy)2 16 20%. 
11 Cu(fod)2 16 0% 
12 Cu(3-[NO2]acac)2 16 0% 
13 Cu(3-[CO2Et]acac)2 16 20% 
14 Cu(hfacac)2. H2O 11 70% 
15 Cu(hfacac)2 (dry) 7.5 99% 
16 Cu(hfacac)2 (dry) 1c 99% 
17 Cu(hfacac)2 (dry) 22d 99% 
18 Cu(hfacac)2 (dry) 36e 99% 
Conditions: 5 mol % catalyst, toluene, 150 °C, 0.1 M. a NMR Yield. b Decomposes at 170 °C. c 5 M. d 1 mol %. e 130 °C. { hf = 
hexafluoro, acac = acetylacetonate, (S,S)-Ph-box = (S,S)-2,2'-Isopropylidene-bis(4-phenyl-2-oxazoline), tf = trifluoro, dbm = 
dibenzoylmethanate, ptfm = 1,3-bis[4-(trifluoromethyl)phenyl]-1,3-propanedionate, accy = 2-acetylcyclohexanone, fod = 
heptafluorobutanoyl)pivaloylmethanate, 3-[NO2]acac = 3-nitroacetylacetonate, 3-[CO2Et]acac = ethyl diacetoacetate} 
 Table 2.2 displays the results of applying these optimized conditions to a 
variety of phthalimide and tosyl protected vinyl aziridines. These products can be 
readily deprotected to give the N-H pyrrolines.17 Simple substrates (entries a-k) 
demonstrate that all substitution patterns are well tolerated resulting in excellent 
yields. Entries d, e, and h display an important synthetic aspect of this rearrangement, 
as each 3-pyrroline can originate from two regioisomeric vinyl aziridine precursors or 
even from their mixture. Some of the simple substrates can rearrange thermally at 
more extreme temperatures, but often at dramatically diminished yield. However, the 




Table 2.2: 3-Pyrroline Synthesis 
Entry Substrate (2.3) Product (2.4) R T (oC) Time  (h) yield 
a Ts 100 5.5 92% 
b   PhthN 100 2 92% 
c Ts 100 1 99% 
d  PhthN 100 2 92% 
e 
 
 PhthN 100 3 96% 
f Ts 100 1 98% 
g   
PhthN 100 0.3 93% 
h 
  





Ts 150 12 80% 
ji Ts 150 7.5 98% 
kg   PhthN 150 0.8
 67%k 
l RN
OTBS   
Ts 100 5 97% 
mg 
  
Ts 120 20 60% 
n 
  
Ts 120 6 95%f 
o Ts 150 20 75%c 
p RN   
PhthN 150 16 93%d,e 
q 
  
PhthN 150 12 94%d 
ra 
  
PhthN 150 21 53% 
sh 
  




PhthN 150 2 56% 
u 
 
Ts 150 1 78% 
v 
 
 Ts 150 1.5 94% 
wa 
  





Ts 150 16 90%
 
(4:1 d.r.) 
Conditions: 5 mol % dry Cu(hfacac)2, 0.1 M in Benzene (100oC) or Toluene (120oC and 150oC). a Racemic. b Isolated yields. c 
Cu(hfacac)2.H2O does not work. d 0.2 M. e 20 mol % Cu(hfacac)2. f Thermal component to reaction.  g Byproducts derived from the 
formation of azomethine ylides are observed in these reactions. h Pyrroles are formed from the retro Diels-Alder reaction in these 
reactions. i Unfortunately when compound 2.1 was synthesized asymmetrically, chirality was not transferred to the product as 
assessed by transesterification with a chiral alcohol. The product 2.2 was found not to epimerize under the given reaction 
conditions. 
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 The copper catalyzed rearrangement has been shown to be quite functional 
group tolerant. These groups include enol ethers, esters, protected alcohols, 
sulfonamides, and imides. This compatibility is important because some of these 
functional groups likely coordinate to the electrophilic copper center and yet do not 
prevent the reaction from occurring. Next, fused and bridged bicyclic compounds 
(entries n-w) can be rearranged to create complex ring systems. With respect to 
protecting groups, we observe that in general the more electron-rich phthalimide 
aziridines rearrange faster than the corresponding tosyl protected aziridines.  Product 
yields vary between protecting groups, but only phthalimide aziridines are competent 
for very strained systems (entries q-t). Entries w and x are particularly noteworthy, 
since they establish the potential for diastereoselective rearrangements. Lastly, the 
diastereomer of the substrate in entry r and the Z-isomer of the substrate in entry j do 
not rearrange under a variety of conditions tested. These substrates display the 
importance of the conformation and sterics of the vinylaziridine when it is bound to 
the catalyst. 
 Investigation into this reaction has revealed that the rearrangement is copper 
specific and with a few exceptions distinct to copper(II) acetylacetone ligands. 
Determination of the mechanism has proved elusive, but the synthesis of two new 
catalysts has probed what the active copper species might be. Substrate 2.3c was 
chosen as a model system for investigation and the results are shown in Figure 2.1. 
The reaction was conducted in sealed NMR tubes under the standard reaction 
conditions except CDCl3 was used as the solvent. Plotting the reaction progress with 
Cu(hfacac)2 (2.5) reveals a characteristic sigmoidal shape suggesting an autocatalytic 
process. When the catalyst loading is changed a dramatic effect on the rate is 
observed. When a mixed acac catalyst is used, Cu(dbm)(hfacac) (2.6)18, a slightly 
slower reaction is observed with a similar profile. Careful analysis of the slope of the 
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line suggests the maximum rate of the reaction is higher than that of Cu(hfacac)2. This 
suggests that a more active catalyst species is produced during the course of the 
reaction. The reaction profile of Cu(hfacac)(TMEDA)Br (2.7)19 is completely different 
with little to no induction period or autocatalytic behavior. This suggests that the 
catalyst is already in its most active form unlike Cu(hfacac)2. This catalyst is inferior 
likely due to a less electrophilic copper(II) center. The mixed complexes, 2.6 and 2.7, 
are peculiar since no other catalysts have even approached the effectiveness of 
Cu(hfacac)2 as demonstrated in Table 2.1. Finally, similar kinetic experiments were 
performed in benzene and those experiments confirmed the same behavior; however 

















































Figure 2.1: Kinetics plot of 2-Methyl-N-Tosyl-2-Vinylaziridine 
 Using all results obtained during this investigation we have produced a 
catalytic cycle shown in Scheme 2.2. We propose that substrate (2.8) binds in the axial 
site of Cu(hfacac)2 to form complex 2.9. The substrate induces disproportionation of 
the Cu(hfacac)2 to form cationic copper(II) complex 2.10 and anionic copper(II) 
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complex X-, which serves as a counterion for the active cationic complex. This in situ 
generated cationic copper(II) catalyst through a Lewis acid activation weakens the C-
N bond of the aziridine. During the ring expansion, it is possible that the copper center 
may chelate to the nearby olefin producing the transition state 2.11. We believe that an 
ordered transition state, without complete heterolysis or homolysis of the C-N bond, is 
necessary to account for the diastereoselectivity observed in the rearrangement of 
substrates 2.3w and 2.3x. The rearrangement produces complex 2.12, which then 
undergoes an associative interchange with more substrate to reform complex 2.10. 
Complexes 2.10 and 2.12 constitute the autocatalytic cycle that we propose is in good 
agreement with the observed kinetics presented in Figure 2.1. Complexes 2.10 and 
2.12 cannot be observed during the course of the reaction because of the paramagnetic 































































Scheme 2.2: Proposed Catalytic Cycle 
 This proposed mechanism accounts for a number of other experimental 
observations not yet mentioned. First, product 2.13 was found to inhibit the reaction 
dramatically. Second, X- was found to not be catalytically competent when 
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synthesized independently.20 Also, reactions with cationic copper(II) complex 2.7 do 
not possess an induction period because it mimics the structure of 2.10 which is the 
active catalyst. Next, copper(II) species are observable (UV-Vis. Spectroscopy, NMR) 
throughout the reaction, but no copper(I) intermediates could be detected nor were 
copper(I) catalysts competent in the rearrangement. Finally, using Singleton’s 
method21 we have obtained preliminary kinetic isotope results for two different vinyl 
aziridine substrates. These studies show significant heavy atom isotope effects at all 
three carbon centers involved in the rearrangement suggesting the reaction is 
concerted in nature.   
 In summary, we have demonstrated that 3-pyrrolines can be readily prepared 
from vinyl aziridines using commercially available copper(II) catalysts. The scope of 
this new catalytic rearrangement is very broad, providing access to a greater range of 
diverse products than other currently available 3-pyrroline forming methods.  
Mechanistic analysis revealed unique autocatalytic behavior and can be summarized 
as a Lewis Acid catalyzed [1,3]-sigmatropic rearrangement. New catalysts were 
synthesized based on these mechanistic insights. These catalysts approach the 
effectiveness of Cu(hfacac)2, but allow more options for electronic tuning and 
induction of asymmetry. Further studies on the mechanism and scope of this ring 
expansion are currently underway. 
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Chapter 3   
 
Novel Asymmetric Synthesis of 












3.1 Background and Significance 
 The pharmaceutical industry is undoubtedly the most important beneficiary of 
new synthetic methods. With a cursory review of the structural motifs of the top 200 
selling drugs1 it becomes quickly apparent that around 90% contain at least one 
nitrogen atom and approximately 65% are decorated with a heterocycle. Not 
surprisingly, the majority of these heterocycles are nitrogenous. In recent years the 
demand for practical asymmetric methods has increased dramatically2 following 
regulatory agencies’ call for enantiomerically pure drug candidates. Given the above 
cited structural preferences it is evident that the need for useful new methods that 
provide access to chiral nitrogen containing heterocycles is significant.   
 Chiral pyrrolidines are one of the most commonly used nitrogen containing 
heterocyclic pharmacophores (Scheme 3.1). The proline like features of a significant 
number of these motifs suggests that nature continues to serve well as a starting design 
template for privileged structural classes. Given the great success of chiral 
pyrrolidines as important pharmaceutical building blocks it follows that a range of 
practical methods3 are needed in order to provide ready access to any targeted 































































Scheme 3.1:  Examples of Pyrrolidine Containing Pharmaceuticals 
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 We recently reported the first catalytic ring expansion of unactivated vinyl 
aziridines (3.11, Scheme 2.2) to 3-pyrrolines (3.12). 4  The substrate scope of this new 
transformation was shown to be quite broad for a range of tosyl and phthalimide 
protected vinyl aziridines,. In planning for evaluating the potential of this new method 
for accessing appropriately protected chiral vinyl aziridines5 the union of an imine and 
suitably activated nucleophile seemed to be the optimal approach. The benefits of this 
net [2+1] disconnection include a convergent route, easy introduction of nitrogen 
protecting groups for evaluation, and most importantly the flexibility of either 
employing a chiral catalyst or a chiral auxiliary based approach. This retrosynthetic 
analysis is highlighted for chiral pyrrolidine 3.13, which we envisioned would 
originate from the copper catalyzed ring expansion of a trans- or cis-vinyl aziridine 
(3.14 and 3.15). These isomeric vinyl aziridines could be accessed from imines 3.17 
and 3.18 and nucleophiles 3.16 and 3.19 in which case either coupling partner could 
serve as the chiral auxiliary. Our analysis further concluded that chiral sulfonium 
species seemed most suitable for the task of serving as a chiral nucleophile (3.16), 
while chiral sulfinamides would best serve the role of a chiral electrohpile (3.18). The 
constitutional aziridine isomers of aziridines 3.14 and 3.15 are also viable precursors.  
These are less attractive from a synthetic perspective as their assembly doesn’t rely on 
using components of similar complexity and their ring expansion would need to be 
perfectly stereoselective. 
 
Scheme 3.2: Retrosynthetic Analysis for Chiral Pyrrolidines 
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3.2 Results and Discussion 
 Before starting to assemble the requisite chiral aziridines needed for our 
studies, we felt it was of critical importance to learn if other nitrogen protecting groups 
beyond Ts and NPhth were compatible where a suitable match for this new reaction. A 
priori, we realized that aryl and acyl groups would be particularly challenging, given 
their known tendency to undergo Claisen rearrangements6 or intramolecular 
displacement reactions.7  Our studies revealed that alkyl, aryl, and amide nitrogen 
protecting groups were incompatible with the reaction conditions and did not afford 
any 3-pyrroline products (Table 3.1). Interestingly, Boc protected aziridine (entry e) 
did ring expand to the desired 3-pyrroline with no detectable amounts of other 
heterocycles. When these results are evaluated in the context of our retrosynthetic 
goals for constructing chiral vinyl aziridine substrates and available reliable 
asymmetric aziridine methods it became evident that sulfonamides would best serve 
our cause. We therefore focused our efforts on evaluating a range of useful 
sulfonamide protecting groups (entries g-h) that would provide users of this 
methodology with choices that would best fit their synthetic task. We were delighted 
to learn that Ns and Bus sulfonamide groups, in addition to p-toluenesulfonamide 
(entry a), were compatible with the ring expansion conditions. Curiously, t-butyl 
sulfinamide protected aziridine (3.20f) failed and instead of affording 3-pyrroline 






Table 3.1: Ring Expansion – Nitrogen Substituent Tolerance 
 
entry Abbreviation P Time (h)Yield of 3.21 Other Products 
a Ts p-toluenesulfonyl 5 92% - 
ba NPhth phthalimideb 2 97% - 
ca Ph phenyl 2 0%c Mixture8 
da Bna benzyl 2 0% (Z)-N-benzylidene-1-phenylbut-2-en-1-amine isolated (86%)9 
e Boc tert-butoxycarbonyl 5 60% - 
f S(O)tBu tert-butylsulfinyl 1 0% (E)-buta-1,3-dien-1-ylbenzene (69%) 
g Bus tert-butylsulfonyl 5 86% - 
h Ns p-nitrobenzenesulfonyl 5 94% - 
i H - 2 0% Polymer 
j Bz benzoyl 5 0% Heine Reaction Products (50%)10 
Conditions: 5% Cu(hfacac)2,150°C a) racemic, b) syn/anti mixture of rotamers. 
 The remarkable success of proline derivatives as organocatalysts, 11 
pharmaceuticals (Scheme 3.1), and natural products12 ensures its status as a privileged 
structural motif. Chiral proline derivatives commonly originate from natural 3-
hydroxy proline. This neglected family of chiral proline products seemed like a perfect 
application of our new methodology. Retrosynthetic analysis for 3.25 (Scheme 3.3) 
reveals that an optimal chiral vinyl aziridine ring expansion substrate (3.24) could 
originate from either a Darzens reaction13 between a bromo acetate (3.22) and a chiral 
conjugated Ellman14 imine (3.23) or alternatively from allyl sulfonium addition to a 
chiral glyoxalate imine.15 With many bromoacetates commercially available, imine 
3.13 being more stable than its glyoxolate counterpart, and an operationally more 
simple reaction the Darzens disconnection was clearly a better fit. In order to better 
understand the scope of the ring expansion, the resulting cis- and trans-vinyl aziridines 
were separated and evaluated individually.   
 
Scheme 3.3: Darzen Reaction Route to Chiral Proline Products 
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 With a scaleable asymmetric route in hand we were able to assess the scope 
and ring expansion capabilities of chiral Bus-protected vinyl aziridines. The twelve 
chiral aziridines substrates shown in Table 3.2 (R = Bus) were accessed using the 
strategy detailed above. These chiral 3-pyrroline products match the cores of many of 
the pharmaceutical proline based angiotensin-converting enzymes and dipeptityl 
peptidase-4 inhibitors introduced in Scheme 3.1. Both cis- and trans-vinyl aziridines 
ring expand in excellent yields in the presence of catalytic amounts of Cu(hfacac)2 to 
3-pyrrolines. Entries e-h are an instructive reminder of the synthetic choices our 
catalytic ring expansion reaction offers. In accessing either enantiomer of the 
fosinopril core there are two suitable choices for each (entries e & f for desired 
configuration and g & h for the enantiomer). Entries i-l are particularly noteworthy 
because they demonstrate how control of the 2,5-pyrroline subsitution pattern can be 
controlled by starting with either a cis- or trans-aziridine. For the examples shown, the 
products could be advanced to the pharmaceutical cores of ramipril and perindopril. 
Entry l is an exception as this highly congested system scrambled prior to ring 
expansion. The absolute configuration of the pyrroline products of entries d, j, and l 










Table  3.2: Synthesis of Proline Based Pharmaceutical Building Blocks   











































Conditions: 5% Cu(hfacac)2, toluene, 5h, 150°C.  Cy=cyclohexyl. R = Bus (3.24 a-l) R = S(O)tBu (3.26 a-l). 
  
 
 A complementary approach to the sulfonium strategy for accessing chiral vinyl 
aziridines en route to 3-pyrroline products is to use a chiral sulfide in place of a chiral 
imine. Although currently less developed than the excellent work of Ellman and Davis 
this strategy would alleviate additional oxidation step prior to ring expansion. In 
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pursuing this alternative starting material assembly strategy we turned our attention to 
the work of Aggarwal16 and coworkers who have shown that chiral sulfonium 
nucleophiles can be used to access aziridines in a highly selective manner. To access 
the requisite chiral vinyl aziridines (3.30, Scheme 3.4) we choose to use his recently 
disclosed limonene based auxiliary (3.29)17 for additions to sulfonamide imines (3.28). 
This scaleable two step asymmetric sequence provided chiral ring expansion 
precursors (3.30) in excellent yield.   
 
Scheme 3.4: Asymmetric Synthesis of Tosyl-Protected Vinylaziridines 
 Chiral 2-aryl-substituted pyrrolidines are important structures that have 
received increased attention in recent years.18 By accessing chiral 3-pyrrolines instead 
of pyrrolidines directly, our asymmetric route provides a double bond handle for 
further functionalization in a substrate controlled manner. We were delighted to learn 
that a large range of vinyl aziridine substrates could be ring expanded stereselectively 
using Cu(hfacac)2 in uniformly excellent yields to their corresponding 2-aryl-3-
pyrrolines (Table 3.3). In all cases, a single stereoisomer is obtained. Both donating 
and electron withdrawing substitutents are well tolerated, including aryl bromides, 
chlorides, iodides, and fluorides. The broad tolerance should serve those researchers 
interested in applying this new methodology to novel complex natural product, 
pharmaceutical, or organocatalytic architectures. Impressively, the corresponding 
chiral cis-vinyl aziridines stereoselectively afford the trans-fused 3-pyrroline products 
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(entries j and k). The absolute configuration of the pyrroline product of entry d was 
firmly established using X-ray crystallography. 
Table 3.3: Ring Expansion of Aryl Substituted Chiral Vinylaziridines 

















































 Daphniglaucin C (3.36), a relatively new member of the daphniphyllium 
alkaloid family, has been demonstrated to show promising tubulin polymerization 
inhibitory activity (Scheme 3.5) and as such a potential anticancer agent.19 Its 
octahydro indole core containing five stereocenters seemed like a perfect fit for both 
demonstrating the use of the chiral method that is the focus of this work.20 Towards 
that end we envisioned using known enone 3.32 to access a sulfonamide imine using 
Ti(OEt)4 and then transformation to the aziridine using Corey-Chaykovsky conditions. 
The resulting aziridine would be oxidized using ammonium molybdate tetrahydrate as 
we have demonstrated in the synthesis of the substrates in Table 3.2. This cheap, 
practical, and simple oxidation protocol, which is commonly employed for accessing 
Julia olefination substrates,21 has not been reported previously for converting 
sulfinamides to sulfonamides (3.34). With the exception of m-CPBA other commonly 
used oxidants were inferior to this practical protocol. We expect the rearrangement of 
aziridine 3.34 to proceed stereoselectively and the resulting 3-pyrroline can be reduced 
in the presence of hydrogen and palladium to afford the desired chiral octahydro 
indole core 3.35 of daphniglaucin C in only five steps from 3.32. Dearomatization of 
the phenolic methyl ether, followed by ring expansion and a substrate controlled 


























Scheme 3.5: Asymmetric Approach Towards Daphniglaucin C 
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 In summary, we have demonstrated new, practical, and complimentary routes 
to access valuable chiral 3-pyrroline products. This was accomplished by coupling an 
imine with the appropriate nucleophile and then catalytically ring expanding the 
resulting chiral vinyl aziridine using Cu(hfacac)2. The substrate scope and functional 
group tolerance of this asymmetric pyrroline approach is very broad and the resulting 
products provide diverse opportunities for further functionalization. Given the 
importance and common occurrence of chiral pyrrolidines as cores of natural products, 
pharmaceuticals and organocatalysts this new strategy is expected to find wide use.  
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Chapter 4   
 
Stereoselective Ring Expansion of 
Vinyl Oxiranes. Mechanistic Insights 












4.1 Background and Significance 
 The central part of our research program is the development of broadly 
applicable atom-efficient synthetic methods to generate structural complexity. We 
recently reported a new copper-catalyzed ring expansion of vinyl oxiranes using 
commercially available, structurally simple, and air stable copper(II) catalysts.1 These 
studies demonstrated the success of this reaction for a broad range of substrates. 
Missing from these early studies were experiments focused on assessing the 
stereoselective potential of the ring expansion. The studies presented herein are aimed 
at addressing this point and to learn if the oxirane C-O bond that is broken during the 
ring expansion could be stereoselectively transferred to the olefin terminus. Moreover, 
an added benefit to the proposed studies would be critical mechanistic insights that 
could shed further light on the exact mechanism of this unique catalytic ring expansion 
reaction. If vinyl oxiranes can indeed be stereoselectivity ring expanded using copper 
catalysts then the practical benefits of this new reaction would be significantly 
expanded. Also this transformation would rival existing methods2 to stereoselectively 
access 2,5-dihydrofurans in terms of efficiency and scope.        
 
Scheme 4.1:  Stereoselective Vinyl Oxirane Ring Expansions 
   Our studies have focused on disubstituted vinyl oxirane substrates (Scheme 
4.1),  which depending on their stereochemistry and olefin geometry could serve as 
precursors for accessing either a 2,5-cis- or a 2,5-trans- substituted 2,5-dihydrofuran 
product. In the case of a stereoselective ring expansion, vinyl oxiranes 4.3 and 4.4 
would be expected to afford the cis-product (4.1) while 4.5 and 4.6 should similary 
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afford the trans-product (4.2). When these substrates are ranked with respect to steric 
crowding during formation of the new C-O bond, vinyl oxiranes 4.3 and 4.5 emerge as 
more suitable precursors for accessing the 2,5-cis- and 2,5-trans dihydrofuran 
products respectively.   
4.2 Results and Discussion 
 Therefore we synthesized vinyl oxiranes 4.7 and 4.11,3 which differ only in the 
oxirane stereochemistry (trans or cis substituted oxiranes). Ring expansion of these 
two substrates afforded symmetrically substituted cis- and trans-dihydrofurans 4.9 and 
4.12 (Table 4.1). Under the standard reaction conditions used in our previous paper 
(entries 5 and 16) we were able to obtain both dihydrofurans in good diastereomeric 
purity, but with low chemical yield due to the formation of byproduct (4.13). Reaction 
optimization revealed that the success relied most strongly on the temperature and 
appropriate catalyst loading. After thorough optimization we were delighted to learn 
that dihydrofuran products 4.9 and 4.12 could be obtained with high levels of 
stereoselectivity and good chemical yield (entries 7 and 18). In general we observe 
that both a lower catalyst loading and slow addition of the catalyst improves the yield 
(chemoselectivity) of the product. These results establish for the first time that vinyl 







Table 4.1: Stereoselective Synthesis of Dihydrofurans 4.9 and 4.12 
 










1 4.7 Cu(acac)2 5 15 1:! 3:1 38 
2 4.7 Cu(tfacac)2 5 15 9:1 6:1 77% 
3 4.7 Cu(FOD)2 5 15 10:1 12:1 84 (71) 
4 4.7 Cu(hfacac)2 10 15 1 : 1 10 : 1 45 
5 4.7 Cu(hfacac)2 5 1 3 : 1 11 : 1 69 
6 4.7 Cu(hfacac)2 1 6 3 : 1 >20:1 75 (70) 
7 4.7 Cu(hfacac)2 5b 8 11 : 1 15 : 1 86 (79) 
8 4.8 Cu(acac)2 5 15 - - 0 
9 4.8 Cu(tfacac)2 5 15 - - 0 
10 4.8 Cu(hfacac)2 5 15 1.5:1 2:1 38 
11 4.8 Cu(hfacac)2 1 40 1:1 3.5:1 41 (24) 
12 4.8 Cu(hfacac)2 5c 12 6:1 3:1 63 
13 4.10 Cu(acac)2 5 15 1.5:1 1:8 50 
14 4.10 Cu(tfacac)2 5 15 5:1 1:10 75 
15 4.10 Cu(hfacac)2 10 1 1 : 7 1 : 10 11 
16 4.10 Cu(hfacac)2 5 2 2 : 1 1 : 12 62 
17 4.10 Cu(hfacac)2 1 15 1 : 1 1 : 8 44 
18d 4.10 Cu(hfacac)2 5 3 2.5 : 1 1 : 18 68 (66) 
19 4.11 Cu(acac)2 5 15 1:2 1:1 17 
20 4.11 Cu(tfacac)2 5 15 2:1 2:1 21 
21 4.11 Cu(hfacac)2 5 15 5:1 1:1 40 
22 4.11 Cu(hfacac)2 1 15 12:1 2:1 33 
a) Estimated by NMR (isolated yield), b) Added via syringe pump (1.25 mol%/hour for 4 hours). c) Added via 
syringe pump (0.6 mol%/hour for 8 hours). d)  0.13 M in benzene.  
 These results are even more profound when one considers the stability of 
reactants and products. DFT calculations (B3LYP/6-311+G(d,p)) on 4.7-4.13 revealed 
that vinyl oxiranes 4.7 and 4.10 are very similar in energy. Closer examination reveals 
that oxirane 4.7 (0.0 kcal/mol) forms the less stable cis-product 4.9 (-13.7 kcal/mol) 
while oxirane 4.10 (1.1 kcal/mol) affords the preferred trans-product 4.12 (-13.9 
kcal/mol). Both dihydrofuran products 4.9 and 4.12 are less stable than the byproduct 
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4.13 (-27.1 kcal/mol) formed in the reaction. These energy relationships strongly 
discredit a mechanism involving a carbocation intermediate. 
 We have expanded our studies to include the seven additional examples 
presented in Table 4.2. Our results are in agreement with what we learned from the 
ring expansion of vinyl oxiranes 4.7 and 4.10, wherein high selectivity was achieved 
by lowering the catalyst loading. As expected, cis-2,5-dihydrofuran products (4.15a-
4.15d) were stereoselectively obtained from (trans,E)-vinyl oxirane precursors (4.14a-
4.14d), while trans-2,5-dihydrofuran products (4.15e-4.15g) were accessed by ring 
expanding (cis,E)-vinyl oxirane substrates (4.14e-4.14g). Both isolated yields and 
stereoselectivity are excellent for all substrates. Functional groups such as ethers, 
esters, enoates, and aryl groups are well tolerated. These new stereoselective results 
allow strategic design of routes to either cis- or trans- 2,5-dihydrofuran targets by 
employing the appropriate vinyl oxirane precursor.     
Table 4.2: Stereoselective Ring Expansion of Vinyl Oxiranes 

































Conditions: 5 mol% Cu(hfacac)2 in toluene at 150 °C. a) Isolated yield of diastereomerically pure material b) Added via syringe
pump (0.6 mol%/hour for 8 hours) c) 2 mol % added via syringe pump (0.11 mol%/hour for 17 hours) d) Added via syringe pump 
(2.5 mol%/hour for 2 hours) e) 100 °C f) Isolated yield of both diastereomers g) benzene. 
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     The anti-cancer agent goniothalesdiol5 (Scheme 4.2) was chosen as a target for 
assessing the value of the new stereoselective copper catalyzed ring expansion 
protocol and to showcase it using an enantiopure oxirane substrate. Goniothalesdiol, a 
densely functionalized tetrahydrofuran based structure, seemed like a perfect target for 
this task. Towards that end, cinnamaldehyde (4.16) was converted to chiral epoxy 
aldehyde 4.17 using Jorgensen’s asymmetric organocatalytic epoxidation protocol.6 
Treatment of 4.17 with vinyl magnesium bromide followed by a Johnson-Claisen 
rearrangement7 of the resulting allylic alcohol efficiently formed vinyl oxirane 4.18 as 
a single (E)-olefin isomer. The copper-catalyzed rearrangement of this chiral oxirane 
afforded cis-2,5-dihydrofuran 4.19 in 70% yield and excellent enantiopurity after 
separation from the trans-diastereomer. Substrate controlled epoxidation of 
dihydrofuan 4.19 was expected to give an epoxide that could be opened in an 
intramolecular fashion to lactone 4.21.8  Surprisingly, epoxidation of 4.19 proved 
troublesome, affording only the corresponding furan.  This problem was solved by 
constructing a cyclic sulfate instead of an epoxide.  Sharpless has shown that these 
reactive synthons can be obtained from vicinal hydroxyl groups.9 Dihydroxylation of 
4.19 selectively afforded 4-epi-goniothalesdiol in high yield. Upon treatment of this 
diol with thionyl chloride and ruthenium tetroxide, cyclic sulfate 4.20 was obtained. 
This activated diol was efficiently opened in an intramolecular fashion to lactone 
4.21.10 Opening of the lactone with Amberlyst-15 in methanol afforded 
goniothalesdiol in only eight steps from cinnamaldehyde. This short asymmetric 




Scheme 4.2: Asymmetric Total Synthesis of Goniothalesdiol     
Reagents and Conditions.  a) H2O2, 4.23, 80%; b) CH2=CHMgBr, 47%; c) CH3C(OMe)3, cat. propionic 
acid, 83%; d) 5 mol% Cu(hfacac)2, toluene, 150°C, 70%; e) cat. OsO4, NMO, acetone, H2O, 99%; f) 
SOCl2, Et3N then NaIO4, RuCl3•3H2O, CH3CN, H2O, 88%; g) 15% H2SO4, THF, 65°C, 87%;  h) 
Amberlyst-15, MeOH, 99%.  NMO = N-methylmorpholine-N-oxide. 
 Detailed kinetic studies of the rearrangement of vinyl oxirane 4.7 revealed a 
sigmoidal curve for the formation of dihydrofuran product 4.9, which is in perfect 
agreement with our studies of vinylaziridines.1c When similar kinetic analyses for cis-
vinyl oxirane substrate 4.10 are performed, the same general observations are made, 
with the added insight that formation and disappearance of small amounts of trans-
vinyl oxirane 4.7 can also be observed in the kinetic trace. This suggests that the active 
catalyst accommodates oxirane isomerization while suppressing the otherwise 
detrimental hydride shift pathway (also observed for 4.14e-4.14g). Based on our data, 
the catalytic cycle shown in Scheme 4.3 is proposed.   
 
Scheme 4.3: Proposed Catalytic Cycle 
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 The kinetic data seem to suggest that following an induction period a more 
active catalyst is formed, which then proceeds to stereoselectively ring expand vinyl 
oxiranes. We envision that Cu(hfacac)2 (4.25) reversibly coordinates to the oxirane 
(4.24) lone pair thus forming substrate-catalyst complex 4.26. This complex may react 
with another Cu(hfacac)2 (4.24) and be transformed to chelated substrate bound 
cationic copper(II) complex 4.27, wherein Cu(hfacac)3- serves as the non-nucleophilic 
counterion (X-).11 This cationic catalyst acts as the optimal Lewis acid that holds the 
substrate together in such a way that the chirality of C-O bond is transferred (without 
scrambling) to the olefin terminus to form dihydrofuran bound copper complex 4.28. 
Simple ligand exchange releases 4.29 and coordinates another vinyl oxirane (4.24). 
This release results in the formation of 4.27 and completesthe first round of the 
catalytic cycle. We further propose that the competing hydride shift product (4.31) is 
formed from copper complex 4.30, wherein the C-O oxirane bond has already been 
broken. An equilibrium arrow is placed between catalyst-substrate complexes 4.26 and 
4.30 based on the kinetic data obtained for vinyl oxirane 4.10 as discussed above. 
Cu(I) mechanistic proposals do not seem to match our data. Copper (I) 
(hfacac)(BTMSA) is the only Cu(I) catalyst that we have shown can ring expand vinyl 
oxiranes, which is because it disproportionates under the reaction conditions to the 
active catalyst, Cu(hfacac)2, and Cu0. This fact is commonly exploited in the field of 
chemical vapor deposition (CVD), wherein fluorinated acetylacetonate copper 
catalysts are routinely employed. Neither spectroscopic data or in situ reduction 
experiments of Cu(hfacac)2 using classic reducing agents such as cobaltocene, 





 Table 4.3: Stereoselective Ring Expansion of Vinyl Oxirane 4.32 
 
Entry    Cu cat. Mol % T °C Solvent ee (%)a 
1 Cu(hfacac)2 10 150 Toluene 61 
2 Cu(hfacac)2 5 150 Toluene 63 
3 Cu(hfacac)2 2.5 150 Toluene 72 
4 Cu(hfacac)2 1 150 Toluene 73 
5  Cu(hfacac)2 0.5 150 Toluene 77 b 
6 Cu(hfacac)2 1 125 Pentane 20 
7 Cu(hfacac)2 1 150 Benzene 77 
8 Cu(hfacac)2 1 150 Fluorobenzene 78 
9 Cu(hfacac)2 1 150 Hexafluorobenzene 56 
10 Cu(hfacac)2 1 125 Toluene 78 
11 Cu(hfacac)2 1 175 Toluene 81 
12 Cu(hfacac)2 1 200 Toluene 79 
13 Cu(acac)2 5 150 Toluene 14 
14 Cu(tfacac)2 5 150 Toluene 15 
15 Cu(FOD)2 5 150 Toluene 23 
16 Cu(hfacac)BTMSA 5 150 Toluene 80 
17 Cu(hfacac)2 1 150 Toluene (0.05 M) 66 
18 Cu(hfacac)2 1 150 Toluene (0.20 M) 62 
19 Cu(hfacac)2 1 150 Toluene (0.40 M) 60 
20 Cu(hfacac)2 0.5 175 Fluorobenzene 92 c,d 
Conditions: Cu cat. at 0.1M for 15 hours a) The ee for 4.33 was determined by chiral HPLC, b) 45 hours, c) 24 hours d) 60% 
isolated yield.   
 Challenging the reaction further we decided to evaluate if chiral mono 
substituted vinyl oxirane substrates such as 4.3213 could be ring expanded to 
dihydrofuran 4.3314 without any stereochemical scrambling. First, the product (4.33) 
was determined not to epimerize under the reaction conditions as is necessary for 
success. As is evident from entries 1-5 the Cu(hfacac)2 catalyst loading impacts the 
stereoselectivity of the reaction, with 0.5 mol% being optimal. This increase in 
enantioselectivity with a decrease in catalyst loading, although rare, is not without 
precedence for metal-catalyzed reactions.15 We decided to evaluate how changing the 
solvent would impact stereoselectivity. When the standard toluene (entry 4) conditions 
are compared to entries 6-9 it was determined that hexafluorobenzene negatively 
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impacts stereoselectively, pentane almost completely erodes it, while benzene and 
fluorobenzene are on par with toluene. The ring expansion can be done at several 
different temperatures with very comparable stereochemical outcomes (entries 10-12). 
Likewise, the concentration of the reaction does not have a dramatic impact on the 
chirality transfer so the standard 0.1 M was used. Lastly, the electronics of the catalyst 
are crucial to success in the rearrangement with the more electrophilic Cu (II) catalysts 
being superior. When this data is analyzed and put together (entries 5, 8, and 11), the 
result was excellent affording dihydrofuran product 4.33 in 92% ee (entry 20).  
 In summary, we have demonstrated that this new copper catalyzed vinyl 
oxirane ring expansion can be performed stereoselectively, therein providing access to 
cis- or trans-products simply by starting with the matching oxirane precursor. 
Similarly we have demonstrated that chiral 2-substituted dihydrofuran products of 
high optical purity can also be obtained. We propose that the active catalyst for the 
ring expansion is an in situ generated cationic copper(II) catalyst. These results were 
utilized to accomplish the shortest asymmetric synthesis of the natural product 
goniothalesdiol, highlighting the powerful retrosynthetic option this new catalytic 
synthetic method offers.   














(1) a) Batory, L. A.; McInnis, C. E.; Njardarson, J. T. J. Am. Chem. Soc. 2006, 
128, 16054-16055. b) Rogers, E.; Araki, H.; Batory, L. A.; McInnis, C. E.; 
Njardarson, J. T. J. Am. Chem. Soc. 2007, 129, 2768-2769. c) Brichacek, M.; 
Lee, D.; Njardarson, J. T. Org. Lett. 2008, 10, 5023-5026.  
(2) a) Brichacek, M.; Njardarson, J. T. Org. Biomol. Chem. 2009, 7, 1761-1770. b) 
Kilroy, T. G.; O’Sullivan, T. P.; Guiry, P. J. Eur. J. Org. Chem. 2005, 4929-
4949. c) Jalce, G.; Franck, X.; Figadere, B. Tetahedron Asymmetry 2009, 20, 
2537-2581. 
(3) a) Lynch, B. M.; Pausacker, K. H. J. Chem. Soc. 1955, 1525-1531. b) Murray, 
R. W.; Singh, M. Org. Synth. 1997, 74, 91-96. 
(4) McGrath, N. A.; Bartlett, E. S.; Sittihan, S.; Njardarson, J. T. Angew Chem. 
Int. Ed. 2009, 48, 8543-8546. 
(5) Isolation: Cao, S. G.; Wu, X. H.; Sim, K. Y.; Tan, B. K. H.; Pereira, J. T.; Goh, 
S. H.Tetrahedron 1998, 54, 2143-2148.  Synthetic Approaches: a) Yoda, H.; 
Nakaseko, Y.; Takabe, K. Synlett 2002, 1532-1534. b) Babjak, M.; Kapitan, P.; 
Gracza, T. Tetrahedron Lett. 2002, 43, 6983-6985. c) Murga, J.; Ruiz, P.; 
Falomir, E.; Carda, M.; Peris, G.; Marco, J. A. J. Org. Chem. 2004, 69, 1987-
1992. d) Yadav, J. S.; Raju, A. K.; Rao, P. P.; Rajaiah, G. Tetrahedron 
Asymmetry 2005, 16, 3283-3290. e) Babjak, M.; Kapitan, P.; Gracza, T. 
Tetrahedron 2005, 61, 2471-2479. f) Carreno, M. C.; Hernandez-Torres, G.; 
Urbano, A.; Colobert, F. Org. Lett. 2005, 7, 5517-5520. g) Prasad, K. R.; 
 80 
                                                                                                                                            
Gholap, S. L. J. Org. Chem. 2006, 71, 3643-3645. h) Ghosh, S.; Rao, C. N.; 
Dutta, S. K. Synlett 2007, 1464-1466.  
(6) Marigo, M.; Franzen, J.; Poulsen, T. B.; Zhuang, W.; Jorgensen, K. E. J. Am. 
Chem. Soc. 2005, 127, 6964-6965. 
(7) a) Johnson, W. S.; Werthemann, L.; Bartlett, W. R.;  Brocksom, T. J.; Li, T. 
T.; Faulkner, D. J.; Petersen, M. R. J. Am. Chem. Soc. 1970, 92, 741-743. b) 
Lee, D. H.; Lee, S. W. Tetrahedron Lett. 1997, 38, 7909-7910. 
(8) Babjak, M.; Kapitan, P.; Gracza, T. Tetrahedron 2005, 61, 2471-2479. 
(9) Gao, Y.; Sharpless, K. B. J. Am. Chem. Soc. 1988, 110, 7538-7539.  
(10) Lactone 4.21 has previously been prepared and completes the formal synthesis 
of (+)-Altholactone (Somfai, P. Tetrahedron 1994, 50, 11315-11320) and (-)-
Etharvensin (Bermejo, A.; Blazquez, M. A.; Serrano, A.; Zafra-Polo, M. C.; 
Cortes, D.J. Nat. Prod. 1997, 60, 1338-1340). 
(11) Truter, M. R.; Fenton, D. E.; Vickery, B. L. J. Chem. Soc. D 1971, 93-94.  
(12) Rickerby, J.; Steinke, J. H. G. Chem. Rev. 2002, 102, 1525-1549. 
(13) Marshall, J. A.; Trometer, J. D. Tetrahedron Lett. 1987, 4985-4988.  
(14) a) Aragones, S.; Bravo, S.; Diaz, Y.; Matheu, M. A.; Castillon, S. Tetrahedron 
Asymmetry 2003, 14, 1847-1856. b) Cleophax, J.; Gero, S. D. Tetrahedron 
Lett. 1966, 5505-5510.  
(15) a) Fairlamb, I. J. S.; Lloyd-Jones,G. C. Chem. Commun. 2000, 2447-2448. b) 
Evans, D. A.; Fandrick, K. R.; Song, H. J. J. Am. Chem. Soc. 2005, 127, 8942-
8943. c) Evans, D. A.; Fandrick, K. R.; Song, H. J.; Scheidt, K. A.; Xu, R. J. 










Chapter 5  
 
The Strategic Marriage of Method and 




















5.1 Background and Significance 
 The marine natural product varitriol (5.1 Scheme 5.1) was recently isolated and 
characterized.1 Screening of varitriol against the National Cancer Institute 60-cell line 
in vitro panel revealed promising activity against a number of important types of 
cancer. This anti-cancer activity, coupled with varitriol’s tetrahydrofuran core, 
constitutes an opportunity to showcase our new copper-catalyzed vinyl oxirane ring 
expansion reaction (the “method”)2 in an application to varitriol (the “motif”).3 Of 
course, this success depends on the judicious choice of substituents (R=?), source 
material and well matched accompanying reactions. The studies presented herein are 
aimed at identifying the most suitable vinyl oxirane substrates for accessing varitriol. 
 
Scheme 5.1:  Motif (Varitriol) and Method (Vinyl Oxirane Ring Expansion) 
 Not surprisingly, given varitriol’s attractive biological profile it has garnered 
the attention of synthetic chemists.  Four syntheses of varitriol (5.1)4 and its 
enantiomer (5.2)5 have been completed to date (Scheme 5.2).6,7 Interestingly, all these 
approaches have utilized chiral pool source materials. With the exception of Taylor’s 
synthesis of 5.2, the longest linear sequences seems excessive for a molecule of 
varitriol’s complexity. Our approach focuses on the rapid synthesis of the 
dihydrofuran core from non-chiral pool starting materials8 with minimal use of 
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Scheme 5.2:  Chiral Pool Total Syntheses of (+)- and (-)-Varitriol 
5.2 Results and Discussion 
 Our synthetic efforts commenced with epoxidation of benzyl protected dienyl 
alcohol 5.7 (Scheme 5.). The two regioisomeric vinyl oxiranes (5.8 and 5.9) were 
separated and subjected to the copper-catalyzed rearrangement conditions. Using 
Cu(hfacac)2, both vinyl oxiranes rearranged to form the expected cis-2,5- dihydrofuran 
5.10 in excellent yield and with high stereoselectivity.3 Substrate controlled 
dihydroxylation (5.11) installed the natural product’s other two stereocenters. At this 
point in the synthesis, the cis-diol was protected as an acetonide (5.12) and the benzyl 
protecting group of the primary alcohol removed by hydrogenolysis. Oxidation of the 
free alcohol (5.13) afforded an aldehyde, which was immediately subjected to a Wittig 
olefination reaction. Tetrahydrofuran product 5.14 is a known synthetic intermediate 
in a recently completed synthesis of varitriol by Jennings and coworkers.5a This new 
synthetic approach allowed us to access 5.14 in eight steps from dienol 5.6, which is 
four steps shorter than the earlier route from D-ribose. It is important to note in 
comparing the two sequences that our new route has not been executed using chiral 
starting materials. Literature examples support the notion that our new synthetic 
sequence lends itself well to established asymmetric epoxidation protocols. For 
example, Somfai11 has demonstrated that 5.7 can be oxidized to (2R,3R)-5.8 in good 
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yield and 95% ee using one of Yian Shi’s chiral diooxirane reagents. Advancing this 
product would provide access to (-)-varitriol (5.2).  Interestingly, Shi has demonstrated 
that when TBS-protected 5.15 is oxidized, a mixture of (2R,3R)- and (4R,5R)- 
epoxides are produced, with the latter being a perfect match with our method to access 
(+)-varitriol (5.1).12    
 
Scheme 5.3:  Formal Synthesis of Varitriol (First Approach) 
 In the total syntheis of natural (+)-varitriol (5.1) by Shaw and coworkers,4a  
protected triol 5.19 (Scheme 5.4) served as a key intermediate. Our stereoselective 
vinyl oxirane ring expansion strategy seemed well-suited for accessing 5.18 and 
further evaluating the functional group compatibility of our methodology. 
Furthermore, we hoped to develop a better diol protecting group, as the aldehyde 
obtained from 5.13 performed very poorly in the Wittig reaction.4a,5a Shaw 
demonstrated in his synthesis that this issue could be addressed by using PMB-
protecting groups instead of an acetonide to mask the diol. Our synthetic route 
commenced with silyl protection of dienol 5.8. The resulting diene was epoxidized to 
furnish vinyl oxiranes 5.16 and 5.17, which were readily separable. Both oxiranes ring 
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expanded efficiently in the presence of Cu(hfacac)2 to produce cis-2,5-dihydrofuran 
5.18 in excellent yield and better than 20:1 stereoselectivity. In concert with our goal 
of making the sequence as practical as possible, we have also successfully ring 
expanded the mixture of epoxides (5.8/5.9 and 5.16/5.17) obtained from the dienes 5.7 
and 5.15 to 2,5-dihydrofurans 5.10 and 5.18, thus eliminating the need to separate the 
two vinyl oxirane constitutional isomers. These ring expansions have been performed 
on gram scale. This result also establishes silyl group compatibility with our ring 
expansion conditions. Substrate controlled dihydroxylation using osmium tetroxide 
afforded 5.19 in only 4 steps from dienol 5.8, which compares very favorably to 
Shaw’s twelve step synthesis of 5.19 from methyl D-mannopyranoside. 
 
Scheme 5.4: Formal Synthesis of Varitriol (Second Approach) 
 Although our new routes to these known synthetic intermediates are shorter 
than previous ones, they are not without room for improvements. In particular, there 
should be a way to bypass using a protecting group on the primary alcohol and thus 
truncate these routes by two more steps. Constitutional vinyl oxirane isomers 5.21 and 
5.24 (Scheme 5.5), which can be accessed in a single step from 5.2013 and 5.2314 
respectively, seemed to fit this goal perfectly. Moreover, the significant steric and 
electronic differences between 5.21 and 5.24 might provide us with further 
mechanistic insights. Interestingly, vinyl oxirane 5.21 decomposed instead of ring 
expanding to the expected 2,5-dihydrofuran product 5.22, while its constitutional 
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isomers (5.24)15 ring expanded nicely in high yield. From a mechanistic perspective, 
this result is interesting. If coordination of the copper catalyst is invoked for the 
mechanism of this reaction, then it is not too surprising that the acrylate olefin moiety 
of 5.21 would be far poorer olefin donor than the olefin of 5.24. Interestingly, the 
equivalent aziridine substrate of 5.21 does successfully ring expand. We attribute this 
difference to the fact that the aziridine coordinates more effectively to the copper 
catalyst than the oxirane and also because of the competing hydride shift pathway the 
vinyl oxirane substrates need to overcome. 16 Upon further analysis, we learned that 
under the reaction conditions the cis-isomer (5.22) had epimerized to the 
thermodynamically more stable trans-isomer (5.26). Although, the epimerization of 
5.22 to 5.26 precluded advancement of this product, this new route succeeded in 
avoiding the use of protecting groups to access a functionalized dihydrofuran product. 
The fact that a mixture of cis- and trans-oxiranes 5.24 and 5.25 ring expanded to form 
trans-2,5-dihydrofuran 5.26 as the main product in excellent yield is noteworthy. We 
have recently demonstrated that trans-E- and cis-E- vinyl oxiranes can be 
stereoselectively ring expanded to syn- and anti-2,5-dihydrofurans respectively. These 
studies did not uncover any epimerizations following ring expansion, but none of 
those substrates contained such an easily epimerizable group like the ester of vinyl 
oxirane 5.24.        
 
Scheme 5.5: Third Synthetic Approach towards Varitriol 
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 Is there room for further improvement? Although this last route is very short, 
the union of the furan moiety and the aryl group would require a three step sequence 
of ester reduction, Wittig olefination, and cross metathesis. The simplest way to shave 
off one more step from this sequence would be to use a Wittig or Julia olefination 
instead of the cross metathesis reaction to join the two fragments. Alternatively, by 
using a substrate such as 5.27 (Scheme 5.6) that contains the desired exocyclic carbon 
atoms there was a possibility of saving three steps and providing access to varitriol in 
only four steps. Towards that end, commercially available triene 5.27 was selectively 
transformed to vinyl oxirane 5.28, which upon treatment with Cu(hfacac)2 ring 
expanded efficiently to the expected cis-2,5-dihydrofuran product 5.29. 
Dihydroxylation of diene 5.29 affords a mixture of products that when protected yields 
acetonide 5.30. This product is only a cross metathesis away from varitriol. At the 
outset, it was well understood that acrylate 5.30 was a poorly matched cross 
metathesis substrate. We have been able to find only one example in the literature 
wherein an acrylate group is exchanged for a terminal olefin.  This was accomplished 
in modest yield using Grubbs second generation catalyst and ethylene.17 Therefore it 
was not entirely surprising that we were unable to convert 5.30 to 5.31 using either 
ethylene or styrene derivatives. Determined to advance this highly desirable substrate, 
we also evaluated relay metathesis substrates18 wherein the ethyl ester had been 
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Scheme 5.6:  Fourth Synthetic Approach towards Varitriol 
 Inspired by how convergently components were brought together by using the 
Darzen’s reaction (Scheme 5.5) and a desire to access enantiopure vinyl oxirane 
starting materials, we decided to explore an alternative approach (Scheme 5.7). We 
argued that addition of an appropriate vinyl nucleophile to a chiral -chloro aldehyde 
would expediently afford the desired chiral vinyl oxirane substrate. Towards that end, 
commercially available aldehyde 5.32 was chlorinated using Jorgensen’s 
organocatalytic procedure19 and the crude product subjected to vinyllithium reagent 
5.3420 to afford vinyl oxirane 5.35. Ring expansion of this vinyl oxirane provided cis-
2,5-dihydrofuran product 5.36, which was then dihydroxylated (5.37). The diol was 
protected as an acetonide and the benzyl ether was deprotected using palladium 
mediated hydrogenolysis to furnish 5.38 in only six steps from aldehyde 5.32. Alcohol 
5.38 is a versatile synthetic intermediate that could be dehydrated to afford cross 
metathesis substrate 5.14 (Scheme 5.3) without relying on the challenging olefination 
step. Alternatively, 5.38 could be oxidized to an aldehyde and then reacted with the 
appropriate aryl anion. The resulting secondary alcohol would then be dehydrated to 
afford varitriol.   
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Scheme 5.7:  Fifth Synthetic Approach towards Varitriol 
 In order to complete the synthesis of varitriol, we then decided to utilize 
readily available diol 5.19. Protection of the diol in 5.19 as an acetal followed by 
treatment with tetrabutyl ammonium fluoride (TBAF) afforded 5.39. A variety of 
sequences can be envisioned to convert primary alcohol 5.39 to varitriol, the most 
successful approach we found is depicted in Scheme 5.8. This involves a Mitsunobu 
reaction with 1-phenyl-1H-tetrazole-5-thiol (PTSH)21 followed by in situ oxidation 
with ammonium molybdate tetrahydrate to give sulfone 5.40. Julia olefination22 with 
aldehyde 5.41 produced exclusively the E-olefin without any furan epimerization in 
high yield. The analogous Julia olefination with the sulfone and aldehyde moieties 
reversed was shown to be inferior due to poor yield and olefin selectivity. 




Scheme 5.8:  Total Synthesis of Varitriol 
 What accounts for the excellent stereoselectivity of our copper catalyzed vinyl 
oxirane ring expansion reaction? We currently favor a chelation model to account for 
the observed success in stereoselectively ring expanding vinyl oxiranes (Scheme 5.9). 
We have previously shown that trans- and cis- E vinyl oxiranes can be 
stereoselectively ring expanded to cis- and trans-2,5-dihydrofuran products 
respectively.3 Not surprisingly, and in accordance with our oxirane-olefin chelation 
model, the corresponding Z-olefins were shown to be poor substrates with the 
exception being  cyclic vinyl oxiranes.      
 
Scheme 5.9:  Chelation Model for Stereoselective Oxirane Ring Expansion 
 91 
 In this chelation scheme, we envision initial coordination of the copper catalyst 
to the lone pairs of the oxirane atom followed by coordination to the olefin prior to 
ring expansion. The 2,5-dihydrofuran (5.44) product forms a less effective chelate 
with the catalyst and is therefore quickly released to turnover the catalyst. The main 
competing pathway for this ring expansion is highly dependent on the steric and 
electronic nature of the vinyl oxirane being investigated. If ring expansion does not 
occur rapidly, an allylic cation (5.48) can be formed that can either form the isomeric 
oxirane and then ring expand or alternatively undergo a 1,2-hydride shift to form 5.49. 
 In conclusion, we have explored the suitability of our new copper catalyzed 
vinyl oxirane ring expansion reaction for the total synthesis of varitriol. In our opinion, 
this reaction is a good match for varitriol as is evident from our expedient approaches. 
To realize this goal, the important secondary challenge of this project became to 
design an optimal synthesis of the vinyl oxirane precursor and the most efficient 
sequence from the dihydrofuran product. This reminds us that in order to accomplish 
short and efficient syntheses, a good method needs the support of good synthetic 
design and insightful selection of starting materials. The message of these synthetic 
explorations towards varitriol is clear. New synthetic methods provide new 
opportunities for synthetic design, which in turn enable better approaches to well 
matched targets. This means that there is a great need for developing useful new 
synthetic methods, especially asymmetric ones that can complement the use of chiral 
pool source materials. 
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A2.1 Experimental Procedures for Chapter 2  
General Information:  
Commercial reagents were purchased and used without further purification. All 
glassware was flame- or oven-dried prior to use and reactions were performed under a 
nitrogen atmosphere unless otherwise noted. Toluene, benzene, dichloromethane, 
diethyl ether, and THF were dried over a column of alumina. Flash chromatography 
was preformed using MP Silitech 32-63D 60Å silica. Thin layer chromatography 
(TLC) was done with EMD 250 μm silica gel 60-F254 plates. 1H and 13C NMR data 
were acquired on a Varian Mercury 300 (300 MHz) or a Varian Inova 400, 500, or 
600 (400, 500 or 600 MHz) spectrometer and referenced to residual protic solvent or 
TMS as an internal standard. IR spectroscopy was done on a Mattson RS-10500 FTIR 
spectrometer. High-resolution mass spectrometry was performed at the University of 




General Procedure for the Rearrangement of Vinylaziridines to 3-Pyrrolines 




To a 4 mL disposable Fisherbrand® vial was added Cu(hfacac)2•H2O (0.005 mmol, 5 
mol %) and dried1 by placing under a vacuum until color change was observed (1-3 h). 
To the catalyst was added a solution of the vinyl aziridine (0.10 mmol) in 
toluene/benzene (0.1 M). The vial was sealed with a Teflon® cap and heated at 100 oC  
or 150 oC until the reaction was complete (TLC or NMR). After cooling to room 
temperature the reaction mixture was filtered through neutral alumina (activity grade 
1) washing with CH2Cl2 or EtOAc. The solvent was removed in vacuo often resulting 
in a product that required no further purification. When purification was necessary, 















N-Phthalimido-9-aza-bicyclo [6.1.0] non-2-ene (2.3p): Cis,cis-1,3-cyclooctadiene 
(0.10 g, 0.92 mmol, 1 equiv) was dissolved in dry CH2Cl2 (9.2 mL, 0.1 M) and N-
amino-phthalimide (0.187 g, 1.15 mmol, 1.25 equiv.) was added. The heterogeneous 
solution was stirred vigorously while iodobenzenediacetate (0.326 g, 1.01 mmol, 1.1 
equiv.) was added portion wise over 1 hour. The solution was stirred at room 
temperature for 14 hours. The reaction was diluted with CH2Cl2, washed with sat. 
NaHCO3, and dried over Na2SO4. The solvent was evaporated and crude mixture 
purified by flash chromatography (Rf = 0.5, 1:1 ether:pentane). Yield 131 mg (53%).  
1H NMR (400 MHz, CDCl3 )   ppm 7.77 (dd, J = 5.4, 3.0 Hz, 2H), 7.67 (dd, J = 5.4, 
3.0 Hz, 2H), 5.94 (dd, J = 11.2, 1.2 Hz, 1H), 5.84 (dddd, J = 11.2, 7.4, 5.4, 1.9 Hz, 
1H), 3.11-3.06 (m, 1H), 2.84-2.78 (m, 1H), 2.48-2.39 (m, 1H), 2.33 (dddd, J = 16.2, 
10.0, 7.4, 1.4 Hz, 1H), 2.06-1.96 (m, 1H), 1.85-1.73 (m, 1H), 1.73-1.64 (m, 2H), 1.63-
1.54 (m, 1H), 1.52-1.43 (m, 1H). 13C NMR (125 MHz, CDCl3   ppm 165.1, 135.1, 
133.9, 130.6, 122.9, 122.2, 50.7, 46.7, 28.8, 26.2, 26.1, 25.6. IR (neat) 2927, 2866, 
1712, 1378, 1184, 1153, 1048, 913, 745, 709, 526 cm-1. ESMS m/z 291.1 ([M+Na]+); 
HRESMS m/z calcd for C16H16N2O2Na ([M+Na]+) 291.1109 found 291.1129. 
 
 




2,2-Spiromethylenecyclohexane-N-(p-Toluenesulfonyl)-aziridine (2.3n): To a 100 mL 
flame-dried round bottom flask was added 30 mL of dry CH3CN. Then 1,2-
dimethylenecyclohexane2 (700 mg, 6.5 mmol, 1.0 equiv) and anhydrous chloramine-
T25 (1.47 g, 6.5 mmol, 1.0 equiv) were added. To this solution N-bromosuccinimide 
(0.23 g, 1.3 mmol, 0.2 equiv.) was added slowly over 30 min. The solution was stirred 
14 hours and then diluted with EtOAc and washed with sat. aqueous NaHCO3 and 
dried over Na2SO4. The solvent was evaporated and the crude mixture was purified by 
flash chromatography (Rf = 0.51, 30% EtOAc:70% hexanes). Yield 120 mg (7%).  
1H NMR (400 MHz, CDCl3)  ppm 7.85 (d, J = 8.1 Hz, 2H), 7.31 (d, J = 8.1 Hz, 2H), 
4.95 (s, 1H), 4.78 (s, 1H), 2.65 (s, 1H), 2.52-2.44 (m, 1H), 2.43 (s, 3H), 2.39 (s, 1H), 
103 
2.26-2.03 (m, 3H), 2.03-1.93 (m, 1H), 1.76-1.55 (m, 3H). 13C NMR (75 MHz, CDCl3  
 ppm 145.7, 143.8, 137.8, 129.4, 127.4, 109.1, 55.5, 41.0, 34.5, 32.8, 27.1, 25.6, 21.6. 
IR (neat) 2936, 2859, 1598, 1322, 1160, 816, 714, 567 cm-1. ESMS m/z 278.1 






1-Tosyl-2-vinylaziridine (2.3a): Prepared according to general procedure C. Spectra 
matched existing literature data.3 
1H NMR (400 MHz, CDCl3) δ 7.83 – 7.80 (m, 2H), 7.35 – 7.31 (m, 2H), 5.56 – 5.45 
(m, 1H), 5.45 – 5.37 (m, 1H), 5.26 – 5.20 (m, 1H), 3.31 – 3.21 (m, 1H), 2.77 (dd, J = 





N-Phthalimido-2-vinylaziridine (2.3b): Prepared according to general procedure B. 
Spectra matched existing literature data.4 
1H NMR (400 MHz, CDCl3) δ 7.80 – 7.77 (m, 2H), 7.70 – 7.68 (m, 2H), 5.77 (ddd, J 
= 17.4, 10.4, 7.2, 1H), 5.56 (ddd, J = 17.2, 1.3, 0.8, 1H), 5.37 (ddd, J = 10.4, 1.3, 0.6, 
1H), 3.09 (ddd, J = 13.0, 7.2, 5.8, 1H), 2.73 (dd, J = 7.8, 2.4, 1H), 2.53 (dd, J = 5.8, 






2-Methyl-N-(p-Toluenesulfonyl)-2-vinylaziridine (2.3c): Prepared according to general 
procedure C.5 
1H NMR (300 MHz, CDCl3 )  ppm 1.65 (s, 3H), 2.42 (s, 3H), 2.61 (s, 1H), 2.63 (s, 
1H), 5.31 (d, J = 10.7 Hz, 1H), 5.41 (d, J = 17.2 Hz, 1H), 5.97 (dd, J = 17.2, 10.7 Hz, 
1H), 7.31 (d, J = 8.2 Hz, 2H) 7.82 (d, J = 8.2 Hz, 2H); 13C NMR (75 MHz, CDCl3) δ 
ppm 143.9, 137.5, 136.9, 129.5, 127.3, 118.3, 49.8, 42.0, 21.6, 18.5; IR (neat) 2989, 
2927, 1598, 1321, 1161, 817, 732, 568 cm-1; ESMS m/z 238.1 ([M+H]+); HRESMS 









N-Phthalimido-(2-methyl-2-vinylaziridine) (2.3d): Prepared according to general 
procedure B. Spectra matched existing literature data.6 
1H NMR (300 MHz, CDCl3) δ 7.84 (dd, J = 5.6, 3.0, 2H), 7.73 (dd, J = 5.4, 3.2, 2H), 
6.09 (dd, J = 17.6, 11.0, 1H), 5.28 (d, J = 17.6, 1H), 5.21 (d, J = 11.0, 1H), 3.36 (d, J = 






N-Phthalimido-2-(prop-1-en-2-yl)aziridine (2.3e): Prepared according to general 
procedure B. Spectra matched existing literature data.7 
1H NMR (400 MHz, CDCl3) δ 7.78 – 7.76 (m, 2H), 7.69 – 7.67 (m, 2H), 5.17 (dt, J = 






2-Methyl-N-(p-toluenesulfonyl)-2-isopropenylaziridine (2.3f): Prepared according to 
general procedure C. 8 
1H NMR (300 MHz, CDCl3)  ppm 7.83 (d, J = 8.3 Hz, 2H), 7.31 (d, J = 8.3 Hz, 2H), 
4.99 (d, J = 0.6 Hz, 1H), 4.89 (d, J = 0.6 Hz, 1H), 2.75 (s, 1H), 2.42 (s, 3H), 2.42 (s, 
1H),  1.82 (s, 3H), 1.78 (s, 3H). 13C NMR (75 MHz, CDCl3)  ppm 144.4, 143.8, 
137.8, 129.5, 127.4, 113.2, 53.2, 41.0, 21.6, 19.0, 18.0. IR (neat) 2978, 1598, 1450, 
1322, 1159, 873, 817, 712, 570 cm-1. ESMS m/z 252.1 ([M+H]+); HRESMS m/z 





N-Phthalimido--(2-methyl-2-(prop-1-en-2-yl)aziridine (2.3g): Prepared according to 
general procedure B. Spectra matched existing literature data.9 
1H NMR (400 MHz, CDCl3) δ 7.84 – 7.74 (m, 1H), 7.71 – 7.67 (m, 1H), 5.13 (s, 0H), 






3-Methyl-N-(phthalimido)-2-vinylaziridine (2.3h, trans:cis 2.5:1): Piperylene 
(technical grade, 0.10 g, 1.47 mmol, 1 equiv) was dissolved in dry CH2Cl2 (7.3 mL, 
0.1 M) and N-amino-phthalimide (0.298 g, 1.84 mmol, 1.25 equiv.) was added. The 
heterogeneous solution was stirred vigorously while iodobenzenediacetate (0.521 g, 
1.62 mmol, 1.1 equiv.) was added portion wise over 1 hour. The solution was stirred at 
room temperature for 6 hours. The reaction was diluted with CH2Cl2, washed with sat. 
NaHCO3, and dried over Na2SO4. The solvent was evaporated and crude mixture 
purified by flash chromatography (Rf = 0.4, 50% ether:50% pentane). Yield 101 mg 
(30%). 
trans: 1H NMR (400 MHz, CDCl3 )  ppm 7.75 (dd, J = 5.6, 3.0 Hz, 2H), 7.67 (dd, J 
= 5.6, 3.0 Hz, 2H), 5.62 (ddd, J = 17.1, 10.3, 7.9 Hz, 1H), 5.41 (ddd, J = 17.1, 1.3, 0.6 
Hz, 1H), 5.27-5.23 (m, 1H), 3.28-3.17 (m, 1H), 2.93 (dq, J = 7.9, 5.6 Hz, 1H), 1.48 (d, 
J = 5.6 Hz, 3H). 13C NMR (125 MHz, CDCl3)  ppm 165.8, 134.6, 134.0, 131.0, 
122.9, 121.4, 50.9, 43.2, 17.0.   
cis: 1H NMR (400 MHz, CDCl3 )  ppm 7.78 (dd, J = 5.6, 2.9 Hz, 2H), 7.69 (dd, J = 
5.6, 2.9 Hz, 2H), 5.77 (ddd, J = 17.4, 10.4, 7.2 Hz, 1H), 5.54 (ddd, J = 17.4, 1.5, 0.7 
Hz, 1H), 5.33 (ddd, J = 10.4, 1.5, 0.7 Hz, 1H), 3.26-3.18 (m, 1H), 2.67 (td, J = 5.9, 
5.9 Hz, 1H), 1.36 (d, J = 5.9 Hz, 3H).  13C NMR (125 MHz, CDCl3)  ppm 166.2, 
134.3, 133.9, 130.4, 123.0, 119.0, 48.8, 45.1, 12.9.  
IR (neat) 2975, 2931, 1881, 1717, 1612, 1466, 1375, 1187, 1134, 984, 896, 709, 526 
cm-1. ESMS m/z 229.1 ([M+H]+); HRESMS m/z calcd for C13H13N2O2 ([M+H]+) 





2-Methyl-1-tosyl-3-vinylaziridine (2.3i): Prepared according to existing literature 
procedure and spectra matched existing literature data.10 
1H NMR (400 MHz, CDCl3) δ 7.81 (d, J = 8.3, 2H), 7.31 (d, J = 0.6, 2H), 5.59 (ddd, J 
= 17.3, 10.4, 7.0, 1H), 5.39 (ddd, J = 17.2, 1.5, 0.9, 1H), 5.29 (ddd, J = 10.4, 1.4, 0.7, 









(E)-Methyl 3-(1-tosylaziridin-2-yl)acrylate (2.3j): Prepared according to existing 
literature procedure and spectra matched existing literature data.11 
1H NMR (400 MHz, CDCl3) δ 7.81 (d, J = 8.3, 2H), 7.34 (dd, J = 8.6, 0.6, 2H), 6.55 
(dd, J = 15.6, 7.5, 1H), 6.10 (dd, J = 15.6, 0.7, 1H), 3.71 (s, 3H), 3.37 – 3.29 (m, 1H), 




(Z)-Methyl 3-(1-tosylaziridin-2-yl)acrylate (2.3j cis): Prepared according to existing 
literature procedure and spectra matched existing literature data.12 
1H NMR (400 MHz, CDCl3) δ 7.83 (d, J = 8.3, 2H), 7.34 (d, J = 8.0, 2H), 5.95 (d, J = 
11.5, 1H), 5.68 (dd, J = 11.5, 8.9, 1H), 4.54 – 4.44 (m, 1H), 3.76 (s, 3H), 2.92 (d, J = 




N-Phthalimido-2-propenoic acid methyl ester-aziridine (2.3k): 2.3b (25.0 mg, 1.17 
mmol, 1 equiv.) was dissolved in CH2Cl2 (1.2 mL, 0.1 M) and cooled to -78 oC under 
an atmosphere of nitrogen. Ozone was bubbled through the solution and the reaction 
was monitored by TLC (~3 hours). The solution was flushed with nitrogen and 
quenched with dimethyl sulfide (0.035 mL, 4.67 mmol, 4 equiv). The reaction was 
warmed to room temperature and the solvent removed. The product (2.18) is unstable 
at room temperature and was used without purification.  
1H NMR (300 MHz, CDCl3 )  ppm 9.27 (d, J = 5.2 Hz, 1H), 7.93-7.67 (m, 4H), 3.23 
(ddd, J = 8.2, 5.2, 5.2 Hz, 1H), 3.03 (dd, J = 8.2, 2.1 Hz, 1H), 2.88 (dd, J = 5.2, 2.1 
Hz, 1H). 13C NMR (125 MHz, CDCl3)  ppm 196.2, 164.5, 134.5, 129.9, 123.4, 45.9, 
34.8. IR (neat) 2935, 1786, 1723, 1468, 1380, 913, 743, 712 cm-1. 
 
In a flame-dried flask under nitrogen, NaH (5.5 mg, 2 equiv) was dissolved in 1 mL of 
THF and cooled to 0 oC. Trimethylphosphonoacetate (0.047 mL, 2 equiv) was added 
drop wise to the solution and allowed to stir for 30 minutes. Then, the crude aldehyde 
prepared before (~25 mg) was dissolved in 0.5 mL of anhydrous THF and added 
slowly. The solution was stirred at 0 oC and monitored by TLC (~4h). The reaction 
was quenched with 1 mL of distilled H2O, then extracted with CH2Cl2, dried on 
Na2SO4, and the solvent removed. (crude E:Z 17:1). The product can be purified by 
silica gel chromatorgraphy (50% ether:50% pentane, Rf = 0.36) yield 21.0 mg (66%).  
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1H NMR (400 MHz, CDCl3 )  ppm 7.79 (dd, J = 5.4, 3.1 Hz, 2H), 7.70 (dd, J = 5.4, 
3.1 Hz, 2H), 6.79 (dd, J = 15.7, 7.5 Hz, 1H), 6.26 (dd, J = 15.7, 0.8 Hz, 1H), 3.76 (s, 
3H), 3.21-3.13 (m, 1H), 2.87 (dd, J = 7.9, 2.2 Hz, 1H), 2.57 (dd, J = 5.5, 2.2 Hz, 1H). 
13C NMR (125 MHz, CDCl3)  ppm 166.2, 164.8, 143.6, 134.2, 130.1, 124.2, 123.2, 
51.7, 42.1, 39.4. IR (neat) 2921, 2852, 1716, 1437, 1376, 1274, 1201, 1045, 977, 913, 
745 cm-1. ESMS m/z 293.0 ([M-H2+Na]+); HRESMS m/z calcd for C14H10N2O4Na 





yl)ethanone13 (1.1 g, 4.6 mmol, 1 equiv) was dissolved in 23 mL of CH2Cl2 (0.2 M) 
and cooled to 0 oC. Et3N (3.8 mL, 27.6 mmol, 6 equiv.) was added followed by 
addition of TBSOTf (2.3 mL, 10.1 mmol, 2.2 equiv.) drop wise. The reaction was 
warmed to room temperature. After 2 h the reaction was quenched with sat. NaCl and 
extracted with CH2Cl2. The solution was dried with Na2SO4 and the solvent removed 
in vacuo . The product was purified using flash chromatography (Rf = 0.45, 30% 
EtOAc:70% hexanes). Yield = 1.50 g (96%,). 
1H NMR (300 MHz, CDCl3 )  ppm 7.81 (d, J = 8.0 Hz, 2H), 7.33 (d, J = 8.0 Hz, 2H), 
4.44 (s, 1H), 4.28 (s, 1H), 3.21 (dd, J = 6.9, 4.4 Hz, 1H), 2.64 (d, J = 6.9 Hz, 1H), 
2.44 (s, 3H), 2.40 (d, J = 4.4 Hz, 1H), 0.85 (s, 9H), 0.08 (s, 3H), 0.05 (s, 3H). 13C 
NMR (75 MHz, CDCl3)  ppm 151.4, 144.3, 135.0, 129.5, 127.7, 95.2, 41.0, 31.1, 
25.4, 21.5, 18.0, -4.8, -5.3.  IR (neat) 2955, 2930, 2858, 1639, 1463, 1330, 1254, 
1162, 1029, 940, 840, 682, 560 cm-1. ESMS m/z 354.1 ([M+H]+); HRESMS m/z 





2-Phenyl-3-(1-phenylvinyl)-N-tosylaziridine (2.3m): PPh3MeBr (10.3 mg, 0.029 
mmol, 1.5 equiv.) was added to 0.25 ml of THF at -78 oC. To this solution n-BuLi (1.6 
M in hexanes, 0.018 ml,  0.029 mmol, 1.5 equiv.) was added and warmed to 0 oC 
while stirring for 30 min. A solution of Phenyl(3-phenyl-N-Tosylaziridine-2-
yl)methanone14 (7.0 mg, 0.19 mmol, 1 equiv.) in 0.25 ml of THF was added. The 
reaction was warmed to room temperature and stirred for 1 hour. The solution was 
diluted with ether, washed with sat NH4Cl, and dried with Na2SO4. The solvent was 
removed in vacuo and purified using flash chromatography  (Rf  = 0.45, 30% 
EtOAc:70% hexanes). Yield = 5.0 mg, (72%).  
108 
1H NMR (300 MHz, CDCl3)  ppm 7.62 (d, J = 8.2 Hz, 2H), 7.47-7.36 (m, 4H), 7.33 
(bs, 3H), 7.32-7.25 (m, 3H), 7.16 (d, J = 8.2 Hz, 2H), 5.58 (bs, 1H), 5.41 (bs, 1H), 
4.18 (d, J = 4.7 Hz, 1H), 3.97 (d, J = 4.7 Hz, 1H), 2.35 (s, 3H). 13C NMR (75 MHz, 
CDCl3 )  ppm 143.9, 141.0, 138.2, 136.9, 132.0, 129.3, 128.8, 128.4, 128.4, 128.2, 
128.1, 127.5, 126.1, 115.8, 51.0, 48.8, 21.5. IR (neat) 3060, 3031, 2923, 1598, 1496, 
1328, 1162, 1087, 931, 911, 752, 697 cm-1. ESMS m/z 398.1([M+Na]+); HRESMS 





2,2-Spiromethylenecyclohexane-N-(p-toluenesulfonyl)-aziridine (2.3n): In a 100 mL 
flame-dried round bottom flask was added 30 mL of dry CH3CN. To this solution was 
added 1,2-dimethylenecyclohexane15 (700 mg, 6.5 mmol, 1.0 equiv) and anhydrous 
chloramine-T25 (1.47 g, 6.5 mmol, 1.0 equiv). To this solution N-bromosuccinimide 
(0.23 g, 1.3 mmol, 0.2 equiv.) was added slowly over 30 min. The solution was stirred 
14 hours and then diluted with EtOAc and washed with sat. aqueous NaHCO3 and 
dried over Na2SO4. The solvent was evaporated and the crude mixture was purified by 
flash chromatography (Rf = 0.51, 30% EtOAc:70% hexanes). Yield 120 mg (7%).  
1H NMR (400 MHz, CDCl3)  ppm 7.85 (d, J = 8.1 Hz, 2H), 7.31 (d, J = 8.1 Hz, 2H), 
4.95 (s, 1H), 4.78 (s, 1H), 2.65 (s, 1H), 2.52-2.44 (m, 1H), 2.43 (s, 3H), 2.39 (s, 1H), 
2.26-2.03 (m, 3H), 2.03-1.93 (m, 1H), 1.76-1.55 (m, 3H). 13C NMR (75 MHz, CDCl3) 
 ppm 145.7, 143.8, 137.8, 129.4, 127.4, 109.1, 55.5, 41.0, 34.5, 32.8, 27.1, 25.6, 21.6. 
IR (neat) 2936, 2859, 1598, 1322, 1160, 816, 714, 567 cm-1. ESMS m/z 278.1 





N-Tosyl-9-aza-bicyclo[6.1.0]non-2-ene (2.3o): Prepared according to general 
procedure B.16 
1H NMR (300 MHz, CDCl3) ppm 7.79 (d, J = 8.21 Hz, 2H), 7.29 (d, J = 8.2 Hz, 
2H), 5.71 (dddd, J = 11.1, 7.5, 5.7, 1.8 Hz, 1H), 5.29 (dd, J = 11.1, 1.1 Hz, 1H), 3.36-
3.30 (m, 1H), 2.94 (ddd, J = 10.3, 7.0, 3.6 Hz, 1H), 2.40 (s, 3H), 2.30-2.14 (m, 1H), 
2.05-1.86 (m, 2H), 1.83-1.46 (m, 3H), 1.44-1.26 (m, 2H). 13C NMR (75 MHz, CDCl3) 
 ppm 144.2, 135.6, 135.5, 129.6, 127.6, 120.5, 46.1, 42.4, 28.7, 26.1, 26.0, 25.3, 21.6. 
IR (neat) 3031, 2930, 2866, 1598, 1322, 1159, 1092, 952, 662, 573 cm-1. ESMS m/z 







N-Phthalimido-9-aza-bicyclo [6.1.0] non-2-ene (2.3p): Cis,cis-1,3-cyclooctadiene 
(0.10 g, 0.92 mmol, 1 equiv) was dissolved in dry CH2Cl2 (9.2 mL, 0.1 M) and N-
amino-phthalimide (0.187 g, 1.15 mmol, 1.25 equiv.) was added. The heterogeneous 
solution was stirred vigorously while iodobenzenediacetate (0.326 g, 1.01 mmol, 1.1 
equiv.) was added portion wise over 1 hour. The solution was stirred at room 
temperature for 14 hours. The reaction was diluted with CH2Cl2, washed with sat. 
NaHCO3, and dried over Na2SO4. The solvent was evaporated and crude mixture 
purified by flash chromatography (Rf = 0.5, 50% ether:50% pentane). Yield 131 mg 
(53%).  
1H NMR (400 MHz, CDCl3 )  ppm 7.77 (dd, J = 5.4, 3.0 Hz, 2H), 7.67 (dd, J = 5.4, 
3.0 Hz, 2H), 5.94 (dd, J = 11.2, 1.2 Hz, 1H), 5.84 (dddd, J = 11.2, 7.4, 5.4, 1.9 Hz, 
1H), 3.11-3.06 (m, 1H), 2.84-2.78 (m, 1H), 2.48-2.39 (m, 1H), 2.33 (dddd, J = 16.2, 
10.0, 7.4, 1.4 Hz, 1H), 2.06-1.96 (m, 1H), 1.85-1.73 (m, 1H), 1.73-1.64 (m, 2H), 1.63-
1.54 (m, 1H), 1.52-1.43 (m, 1H). 13C NMR (125 MHz, CDCl3 )  ppm 165.1, 135.1, 
133.9, 130.6, 122.9, 122.2, 50.7, 46.7, 28.8, 26.2, 26.1, 25.6. IR (neat) 2927, 2866, 
1712, 1378, 1184, 1153, 1048, 913, 745, 709, 526 cm-1. ESMS m/z 291.1 ([M+Na]+); 





N-Phthalimido-8-aza-bicyclo [5.1.0] oct-2-ene (2.3q): Cis,cis-1,3-cyclooheptadiene 
(0.10 g, 1.06 mmol, 1 equiv) was dissolved in dry CH2Cl2 (10.6 mL, 0.1 M) and N-
amino-phthalimide (0.215 g, 1.33 mmol, 1.25 equiv.) was added. The heterogeneous 
solution was stirred vigorously while iodobenzenediacetate (0.376 g, 1.17 mmol, 1.1 
equiv.) was added portion wise over 1 hour. The solution was stirred at room 
temperature for 14 hours. The reaction was diluted with CH2Cl2, washed with sat. 
NaHCO3, and dried over Na2SO4. The solvent was evaporated and crude mixture 
purified by flash chromatography (Rf = 0.4, 30% ether:70% pentane). Yield 270 mg 
(71%).  
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1H NMR (500 MHz, CDCl3 )  ppm 7.76 (2 H, dd, J = 5.4, 3.0 Hz), 7.67 (2 H, dd, J = 
5.4, 3.0 Hz), 6.14 (1 H, m), 5.93 (1 H, m), 3.06 (1 H, ddd, J = 8.2, 4.1, 4.1 Hz), 2.89 (1 
H, ddd, J = 8.2, 5.1, 0.57 Hz), 2.58-2.52 (1 H, m), 2.33-2.25 ( 1 H, m), 2.12-2.01 (2 H, 
m), 1.70-1.63 (2 H, m). 13C NMR (126 MHz, CDCl3 )  ppm 165.1, 137.1, 133.9, 
130.5, 123.3, 122.9, 52.1, 47.8, 31.1, 29.0, 23.7. IR (neat) 3020, 2930, 1713, 1377, 
1156, 909, 987, 707 cm-1; ESMS m/z 255.1 ([M+H]+); HRESMS m/z calcd for 





5-(tert-Butyldimethylsilyloxy)-N-phthalimido-8-aza-bicyclo [5.1.0] oct-2-ene (2.3r 
cis): tert-Butyl((3Z,5Z)-cyclohepta-3,5-dienyloxy)dimethylsilane17 (0.10 g, 0.45 
mmol, 1 equiv) was dissolved in dry CH2Cl2 (4.5 mL, 0.1 M) and N-amino-
phthalimide (0.091 mg, 0.56 mmol, 1.25 equiv.) was added. The heterogeneous 
solution was stirred vigorously while iodobenzenediacetate (0.159 g, 0.50 mmol, 1.1 
equiv.) was added portion wise over 1 hour. The solution was stirred at room 
temperature for 20 hours. The reaction was diluted with CH2Cl2, washed with sat. 
NaHCO3, and dried over Na2SO4. The solvent was evaporated and crude mixture 
purified by flash chromatography (Rf = 0.5, 20% ether:80% pentane). Yield 81 mg 
(47%).  
 
(2.3r cis): 1H NMR (600 MHz, CDCl3 )  7.77 (dd, J = 5.5, 3.0 Hz, 2H), 7.68 (dd, J = 
5.5, 3.0 Hz, 2H), 6.13 (dddd, J = 11.3, 3.1, 2.0, 1.2 Hz, 1H), 5.68-5.64 (m, 1H), 3.98 
(dddd, J = 10.8, 8.3, 4.5, 2.3 Hz, 1H), 2.94 (dt, J = 8.2, 8.1, 0.6 Hz, 1H), 2.90 (dd, J = 
7.8, 1.6 Hz, 1H), 2.77-2.72 (m, 1H), 2.67-2.61 (m, 1H), 2.28-2.21 (m, 1H), 1.86 (ddd, 
J = 14.2, 10.9, 7.8 Hz, 1H), 0.90 (s, 9H), 0.10 (s, 3H), 0.08 (s, 3H). 13C NMR (126 
MHz, CDCl3 )  ppm 165.0, 134.0, 130.4, 130.3, 123.0, 122.9, 67.1, 45.5, 44.9, 41.3, 
37.3, 25.8, 18.1, -4.7, -4.8. IR (neat) 2927, 2855, 1717, 1573, 1465, 1376, 1106, 1070, 
913, 745 cm-1. ESMS m/z 385.2 ([M+H]+); HRESMS m/z calcd for C21H29N2O3Si 
([M+H]+) 385.1947 found 385.1942. Stereochemistry confirmed by NOESY. 
 
(2.3r trans): 1H NMR (400 MHz, CDCl3 )  ppm 7.77 (dd, J = 5.4, 3.0 Hz, 2H), 7.68 
(dd, J = 5.4, 3.0 Hz, 2H), 6.19 (ddd, J = 11.4, 4.8, 2.9 Hz, 1H), 5.83 (ddd, J = 11.4, 
8.0, 3.5 Hz, 1H), 3.88 (dddd, J = 9.6, 9.5, 3.1, 3.1 Hz, 1H), 2.97-2.79 (m, 2H), 2.44-
2.26 (m, 1H), 2.26-2.16 (m, 1H), 0.89 (s, 9H), 0.10 (s, 3H), 0.07 (s, 3H). 13C NMR 
(75 MHz, CDCl3 )  ppm 165.0, 134.0, 131.6, 130.5, 124.5, 123.0, 68.4, 47.3, 47.1, 
40.1, 38.3, 25.8, 18.1, -4.8, -4.9. IR (neat) 2958, 2859, 1713, 1659, 1642, 1378,1254, 
111 
1074, 913, 745 cm-1. ESMS m/z 385.2 ([M+H]+); HRESMS m/z calcd for 





N-Phthalimido-7-azabicyclo[4.1.0]hept-2-ene (2.3s): Prepared according to general 






(-)-α-Phellandrene (technical 65%) (0.135 g, 0.644 mmol, 1 equiv) was dissolved in 
dry CH2Cl2 (9.2 mL, 0.1 M) and N-amino-phthalimide (0.187 g, 1.15 mmol, 1.25 
equiv.) was added. The heterogeneous solution was stirred vigorously while 
iodobenzenediacetate (0.326 g, 1.01 mmol, 1.1 equiv.) was added portion wise over 1 
hour. The solution was stirred at room temperature for 14 hours. The reaction was 
diluted with CH2Cl2, washed with sat. NaHCO3, and dried over Na2SO4. The solvent 
was evaporated and crude mixture purified by flash chromatography (Rf = 0.5, 20% 
ether:80% pentane) and then recrystallized from a solution of ether and pentane. Yield 
20 mg (23%).  
1H NMR (400 MHz, CDCl3 )  ppm  7.73 (dd, J = 5.4, 3.1 Hz, 2H), 7.65 (dd, J = 5.4, 
3.1 Hz, 2H), 5.62-5.53 (m, 1H), 2.95 (ddd, J = 7.7, 2.5, 1.1 Hz, 1H), 2.73 (d, J = 7.7 
Hz, 1H), 2.25-2.17 (m, 1H), 2.15-2.07 (m, 1H), 2.06 (d, J = 1.85 Hz, 3H), 1.99-1.87 
(m, 1H), 1.85-1.75 (m, 1H), 1.03 (d, J = 6.8 Hz, 3H), 0.97 (d, J = 6.8 Hz, 3H).  13C 
NMR (125 MHz, CDCl3)  ppm 165.1, 134.0, 130.5, 129.6, 125.0, 122.9, 48.6, 44.6, 
36.5, 31.3, 24.4, 21.7, 20.4, 20.3. IR (neat) 2956, 1714, 1684, 1653, 1635, 1616, 1558, 
1507, 1457, 1419, 1374  cm-1. ESMS m/z 297.2 ([M+H]+); HRESMS m/z calcd for 








N-Tosyl-1-vinyl-7-aza-bicyclo[4.1.0]heptane (2.3u): Methyltriphenylphosphonium 
bromide (0.256g, 0.72 mmol, 2 equiv.) was stirred under nitrogen in dry THF (4 mL) 
and cooled to -20 oC. A solution of potassium bis(trimethylsilyl)amide (0.5M in 
toluene, 1.4 mL, 0.72 mmol, 2 equiv.) was added dropwise and the resultant solution 
was stirred for 20 min. before addition of aziridino aldehyde19 (0.1 g, 0.36 mmol, 1 
equiv.) in 1 mL of THF. After 1 h at -20 oC the reaction was complete by TLC and 
was quenched with H2O, extracted with ether, and dried with Na2SO4. The solvent was 
removed and the crude mixture purified by flash chromatography (Rf = 0.8, 30% 
ether: 70% pentanes). Yield 55 mg (55%). 
1H NMR (500 MHz, CDCl3 )  ppm 7.82 (d, J = 8.2 Hz, 2H), 7.31 (d, J = 8.2 Hz, 2H), 
6.29 (dd, J = 17.4, 10.8 Hz, 1H), 5.47 (dd, J = 17.4, 0.7 Hz, 1H), 5.42 (dd, J = 10.8, 
0.7 Hz, 1H), 3.28 (d, J = 5.4 Hz, 1H), 2.44 (s, 3H), 2.18 (ddd, J = 7.9, 4.7, 4.7 Hz, 
1H), 1.96-1.88 (m, 1H), 1.88-1.81 (m, 1H), 1.64-1.56 (m, 1H), 1.51-1.32 (m, 3H), 
1.18-1.07 (m, 1H).  13C NMR (125 MHz, CDCl3)  ppm 143.5, 138.3, 136.1, 129.4, 
127.1, 118.9, 53.5, 47.6, 26.6, 22.6, 21.6, 20.1, 19.0. IR (neat) 2939, 2864, 1326, 
1154, 1090, 977, 933, 732, 659, 572 cm-1. ESMS m/z 278.1 ([M+H]+); HRESMS m/z 





N-Cyclohexenylmethylen-4-methylbenzenesulfonamide: A mixture of 1-Cyclohexene-
1-carboxaldehyde (0.10g, 0.91 mmol, 1 equiv.), p-toluenesulfonamide (0.155g, 0.91 
mmol, 1 equiv.), activated MS 4A and catalytic amount of Amberlyst-15 in dry 
toluene (5 mL) was heated in a sealed tube for 12 h. The mixture was filtered through 
Celite and concentrated. The resulting yellow oil was used in the next reaction (mostly 
pure) or can be purified by silica gel flash chromatography (slightly unstable). Yield 
215 mg  (90%).  
1H NMR (500 MHz, CDCl3 )  ppm 8.40 (s, 1H), 7.72 (d, J = 8.2 Hz, 2H), 7.22 (d, J 
= 8.2 Hz, 2H), 6.75-6.71 (m, 1H), 2.33 (s, 3H), 2.29-2.20 (m, 2H), 2.19-2.13 (m, 2H), 
1.59-1.50 (m, 4H). 13C NMR (125 MHz, CDCl3)  ppm 172.3, 153.8, 144.1, 137.2, 
135.6, 129.6, 127.8, 27.3, 22.7, 21.6, 21.5, 21.2. IR (neat) 2934, 2863, 1628, 1567, 
1319, 1158, 1090, 930, 807, 777, 696, 655, 568 cm-1. ESMS m/z 264.1 ([M+H]+); 
HRESMS m/z calcd for C14H18NO2S ([M+H]+) 264.1058 found 264.1058. 
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2-Cyclohexenyl-N-tosylaziridine (2.3v): Diethyl zinc (1.0 M in Hexanes, 0.4 ml, 0.4 
mmol, 2.1 equiv.) was added to a stirred solution of chloroiodomethane (62 mg, 0.34 
mmol, 2 equiv.) in 2 mL of dry CH2Cl2 under N2 at 0 oC. The solution is stirred for 10 
min. then tetrahydrothiophene is added (46 mg, 0.52 mmol, 3 equiv.). Lastly, the 
imine (2.26, 46 mg, 0.17 mmol, 1 equiv.) was added and reaction is warmed to RT 
slowly over 4 h. The reaction is quenched with sat. Na2S2O3 and extracted with 
CH2Cl2. The solution is dried with Na2SO4, solvent removed and purified by flash 
chromatography (Rf = 0.6, 20% ether: 80% pentanes). Yield 36 mg (75%).  
1H NMR (300 MHz, CDCl3 )  ppm 7.83 (d, J = 8.2 Hz, 2H), 7.33 (d, J = 8.2 Hz, 2H), 
5.82-5.77 (m, 1H), 3.24 (dd, J = 7.0, 4.8 Hz, 1H), 2.64 (d, J = 7.0 Hz, 1H), 2.45 (s, 
3H), 2.30 (d, J = 4.8 Hz, 1H), 2.03-1.93 (m, 2H), 1.91-1.62 (m, 2H), 1.63-1.47 (m, 
4H). 13C NMR (75 MHz, CDCl3)   ppm 144.3, 135.2, 131.4, 129.6, 127.9, 127.8, 
43.9, 32.1, 25.1, 23.9, 22.0, 21.7. IR (neat) 2927, 2859, 1597, 1449, 1323, 1160, 1094, 
958, 902, 815, 718, 669, 572 cm-1. ESMS m/z 278.1 ([M+H]+); HRESMS m/z calcd 





(E)-Methyl-3-(N-tosyl-7-aza-bicyclo[4.1.0]heptan-1-yl)acrylate (2.3w): Trimethyl 
phosphonoacetate (32 mg, 0.18 mmol, 2 equiv.) was stirred under nitrogen in dry THF 
(4 mL) and cooled to 0 oC. NaH (7 mg, 0.18 mmol, 2 equiv., 60% dispersion in 
mineral oil) was added to the solution and stirred for 5 min. The aziridino aldehyde20 
(0.025 g, 0.09 mmol, 1 equiv.) in 1 mL of THF was added slowly. The solution is 
warmed to room temperature overnight then quenched with H2O and extracted with 
CH2Cl2. The solution was dried with Na2SO4 and the solvent removed. The crude 
mixture is  purified by flash chromatography (Rf = 0.2, 30% ether: 70% pentanes). 
Yield 28 mg (95%, E:Z = 7:1).  
1H NMR (300 MHz, CDCl3 )  ppm 7.82 (d, J = 8.4 Hz, 2H), 7.33 (d, J = 8.4 Hz, 2H), 
7.27 (d, J = 15.9 Hz, 1H), 6.12 (d, J = 15.9 Hz, 1H), 3.79 (s, 3H), 3.38 (d, J = 5.3 Hz, 
1H), 2.46 (s, 3H), 2.25-2.08 (m, 1H), 2.04-1.91 (m, 1H), 1.90-1.77 (m, 1H), 1.76-1.63 
(m, 1H), 1.56-1.36 (m, 3H), 1.23-1.05 (m, 1H). 13C NMR (75 MHz, CDCl3)   ppm 
166.0, 145.2, 144.0, 137.4, 129.5, 127.3, 124.2, 51.8, 51.3, 48.0, 26.6, 22.6, 21.6, 19.8, 
18.8. IR (neat) 2945, 2862, 1724, 1650, 1597, 1436, 1313, 1154, 1090, 981, 929, 668, 
583 cm-1. ESMS m/z 336.1 ([M+H]+); HRESMS m/z calcd for C17H22NO4S 







(E)-Methyl-3-(3-methyl-1-tosylaziridin-2-yl)acrylate (2.3x): Prepared according to 
existing literature procedure and spectra matched existing literature data.21 
1H NMR (300 MHz, CDCl3) δ 7.81 (d, J = 8.3, 1H), 7.32 (d, J = 8.4, 1H), 6.83 (dd, J 
= 15.6, 8.7, 1H), 6.06 (d, J = 15.6, 1H), 4.18 (qd, J = 7.1, 2.1, 1H), 3.20 (dd, J = 8.7, 






1-Tosyl-2,5-dihydro-1H-pyrrole (2.4a): Prepared according to general procedure A. 
Spectra matched existing literature data.22 
1H NMR (300 MHz, CDCl3) δ 7.75 – 7.69 (m, 2H), 7.31 (d, J = 8.3, 2H), 5.65 (s, 2H), 





N-Phthalimido-2,5-dihydro-1H-pyrrole (2.4a): Prepared according to general 
procedure A. 
1H NMR (400 MHz, CDCl3)   ppm 7.85 (dd, J = 5.4, 3.1 Hz, 2H), 7.74 (dd, J = 5.4, 
3.1 Hz, 2H), 5.87 (s, 2H), 4.19 (s, 4H). 13C NMR (125 MHz, CDCl3) δ ppm 167.2, 
134.3, 130.2, 126.3, 123.3, 59.7. IR (neat) 2907, 2849, 1708, 1614, 1466, 1380, 1123, 
1010, 881, 713, 523 cm-1. ESMS m/z 237.1 ([M+Na]+); HRESMS m/z calcd for 




3-Methyl-1-tosyl-2,5-dihydro-1H-pyrrole (2.4c): Prepared according to general 
procedure A. Spectra matched existing literature data.23  
1H NMR (400 MHz, CDCl3): δ ppm 1.66 (mc, 3H), 2.43 (s, 3H), 3.95–3.98 (m, 2H), 
4.05–4.09 (m, 2H), 5.25 (mc, 1H), 7.32 (m, 2H), 7.72 (m, 2H); 13C NMR (100.6 
115 
MHz, CDCl3): δ ppm 14.1, 21.5, 55.1,57.7, 119.1, 127.5, 129.7, 134.4, 135.1, 143.3; 






3-Methyl-N-Phthalimido-2,5-dihydro-1H-pyrrole (2.4d): Prepared according to 
general procedure A. 
1H NMR (500 MHz, CDCl3)   ppm 7.85 (dd, J = 5.4, 3.1 Hz, 2H), 7.73 (dd, J = 5.4, 
3.1 Hz, 2H), 5.46 (s, 1H), 4.17 (bs, 2H), 4.08 (bs, 2H), 1.77 (s, 3H). 13C NMR (125 
MHz, CDCl3) δ ppm 167.2, 135.8, 134.3, 130.4, 123.3, 120.0, 62.4, 60.1, 14.6. IR 
(neat) 2965, 2853, 1783, 1723, 1382, 1202, 1117, 1052, 913, 885, 712, 523 cm-1. 
ESMS m/z 251.1 ([M+Na]+); HRESMS m/z calcd for C13H12N2O2Na ([M+Na]+) 





3-Methyl-N-phthalimido-2,5-dihydro-1H-pyrrole (2.4d): Prepared according to 
general procedure A. 
1H NMR (500 MHz, CDCl3)   ppm 7.85 (dd, J = 5.4, 3.1 Hz, 2H), 7.73 (dd, J = 5.4, 
3.1 Hz, 2H), 5.46 (s, 1H), 4.17 (bs, 2H), 4.08 (bs, 2H), 1.77 (s, 3H). 13C NMR (125 
MHz, CDCl3) δ ppm 167.2, 135.8, 134.3, 130.4, 123.3, 120.0, 62.4, 60.1, 14.6. IR 
(neat) 2965, 2853, 1783, 1723, 1382, 1202, 1117, 1052, 913, 885, 712, 523 cm-1. 
ESMS m/z 251.1 ([M+Na]+); HRESMS m/z calcd for C13H12N2O2Na ([M+Na]+) 





3,4-Dimethyl-1-tosyl-2,5-dihydro-1H-pyrrole (2.4f): Prepared according to general 





3,4-Dimethyl-N-(phthalamido)-3-pyrroline (2.4g): Prepared according to general 
procedure A. 
1H NMR (400 MHz, CDCl3)  ppm  7.84 (dd, J = 5.6, 3.0 Hz, 2H), 7.73 (dd, J = 5.6, 
3.0 Hz, 2H), 4.08 (s, 4H), 1.65 (s, 6H). 13C NMR (125 MHz, CDCl3) δ ppm 167.3, 
134.2, 130.3, 126.9, 123.3, 63.7, 11.4. IR (neat)  2884, 2849, 1727, 1381, 1207, 1118, 
1061, 913, 744, 711 cm-1. ESMS m/z 265.1 ([M+Na]+); HRESMS m/z calcd for 





2-Methyl-N-(phthalamido)-3-pyrroline (2.4h): Prepared according to general 
procedure A. 
1H NMR (400 MHz, CDCl3)   ppm  7.84 (dd, J = 5.5, 3.0 Hz, 2H), 7.73 (dd, J = 5.5, 
3.0 Hz, 2H), 5.82 (ddd, J = 6.3, 4.1, 2.1 Hz, 1H), 5.74 (tdd, J = 6.7, 2.4, 1.8, 1.8 Hz, 
1H), 4.58-4.48 (m, 1H), 4.28 (dddd, J = 12.8, 4.4, 2.5, 1.8 Hz, 1H), 4.08 (tdd, J = 
12.8, 5.1, 2.0, 2.0 Hz, 1H), 1.21 (d, J = 6.5 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 
ppm 167.5, 134.2, 131.7, 130.1, 125.4, 123.3, 65.3, 59.0, 20.3. IR (neat) 2972.6, 2848, 
1738, 1723, 1378, 1203, 882, 713 cm-1. ESMS m/z 251.1 ([M+Na]+); HRESMS m/z 





2-Methyl-1-tosyl-2,5-dihydro-1H-pyrrole (2.4i): Prepared according to general 





Methyl 1-tosyl-2,5-dihydro-1H-pyrrole-2-carboxylate (2.4j): Prepared according to 






Methyl-N-phthalimido-2-carboxylate-3-pyrroline (2.4j): General procedure A did not 





Methyl-N-phthalimido-2-carboxylate-3-pyrroline (2.4k): Prepared according to 
general procedure A. 
1H NMR (500 MHz, CDCl3 )  ppm 7.87 (dd, J = 5.5, 3.1 Hz, 2H), 7.75 (dd, J = 5.5, 
3.1 Hz, 2H), 6.01 (ddd, J = 6.6, 4.5, 2.0 Hz, 1H), 5.94 (dddd, J = 6.6, 2.2, 2.1, 2.0 Hz, 
1H), 5.19 (ddd, J = 7.4, 5.1, 2.3 Hz, 2H), 4.26-4.23 (m, 1H), 3.73 (s, 3H). 13C NMR 
(125 MHz, CDCl3)  ppm 171.0, 166.7, 134.4, 130.1, 128.4, 125.2, 123.5, 71.0, 60.2, 
52.4. IR (neat) 2952, 2862, 1787, 1725, 1467, 1382, 1204, 1121, 886, 715, 618, 523 
cm-1. ESMS m/z 295.1 ([M+Na]+); HRESMS m/z calcd for C14H12N2O4Na 





3-(t-Butyldimethylsiloxy)-N-tosyl-3-pyrroline (2.4l): Prepared according to general 
procedure A. 
 1H NMR (300 MHz, CDCl3) ppm 7.71 (d, J = 8.2 Hz, 2H), 7.32 (d, J = 8.2 Hz, 
2H), 4.51 (m, 1H), 4.08-4.00 (m, 2H), 3.92-3.84 (m, 2H), 2.42 (s, 3H), 0.86 (s, 9H), 
0.10 (s, 6H). 13C NMR (75 MHz, CDCl3)  ppm 148.6, 143.4, 133.9, 129.7, 127.5, 
96.7, 53.1, 52.4, 25.4, 21.5, 18.0, -4.9. IR (neat) 2955, 2930, 2859, 1662, 1349, 1265, 
1165, 842, 669, 549 cm-1. ESMS m/z 354.1 ([M+H]+); HRESMS m/z calcd for 







2,4-Diphenyl-N-tosyl-3-pyrroline (2.4m): Prepared according to general procedure A. 
1H NMR (400 MHz, CDCl3)  ppm 7.55 (d, J = 8.2 Hz, 2H), 7.35-7.33 (m, 1H), 7.33 
(bs, 3H), 7.32-7.25 (m, 6H), 7.19 (d, J = 8.2 Hz, 2H), 6.01 (dd, J = 2.0, 2.0, 1H), 5.66 
(ddd, J = 5.1, 2.5, 2.5 Hz, 1H), 4.74-4.61 (m, 2H), 2.37 (s, 3H). 13C NMR (125 MHz, 
CDCl3 )  ppm 143.2, 140.5, 136.2, 135.3, 132.3, 129.5, 128.6, 128.7, 128.5, 127.9, 
127.4, 127.2, 125.6, 124.0, 71.0, 55.4, 21.5. IR (neat) 3061, 3030, 2920, 2863, 1598, 
1495, 1450, 1347, 1163, 1098, 752, 665, 599, 547 cm-1. ESMS m/z 376.1([M+H]+); 













2-Tosyl-2,3,4,5,6,7-hexahydro-1H-isoindole (2.4n): Prepared according to general 
procedure A. Spectra matched existing literature data.27 
m.p. 133-134 oC. IR (nujol) 1340, 1162, 1099, 718 and 663 cm-1. 1H NMR (250 
MHz, CDCl3)  ppm 7.72 (2 H, d, J8.4, ArH), 7.32 (2 H, d, J8.4, ArH), 3.96 (4 H, s, 1-
H, and 3-H,), 2.43 (3 H, s, CH,), 2.0-1.8 (4 H, m, 2 x CH,) and 1.7-1.5 (4 H, m, 2 x 
CH,); 13C NMR (62.9 MHz, CDCl3)  ppm 143.2 , 134.5, 129.7, 127.6, 122.6, 57.1, 




N-Tosyl-9-aza-bicyclo[4.2.1]non-7-ene (2.4o): Prepared according to general 
procedure A. The Cu(hfacac)2 must be scrupulously dried prior to use. 
1H NMR (400 MHz, CDCl3)  ppm 7.65 (d, J = 8.2 Hz, 2H), 7.22 (d, J = 8.2 Hz, 2H), 
5.50 (d, J = 1.1 Hz, 2H), 4.69 (td, J = 6.3, 1.1, 2H), 2.39 (s, 3H), 2.02-1.92 (m, 2H), 
1.80-1.64 (m, 2H), 1.61-1.43 (m, 4H). 13C NMR (75 MHz, CDCl3 )  ppm 142.9, 
136.1, 130.8, 129.3, 127.0, 64.6, 33.1, 24.2, 21.5 cm-1. IR (neat) 2924, 2852, 1596, 
1337, 1298, 1159, 1104, 1044, 822, 666, 606 cm-1. ESMS m/z 278.1 ([M+H]+); 






N-Phthalimido-9-aza-bicyclo [4.2.1] non-7-ene (2.4p): Prepared according to general 
procedure A. 
1H NMR (500 MHz, CDCl3 )  ppm 7.78 (dd, J = 5.4, 3.1 Hz, 2H), 7.69 (dd, J = 5.4, 
3.1 Hz, 2H), 5.97 (d, J = 0.9 Hz, 2H), 4.17 (d, J = 6.5 Hz, 2H), 1.97 (ddd, J = 12.9, 
11.9, 6.5 Hz, 2H), 1.93-1.85 (m, 2H), 1.64-1.47 (m, 2H), 1.44-1.35 (m, 2H). 13C NMR 
(125 MHz, CDCl3 )  ppm 167.3, 134.0, 131.8, 130.2, 123.0, 72.1, 32.4, 24.4. IR 
(neat) 2920, 2853, 1725, 1374, 1202, 1079, 913, 745, 711, 673 cm-1. ESMS m/z 291.1 






N-Phthalimido-8-aza-bicyclo [3.2.1] oct-6-ene (2.4q): Prepared according to general 
procedure A. 
1H NMR (500 MHz, CDCl3 )  ppm 7.76-7.71 (m, 2H), 7.68-7.63 (m, 2H), 6.14 (bs, 
2H), 4.27 (bs,  2H), 2.13-2.02 (m, 2H), 1.51-1.42 (m, 4H). 13C NMR (125 MHz, 
CDCl3 )  ppm 166.2, 133.8, 130.4, 129.8, 122.8, 68.0, 26.0, 15.9. IR (neat) 2936, 
1772, 1713, 1371, 1318, 1118, 1043, 876, 707 cm-1.  ESMS m/z 277.1 ([M+Na]+); 





3-(tert-Butyldimethylsilyloxy)-N-phthalimido-8-aza-bicyclo [3.2.1] oct-6-ene (2.4r): 
Prepared according to general procedure A. 
1H NMR (400 MHz, CDCl3 )  ppm 7.73 (dd, J = 5.6, 3.0 Hz, 2H), 7.65 (dd, J = 5.6, 
3.0 Hz, 2H), 6.15-6.12 (m, 2H), 4.34 (dd,  J = 2.8, 2.8 Hz, 2H), 3.84 (m, 1H), 2.04 
(ddd, J = 12.3, 9.3, 2.8 Hz, 2H), 1.92 (ddd, J = 13.5, 6.8, 3.2, Hz, 2H), 1.90 (dd, J = 
6.8, 3.2 Hz, 1H), 0.86 (s, 9H), 0.00 (s, 6H).  13C NMR (125 MHz, CDCl3 )  ppm 
166.0, 133.8, 130.4, 130.3, 122.8, 66.7, 65.1, 36.0, 25.8, 25.6, 18.0, -4.7. IR (neat) 
2925, 2855, 1725, 1584, 1443, 1380, 1238, 1173, 1107, 913, 744 cm-1. ESMS m/z 
120 
385.2 ([M+H]+); HRESMS m/z calcd for C21H29N2O3Si([M+H]+) 385.1947 found 





trans-3-(tert-Butyldimethylsilyloxy)-N-phthalimido-8-aza-bicyclo [3.2.1] oct-6-ene 
(2.4r trans): General procedure A did not furnish product but slowly decomposed 





N-Phthalimido-7-azabicyclo[2.2.1]hept-2-ene (2.4s): Prepared according to general 















Prepared according to general procedure A. 
1H NMR (400 MHz, CDCl3 )  ppm 7.70 (dd, J = 5.5, 3.0 Hz, 2H), 7.62 (dd, J = 5.5, 
3.0 Hz, 2H), 5.60-5.53 (m, 1H), 4.71-4.65 (m, 1H), 2.17-2.07 (m, 1H), 2.04-1.95 (m, 
1H), 1.88 (d, J = 1.7 Hz, 3H), 1.03-0.92 (m, 1H), 0.91 (d, J = 5.8 Hz, 3H), 0.85 (d, J 
= 6.1 Hz, 3H), 0.72 (dd, J = 11.3, 4.3 Hz, 1H). 13C NMR (125 MHz, CDCl3)   ppm 
166.1, 145.7, 133.6, 130.6, 122.6, 122.0, 69.6, 69.0, 45.2, 32.4, 28.3, 21.4, 21.0. IR 
(neat) 2958, 1717, 1684, 1653, 1558, 1507, 1457, 1375, 1260, 750 cm-1. ESMS m/z 







N-Tosyl-2,4,5,6,7,7a-hexahydro-1H-indole (2.4u): Prepared according to general 
procedure A. 
1H NMR (600 MHz, CDCl3 )  ppm  7.73 (d, J = 8.0 Hz, 2H), 7.32 (d, J = 8.0 Hz, 
2H), 5.15 (bs, 1H), 4.16-4.07 (m, 1H), 4.02-3.97 (m, 2H), 2.53-2.46 (m, 1H), 2.43 (s, 
3H), 2.43-2.39 (m, 1H), 1.90-1.73 (m, 3H), 1.44-1.31 (m, 1H), 1.23-1.14 (m, 1H). 13C 
NMR (125 MHz, CDCl3)  ppm 143.2, 141.7, 134.8, 129.6, 127.5, 114.1, 66.4, 54.8, 
36.4, 28.3, 26.4, 23.9, 21.5. IR (neat) 2994, 2858, 1598, 1447, 1344, 1163, 1100, 
1068, 1043, 815, 675, 589, 550 cm-1. ESMS m/z 278.1 ([M+H]+); HRESMS m/z 





N-Tosyl-2,4,5,6,7,7a-hexahydro-1H-indole (2.4u): Prepared according to general 
procedure A. 
1H NMR (600 MHz, CDCl3 )  ppm  7.73 (d, J = 8.0 Hz, 2H), 7.32 (d, J = 8.0 Hz, 
2H), 5.15 (bs, 1H), 4.16-4.07 (m, 1H), 4.02-3.97 (m, 2H), 2.53-2.46 (m, 1H), 2.43 (s, 
3H), 2.43-2.39 (m, 1H), 1.90-1.73 (m, 3H), 1.44-1.31 (m, 1H), 1.23-1.14 (m, 1H). 13C 
NMR (125 MHz, CDCl3)  ppm 143.2, 141.7, 134.8, 129.6, 127.5, 114.1, 66.4, 54.8, 
36.4, 28.3, 26.4, 23.9, 21.5. IR (neat) 2994, 2858, 1598, 1447, 1344, 1163, 1100, 
1068, 1043, 815, 675, 589, 550 cm-1. ESMS m/z 278.1 ([M+H]+); HRESMS m/z 





Methyl-N-tosyl-2,4,5,6,7,7a-hexahydro-1H-indole-2-carboxylate (± 2.4w): Prepared 
according to general procedure A. 
1H NMR (400 MHz, CDCl3 )  ppm 7.75 (d, J = 8.2 Hz, 2H), 7.29 (d, J = 8.2 Hz, 2H), 
5.13 (dd, J = 2.0, 1.9 Hz, 1H), 4.97 (ddd, J = 3.3, 2.1, 2.0 Hz, 1H), 4.09-3.98 (m, 1H), 
3.73 (s, 3H), 2.40 (s, 3H), 2.39-2.35 (m, 1H), 2.35-2.26 (m, 1H), 1.95-1.80 (m, 1H), 
1.80-1.71 (m, 2H), 1.54-1.41 (m, 1H), 1.39-1.12 (m, 2H). 13C NMR (75 MHz, CDCl3) 
 ppm 170.9, 145.3, 143.6, 135.5, 129.7, 127.6, 113.6, 68.0, 67.2, 52.6, 36.4, 28.3, 
122 
26.3, 23.7, 21.6. IR (neat) 2940, 2861, 1760, 1737, 1436, 1349, 1276, 1164, 1100, 
913, 748, 593 cm-1. ESMS m/z 336.1 ([M+H]+); HRESMS m/z calcd for C17H22NO4S 





cis-Methyl 5-methyl-1-tosyl-2,5-dihydro-1H-pyrrole-2-carboxylate (± 2.4x): Prepared 






















2.31 2.32  
(E)-(S)-sec-Butyl 3-((R)-1-tosylaziridin-2-yl)acrylate (2.31): A solution of n-BuLi in 
hexanes (1.57 M, 290 μL, 0.45 mmol, 2.5 equiv.) was added drop wise to a solution of 
(S)-2-butanol (41 μL, 0.45 mmol) in THF (1.5 mL) at 0 °C. After stirring for 15 min 
the solution was cooled to -78 °C and to it was added 2.3j (R)30 (substrate 10) (50 mg, 
0.18 mmol, 1 equiv.) in THF (1.5 mL). The reaction was warmed to 0 °C, stirred for 
45 min, and poured into a separatory funnel containing Et2O and H2O. The crude 
material was extracted with Et2O, washed with H2O and brine, dried over Na2SO4, and 
evaporated to dryness. Flash chromatography (Rf = 0.45, 30% EtOAc:70% hexanes) 
afforded vinylaziridine 2.31 as a 8:1 mixture of diastereomers. Yield 48 mg (82%).  
1H NMR (400 MHz, CDCl3 )  ppm  7.82 (d, J = 8.2 Hz, 2H), 7.35 (d, J = 8.2 Hz, 
2H), 6.53 (dd, J = 15.6, 7.5 Hz, 1H), 6.10 (d, J=15.6 Hz, 1H), 4.87 (tq, J = 13.4,  6.3, 
Hz, 1H), 3.36 (ddd, J = 7.5, 7.2, 4.2 Hz, 1H), 2.86 (d, J = 7.2 Hz, 1H), 2.45 (s, 3H), 
2.27 (d, J = 4.2 Hz, 1H), 1.57 (dq, J = 13.4, 7.4 Hz, 2H), 1.21 (d, J = 6.3 Hz, 3H), 
0.88 (t, J = 7.4 Hz, 3H). 13C NMR (75 MHz, CDCl3)   ppm 164.9, 144.9, 141.2, 
134.5, 129.8, 127.9, 125.8, 72.7, 38.5, 34.6, 28.7, 21.6, 19.3, 9.6. IR (neat) 2974, 
2936, 1714, 1659, 1328, 1163, 1091, 980, 869, 816, 689, 569 cm-1. ESMS m/z 346.1 
([M+Na]+); HRESMS m/z calcd for C16H21NO4SNa ([M+Na]+) 346.1089 found 
346.1087. 
 
(S)-((S) sec-Butyl)-N-tosyl-2,5-dihydro-1H-pyrrole-2-carboxylate (2.32): Prepared 
according to general procedure A. 
1H NMR (400 MHz, CDCl3 )  ppm 7.80 (d, J = 8.2 Hz, 2H), 7.31 (d, J = 8.2 Hz, 2H), 
5.84 (m, 1H), 5.66 (m, 1H), 5.10 (m, 1H), 4.98-4.84 (m, 1H), 4.21-4.15 (m, 2H), 2.42 
(s, 3H), 1.68-1.49 (m, 2H), 1.25 (d, J = 6.3 Hz, 3H), 0.90 (t, J = 7.5 Hz, 3H). 13C 
123 
NMR (125 Mhz, CDCl3)  ppm 169.4, 143.7, 135.3, 129.7, 128.3, 127.5, 127.5, 
124.9, 73.9, 68.4, 55.0, 28.7, 21.6, 19.4, 9.6 cm-1. IR (neat) 294, 2934, 1752, 1728, 
1598, 1454, 1351, 1165, 1110, 817, 671, 598, 549 cm-1. ESMS m/z 346.1 ([M+Na]+); 




N-Tosyl hydroxyproline methyl ester (2.34):31 To a suspension of L-hydroxyproline 
methyl ester hydrochloride (350 mg, 1.9 mmol, 1 equiv.) in CH2Cl2 (10 mL) was 
added triethylamine (1.34 mL, 9.5 mmol, 5 equiv.) at 0 °C. The solution was stirred 
for 10 minutes at which point p-toluenesulfonyl chloride (725 mg, 3.8 mmol, 2 equiv.) 
in CH2Cl2 (10 mL) was added, followed by DMAP (24 mg, 0.20 mmol, 0.1 equiv.). 
The reaction mixture was allowed to warm to room temperature and stirred for 12 h. 
The solution was poured over EtOAc and washed with aqueous NH4Cl (sat.) and 
brine. The organic layer was dried over anhydrous Na2SO4, evaporated to dryness, and 
purified by flash chromatography. Yield: 565 mg (98%). 
 
N-Tosyl dehydroproline methyl ester (2.4j (R)):32 To a solution of N-tosyl 
hydroxyproline methyl ester (50 mg, 0.17 mmol, 1 equiv.) in CH2Cl2 (2 mL) was 
added Martin Sulfurane dehydrating reagent (343 mg, 0.51 mmol, 3 equiv.) at 0 °C. 
After stirring for 1 h the reaction solvent was removed by rotary evaporation and the 
remaining residue was purified by flash chromatography. Yield 28.2 mg (60%). 
 
N-Tosyl Dehydroproline (S)-2-Butanol Ester (2.35):33 N-Tosyl dehydroproline methyl 
ester 2.4j (R) (14 mg, 0.05 mmol, 1 equiv.) and trimethyltin hydroxide (45 mg, 0.25 
mmol, 5 equiv.) were dissolved in DCE (500 μL) and heated to 80 °C for 3 h in a 
sealed tube. The solvent was removed by rotary evaporation and the remaining residue 
was dissolved in EtOAc (2 mL) and washed with 5% aqueous HCl (3x). The solution 
was dried over Na2SO4 and concentrated by rotary evaporation. The crude hydrolysis 
product was immediately dissolved in CH2Cl2 (500 μL) and cooled to 0 °C. (S)-2-
Butanol (40 μL, 0.43 mmol, 8.5 equiv.), EDCI (11.5 mg, 0.06 mmol, 1.2 equiv), and 
DMAP (0.3 mg, 0.005 mmol. 0.1 equiv) were added sequentially. The reaction 
mixture was warmed to room temperature and stirred overnight. It was diluted with 
CH2Cl2 and washed with H2O, brine, and dried over Na2SO4. Purification by flash 
chromatography (Rf = 0.40, 30% EtOAc:70% hexanes) afforded N-tosyl 
dehydroproline (S)-2-butanol ester as a 6.3:1 mixture of diastereomers. Yield: 12.0 mg 
(70% from 2.4j (R)). 
1H NMR (400 MHz, CDCl3 )  ppm 7.80 (d, J = 8.2 Hz, 2H), 7.31 (d, J = 8.2 Hz, 2H), 
5.84 (m, 1H), 5.66 (m, 1H), 5.10 (m, 1H), 4.98-4.84 (m, 1H), 4.21-4.15 (m, 2H), 2.42 
(s, 3H), 1.68-1.49 (m, 2H), 1.25 (d, J = 6.3 Hz, 3H), 0.90 (t, J = 7.5 Hz, 3H). 13C 
124 
NMR (125 MHz, CDCl3)  ppm 169.4, 143.7, 135.3, 129.7, 128.3, 127.5, 127.5, 
124.9, 73.9, 68.4, 55.0, 28.7, 21.6, 19.4, 9.6 cm-1. IR (neat) 294, 2934, 1752, 1728, 
1598, 1454, 1351, 1165, 1110, 817, 671, 598, 549 cm-1. ESMS m/z 346.1 ([M+Na]+); 








































A2.2 1H and 13C NMR Spectra for Chapter 2  
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A2.3 Crystal Structure Data for Chapter 2  
 
Figure A2.1: Crystal Structure of Monomer: Copper(II) bis(1,1,1,5,5,5-











Figure A2.2: Crystal Structure of Chain 
 
Table A2.1: Crystal Data and Structure Refinement  
Empirical formula C26 H19 Cu F12 N2 O6  Theta range for data collection 1.99 to 33.60°. 
Formula weight 746.97  Index ranges -23<=h<=24, -11<=k<=13, -32<=l<=32 
Temperature 173(2) K  Reflections collected 20748 
Wavelength 0.71073 Å  Independent reflections 9274 [R(int) = 0.0259] 
Crystal system Monoclinic  Completeness to theta = 33.60° 88.9 % 
Space group C2  Absorption correction Semi-empirical from equivalents 
Unit cell dimensions a = 15.749(3) Å   = 90°  Max. and min. transmission 0.9190 and 0.6268 
 b = 9.1568(18) Å   = 98.84(3)°  Refinement method Full-matrix least-squares on 
F2 
 c = 20.736(4) Å    = 90°.  Data / restraints / parameters 9274 / 1 / 510 
Volume 2954.8(10) Å3  Goodness-of-fit on F2 1.046 
Z 4  Final R indices [I>2sigma(I)] R1 = 0.0461, wR2 = 0.1226 
Density (calculated) 1.679 Mg/m3  R indices (all data) R1 = 0.0831, wR2 = 0.1389 
Absorption coefficient 0.859 mm-1  Absolute structure parameter 0.509(9) 
F(000) 1496  Largest diff. peak and hole 0.707 and -0.643 e.Å-3 


























Table A2.2: Atomic Coordinates and Equivalent  Isotropic Displacement Pparameters 
 x y z Ueq  x y z Ueq 
Cu(1) 378(1) 3072(1) 2163(1) 30(1) C(1) 320(1) -699(2) 2033(1) 37(1) 
F(4) -1018(2) 1744(3) 4019(1) 115(1) C(2) -158(1) -1136(2) 1381(1) 34(1) 
F(5) -108(1) 3453(4) 4209(1) 103(1) C(3) -566(1) -367(2) 872(1) 43(1) 
F(6) -1441(2) 3909(4) 3976(1) 108(1) C(4) -959(1) -1194(3) 337(1) 49(1) 
F(4') -666(4) 4480(5) 4045(2) 115(2) C(5) -955(1) -2705(3) 324(1) 50(1) 
F(5') -275(3) 2327(6) 4204(2) 106(2) C(6) -548(1) -3471(3) 857(1) 49(1) 
F(6') -1529(2) 2636(7) 3963(1) 97(2) C(7) -159(1) -2649(2) 1393(1) 40(1) 
F(1) 851(1) 3425(4) 109(1) 165(1) C(8) 315(1) -3216(2) 2003(1) 42(1) 
F(2) 1959(1) 1923(2) 311(1) 101(1) N(9) 542(1) -1918(4) 2378(1) 35(1) 
F(3) 2064(1) 4204(2) 339(1) 79(1) N(10) 1124(1) -1971(3) 2959(1) 40(1) 
F(7) -2237(2) 3532(7) 988(1) 131(3) C(11) 808(1) -1179(3) 3488(1) 53(1) 
F(8) -2859(2) 4161(4) 1738(2) 69(1) C(12) 1443(2) -214(3) 3896(1) 64(1) 
F(9) -2772(2) 1944(5) 1652(3) 120(2) C(13) 1438(2) -117(4) 4557(2) 115(1) 
F(7') -2284(2) 2022(4) 1054(1) 76(1) C(14) 1118(3) -1095(4) 4960(2) 134(1) 
F(8') -2968(1) 2837(9) 1765(1) 126(2) C(15) 1432(3) -2494(5) 5068(2) 153(2) 
F(9') -2384(2) 4265(4) 1228(2) 122(2) C(16) 1314(3) -3727(4) 4588(2) 106(1) 
F(10) 3010(1) 3617(5) 3318(1) 146(2) C(17) 1428(2) -3664(3) 3939(2) 72(1) 
F(11) 3595(1) 4169(3) 2563(1) 66(1) C(18) 781(1) -2770(3) 3487(1) 45(1) 
F(12) 3519(2) 1912(3) 2665(2) 99(1) C(19) 1547(1) 3226(4) 460(1) 61(1) 
F(10') 3674(2) 2553(13) 2512(2) 209(5) C(20) 1464(1) 3101(5) 1196(1) 38(1) 
F(11') 3024(2) 2185(6) 3307(2) 86(1) C(21) 2212(1) 3153(5) 1643(1) 58(1) 
F(12') 3264(3) 4198(5) 2998(2) 102(2) C(22) 2195(1) 3103(5) 2308(1) 41(1) 
O(1) 500(1) 530(1) 2234(1) 54(1) C(23) 3064(1) 3082(7) 2759(1) 68(1) 
O(2) 486(1) -4419(2) 2206(1) 62(1) C(24) -2304(1) 3066(7) 1535(1) 67(1) 
O(3) 706(1) 3110(3) 1303(1) 33(1) C(25) -1445(1) 3058(5) 2011(1) 40(1) 
O(4) 1566(1) 3087(3) 2596(1) 34(1) C(26) -1483(1) 3117(5) 2672(1) 45(1) 
O(5) 29(1) 3108(3) 3017(1) 38(1) C(27) -730(1) 3087(5) 3119(1) 36(1) 
O(6) -805(1) 3056(3) 1725(1) 37(1) C(28) -818(1) 3109(6) 3847(1) 56(1) 
Atomic coordinates ( x 104) and equivalent  isotropic displacement parameters (Å2x 103). 
U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
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Table A2.3: Bond Lengths [Å] and Angles [°] 
Bond lengths [Å] Angles [°] Angles [°] 
Cu(1)- -O(3)  1.9313(10) O(3)- Cu(1) -O(5) 177.79(11) F(12')- C(23) -F(10) 47.4(4) 
Cu(1)- -O(5)  1.9327(10) O(3)- Cu(1) -O(6) 86.66(4) F(10')- C(23) -F(10) 133.1(3) 
Cu(1)- -O(6)  1.9427(10) O(5)- Cu(1) -O(6) 92.39(4) F(12')- C(23) -F(12) 131.4(3) 
Cu(1)- -O(4)  1.9470(10) O(3)- Cu(1) -O(4) 92.94(4) F(10')- C(23) -F(12) 32.7(5) 
Cu(1)- -O(2)#1  2.3040(18) O(5)- Cu(1) -O(4) 88.01(4) F(10)- C(23) -F(12) 124.1(3) 
Cu(1)- -O(1)  2.3390(15) O(6)- Cu(1) -O(4) 179.59(4) F(12')- C(23) -F(11) 50.3(4) 
F(4)- -C(28)  1.351(6) O(3)- Cu(1) -O(2)#1 89.35(9) F(10')- C(23) -F(11) 68.0(5) 
F(5)- -C(28)  1.286(3) O(5)- Cu(1) -O(2)#1 88.73(10) F(10)- C(23) -F(11) 96.8(4) 
F(6)- -C(28)  1.286(4) O(6)- Cu(1) -O(2)#1 94.91(9) F(12)- C(23) -F(11) 99.86(18) 
F(4')- -C(28)  1.331(7) O(4)- Cu(1) -O(2)#1 85.14(9) F(12')- C(23) -F(11') 102.3(4) 
F(5')- -C(28)  1.264(5) O(3)- Cu(1) -O(1) 92.58(9) F(10')- C(23) -F(11') 103.6(6) 
F(6')- -C(28)  1.258(4) O(5)- Cu(1) -O(1) 89.50(10) F(10)- C(23) -F(11') 58.3(3) 
F(1)- -C(19)  1.2324(19) O(6)- Cu(1) -O(1) 94.93(9) F(12)- C(23) -F(11') 74.8(4) 
F(2)- -C(19)  1.415(3) O(4)- Cu(1) -O(1) 85.03(9) F(11)- C(23) -F(11') 138.6(2) 
F(3)- -C(19)  1.261(3) O(2)#1-Cu(1) -O(1) 170.06(5) F(12')- C(23) -C(22) 114.1(5) 
F(7)- -C(24)  1.231(4) C(1)- O(1) -Cu(1) 152.26(13) F(10')- C(23) -C(22) 114.9(3) 
F(8)- -C(24)  1.435(5) C(8)- O(2) -Cu(1)#2 153.42(15) F(10)- C(23) -C(22) 111.9(2) 
F(9)- -C(24)  1.310(6) C(20)- O(3) -Cu(1) 124.35(8) F(12)- C(23) -C(22) 111.9(4) 
F(7')- -C(24)  1.386(5) C(22)- O(4) -Cu(1) 124.25(8) F(11)- C(23) -C(22) 109.2(3) 
F(8')- -C(24)  1.233(3) C(27)- O(5) -Cu(1) 124.77(8) F(11')- C(23) -C(22) 110.7(3) 
F(9')- -C(24)  1.266(6) C(25)- O(6) -Cu(1) 124.40(8) F(8')- C(24) -F(7) 127.8(2) 
F(10)- -C(23)  1.273(4) O(1)- C(1) -N(9) 123.92(18) F(8')- C(24) -F(9') 108.5(5) 
F(11)- -C(23)  1.401(5) O(1)- C(1) -C(2) 127.89(17) F(7)- C(24) -F(9') 41.6(4) 
F(12)- -C(23)  1.320(6) N(9)- C(1) -C(2) 108.18(17) F(8')- C(24) -F(9) 42.1(4) 
F(10')- -C(23)  1.254(6) C(3)- C(2) -C(7) 122.39(19) F(7)- C(24) -F(9) 125.0(4) 
F(11')- -C(23)  1.410(6) C(3)- C(2) -C(1) 132.91(18) F(9')- C(24) -F(9) 139.3(3) 
F(12')- -C(23)  1.157(7) C(7)- C(2) -C(1) 104.60(17) F(8')- C(24) -F(7') 106.0(4) 
O(1)- -C(1)  1.218(2) C(2)- C(3) -C(4) 115.86(19) F(7)- C(24) -F(7') 64.0(3) 
O(2)- -C(8)  1.195(3) C(5)- C(4) -C(3) 123.4(2) F(9')- C(24) -F(7') 104.4(3) 
O(2)- -Cu(1)#2  2.3040(18) C(4)- C(5) -C(6) 119.7(2) F(9)- C(24) -F(7') 70.6(4) 
O(3)- -C(20)  1.2481(15) C(5)- C(6) -C(7) 117.0(2) F(8')- C(24) -F(8) 54.1(4) 
O(4)- -C(22)  1.2344(16) C(2)- C(7) -C(6) 121.5(2) F(7)- C(24) -F(8) 99.8(4) 
O(5)- -C(27)  1.2454(16) C(2)- C(7) -C(8) 111.67(19) F(9')- C(24) -F(8) 61.5(3) 
O(6)- -C(25)  1.2463(16) C(6)- C(7) -C(8) 126.7(2) F(9)- C(24) -F(8) 96.1(2) 
C(1)- -N(9)  1.343(3) O(2)- C(8) -N(9) 123.3(2) F(7')- C(24) -F(8) 140.8(2) 
C(1)- -C(2)  1.498(2) O(2)- C(8) -C(7) 133.6(2) F(8')- C(24) -C(25) 117.57(19) 
C(2)- -C(3)  1.347(3) N(9)- C(8) -C(7) 103.08(18) F(7)- C(24) -C(25) 113.6(2) 
C(2)- -C(7)  1.385(2) C(1)- N(9) -N(10) 124.7(3) F(9')- C(24) -C(25) 109.6(4) 
C(3)- -C(4)  1.406(3) C(1)- N(9) -C(8) 112.19(13) F(9)- C(24) -C(25) 109.9(4) 
C(4)- -C(5)  1.384(3) N(10)- N(9) -C(8) 120.9(3) F(7')- C(24) -C(25) 110.0(3) 
C(5)- -C(6)  1.381(3) N(9)- N(10) -C(11) 111.99(16) F(8)- C(24) -C(25) 109.2(3) 
C(6)- -C(7)  1.404(3) N(9)- N(10) -C(18) 112.77(16) O(6)- C(25) -C(26) 129.33(12) 
C(7)- -C(8)  1.462(3) C(11)- N(10) -C(18) 59.21(12) O(6)- C(25) -C(24) 112.82(12) 
C(8)- -N(9)  1.434(4) C(18)- C(11) -N(10) 61.06(18) C(26)- C(25) -C(24) 117.79(13) 
N(9)- -N(10)  1.3980(15) C(18)- C(11) -C(12) 127.4(2) C(25)- C(26) -C(27) 119.91(13) 
N(10)- -C(11)  1.466(3) N(10)- C(11) -C(12) 116.15(19) O(5)- C(27) -C(26) 129.03(12) 
N(10)- -C(18)  1.485(3) C(13)- C(12) -C(11) 119.7(2) O(5)- C(27) -C(28) 113.60(11) 
C(11)- -C(18)  1.458(3) C(12)- C(13) -C(14) 128.6(3) C(26)- C(27) -C(28) 117.30(12) 
C(11)- -C(12)  1.496(3) C(13)- C(14) -C(15) 123.3(4) F(6')- C(28) -F(5') 103.5(4) 
C(12)- -C(13)  1.375(4) C(14)- C(15) -C(16) 126.0(3) F(6')- C(28) -F(6) 54.9(3) 
C(13)- -C(14)  1.373(5) C(17)- C(16) -C(15) 126.3(3) F(5')- C(28) -F(6) 132.0(3) 
C(14)- -C(15)  1.379(5) C(16)- C(17) -C(18) 116.7(3) F(6')- C(28) -F(5) 133.8(2) 
C(15)- -C(16)  1.497(5) C(11)- C(18) -N(10) 59.73(17) F(5')- C(28) -F(5) 49.3(3) 
C(16)- -C(17)  1.386(5) C(11)- C(18) -C(17) 121.5(2) F(6)- C(28) -F(5) 111.2(4) 
C(17)- -C(18)  1.515(4) N(10)- C(18) -C(17) 115.9(2) F(6')- C(28) -F(4') 112.8(5) 
C(19)- -C(20)  1.556(2) F(1)- C(19) -F(3) 108.8(3) F(5')- C(28) -F(4') 106.2(4) 
C(20)- -C(21)  1.3836(18) F(1)- C(19) -F(2) 113.1(2) F(6)- C(28) -F(4') 60.3(4) 
C(21)- -C(22)  1.384(2) F(3)- C(19) -F(2) 102.92(14) F(5)- C(28) -F(4') 59.3(3) 
C(22)- -C(23)  1.5347(19) F(1)- C(19) -C(20) 112.87(13) F(6')- C(28) -F(4) 51.6(3) 
C(24)- -C(25)  1.547(2) F(3)- C(19) -C(20) 113.6(2) F(5')- C(28) -F(4) 59.0(4) 
C(25)- -C(26)  1.3809(19) F(2)- C(19) -C(20) 105.2(2) F(6)- C(28) -F(4) 104.7(3) 
C(26)- -C(27)  1.3894(18) O(3)- C(20) -C(21) 128.30(13) F(5)- C(28) -F(4) 106.8(3) 
C(27)- -C(28)  1.536(2) O(3)- C(20) -C(19) 113.69(11) F(4')- C(28) -F(4) 145.9(3) 
C(21)- C(20) -C(19) 117.61(13) F(6')- C(28) -C(27) 113.6(2) 
C(20)- C(21) -C(22) 121.40(14) F(5')- C(28) -C(27) 114.4(3) 
O(4)- C(22) -C(21) 128.59(12) F(6)- C(28) -C(27) 113.6(3) 
O(4)- C(22) -C(23) 114.25(12) F(5)- C(28) -C(27) 112.02(17) 
C(21)- C(22) -C(23) 117.15(13) F(4')- C(28) -C(27) 106.1(4) 
Symmetry transformations used to 
generate equivalent atoms: 
#1 x,y+1,z    #2 x,y-1,z 
 
F(12')- C(23) -F(10') 109.9(6) F(4)- C(28) -C(27) 107.9(3) 
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Table A2.4:  Anisotropic Displacement Parameters   
 U11 U22 U33 U23 U13 U12 
Cu(1) 27(1) 35(1) 27(1) -1(1) 2(1) -1(1) 
F(4) 189(3) 106(2) 51(1) 23(1) 27(2) -42(2) 
F(5) 50(1) 224(4) 35(1) -32(2) 8(1) -39(2) 
F(6) 132(2) 133(2) 58(2) -25(2) 16(2) 61(2) 
F(4') 206(5) 93(3) 56(2) -33(2) 47(3) -34(3) 
F(5') 79(2) 202(5) 38(2) 43(2) 20(2) 56(3) 
F(6') 40(1) 219(7) 39(1) 33(2) 26(1) 6(2) 
F(1) 44(1) 413(3) 39(1) 81(1) 4(1) 18(2) 
F(2) 195(2) 65(1) 56(1) -33(1) 57(1) -23(1) 
F(3) 62(1) 120(1) 59(1) 2(1) 20(1) -19(1) 
F(7) 28(1) 334(8) 31(1) 29(3) 4(1) 12(2) 
F(8) 47(1) 83(2) 72(2) 12(2) -3(1) 20(1) 
F(9) 26(1) 105(3) 212(5) -58(3) -35(2) 1(2) 
F(7') 49(1) 129(2) 46(1) -43(1) -7(1) 2(2) 
F(8') 27(1) 301(6) 50(1) 0(4) 11(1) -12(3) 
F(9') 94(2) 89(2) 155(3) 29(2) -75(2) 16(2) 
F(10) 45(1) 356(7) 32(1) -29(2) -9(1) -11(2) 
F(11) 41(1) 86(2) 65(1) -8(1) -10(1) -24(1) 
F(12) 46(1) 89(2) 148(3) 28(2) -32(2) 2(1) 
F(10') 38(2) 546(16) 43(2) -6(5) 4(2) 70(5) 
F(11') 41(2) 168(4) 42(2) 44(2) -11(2) 5(2) 
F(12') 90(3) 104(3) 94(3) 1(3) -44(2) -52(2) 
O(1) 75(1) 21(1) 62(1) -1(1) 1(1) 1(1) 
O(2) 83(1) 33(1) 60(1) -1(1) -21(1) 3(1) 
O(3) 29(1) 41(1) 28(1) 2(1) 1(1) -5(1) 
O(4) 28(1) 44(1) 29(1) 2(1) 1(1) 4(1) 
O(5) 33(1) 52(1) 29(1) 3(1) 3(1) 2(1) 
O(6) 29(1) 53(1) 28(1) -4(1) 2(1) 3(1) 
C(1) 35(1) 34(1) 42(1) -5(1) 9(1) 0(1) 
C(2) 33(1) 30(1) 38(1) 2(1) 6(1) -4(1) 
C(3) 45(1) 41(1) 44(1) 0(1) 8(1) 8(1) 
C(4) 35(1) 74(1) 38(1) 9(1) 7(1) 3(1) 
C(5) 45(1) 60(1) 44(1) -7(1) -2(1) 1(1) 
C(6) 43(1) 50(1) 52(1) -13(1) 7(1) -4(1) 
C(7) 33(1) 47(1) 41(1) -5(1) 9(1) -7(1) 
C(8) 46(1) 29(1) 50(1) -10(1) 1(1) -2(1) 
N(9) 35(1) 28(1) 41(1) -1(2) 1(1) 1(2) 
N(10) 34(1) 43(1) 42(1) -8(2) 2(1) 10(1) 
C(11) 49(1) 63(1) 45(1) -9(1) 4(1) 18(1) 
C(12) 52(1) 81(2) 57(1) -34(1) 6(1) -18(1) 
C(13) 161(3) 82(2) 78(2) -4(2) -55(2) -47(2) 
C(14) 206(3) 112(2) 106(2) -57(2) 91(2) -40(2) 
C(15) 264(5) 134(4) 58(2) -13(2) 15(3) 47(3) 
C(16) 151(3) 96(2) 60(2) 39(2) -19(2) -37(2) 
C(17) 92(2) 54(2) 63(2) 7(1) -6(2) 5(1) 
C(18) 41(1) 54(1) 41(1) 3(1) 2(1) 8(1) 
C(19) 33(1) 113(2) 38(1) -47(1) 5(1) -20(1) 
C(20) 32(1) 53(1) 29(1) 1(2) 0(1) 6(2) 
C(21) 30(1) 108(2) 34(1) -9(2) 3(1) -9(2) 
C(22) 29(1) 57(1) 35(1) -2(2) -1(1) -11(2) 
C(23) 28(1) 132(2) 41(1) 24(3) -3(1) 8(3) 
C(24) 33(1) 118(2) 48(1) -23(3) -2(1) 2(3) 
C(25) 32(1) 54(1) 34(1) -3(2) 1(1) 15(2) 
C(26) 33(1) 66(1) 38(1) 6(2) 8(1) -3(2) 
C(27) 36(1) 42(1) 31(1) 0(2) 6(1) 6(2) 
C(28) 47(1) 84(1) 39(1) 15(2) 12(1) 1(3) 
Anisotropic displacement parameters  (Å2x 103). The anisotropic displacement factor exponent takes the form:  -22[ h2 a*2U11 









Table A2.5:  Hydrogen Coordinates and Isotropic Displacement Parameters 
H(3A) -587 670 874 52 
H(4A) -1242 -689 -36 59 
H(5A) -1231 -3213 -50 60 
H(6A) -533 -4509 860 58 
H(10A) 1711 -1993 2942 48 
H(11A) 233 -712 3355 63 
H(12A) 1849 329 3699 77 
H(13A) 1688 742 4762 138 
H(14A) 496 -1192 4795 161 
H(14B) 1165 -623 5393 161 
H(15A) 1205 -2849 5459 184 
H(15B) 2060 -2389 5199 184 
H(16A) 1696 -4518 4786 127 
H(16B) 719 -4080 4585 127 
H(17A) 1418 -4675 3769 86 
H(17B) 2007 -3262 3921 86 
H(18A) 200 -3220 3364 55 
H(21A) 2749 3224 1490 69 
H(26A) -2023 3177 2820 54 
Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
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A3.1 Experimental Procedures for Chapter 3 
 
General Information:  Commercial reagents were purchased and used without 
further purification.  All glassware was flame dried and reactions were performed 
under a nitrogen atmosphere, unless otherwise stated.  Toluene, benzene, 
dichloromethane, diethyl ether, and THF were dried over a column of alumina.  Flash 
chromatography was done with Silicycle SiliaFlash® F60 silica, and thin layer 
chromatography (TLC) was performed with EMD 250 μm silica gel 60-F254 plates.  1H 
and 13C NMR data was acquired on a Varian Inova 400, 500, or 600 (400, 500 or 600 
MHz) or an ARX 300 Bruker (300 MHz) spectrometer and referenced to residual 
protic solvent. IR spectra were taken on a Mattson Instruments Research Series FTIR 
spectrometer.  High-resolution mass spectrometry was performed at the University of 
Illinois at Urbana-Champaign facility.  Enantiomeric ratios were determined on an HP 
1100 Series HPLC with a Daicel Chiracel® OD-H (0.46 cm x 25 cm) column. 
Measurements of optical rotation were done on a Rudolph Research Analytic Autopol 





2-Phenyl-1-tosyl-3-vinylaziridine (3.20a): To a solution of aziridine 3.20i (0.040 
mmol, in CH2Cl2 and THF as described below) was added p-toluenesulfonyl chloride 
(11.5 mg, 0.060 mmol, 1.5 equiv.). Lastly, triethylamine (0.025 mL, 18.2 mg, 0.18 
mmol, 4.5 equiv.) was added and the reaction was stirred for 12 hours at room 
temperature. The reaction is concentrated and then purified by chromatography on 
silica gel to yield aziridine 3.20a (4.4 mg, 37%). This aziridine has previously been 
prepared and characterized as a cis/trans mixture.1 
1H NMR (600 MHz, CDCl3) δ 7.84 (d, J = 8.3, 2H), 7.29 – 7.24 (m, 5H), 7.17 (dd, J = 
7.6, 1.8, 2H), 6.33 (dt, J = 17.0, 10.0, 1H), 5.57 (d, J = 17.0, 1H), 5.48 (d, J = 10.3, 
1H), 4.05 (d, J = 4.0, 1H), 3.30 (dd, J = 9.7, 4.1, 1H), 2.40 (s, 3H). 13C NMR (151 
MHz, CDCl3) δ 144.4, 137.2, 135.2, 131.3, 129.8, 128.8, 128.5, 127.7, 126.5, 123.0, 







cis/trans-N-Phthalimido-2-phenyl-3-vinylaziridine (3.20b): trans-1-phenyl-butadiene2 
(0.50g, 3.8 mmol, 1 equiv.) was dissolved in dry CH2Cl2 (40 mL, 0.1 M) and N-
amino-phthalimide (1.25 g, 7.68 mmol, 2.0 equiv.) was added. The heterogeneous 
solution was stirred vigorously while iodobenzenediacetate (1.86 g, 7.68 mmol, 1.0 
equiv.) was added portion wise over 15 minutes. The solution was stirred at room 
temperature for 14 hours. The reaction was diluted with CH2Cl2, washed with sat. 
NaHCO3, and dried over Na2SO4. The solvent was evaporated and crude mixture 
purified by flash chromatography to yield aziridine 3.20b (0.716 g, 64%). This 
aziridine has previously been prepared using an alternative method and characterized.3 
Major invertomer: 1H NMR (400 MHz, CDCl3) δ 7.80 (dd, J = 5.5, 3.0, 2H), 7.70 (dd, 
J = 5.5, 3.0, 2H), 7.49 – 7.44 (m, 2H), 7.42 – 7.32 (m, 3H), 5.78 (ddd, J = 17.1, 10.4, 
7.9, 1H), 5.56 (ddd, J = 17.1, 1.1, 0.6, 1H), 5.37 (dd, J = 10.3, 1.1, 1H), 4.20 (d, J = 
5.4, 1H), 3.42 (dd, J = 7.9, 5.4, 1H). 13C NMR (101 MHz, CDCl3) δ 165.9 136.4, 
134.3, 130.7, 130.6, 128.8, 128.3, 127.2, 123.3, 122.4, 52.2, 48.6. IR (neat) 3191, 





1,2-Diphenyl-3-vinylaziridine (3.20c): 2-phenyl-3-vinyloxirane4 (0.10 g, 0.68 mmol, 1 
equiv.) was heated neat in aniline (0.50 mL, 0.51 g, 5.49 mmol, 8 equiv.) at 85oC for 6 
days. The amino alcohol can be isolated by silica gel chromatography but was used 
crude in the next step. The amino alcohol has been synthesized by an alternate route 
and characterized previously.5 To the crude amino alcohol was added THF (12 mL, 
0.05 M) and PPh3 (0.54 g, 2.05 mmol, 3 equiv.). Lastly, diisopropyl azodicarboxylate 
(0.40 mL, 0.42 g, 2.05 mmol, 3 equiv.) is added slowly and the reaction is stirred for 
40 hours at room temperature. The reaction is concentrated and purified by 
chromatography on silica gel to yield aziridine 3.20c (0.065 g, 43%). This aziridine 
has previously been prepared using an alternative method and characterized.6 
1H NMR (400 MHz,CDC) δ 7.39 – 7.30 (m, 4H), 7.30 – 7.17 (m, 3H), 6.99 – 6.91 (m, 
3H), 5.52 – 5.40 (m, 1H), 5.29 – 5.15 (m, 2H), 3.26 (d, J = 2.7, 1H), 3.12 – 3.01 (m, 
1H). 13C NMR (101 MHz, CDCl3) δ 149.8, 138.5, 134.8, 129.0, 128.6, 127.6, 126.4, 
122.3, 120.9, 119.4, 51.2, 48.1. IR (neat) 3062, 1597, 1488, 1455, 1430, 1395, 1310, 
1265, 1154, 987, 905, 758, 695 cm-1. HRMS (ESI) m/z 222.1286 [calculated mass for 






anti-1-(Benzylamino)-1-phenylbut-3-en-2-ol: 2-phenyl-3-vinyloxirane7 (0.079 g, 0.54 
mmol, 1 equiv.) was heated neat in benzylamine (0.50 mL, 0.49 g, 4.58 mmol, 8.5 
equiv.) at 85oC for 2 days. The crude reaction was loaded on to a column of silica gel 
and amino alcohol can be isolated by silica gel chromatography to anti amino alcohol 
(0.128 g, 93%). A small amount of the syn amino alcohol was isolated and 
characterized presumably from the vinyloxirane starting material not being completely 
isomerically pure. 
NH
OH 3.43  
 
anti-1-(Benzylamino)-1-phenylbut-3-en-2-ol: 
1H NMR (400 MHz, CDCl3) δ 7.34 – 7.20 (m, 5H), 5.57 (ddd, J = 17.3, 10.3, 8.3, 
1H), 5.21 (dd, J = 10.3, 1.6, 1H), 5.13 – 5.08 (m, 1H), 4.69 (d, J = 5.1, 1H), 3.82 (d, J 
= 13.3, 1H), 3.66 (d, J = 13.3, 1H), 3.32 (dd, J = 8.2, 5.1, 1H). 13C NMR (101 MHz, 
CDCl3) δ 140.9, 140.1, 136.7, 128.6, 128.3(0), 128.2(9), 127.7, 127.3, 126.9, 119.1, 
74.6, 66.4, 51.1. IR (neat) 3420, 3026, 1493, 1452, 1027, 991, 921, 748, 697 cm-1. 
HRMS (ESI) m/z 254.1539 [calculated mass for C17H20NO (M+H+) 254.1545]. 
 
NH
OH 3.44  
 
syn-1-(Benzylamino)-1-phenylbut-3-en-2-ol: 
1H NMR (400 MHz, CDCl3) δ 7.39 – 7.23 (m, 10H), 5.65 (ddd, J = 17.2, 10.5, 5.8, 
1H), 5.28 (dt, J = 17.2, 1.6, 1H), 5.17 – 5.13 (m, 1H), 4.29 – 4.25 (m, 1H), 3.82 (d, J = 
5.2, 1H), 3.76 (d, J = 13.1, 1H), 3.59 (d, J = 13.1, 1H), 2.71 (bs, 1H), 1.95 (bs, 1H). 
13C NMR (101 MHz, CDCl3) δ 140.2, 139.4, 137.0, 128.7, 128.6, 128.4, 128.2, 127.8, 
127.3, 117.3, 75.3, 66.3, 51.3. IR (neat) 3326, 3026, 2847, 1652, 1439, 1453, 1363, 
1116, 1027, 992, 924, 683 cm-1. HRMS (ESI) m/z 254.1537 [calculated mass for 





trans-1-Benzyl-2-phenyl-3-vinylaziridine (3.20d trans): To anti-1-(benzylamino)-1-
phenylbut-3-en-2-ol (0.045 g, 0.178 mmol, 1 equiv.) was added THF (2 mL, 0.1 M) 
and PPh3 (0.070 g, 0.27 mmol, 1.5 equiv.). Lastly, diisopropyl azodicarboxylate 
(0.050 mL, 0.053 g, 0.26 mmol, 1.5 equiv.) is added slowly and the reaction is stirred 
for 10 hours at room temperature. The reaction is concentrated and purified by 
chromatography on silica gel to yield aziridine 3.20d (22.5 mg, 57%). This aziridine 
has previously been prepared using an alternative method but not characterized.8 
 
1H NMR (400 MHz, CDCl3) δ 7.39 – 7.18 (m, 5H), 5.96 (dt, J = 16.9, 9.7, 1H), 5.49 – 
5.42 (m, 1H), 5.35 (dd, J = 10.3, 1.1, 1H), 4.02 (d, J = 14.2, 1H), 3.79 (d, J = 14.3, 
1H), 2.77 – 2.71 (m, 2H). 13C NMR (101 MHz, CDCl3) δ 139.9(3), 139.8(5), 132.9, 
128.5(2), 128.4(8), 127.9, 127.1, 127.0, 126.3, 120.8, 56.9, 50.4, 49.4. IR (neat) 3028, 
1773, 1632, 1603, 1495 1452, 1355, 1250, 1026, 914, 731, 696 cm-1. HRMS (ESI) 





tert-Butyl 2-phenyl-3-vinylaziridine-1-carboxylate (3.20e): 
 
To a solution of aziridine 3.20i (0.040 mmol, in CH2Cl2 and THF as described below) 
was added Di-tert-butyl dicarbonate (17.5 mg, 0.080 mmol, 2 equiv.). Lastly, 
triethylamine (8.4 mg, 0.083 mmol, 1 equiv.) was added and the reaction was stirred 
for 8 hours at room temperature. The reaction is concentrated and then purified by 
chromatography on silica gel to yield aziridine 3.20e (3.0 mg, 37%).  
1H NMR (400 MHz, CDCl3) δ 7.36 – 7.27 (m, 5H), 5.55 – 5.40 (m, 2H), 5.37 – 5.33 
(m, 1H), 3.46 (d, J = 3.0, 1H), 3.10 (dd, J = 8.0, 3.0, 1H), 1.45 (d, J = 15.1, 9H). 13C 
NMR (101 MHz, CDCl3) δ 162.2, 136.6, 133.6, 128.7, 128.0, 126.6, 120.4, 81.8, 49.7, 







1-(tert-Butylsulfinyl)-2-phenyl-3-vinylaziridine (3.20f): Compound prepared according 
to literature procedure and matched existing characterization data.9 
1H NMR (400 MHz, CDCl3) δ 7.38 – 7.27 (m, 1H), 6.34 – 6.21 (m, 0H), 5.46 (dd, J = 
17.0, 0.7, 0H), 5.35 (dd, J = 10.2, 0.7, 0H), 3.54 (d, J = 3.6, 0H), 3.16 (dd, J = 9.4, 3.6, 






1-(tert-Butylsulfonyl)-2-phenyl-3-vinylaziridine (3.20g):  
1H NMR (400 MHz, CDCl3) δ 7.42 – 7.31 (m, 3H), 7.30 – 7.24 (m, 2H), 6.18 (dt, J = 
17.0, 10.0, 1H), 5.58 (d, J = 17.0, 1H), 5.45 (d, J = 10.3, 1H), 3.82 (d, J = 3.9, 1H), 
3.29 (dd, J = 9.8, 3.9, 1H), 1.41 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 135.4, 131.6, 
129.1, 128.7, 126.4, 122.4, 60.5, 54.1, 49.8, 24.2. IR (neat) 2980, 2929, 1608, 1457, 
1395, 1306, 1197, 1130, 1071, 890 cm-1. HRMS (ESI) m/z 288.1038 [calculated mass 





1-((4-Nitrophenyl)sulfonyl)-2-phenyl-3-vinylaziridine (3.20h):  
1H NMR (400 MHz, CDCl3) δ 8.33 (d, J = 8.6, 2H), 8.14 (d, J = 8.6, 2H), 7.29 (s, 
3H), 7.17 (s, 2H), 6.33 – 6.21 (m, 1H), 5.64 (d, J = 17.0, 1H), 5.55 (d, J = 10.3, 1H), 
4.12 (d, J = 4.1, 1H), 3.43 (dd, J = 9.7, 3.9, 1H). 13C NMR (101 MHz, CDCl3) δ 
150.6, 145.7, 134.2, 130.7, 129.0(3), 128.9(5), 128.9(1), 126.4, 124.5, 124.0, 56.0, 






2-Phenyl-3-vinylaziridine (3.20i): To a stirred solution of N-sulfinylaziridine 3.20f 
(0.010 g, 0.040 mmol, 1 equiv.) in THF (0.4 mL, 0.1 M) was added dropwise 
concentrated HI (0.070 mL, 0.115 g, 0.51 mmol, 12.8 equiv., 55%). The solution was 
stirred for 5 minutes when the starting material had reacted as judged by TLC. The 
reaction was cooled to 0oC and then quenched with a KOH solution (0.060 g, 1.1 
mmol, 27 equiv.) and then warmed to room temperature. The biphasic solution is 
stirred for 45 minutes and then extracted with CH2Cl2 three times. The organic phase 
is dried and then concentrated. Note: in our hands aziridine (3.20i) was extremely 
unstable when neat. It appears to be quite stable to base and acid but polymerizes 
when concentrated to dryness. Full characterization data has been reported for this 
compound.10 
1H NMR (500 MHz, c6d6) δ 7.14 – 7.01 (m, 5H), 5.19 – 5.11 (m, 1H), 5.06 (dd, J = 






1H NMR (600 MHz, CDCl3) δ 8.01 (dd, J = 8.1, 1.0, 2H), 7.52 (t, J = 7.4, 1H), 7.41 (t, 
J = 7.8, 2H), 7.39 – 7.34 (m, 4H), 7.33 – 7.29 (m, 1H), 5.45 (d, J = 16.9, 1H), 5.33 
(ddd, J = 16.9, 10.0, 9.2, 1H), 5.20 (d, J = 10.2, 1H), 3.74 (d, J = 2.8, 1H), 3.37 (dd, J 
= 9.0, 2.8, 1H).  13C NMR (101 MHz, CDCl3) δ 176.8, 136.8, 133.8, 133.4, 132.9, 
129.4, 128.9, 128.5, 128.1, 126.5, 120.7, 52.2, 45.4. IR (neat) 2916, 1667, 1599, 1448, 






1H NMR (400 MHz, CDCl3) δ 7.51 (d, J = 8.3, 2H), 7.31 – 7.22 (m, 5H), 7.19 (d, J = 
7.9, 2H), 5.79 (dq, J = 6.1, 2.0, 1H), 5.65 (dq, J = 6.3, 2.2, 1H), 5.52 (td, J = 4.6, 2.2, 
1H), 4.35 (ddd, J = 14.6, 4.8, 2.3, 1H), 4.26 (ddt, J = 14.5, 5.6, 2.0, 1H), 2.38 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ 143.3, 140.6, 135.7, 130.8, 129.7, 128.7, 128.0, 127.5, 
127.4, 124.7, 70.4, 55.6, 21.7. IR (neat) 3030, 2867, 1597, 1493, 1455, 1345, 1162, 
 189 
1092, 1057, 831, 815, 666, 596, 547 cm-1. HRMS (ESI) m/z 300.1055 [calculated 






1H NMR (400 MHz, CDCl3) δ 7.79 (dd, J = 5.5, 3.1, 2H), 7.70 (dd, J = 5.5, 3.1, 2H), 
7.49 (d, J = 7.3, 2H), 7.32 (t, J = 7.4, 2H), 7.27 – 7.20 (m, 1H), 5.96 (ddd, J = 6.5, 4.2, 
2.2, 1H), 5.86 – 5.81 (m, 1H), 5.70 – 5.63 (m, 1H), 4.40 – 4.33 (m, 1H), 4.30 – 4.22 
(m, 1H). 13C NMR (101 MHz, CDCl3) δ 167.4, 141.3, 134.4, 131.9, 130.4, 128.6, 
127.8, 127.6, 126.1, 123.5, 72.7, 59.5. IR (neat) 3205, 1721, 1467, 1378, 1306, 1203, 
1118, 1053, 883, 713, 662 cm-1. HRMS (ESI) m/z 291.1125 [calculated mass for 






1H NMR (400 MHz, CDCl3) δ 8.43 (s, 1H), 7.81 (dd, J = 6.6, 3.1, 2H), 7.48 – 7.20 
(m, 8H), 5.83 (ddd, J = 10.7, 8.9, 1.7, 1H), 5.77 – 5.62 (m, 1H), 5.40 (d, J = 8.8, 1H), 
1.83 (d, J = 1.7, 3H). 13C NMR (101 MHz, CDCl3) δ 161.0, 143.6, 136.6, 132.5, 





tert-Butyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxylate (3.21e): Exists as an 
interconverting mixture on the NMR timescale of rotamers about the carbamate bond 
(2.4:1@21oC in CDCl3). Compound previously characterized.11 
Major: 1H NMR (400 MHz, CDCl3) δ 7.33 – 7.17 (m, 5H), 5.90 (dd, J = 6.2, 1.8, 1H), 
5.73 (dd, J = 6.2, 2.0, 1H), 5.37 (s, 1H), 4.37 – 4.33 (m, 2H), 1.21 (s, 9H). 
Minor: 1H NMR (400 MHz, CDCl3) δ 7.36 – 7.15 (m, 5H), 5.85 (d, J = 6.3, 1H), 5.80 
– 5.74 (m, 1H), 5.52 (s, 1H), 4.32 – 4.26 (m, 2H), 1.43 (s, 9H). 







1H NMR (400 MHz, CDCl3) δ 7.37 – 7.23 (m, 5H), 5.93 (dq, J = 6.2, 2.0, 1H), 5.87 
(dq, J = 6.1, 2.1, 1H), 5.76 (dq, J = 6.8, 2.3, 1H), 4.72 (dq, J = 14.4, 2.2, 1H), 4.15 
(ddt, J = 14.4, 5.6, 2.1, 1H), 1.07 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 141.7, 
130.2, 128.7, 128.2(6), 128.2(5), 125.1, 70.8, 60.9, 57.6, 24.3. IR (neat) 2976, 1455, 
1312, 1130, 1105, 1041, 986, 858, 760, 680 cm-1. HRMS (ESI) m/z 266.1204 






1H NMR (400 MHz, CDC3) δ 8.10 (d, J = 8.6, 2H), 7.55 (d, J = 8.6, 2H), 7.29 – 7.18 
(m, 3H), 7.12 (d, J = 7.3, 2H), 5.94 – 5.89 (m, 1H), 5.75 – 5.70 (m, 1H), 5.63 (d, J = 
2.8, 1H), 4.51 (d, J = 14.1, 1H), 4.29 – 4.21 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 
149.7, 145.3, 139.0, 130.6, 128.8, 128.6, 128.1, 128.0, 124.7, 124.0, 70.6, 55.5. IR 
(neat) 3104, 2867, 1605, 1527, 1349, 1167, 1110, 852, 737, 625 cm-1. HRMS (ESI) 





(S)-(+)-t-Butylsulfimine 3.23a: To a solution of acrolein (2 mL, 30.50 mmol, 1.10 
equiv) in THF (110 mL) was added Ti(OEt)4 (33-35% soln, 36 mL, 58.48 mmol, 2.10 
equiv). The reaction mixture was stirred a room temperature for 15 min and then (S)-(-
)-t-butylsulfinamide (3.3707 g, 27.81 mmol, 1 equiv) was added. The reaction mixture 
was stirred at room temperature overnight and then it was quenched by adding brine 
(30 mL). The resulting slurry was filtered through a pad of celite and rinsed with 
EtOAc (400 mL). The filtrate was washed with brine (100 mL) and the aqueous 
washing was extracted with EtOAc (100 mL). The combined organic phases were 
dried over MgSO4, filtered and concentrated in vacuo. The resultant yellow oil was 
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chromatographed on silica gel employing 4:1 hexanes:EtOAc as eluent to furnish 
3.23a (1.7367 g, 36% yield) as a yellow oil.  
[]D21 +531.23° (c 0.46, CHCl3); FTIR (thin film/KCl) 2978, 2961, 2926, 2903, 2869, 
1625, 1577, 1474, 1458, 1390, 1363, 1324, 1185, 1085, 1003, 946, 719, 580, 563, 483, 
464, 427, 405 cm-1; 1H NMR (300 MHz, CDCl3) δ 8.22 (d, J = 9.3 Hz, 1H), 6.75 – 
6.62 (m, 1H), 6.03 – 6.02 (m, 1H), 5.99 – 5.97 (m, 1H), 1.21 (s, 9H); 13C NMR (75 
MHz, CDCl3)  164.3, 134.7, 131.7, 57.45, 22.5; HRMS (ESI) m/z  160.0789 [calcd 





(S)-(+)-t-Butylsulfimine 3.23c: To a solution of 2-methylenepentenal (1.5079 g, 15.37 
mmol, 1.10 equiv) in THF (56 mL) was added Ti(OEt)4 (33-35% soln, 17.5 mL, 28.43 
mmol, 2.03 equiv) followed by (S)-(-)-t-butylsulfinamide (1.6967 g, 14 mmol, 1 
equiv) was added. The reaction mixture was stirred at room temperature for 5.5 h and 
then it was diluted with EtOAc (56 mL) and quenched by adding brine (15 mL). The 
resulting slurry was filtered through a pad of celite and rinsed with EtOAc (500 mL). 
The filtrate was washed with brine (100 mL) and the aqueous washing was extracted 
with EtOAc (100 mL). The combined organic phases were dried over MgSO4, filtered 
and concentrated in vacuo. The resultant yellow oil was chromatographed on silica gel 
employing 9:1 hexanes:EtOAc as eluent to furnish 3.23c (488.4 mg, 16% yield) as a 
yellowish oil. 
[]D21 +278.11° (c 0.47, CHCl3); FTIR (thin film/KCl) 2959, 2931, 2873, 1734, 1699, 
1653, 1634, 1623, 1580, 1560, 1542, 1521, 1507, 1488, 1473, 1458, 1420, 1389, 1379, 
1363, 1335, 1323, 1257, 1249, 1227, 1178, 1087, 1016, 987, 924, 791, 752, 742, 611, 
601, 575, 545, 524, 519, 508, 499, 472, 444, 426, 419, 403 cm-1; 1H NMR (300 MHz, 
CDCl3) δ 8.13 (s, 1H), 5.75-5.73 (m, 1H), 5.68 (s, H), 2.41 – 2.20 (m, 2H), 1.59 – 1.42 
(m, 2H), 1.16 (s, 9H), 0.88 (t, J = 7.3 Hz, 3H); 13C NMR (75 MHz, CDCl3)  165.2, 
146.1, 128.8, 57.4, 32.5, 22.6, 21.3, 13.9; HRMS (ESI) m/z  202.1256 [calcd for 






(R)-(-)-t-Butylsulfimine 3.23e: To a solution of 2-cyclohexyl-hex-5-enal (365.8 mg, 
2.65 mmol, 1.08 equiv) in THF (10 mL) was added Ti(OEt)4 (33-35% soln, 3.5 mL, 
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5.69 mmol, 2.15 equiv) followed by (R)-(+)-t-butylsulfinamide (297.1 mg, 2.45 mmol, 
1 equiv) was added. The reaction mixture was stirred at room temperature overnight 
and then it was diluted with EtOAc (10 mL) and quenched by adding brine (3 mL). 
The resulting slurry was filtered through a pad of celite and rinsed with EtOAc (100 
mL). The filtrate was washed with brine (100 mL) and the aqueous washing was 
extracted with EtOAc (50 mL). The combined organic phases were dried over MgSO4, 
filtered and concentrated in vacuo. The resultant yellow oil was chromatographed on 
silica gel employing 85:15 hexanes:EtOAc as eluent to furnish 3.23e (473.5 mg, 74% 
yield) as a yellowish oil. Spectroscopic data for this material was identical to that for 
















(S)-(+)-t-Butylsulfimine 3.23g: To a solution of 2-cyclohexyl-hex-5-enal (2.0991 g, 
15.19 mmol, 1.10 equiv) in THF (55 mL) was added Ti(OEt)4 (33-35% soln, 17 mL, 
27.61 mmol, 1.98 equiv) followed by (S)-(-)-t-butylsulfinamide (1.6882 g, 13.93 
mmol, 1 equiv) was added. The reaction mixture was stirred at room temperature for 
5.5 h and then it was diluted with EtOAc (55 mL) and quenched by adding brine (15 
mL). The resulting slurry was filtered through a pad of celite and rinsed with EtOAc 
(500 mL). The filtrate was washed with brine (100 mL) and the aqueous washing was 
extracted with EtOAc (100 mL). The combined organic phases were dried over 
MgSO4, filtered and concentrated in vacuo. The resultant yellow oil was 
chromatographed on silica gel employing 9:1 hexanes:EtOAc as eluent to furnish 
3.23g (2.2912 g, 68% yield) as a yellowish oil.  
[]D21 +294.27° (c 1.05, CHCl3); FTIR (thin film/KCl) 2980, 2927, 2853, 1619, 1581, 
1475, 1460, 1450, 1390, 1363, 1343, 1324, 1266, 1227, 1179, 1135, 1088, 1053, 1031, 
1017, 988, 920, 892, 787, 744, 604, 572, 530, 512, 483, 450, 413, 403 cm-1; 1H NMR 
(300 MHz, CDCl3) δ 8.11 (s, 1H), 5.74 (s, 1H), 5.66 (s, 1H), 2.63 – 2.52 (m, 2H), 1.84 
– 1.65 (m, 4H), 1.41 – 1.07 (m, 6H), 1.19 (s, 9H); 13C NMR (75 MHz, CDCl3)  
165.2, 151.6, 127.1, 57.5, 38.3, 33.0, 32.0, 26.8, 26.8, 26.5, 22.7; HRMS (ESI) m/z  





(S)-(+)-t-Butylsulfimine 3.23i: To a solution of 1-cyclohexene-1-carboxaldehyde (1.7 
mL, 14.91 mmol, 1.10 equiv) in THF (55 mL) was added Ti(OEt)4 (33-35% soln, 17 
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mL, 27.61 mmol, 2.03 equiv) followed by (S)-(-)-t-butylsulfinamide (1.6485 g, 13.60 
mmol, 1 equiv) was added. The reaction mixture was stirred at room temperature 
overnight and then it was diluted with EtOAc (55 mL) and quenched by adding brine 
(15 mL). The resulting slurry was filtered through a pad of celite and rinsed with 
EtOAc (500 mL). The filtrate was washed with brine (100 mL) and the aqueous 
washing was extracted with EtOAc (100 mL). The combined organic phases were 
dried over MgSO4, filtered and concentrated in vacuo. The resultant yellow oil was 
chromatographed on silica gel employing 8:2 hexanes:EtOAc as eluent to furnish 
3.23i (2.6530 g, 83% yield) as a yellow oil. 
[]D21 +351.65° (c 1.41, CHCl3); FTIR (thin film/KCl) 2978, 2931, 2865, 2843, 2825, 
1634, 1581, 1474, 1456, 1434, 1389, 1362, 1335, 1303, 1267, 1229, 1191, 1136, 1086, 
1045, 1016, 986, 928, 839, 794, 785, 741, 669, 586, 549, 507, 485, 464, 447, 434, 408 
cm-1; 1H NMR (300 MHz, CDCl3) δ 8.11 (s, 1H), 6.53 – 6.50 (m, 1H), 2.35 – 2.25 (m, 
4H), 1.73 – 1.63 (m, 4H), 1.19 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 165.0, 144.6, 
137.1, 56.9, 26.4, 23.3, 22.4, 22.0, 21.7; HRMS (ESI) m/z  214.1260 [calcd for 





(S)-(+)-t-Butylsulfimine 3.23k: To a solution of 2-cyclopentene-1-carboxaldehyde 
(2.0115 g, 20.93 mmol, 1.10 equiv) in THF (75 mL) was added Ti(OEt)4 (33-35% 
soln, 24 mL, 38.99 mmol, 2.05 equiv) followed by (S)-(-)-t- butylsulfinamide (2.3075 
g, 19.04 mmol, 1 equiv) was added. The reaction mixture was stirred at room 
temperature for 5 h and then it was diluted with EtOAc (73 mL) and quenched by 
adding brine (20 mL). The resulting slurry was filtered through a pad of celite and 
rinsed with EtOAc (500 mL). The filtrate was concentrated in vacuo. The resultant 
orange oil was chromatographed on silica gel employing 85:15 hexanes:EtOAc as 
eluent to furnish 3.23k (2.9046 g, 77% yield) as a yellow oil. 
[]D21 +327.24° (c 2.07, CHCl3); FTIR (thin film/KCl) 3134, 3045, 2957, 2926, 2901, 
2870, 2841, 1695, 1619, 1574, 1507, 1474, 1456, 1443, 1390, 1362, 1338, 1297, 1257, 
1227, 1181, 1167, 1130, 1085, 1039, 1018, 984, 954, 921, 906, 889, 822, 793, 754, 
687, 646, 625, 584, 532, 506, 499, 476, 458 cm-1; 1H NMR (300 MHz, CDCl3) δ 8.41 
(s, 1H), 6.53 (dd, J = 4.1, 2.6 Hz, 1H), 2.64 – 2.52 (m, 4H), 2.05 – 1.92 (m, 2H), 1.19 
(s, 9H); 13C NMR (75 MHz, CDCl3) δ 159.0, 145.7, 142.6, 56.6, 33.4, 29.9, 22.5, 






anti Aziridine 3.26a and syn aziridine 3.26b: (S)-(+)-t-Butylsulfimine 3.23a (656.1 
mg, 4.12 mmol, 1 equiv) was taken in CH3CN (1 mL) and concentrated under high 
vacuum in order to azeotropically remove water. Then it was dissolved in THF (25 
mL) and cooled to -78 ºC. t-Butylbromoacetate (1.9 mL, 12.86 mmol, 3.12 equiv) was 
added and the reaction mixture was stirred at -78 ºC for 15 min. LHMDS (1.0 M soln 
in THF, 8.5 mL, 8.5 mmol, 2.06 equiv) was added ad the reaction mixture was 
allowed to warm to room temperature overnight. The reaction mixture was worked-up 
by diluting with EtOAc (100 mL) and washing with brine (2 X 50 mL). The aqueous 
washings were extracted with EtOAc (2 X 100 mL) and the combined organic phases 
were dried over MgSO4, filtered and concentrated in vacuo to a yellow oil. Silica gel 
chromatography employing 9:1 hexanes:EtOAc as eluent furnished two products: 
3.26a (165 mg, 15% yield, eluted second) as a yellow oil and 3.26b (916.3 mg, 81% 
yield, eluted first) as a yellow oil. 
3.26a: []D21 +122.24° (c 0.26, CHCl3); FTIR (thin film/KCl) 2980, 2931, 2908, 
2871, 1728, 1477, 1462, 1452, 1442, 1435, 1392, 1368, 1332, 1310, 1230, 1155, 1105, 
1086, 985, 921, 894, 835, 794, 778, 746, 725, 618, 588, 562, 467 cm-1; 1H NMR (300 
MHz, CDCl3) δ 5.82 (ddd, J = 17.2, 10.1, 8.9 Hz, 1H), 5.46 (d, J = 16.7 Hz, 1H), 5.31 
(d, J = 10.7 Hz, 1H), 3.31 (dd, J = 8.8, 3.3 Hz, 1H), 3.00 (d, J = 3.4 Hz, 1H), 1.48 (s, 
9H), 1.24 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 167.2, 133.0, 121.2, 83.1, 57.4, 48.4, 
42.0, 28.1, 22.6; HRMS (ESI) m/z  274.1472 [calcd for C13H24NO3S (M+H) 
274.1177].  
3.26b: []D21 +76.92° (c 0.47, CHCl3); FTIR (thin film/KCl) 3088, 2980, 2934, 2907, 
2872, 1739, 1728, 1641, 1477, 1460, 1392, 1368, 1332, 1300, 1277, 1254, 1220, 1153, 
1084, 1051, 1037, 1019, 993, 974, 937, 883, 842, 793, 773, 738, 688, 593, 575, 550, 
469, 460, 433, 412 cm-1; 1H NMR (300 MHz, CDCl3) δ 5.79 5.49 (dd, J = 17.3, 1.0 
Hz, 1H), 5.33 (dd, J = 10.4, 0.9 Hz, 1H), 3.38 (d, J = 7.2 Hz, 1H), 2.90 (t, J = 7.6 Hz, 
1H), 1.46 (s, 9H), 1.25 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 166.1, 131.3, 121.0, 



















3.26c 3.26d  
 
anti Aziridine 3.26c and syn aziridine 3.26d: (S)-(+)-t-Butylsulfimine 3.23c (405.3 
mg, 2.01 mmol, 1 equiv) was taken in CH3CN (1 mL) and concentrated under high 
vacuum in order to azeotropically remove water. Then it was dissolved in THF (12 
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mL) and cooled to -78 ºC. t-Butylbromoacetate (0.9 mL, 6.01 mmol, 3.03 equiv) was 
added and the reaction mixture was stirred at -78 ºC for 15 min. LHMDS (1.0 M soln 
in THF, 4 mL, 4 mmol, 1.99 equiv) was added ad the reaction mixture was allowed to 
warm to room temperature overnight. The reaction mixture was worked-up by diluting 
with EtOAc (100 mL) and washing with brine (2 X 50 mL). The aqueous washings 
were extracted with EtOAc (2 X 100 mL) and the combined organic phases were dried 
over MgSO4, filtered and concentrated in vacuo to a brown oil. Silica gel 
chromatography employing 9:1 hexanes:EtOAc as eluent furnished two products: 
3.26c(154.7 mg, 24% yield, eluted second) as a yellow oil and 3.26d (251.2 mg, 40% 
yield, eluted first) as a yellow solid. 
3.26c: []D21 +111.58° (c 0.13, CHCl3); FTIR (thin film/KCl) 2976, 2960, 2931, 
2908, 2872, 1730, 1475, 1458, 1392, 1367, 1338, 1321, 1302, 1250, 1219, 1155, 1105, 
987, 904, 883, 879, 852, 837, 820, 796, 721, 590 cm-1; 1H NMR (300 MHz, CDCl3) δ 
5.14 (s, 1H), 5.00 (d, J = 1.2 Hz, 1H), 3.29 (d, J = 3.4 Hz, 1H), 2.94 (d, J = 3.5 Hz, 
1H), 1.99 – 1.84 (m, 2H), 1.51 (s, 9H), 1.51 – 1.42 (m, 2H), 1.23 (s, 9H), 0.90 (t, J = 
7.3 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 167.1, 143.1, 114.5, 83.4, 56.6, 48.6, 
42.6, 34.0, 28.3, 28.2, 28.2, 22.0, 21.0, 14.0; HRMS (ESI) m/z  316.1943 [calcd for 
C16H30NO3S (M+H) 316.1946]. 
3.26d: []D21 +48.97° (c 2.04, CHCl3); FTIR (thin film/KCl) 3092, 3061, 2960, 2933, 
2872, 1743, 1727, 1650, 1579, 1477, 1458, 1392, 1367, 1292, 1254, 1226, 1156, 1085, 
1040, 1020, 985, 956, 932, 909, 880, 847, 791, 775, 731, 662, 627, 596, 571, 556, 526, 
503, 472, 460, 444, 431, 412, 405 cm-1; 1H NMR (300 MHz, CDCl3) δ 5.13 (s, 1H), 
4.97 (d, J = 1.1 Hz, 1H), 3.40 (d, J = 7.4 Hz, 1H), 2.84 (d, J = 7.4 Hz, 1H), 2.07 (t, J = 
7.7 Hz, 2H), 1.54 – 1.42 (m, 2H), 1.41 (s, 9H), 1.29 (s, 9H), 0.92 (t, J = 7.3 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δ 165.2, 140.6, 112.9, 81.6, 57.3, 39.9, 36.6, 36.0, 27.8, 






anti Aziridine 3.26e and syn aziridine 3.26h: (R)-(-)-t-Butylsulfimine 3.23e (473.5 
mg, 1.96 mmol, 1 equiv) was taken in CH3CN (1 mL) and concentrated under high 
vacuum in order to azeotropically remove water. Then it was dissolved in THF (12 
mL) and cooled to -78 ºC. t-Butylbromoacetate (0.87 mL, 5.89 mmol, 3 equiv) was 
added and the reaction mixture was stirred at -78 ºC for 15 min. LHMDS (1.0 M soln 
in THF, 4 mL, 4 mmol, 2.04 equiv) was added ad the reaction mixture was allowed to 
warm to room temperature overnight. The reaction mixture was worked-up by diluting 
with EtOAc (50 mL) and washing with brine (2 X 25 mL). The aqueous washings 
were extracted with EtOAc (2 X 50 mL) and the combined organic phases were dried 
over MgSO4, filtered and concentrated in vacuo to a yellowish oil. Silica gel 
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chromatography employing 9:1 hexanes:EtOAc as eluent furnished two products: 
3.26e (157.9 mg, 23% yield, eluted second) as a yellow oil and 3.26h (331.3 mg, 48% 
yield, eluted first) as a yellow oil. Spectroscopic data for these materials was identical 





anti Aziridine 3.26g and syn aziridine 3.26f: (S)-(+)-t-Butylsulfimine 3.23g (131.8 
mg, 0.55 mmol, 1 equiv) was taken in CH3CN (1 mL) and concentrated under high 
vacuum in order to azeotropically remove water. Then it was dissolved in THF (3.3 
mL) and cooled to -78 ºC. t-Butylbromoacetate (0.16 mL, 1.08 mmol, 1.99 equiv) was 
added and the reaction mixture was stirred at -78 ºC for 15 min. LHMDS (1.0 M soln 
in THF, 0.71 mL, 0.71 mmol, 1.3 equiv) was added ad the reaction mixture was 
allowed to warm to room temperature overnight. The reaction mixture was worked-up 
by diluting with EtOAc (50 mL) and washing with brine (2 X 25 mL). The aqueous 
washings were extracted with EtOAc (2 X 50 mL) and the combined organic phases 
were dried over MgSO4, filtered and concentrated in vacuo to a yellow oil. Silica gel 
chromatography employing 9:1 hexanes:EtOAc as eluent furnished two products: 
3.26g (53.7 mg, 28% yield, eluted second) as a colorless oil and 3.26f (133.5 mg, 69% 
yield, eluted first) as a colorless oil. 
3.26g: []D21 +151.63° (c 0.22, CHCl3); FTIR (thin film/KCl) 2979, 2927, 2854, 
1729, 1477, 1462, 1450, 1412, 1392, 1368, 1341, 1312, 1249, 1219, 1156, 1106, 979, 
912, 905, 892, 838, 797, 745, 731, 588, 414, 404 cm-1; 1H NMR (300 MHz, CDCl3) δ 
5.03 (s, 1H), 4.92 (s, 1H), 3.23 (d, J = 3.4 Hz, 1H), 2.80 (d, J = 3.4 Hz, 1H), 1.89 (t, J 
= 11.2 Hz, 1H), 1.75- 1-65 (m, 4H), 1.50 (s, 9H), 1.22 (s, 9H), 1.29 – 1.04 (m, 6H); 
13C NMR (75 MHz, CDCl3) δ 167.0, 148.7, 111.3, 83.4, 56.6, 47.0, 44.3, 41.7, 32.7, 
32.6, 28.1, 26.7, 26.6, 26.2, 22.0; HRMS (ESI) m/z  356.2247 [calcd for C19H34NO3S 
(M+H) 356.2259]. 
3.26f: []D21 +51.33° (c 0.46, CHCl3); FTIR (thin film/KCl) 2978, 2932, 2926, 2854, 
1741, 1727, 1643, 1478, 1451, 1425, 1392, 1367, 1351, 1293, 1250, 1226, 1192, 1156, 
1084, 1038, 983, 953, 911, 891, 849, 791, 774, 730, 651, 634, 595, 564, 478, 457, 432, 
422, 416, 404 cm-1; 1H NMR (300 MHz, CDCl3) δ 5.09 (s, 1H), 4.92 (s, 1H), 3.36 (d, 
J = 7.4 Hz, 1H), 2.85 (d, J = 7.3 Hz, 1H), 1.97 (t, J = 11.2 Hz, 1H), 1.84 – 1.59 (m, 
4H), 1.37 (s, 9H), 1.25 (s, 9H), 1.31 -1.02 (m, 6H); 13C NMR (75 MHz, CDCl3) δ 
165.6, 145.8, 111.2, 82.0, 57.7, 43.0, 39.9, 36.7, 32.5, 31.7, 28.2, 26.7, 26.6, 26.3, 






anti Aziridine 3.26i and syn aziridine 3.26j: (S)-(+)-t-Butylsulfimine 3.23i(738.5 mg, 
3.46 mmol, 1 equiv) was taken in CH3CN (1 mL) and concentrated under high 
vacuum in order to azeotropically remove water. Then it was dissolved in THF (21 
mL) and cooled to -78 ºC. t-Butylbromoacetate (1.6 mL, 10.83 mmol, 3.13 equiv) was 
added and the reaction mixture was stirred at -78 ºC for 15 min. LHMDS (1.0 M soln 
in THF, 7 mL, 7 mmol, 2.02 equiv) was added ad the reaction mixture was allowed to 
warm to room temperature overnight. The reaction mixture was worked-up by diluting 
with EtOAc (100 mL) and washing with brine (2 X 50 mL). The aqueous washings 
were extracted with EtOAc (2 X 100 mL) and the combined organic phases were dried 
over MgSO4, filtered and concentrated in vacuo to a yellow oil. Silica gel 
chromatography employing 9:1 hexanes:EtOAc as eluent furnished two products: 
3.26i (268.8 mg, 24% yield, eluted second) as a yellow oil and 3.26j (824.8 mg, 73% 
yield, eluted first) as a cream colored solid. 
3.26i: []D21 +80.37° (c 1.50, CHCl3); FTIR (thin film/KCl) 2979, 2930, 2863, 2838, 
1729, 1662, 1632, 1582, 1511, 1475, 1459, 1439, 1394, 1368, 1343, 1327, 1302, 1226, 
1157, 1105, 1045, 1016, 977, 929, 896, 865, 846, 789, 741, 730, 688, 675, 647, 617, 
592, 562, 540, 495, 478, 462, 444, 436, 419, 404 cm-1; 1H NMR (300 MHz, CDCl3) δ 
5.78 – 5.74 (m, 1H), 3.16 (d, J = 3.5 Hz, 1H), 2.90 (d, J = 3.5 Hz, 1H), 1.93 (s, 2H), 
1.83 – 1.30 (m, 6H), 1.39 (s, 9H), 1.10 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 167.5, 
131.7, 129.2, 83.2, 56.4, 50.2, 40.4, 28.1, 25.4, 23.6, 22.4, 22.3, 21.9; HRMS (ESI) 
m/z  328.1936 [calcd for C17H30NO3S (M+H) 328.1946].  
3.26j: []D21 +74.80° (c 0.48, CHCl3); FTIR (thin film/KCl) 3091, 2981, 2936, 2878, 
1744, 1643, 1481, 1459, 1438, 1396, 1370, 1316, 1281, 1226, 1157, 1132, 1046, 1035, 
992, 977, 941, 890, 849, 836, 810, 791, 739, 691, 677, 626, 580, 551, 525, 472, 442, 
436 cm-1; 1H NMR (300 MHz, CDCl3) δ 5.61 (s, 1H), 3.16 (d, J = 7.4 Hz, 1H), 2.55 
(d, J = 7.2 Hz, 1H), 1.80 (s, 4H), 1.46 – 1.31 (m, 4H), 1.22 (s, 9H), 1.08 (s, 9H); 13C 
NMR (75 MHz, CDCl3) δ 165.5, 129.5, 125.2, 81.3, 57.2, 40.4, 35.8, 27.7, 26.3, 24.5, 






anti Aziridine 3.26k and syn aziridine 3.26l: (S)-(+)-t-Butylsulfimine 3.23k (609,5 
mg, 3.06 mmol, 1 equiv) was taken in CH3CN (1 mL) and concentrated under high 
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vacuum in order to azeotropically remove water. Then it was dissolved in THF (18.5 
mL) and cooled to -78 ºC. t-Butylbromoacetate (1.35 mL, 9.14 mmol, 2.99 equiv) was 
added and the reaction mixture was stirred at -78 ºC for 15 min. LHMDS (1.0 M soln 
in THF, 6.1 mL, 6.1 mmol, 2 equiv) was added ad the reaction mixture was allowed to 
warm to room temperature overnight. The reaction mixture was worked-up by diluting 
with EtOAc (100 mL) and washing with brine (2 X 50 mL). The aqueous washings 
were extracted with EtOAc (2 X 100 mL) and the combined organic phases were dried 
over MgSO4, filtered and concentrated in vacuo to a brown oil. Silica gel 
chromatography employing 9:1 hexanes:EtOAc as eluent furnished two products: 
3.26k (295.1 mg, 31% yield, eluted second) as a yellow oil and 3.26l (641.0 mg, 67% 
yield, eluted first) as a yellow oil. 
 
3.26k: []D21 +101.98° (c 0.90, CHCl3); FTIR (thin film/KCl) 2978, 2956, 2930, 
2905, 2867, 2849, 1730, 1685, 1475, 1458, 1395, 1368, 1345, 1326, 1301, 1255, 1220, 
1154, 1104, 1040, 1019, 974, 951, 912, 900, 876, 849, 788, 764, 743, 692, 591 cm-1; 
1H NMR (300 MHz, CDCl3) δ 5.88 – 5.84 (m, 1H), 3.51 (d, J = 3.5 Hz, 1H), 3.03 (d, 
J = 3.5 Hz, 1H), 2.41 – 2.33 (m, 2H), 2.31 – 2.09 (m, 2H), 1.94 – 1.82 (m, 2H), 1.51 
(s, 9H), 1.22 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 167.1, 138.2, 132.3, 83.0, 56.4, 
44.9, 41.4, 32.8, 31.5, 28.0, 23.0, 21.8; HRMS (ESI) m/z  314.1803 [calcd for 
C16H28NO3S (M+H) 314.1790].  
 
3.26l: []D21 +81.87° (c 2.05, CHCl3); FTIR (thin film/KCl) 3470, 3060, 3047, 2976, 
2955, 2932, 2903, 2868, 2848, 2750, 2719, 2154, 1809, 1743, 1727, 1655, 1647, 1618, 
1575, 1558, 1541, 1478, 1458, 1392, 1365, 1317, 1296, 1250, 1223, 1153, 1083, 1051, 
1021, 958, 930, 898, 847, 793, 768, 716, 664, 644, 620, 593, 557, 506, 499, 491, 470, 
455, 428, 404 cm-1; 1H NMR (300 MHz, CDCl3) δ 5.76 – 5.73 (m, 1H), 3.40 (d, J = 
7.4 Hz, 1H), 2.93 (d, J = 7.2 Hz, 1H), 2.38 – 2.26 (m, 4H), 1.93 – 1.81 (m, 2H), 1.41 
(s, 9H), 1.28 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 165.7, 136.9, 129.7, 81.6, 57.3, 
36.9, 35.9, 33.2, 32.3, 27.8, 23.3, 22.3; HRMS (ESI) m/z  314.1803 [calcd for 





anti Aziridine 3.24a: To a solution of anti aziridine 3.24a (68.8 mg, 0.25 mmol, 1 
equiv) in CH2Cl2 (2.5 mL) was added mCPBA (70-75%, 91.8 mg, 0.39 mmol, 1.53 
equiv). The reaction mixture was stirred at room temperature for 15 min and then it 
was diluted with CH2Cl2 (25 mL) and washed with 10% aqueous NaHSO3 (12.5 mL), 
saturated aqueous NaHCO3 (12.5 mL) and brine (12.5 mL). The aqueous washings 
were extracted with CH2Cl2 (2 X 25 mL) and the combined organic phases were dried 
over MgSO4, filtered and concentrated in vacuo. Silica gel chromatography employing 
85:15 hexanes:EtOAc as eluent furnished 3.24a (66.2 mg, 91% yield) as a yellow oil. 
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[]D21 +2.11° (c 1.21, CHCl3); FTIR (thin film/KCl) 3092, 2981, 2936, 2878, 1741, 
1639, 1480, 1459, 1440, 1396, 1370, 1321, 1311, 1243, 1210, 1157, 1135, 1111, 1063, 
1023, 986, 954, 907, 871, 837, 808, 777, 759, 730, 681, 657, 634, 554, 520, 501, 471, 
450, 441, 431, 416, 402 cm-1; 1H NMR (300 MHz, CDCl3) δ 5.93 (dt, J = 17.0, 9.8 
Hz, 1H), 5.64 (dd, J = 16.9, 0.7 Hz, 1H), 5.46 (d, J = 10.2 Hz, 1H), 3.46 (dd, J = 9.5, 
3.7 Hz, 1H), 3.33 (d, J = 3.7 Hz, 1H), 1.48 (s, 9H), 1.47 (s, 9H); 13C NMR (75 MHz, 
CDCl3) δ 165.6, 130.5, 123.1, 83.0, 60.9, 48.2, 45.8, 27.9, 23.9; HRMS (ESI) m/z  





syn Aziridine 3.24b: To a solution of syn aziridine 3.26b (183.6 mg, 0.67 mmol, 1 
equiv) in CH2Cl2 (6.7 mL) was added mCPBA (70-75%, 236.8 mg, 1 mmol, 1.48 
equiv). The reaction mixture was stirred at room temperature for 15 min and then it 
was diluted with CH2Cl2 (25 mL) and washed with 10% aqueous NaHSO3 (12.5 mL), 
saturated aqueous NaHCO3 (12.5 mL) and brine (12.5 mL). The aqueous washings 
were extracted with CH2Cl2 (2 X 25 mL) and the combined organic phases were dried 
over MgSO4, filtered and concentrated in vacuo. Silica gel chromatography employing 
9:1 hexanes:EtOAc as eluent furnished 3.24b (176.3 mg, 91% yield) as a colorless oil:  
[]D21 -15.70° (c 1.59, CHCl3); FTIR (thin film/KCl) 3091, 2981, 2936, 2878, 1744, 
1643, 1481, 1459, 1438, 1396, 1370, 1316, 1281, 1226, 1157, 1132, 1046, 1035, 992, 
977, 941, 890, 849, 836, 810, 791, 739, 691, 677, 626, 580, 551, 525, 472, 442, 436 
cm-1; 1H NMR (300 MHz, CDCl3) δ 5.79 – 5.67 (m, 1H), 5.57 (dd, J = 17.3, 1.5 Hz, 
1H), 5.41 (dd, J = 10.2, 1.4 Hz, 1H), 3.43 (d, J = 7.3 Hz, 1H), 3.39 (d, J = 7.4 Hz, 1H). 
1.50 (s, 9H), 1.46 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 164.3, 129.3, 122.6, 82.8, 
59.7, 44.3, 42.2, 27.9, 23.8; HRMS (ESI) m/z  312.1246 [calcd for C13H23NO4SNa 





anti Aziridine 3.24c: To a solution of anti aziridine 3.26c (99.4 mg, 0.32 mmol, 1 
equiv) in CH2Cl2 (3.2 mL) was added mCPBA (70-75%, 114.9 mg, 0.48 mmol, 1.53 
equiv). The reaction mixture was stirred at room temperature for 15 min and then it 
was diluted with CH2Cl2 (25 mL) and washed with 10% aqueous NaHSO3 (12.5 mL), 
saturated aqueous NaHCO3 (12.5 mL) and brine (12.5 mL). The aqueous washings 
were extracted with CH2Cl2 (2 X 25 mL) and the combined organic phases were dried 
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over MgSO4, filtered and concentrated in vacuo. Silica gel chromatography employing 
9:1 hexanes:EtOAc as eluent furnished 3.24c (78.8 mg, 75% yield) as a colorless oil. 
]D21 +27.23° (c 0.08, CHCl3); FTIR (thin film/KCl) 2978, 2962, 2935, 2875, 1741, 
1645, 1481, 1456, 1394, 1369, 1323, 1257, 1254, 1250, 1223, 1159, 1132, 1113, 1097, 
1059, 1039, 1020, 989, 970, 930, 926, 922, 879, 864, 858, 839, 808, 756, 733, 685, 
654, 644, 640, 621, 596, 557, 544, 538, 534, 515, 496, 471, 453, 436, 415, 409, 403 
cm-1; 1H NMR (300 MHz, CDCl3) δ 5.21 (s, 1H), 5.07 (d, J = 1.0 Hz, 1H), 3.72 (d, J 
= 3.8 Hz, 1H), 3.14 (d, J = 3.8 Hz, 1H), 2.06 – 1.93 (m, 2H), 1.51 (s, 9H), 1.55 – 1.39 
(m, 2H), 1.45 (s, 9H), 0.93 (t, J = 7.3 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 165.3, 
142.0, 115.3, 83.4, 61.0, 49.0, 46.2, 34.5, 28.0, 24.2, 21.0, 14.0; HRMS (ESI) m/z  















syn Aziridine 3.24d: To a solution of syn aziridine 3.26d (204 mg, 0.65 mmol, 1 
equiv) in CH2Cl2 (6.5 mL) was added mCPBA (70-75%, 235.3 mg, 0.99 mmol, 1.53 
equiv). The reaction mixture was stirred at room temperature for 15 min and then it 
was diluted with CH2Cl2 (25 mL) and washed with 10% aqueous NaHSO3 (12.5 mL), 
saturated aqueous NaHCO3 (12.5 mL) and brine (12.5 mL). The aqueous washings 
were extracted with CH2Cl2 (2 X 25 mL) and the combined organic phases were dried 
over MgSO4, filtered and concentrated in vacuo. Silica gel chromatography employing 
9:5 hexanes:EtOAc as eluent furnished 3.24d (182.5 mg, 85% yield) as a colorless oil. 
[]D21 +8.69° (c 0.95, CHCl3); FTIR (thin film/KCl) 3095, 2978, 2965, 2935, 2875, 
1746, 1731, 1651, 1579, 1481, 1459, 1432, 1395, 1369, 1315, 1230, 1190, 1157, 1133, 
1058, 1040, 987, 957, 914, 881, 849, 838, 810, 792, 734, 688, 678, 644, 603, 558, 518, 
484, 465, 437, 408, 402 cm-1; 1H NMR (300 MHz, CDCl3) δ 5.18 (s, 1H), 5.01 (d, J = 
1.3 Hz, 1H), 3.45 (d, J = 7.6 Hz, 1H), 3.38 (d, J = 7.6 Hz, 1H), 2.09 (t, J = 7.7 Hz, 
2H), 1.54 (s, 9H), 1.51 – 1.45 (m, 2H), 1.42 (s, 9H), 0.93 (t, J = 7.3 Hz, 3H); 13C 
NMR (75 MHz, CDCl3) δ 163.9, 139.5, 113.8, 82.7, 60.1, 45.1, 43.7, 36.6, 28.1, 24.0, 






anti Aziridine 3.24e: To a solution of anti aziridine 3.26e (157.9 mg, 0.44 mmol, 1 
equiv) in CH2Cl2 (4.5 mL) was added mCPBA (70-75%, 158 mg, 0.66 mmol, 1.5 
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equiv). The reaction mixture was stirred at room temperature for 2.5 h and then it was 
diluted with CH2Cl2 (25 mL) and washed with concentrated aqueous NaHSO3 (12.5 
mL), saturated aqueous NaHCO3 (12.5 mL) and brine (12.5 mL). The aqueous 
washings were extracted with CH2Cl2 (2 X 25 mL) and the combined organic phases 
were dried over MgSO4, filtered and concentrated in vacuo. Silica gel chromatography 
employing 9:1 hexanes:EtOAc as eluent furnished 3.24e (101.8 mg, 62% yield) as a 






syn Aziridine 3.24f: To a solution of anti aziridine 3.26f (245.4 mg, 0.69 mmol, 1 
equiv) in CH2Cl2 (7 mL) was added mCPBA (70-75%, 246.6 mg, 1.04 mmol, 1.5 
equiv). The reaction mixture was stirred at room temperature for 15 min and then it 
was diluted with CH2Cl2 (25 mL) and washed with 20% NaHSO3 (12.5 mL), saturated 
aqueous NaHCO3 (12.5 mL) and brine (12.5 mL). The aqueous washings were 
extracted with CH2Cl2 (2 X 25 mL) and the combined organic phases were dried over 
MgSO4, filtered and concentrated in vacuo. Silica gel chromatography employing 9:1 
hexanes:EtOAc as eluent furnished 3.24f (239.8 mg, 94% yield) as a yellow oil. An 
analytical sample (white crystals) was obtained by a second flash chromatography 
employing 9:1 hexanes:EtOAc as eluent. 
[]D21 +13.83° (c 0.59, CHCl3); FTIR (thin film/KCl) 2979, 2937, 2929, 2923, 2855, 
1744, 1728, 1644, 1480, 1451, 1395, 1368, 1318, 1230, 1199, 1156, 1130, 1060, 1039, 
984, 954, 915, 891, 849, 838, 811, 796, 777, 735, 684, 655, 600, 563, 550, 524 cm-1; 
1H NMR (300 MHz, CDCl3) δ 5.14 (s, 1H), 4.97 (s, 1H), 3.42 (d, J = 7.6 Hz, 1H), 
3.38 (d, J = 7.7 Hz, 1H), 2.05 – 1.91 (m, 1H), 1.87 – 1.61 (m, 4H), 1.50 (s, 9H), 1.39 
(s, 9H), 1.33 – 0.99 (m, 6H); 13C NMR (75 MHz, CDCl3) δ 163.8, 144.3, 111.9, 82.6, 
60.1, 45.2, 43.8, 42.9, 32.4, 31.7, 28.2, 26.7, 26.5, 26.3, 24.0; HRMS (ESI) m/z  





anti Aziridine 3.24g: To a solution of anti aziridine 3.26g (46.1 mg, 0.13 mmol, 1 
equiv) in CH2Cl2 (1.4 mL) was added mCPBA (70-75%, 49.3 mg, 0.21 mmol, 1.6 
equiv). The reaction mixture was stirred at room temperature for 1 h and then it was 
diluted with CH2Cl2 (25 mL) and washed with concentrated aqueous NaHSO3 (12.5 
mL), saturated aqueous NaHCO3 (12.5 mL) and brine (12.5 mL). The aqueous 
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washings were extracted with CH2Cl2 (2 X 25 mL) and the combined organic phases 
were dried over MgSO4, filtered and concentrated in vacuo. Silica gel chromatography 
employing 9:1 hexanes:EtOAc as eluent furnished 3.24g (36.4 mg, 76% yield) as a 
yellowish oil. An analytical sample (white needles) was obtained by a second flash 
chromatography employing 9:1 hexanes:EtOAc as eluent. 
[]D21 +47.15° (c 0.19, CHCl3); FTIR (thin film/KCl) 2981, 2928, 2854, 1741, 1480, 
1450, 1395, 1369, 1323, 1222, 1158, 1132, 1096, 982, 967, 913, 892, 840, 808, 743, 
683, 418, 403 cm-1; 1H NMR (300 MHz, CDCl3) δ 5.05 (s, 1H), 4.98 (s, 1H), 3.68 (d, 
J = 3.8 Hz, 1H), 3.01 (d, J = 3.8 Hz, 1H), 1.96 (t, J = 11.3 Hz, 1H), 1.84 – 1.64 (m, 
4H), 1.50 (s, 9H), 1.44 (s, 9H), 1.37 – 1.07 (m, 6H); 13C NMR (75 MHz, CDCl3) δ 
165.1, 147.9, 111.6, 83.3, 60.9, 47.8, 47.6, 42.0, 32.5, 32.5, 28.0, 26.7, 26.6, 26.3, 





syn Aziridine 3.24h: To a solution of syn aziridine 3.26h (331.3 mg, 0.93 mmol, 1 
equiv) in CH2Cl2 (9.5 mL) was added mCPBA (70-75%, 347.7 mg, 1.46 mmol, 1.57 
equiv). The reaction mixture was stirred at room temperature for 100 min and then it 
was diluted with CH2Cl2 (25 mL) and washed with concentrated aqueous NaHSO3 
(12.5 mL), saturated aqueous NaHCO3 (12.5 mL) and brine (12.5 mL). The aqueous 
washings were extracted with CH2Cl2 (2 X 25 mL) and the combined organic phases 
were dried over MgSO4, filtered and concentrated in vacuo. Silica gel chromatography 
employing 9:1 hexanes:EtOAc as eluent furnished 3.24h (293.1 mg, 84% yield) as 






anti Aziridine 3.24i: To a solution of anti aziridine 3.26i (92 mg, 0.28 mmol, 1 equiv) 
in CH2Cl2 (2.8 mL) was added NaHCO3 (118.6 mg, 1.41 mmol, 5.03 equiv) followed 
by mCPBA (70-75%, 92.3 mg, 0.39 mmol, 1.38 equiv). The reaction mixture was 
stirred at room temperature for 15 min and then it was diluted with CH2Cl2 (30 mL) 
and washed with 5% aqueous NaHSO3 (15 mL), 1M NaOH (15 mL) and brine (15 
mL). The aqueous washings were extracted with CH2Cl2 (2 X 30 mL) and the 
combined organic phases were dried over MgSO4, filtered and concentrated in vacuo. 
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Silica gel chromatography employing 9:1 hexanes:EtOAc as eluent furnished 3.24i 
(84.8 mg, 88% yield) as a colorless oil. 
[]D22 +24.54° (c 0.78, CHCl3); FTIR (thin film/KCl) 2980, 2933, 2862, 2837, 1743, 
1732, 1479, 1456, 1437, 1423, 1416, 1394, 1369, 1342, 1321, 1250, 1221, 1157, 1132, 
1109, 1095, 1070, 1045, 980, 939, 908, 872, 845, 829, 808, 795, 756, 731, 700, 673, 
661, 621, 607, 559, 511, 469, 430, 422, 418, 407, 403 cm-1; 1H NMR (300 MHz, 
CDCl3) δ 6.00 (s, 1H), 3.69 (d, J = 3.8 Hz, 1H), 3.25 (d, J = 3.8 Hz, 1H), 2.07 (s, 2H), 
1.98 – 1.77 (m, 2H), 1.73 – 1.53 (m, 4H), 1.50 (s, 9H), 1.43 (s, 9H); 13C NMR (75 
MHz, CDCl3) δ 165.7, 130.7, 130.2, 83.0, 60.7, 51.1, 43.7, 27.9, 25.4, 24.0, 23.9, 






syn Aziridine 3.24j: To a solution of syn aziridine 3.26j (104.7 mg, 0.31 mmol, 1 
equiv) in CH2Cl2 (3.1 mL) was added mCPBA (70-75%, 102 mg, 0.43 mmol, 1.34 
equiv). The reaction mixture was stirred at room temperature for 15 min and then it 
was diluted with CH2Cl2 (50 mL) and washed with 10% aqueous NaHSO3 (25 mL), 
saturated aqueous NaHCO3 (25 mL) and brine (25 mL). The aqueous washings were 
extracted with CH2Cl2 (2 X 50 mL) and the combined organic phases were dried over 
MgSO4, filtered and concentrated in vacuo. Silica gel chromatography employing 9:1 
hexanes:EtOAc as eluent furnished 3.24j (76.9 mg, 73% yield) as a colorless oil. An 
analytical sample (colorless oil) was obtained by a second flash chromatography 
employing 9:1 hexanes:EtOAc as eluent. 
[]D21 +189.63° (c 0.85, CHCl3); FTIR (thin film/KCl) 2979, 2931, 2889, 2880, 2861, 
2838, 1747, 1729, 1481, 1459, 1440, 1395, 1368, 1341, 1316, 1229, 1157, 1130, 1077, 
1046, 1033, 959, 922, 895, 846, 811, 783, 757, 732, 686, 553, 527, 515, 468, 432, 418, 
412 cm-1; 1H NMR (300 MHz, CDCl3) δ 5.81 -5-84 (m, 1H), 3.37 (d, J = 7.6 Hz, 1H), 
3.28 (d, J = 7.6 Hz, 1H), 2.0 – 1.93 (m, 4H), 1.50 (s, 9H), 1.43 – 1.62 (m, 4H), 1.40 (s, 
9H); 13C NMR (75 MHz, CDCl3) δ 164.3, 128.6, 126.6, 82.5, 60.1, 45.1, 44.1, 28.1, 
26.4, 24.8, 24.1, 22.4, 22.2; HRMS (ESI) m/z  344.1896 [calcd for C17H30NO4S 






anti Aziridine 3.24k: To a solution of anti aziridine 3.26k (49.8 mg, 0.16 mmol, 1 
equiv) in CH2Cl2 (1.6 mL) was added mCPBA (70-75%, 91.8 mg, 0.39 mmol, 1.53 
equiv). The reaction mixture was stirred at room temperature for 10 min and then it 
was diluted with CH2Cl2 (30 mL) and washed with 5% aqueous NaHSO3 (15 mL), 1M 
NaOH (15 mL) and brine (15 mL). The aqueous washings were extracted with CH2Cl2 
(2 X 30 mL) and the combined organic phases were dried over MgSO4, filtered and 
concentrated in vacuo. Silica gel chromatography employing 9:1 hexanes:EtOAc as 
eluent furnished 3.24k (22.5 mg, 45% yield) as a colorless oil. 
[]D21 +3.35° (c 0.44, CHCl3); FTIR (thin film/KCl) 2980, 2958, 2933, 2872, 2848, 
1741, 1479, 1458, 1417, 1414, 1394, 1369, 1321, 1250, 1221, 1155, 1132, 1105, 1092, 
1041, 1024, 976, 953, 924, 839, 823, 810, 793, 771, 710, 700, 671, 553, 509 cm-1; 1H 
NMR (300 MHz, CDCl3) δ 6.02 – 6.00 (m, 1H), 3.83 (d, J = 3.5 Hz, 1H), 3.33 (d, J = 
3.7 Hz, 1H), 2.45 – 2.18 (m, 4H), 1.97 – 1.84 (m, 2H), 1.49 (s, 9H), 1.43 (s, 9H); 13C 
NMR (75 MHz, CDCl3) δ 165.7, 136.5, 134.7, 83.1, 60.9, 46.1, 44.6, 32.9, 31.8, 27.9, 

















syn Aziridine 3.24l: Ammonium molibdate tetrahydrate (40.6 mg, 3.29 X 10-2 mmol, 
0,2 equiv) was added to an aqueous solution of H2O2 (30%, 0.17 mL, 1.67 mmol, 
10.01 equiv) cooled to 0 ºC. The mixture was stirred at this temperature for 10 min an 
then a solution of syn aziridine 3.26l (51.7 mg, 0.16 mmol, 1 equiv) in EtOH (1.5 mL) 
was added. The reaction mixture was stirred at room temperature for 5.5 h and then it 
was diluted with CH2Cl2 (25 mL) and washed with 10% aqueous NaHSO3 (12.5 mL), 
saturated aqueous NaHCO3 (25 mL) and brine (25 mL). The aqueous washings were 
extracted with CH2Cl2 (2 X 25 mL) and the combined organic phases were dried over 
MgSO4, filtered and concentrated in vacuo. Silica gel chromatography employing 9:1 
hexanes:EtOAc as eluent furnished 3.24l (51.1 mg, 94% yield) as a colorless oil. 
[]D21 +39.74° (c 0.53, CHCl3); FTIR (thin film/KCl) 2979, 2935, 2873, 2850, 1747, 
1732, 1481, 1458, 1395, 1368, 1317, 1251, 1227, 1156, 1130, 1050, 1023, 961, 933, 
899, 857, 847, 811, 782, 733, 692, 553, 516 cm-1; 1H NMR (300 MHz, CDCl3) δ 5.83 
– 5.81 (m, 1H), 3.50 (d, J = 7.6 Hz, 1H), 3.44 (d, J = 7.6 Hz, 1H), 2.39 – 2.27 (m, 4H), 
1.97 – 1.81 (m, 2H), 1.53 (s, 9H), 1.43 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 164.4, 
135.6, 131.3, 82.7, 60.1, 44.6, 41.2, 33.3, 32.6, 28.1, 24.1, 23.5; HRMS (ESI) m/z  
330.1753 [calcd for C16H28NO4S (M+H) 330.1739], 352.1545 [calcd for 






(+)-Dehydroproline 3.25a: Aziridine 3.24a (54.2 mg, 0.187 mmol, 1 equiv) was taken 
in a 5 mM solution of Cu(hfacac)2.H2O in toluene (1.9 mL, 9.5 X 10-3 mmol, 0.05 
equiv). The mixture was stirred in a sealed tube at 150 ºC for 5 h and then it was 
allowed to cool to room temperature and concentrated in vacuo The resultant brown 
solid was chromatographed on silica gel employing 9:1 hexanes:EtOAc as eluent to 
furnish 3.25a (38.9 mg, 72% yield) as white crystals. Spectroscopic data for this 
material was identical to that for its enantiomer 3.25b but with opposite optical 





(-)-Dehydroproline 3.25b: Aziridine 3.24b (76.4 mg, 0.264 mmol, 1 equiv) was taken 
in a 5 mM solution of Cu(hfacac)2.H2O in toluene (2.6 mL, 1.3 X 10-2 mmol, 0.05 
equiv). The mixture was stirred in a sealed tube at 150 ºC for 5 h and then it was 
allowed to cool to room temperature and concentrated in vacuo The resultant brown 
solid was chromatographed on silica gel employing 9:1 hexanes:EtOAc as eluent to 
furnish 3.25b (59 mg, 77% yield) as white crystals. 
[]D21 -215.83° (c 0.46, CHCl3); FTIR (thin film/KCl) 2978, 2938, 2923, 2874, 1742, 
1483, 1462, 1395, 1369, 1338, 1318, 1307, 1244, 1221, 1203, 1160, 1135, 1108, 1050, 
1026, 984, 948, 927, 876, 831, 823, 791, 731, 685, 672, 588, 530, 517, 469, 414 cm-1; 
1H NMR (300 MHz, CDCl3) δ 5.99 – 5.90 (m, 1H), 5.82 – 5.73 (m, 1H), 5.23 (s, 1H), 
4.56 (d, J = 14.4 Hz, 1H), 4.19 (d, J = 12.1 Hz, 1H), 1.45 (s, 9H), 1.43 (s, 9H); 13C 
NMR (75 MHz, CDCl3) δ 170.1, 129.0, 125.6, 82.2, 69.7, 61.7, 57.4, 28.1, 24.5; 





(+)-Dehydroproline 3.25c: Aziridine 3.24c (27.1 mg, 0.082 mmol, 1 equiv) was taken 
in a 5 mM solution of Cu(hfacac)2.H2O in toluene (0.82 mL, 4.1 X 10-3 mmol, 0.05 
equiv). The mixture was stirred in a sealed tube at 150 ºC for 5 h and then it was 
allowed to cool to room temperature and concentrated in vacuo The resultant brown 
oil was chromatographed on silica gel employing 9:1 hexanes:EtOAc as eluent to 
furnish 3.25c (23.5 mg, 87% yield) as a yellowish oil. Spectroscopic data for this 
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material was identical to that for its enantiomer 3.25d but with opposite optical 
rotation: []D21 +197.94° (c 0.28, CHCl3)  
 




(-)-Dehydroproline 3.25d: Aziridine 3.24d (97.3 mg, 0.294 mmol, 1 equiv) was taken 
in a 5 mM solution of Cu(hfacac)2.H2O in toluene (2.94 mL, 1.47 X 10-2 mmol, 0.05 
equiv). The mixture was stirred in a sealed tube at 150 ºC for 5 h and then it was 
allowed to cool to room temperature and concentrated in vacuo The resultant brown 
solid was chromatographed on silica gel employing 9:1 hexanes:EtOAc as eluent to 
furnish 3.25d (83.5 mg, 86% yield) as tan crystals.  
[]D21 -197.45° (c 0.46, CHCl3); FTIR (thin film/KCl) 2971, 2962, 2934, 2873, 1742, 
1481, 1460, 1394, 1368, 1318, 1251, 1212, 1158, 1132, 1078, 1047, 1023, 987, 953, 
918, 879, 837, 827, 808, 776, 766, 737, 681, 631, 601, 584, 569, 557, 548, 514, 503, 
497, 487, 480 cm-1; 1H NMR (300 MHz, CDCl3) δ 5.35 – 5.32 (m, 1H), 5.09 (s, 1H), 
4.33 (d, J = 13.6 Hz, 2H), 4.08 (d, J = 12.2 Hz, 2H), 2.05 (t, J = 7.4 Hz, 2H), 1.50 – 
1.40 (m, 1H), 1.41 (s, 9H), 1.38 (s, 9H), 0.88 (t, J = 7.3 Hz, 3H); 13C NMR (75 MHz, 
CDCl3) δ 170.5, 143.6, 118.4, 81.8, 69.9, 61.6, 59.1, 30.6, 28.0, 24.5, 20.6, 13.8; 




(-)-Dehydroproline 3.25e: Aziridine 3.24e (101.8 mg, 0.274 mmol, 1 equiv) was taken 
in a 5 mM solution of Cu(hfacac)2.H2O in toluene (2.74 mL, 1.37 X 10-2 mmol, 0.05 
equiv). The mixture was stirred in a sealed tube at 150 ºC for 5 h and then it was 
allowed to cool to room temperature and concentrated in vacuo The resultant brown 
solid was chromatographed on silica gel employing 9:1 hexanes:EtOAc as eluent to 
furnish 3.25e (91.2 mg, 90% yield) as a beige solid. Spectroscopic data for this 
material was identical to that for its enantiomer 3.25g but with opposite optical 
rotation. 
[]D21 -162.36° (c 0.71, CHCl3); FTIR (thin film/KCl)  2978, 2928, 2855, 1742, 1655, 
1481, 1451, 1394, 1368, 1319, 1254, 1233, 1212, 1158, 1134, 1054, 1022, 1005, 988, 
953, 919, 891, 837, 833, 808, 781, 736, 678, 590, 513, 471cm-1; 1H NMR (300 MHz, 
CDCl3) δ 5.33 – 5.26 (m, 1H), 5.08 (bs, 1H), 4.39 (d, J = 13.6 Hz, 1H), 4.12 (d, J = 
11.2 Hz, 1H), 2.03 (t, J = 10.3 Hz, 1H), 1.81 – 1.56 (m, 4H), 1.41 (s, 9H), 1.38 (s, 9H), 
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1.29 – 1.05 (m, 6H); 13C NMR (75 MHz, CDCl3) δ 170.6, 148.8, 116.6, 81.7, 69.9, 
61.6, 57.9, 37.8, 31.8, 31.6, 28.1, 26.15, 26.11, 26.10, 24.5; HRMS (ESI) m/z  













(-)-Dehydroproline 3.25e: Aziridine 3.24f (103.4 mg, 0.278 mmol, 1 equiv) was taken 
in a 5 mM solution of Cu(hfacac)2.H2O in toluene (2.8 mL, 1.4 X 10-2 mmol, 0.05 
equiv). The mixture was stirred in a sealed tube at 150 ºC for 5 h and then it was 
allowed to cool to room temperature and concentrated in vacuo The resultant brown 
solid was chromatographed on silica gel employing 9:1 hexanes:EtOAc as eluent to 





(+)-Dehydroproline 3.25g: Aziridine 3.24g (129.1 mg, 0.347 mmol, 1 equiv) was 
taken in a 5 mM solution of Cu(hfacac)2.H2O in toluene (3.5 mL, 1.75 X 10-2 mmol, 
0.05 equiv). The mixture was stirred in a sealed tube at 150 ºC for 5 h and then it was 
allowed to cool to room temperature and concentrated in vacuo The resultant brown 
solid was chromatographed on silica gel employing 9:1 hexanes:EtOAc as eluent to 
furnish 3.25g (104.7 mg, 81% yield) as an off-white solid. Spectroscopic data for this 
material was identical to that for the product of the rearrangement of 3.25h: []D21 





(+)-Dehydroproline 3.25g: Aziridine 3.24h (101.2 mg, 0.272 mmol, 1 equiv) was 
taken in a 5 mM solution of Cu(hfacac)2.H2O in toluene (2.72 mL, 1.36 X 10-2 mmol, 
0.05 equiv). The mixture was stirred in a sealed tube at 150 ºC for 5 h and then it was 
allowed to cool to room temperature and concentrated in vacuo The resultant brown 
solid was chromatographed on silica gel employing 9:1 hexanes:EtOAc as eluent to 
furnish 3.25g (84.5 mg, 83% yield) as tan crystals.  
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[]D21 +165.74° (c 0.58, CHCl3); FTIR (thin film/KCl) 2978, 2928, 2855, 1742, 1657, 
1585, 1481, 1451, 1394, 1368, 1319, 1254, 1233, 1212, 1158, 1133, 1054, 1023, 1005, 
988, 953, 920, 891, 837, 833, 808, 781, 738, 678, 590, 513, 470 cm-1; 1H NMR (300 
MHz, CDCl3) δ 5.32 – 5.26 (m, 1H), 5.09 (bs, 1H), 4.39 (d, J = 13.5 Hz, 1H), 4.13 (d, 
J = 10.9 Hz, 1H), 2.10 – 1.97 (m, 1H), 1.83 – 1.57 (m, 4H), 1.42 (s, 9H), 1.38 (s, 9H), 
1.29 – 1.08 (m, 6H); 13C NMR (75 MHz, CDCl3) δ 170.6, 148.8, 116.7, 81.8, 69.9, 
61.7, 57.9, 37.8, 31.8, 31.7, 28.1, 26.17, 26.13, 26.12, 24.5; HRMS (ESI) m/z  





(+)-Dehydroproline 3.25i: Aziridine 3.24i (48.2 mg, 0.14 mmol, 1 equiv) was taken in 
a 5 mM solution of Cu(hfacac)2.H2O in toluene (1.4 mL, 7 X 10-3 mmol, 0.05 equiv). 
The mixture was stirred in a sealed tube at 150 ºC for 5 h and then it was allowed to 
cool to room temperature and concentrated in vacuo to a brown oil. Silica gel 
chromatography employing 9:1 hexanes:EtOAc as eluent furnished two products: 
3.25i (32.3 mg, 67% yield, eluted first) as a yellowish oil and 3.54 (4.9 mg, 10% yield, 
eluted second) as a yellowish oil.  
 
3.25i: []D21 +147.71° (c 0.85, CHCl3); FTIR (thin film/KCl) 2978, 2937, 2858, 1743, 
1728, 1672, 1481, 1456, 1394, 1369, 1315, 1279, 1250, 1232, 1211, 1159, 1147, 1132, 
1107, 1092, 1080, 1061, 1032, 1020, 993, 966, 951, 918, 872, 858, 839, 829, 808, 779, 
764, 742, 685, 658, 652, 648, 611, 582, 544, 517, 494, 465, 445, 430, 426, 407, 403 
cm-1; 1H NMR (300 MHz, CDCl3) δ 5.20 (s, 1H), 5.07 (s, 1H), 4.60 – 4.52 (m, 1H), 
2.51 – 2.42 (m, 1H), 2.24 (s, 1H), 1.99 (t, J = 13.0 Hz, 1H), 1.76 (d, J = 8.2 Hz, 2H), 
1.64 – 1.47 (m, 1H), 1.42 (s, 9H), 1.36 (s, 9H), 1.32 – 1.10 (m, 2H); 13C NMR (75 
MHz, CDCl3) δ 170.8, 145.5, 114.4, 81.8, 70.2, 68.8, 61.0, 36.4, 28.6, 28.0, 27.0, 24.7, 
24.3; HRMS (ESI) m/z  344.1900 [calcd for C17H30NO4S (M+H) 344.1896]; 366.1719 
[calcd for C17H29NO4SNa (M+Na) 366.1715].  
 
3.54:. Spectroscopic data for this material was identical to that for its enantiomer 3.25j 
but with opposite optical rotation: []D21 +266.71° (c 0.10, CHCl3); 1H NMR (300 
MHz, CDCl3) δ 5.29 (d, J = 2.0 Hz, 1H), 4.60 (bs, 1H), 4.53 (dd, J = 9.9, 4.5 Hz, 1H), 
2.55 – 2.46 (m, 2H), 2.12 – 1.98 (m, 1H), 1.85 – 1.76 (m, 2H), 1.46 (s, 9H), 1.41 (s, 
9H), 1.38 – 1.10 (m, 3H). 
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(-)-Dehydroproline 3.25j: Aziridine 3.24j (76.9 mg, 0.224 mmol, 1 equiv) was taken 
in a 5 mM solution of Cu(hfacac)2.H2O in toluene (2.23 mL, 1.115 X 10-2 mmol, 0.05 
equiv). The mixture was stirred in a sealed tube at 150 ºC for 5 h and then it was 
allowed to cool to room temperature and concentrated in vacuo The resultant brown 
solid was chromatographed on silica gel employing 9:1 hexanes:EtOAc as eluent to 
furnish 3.25j (66.7 mg, 87% yield) as tan crystals. 
[]D21 -281.37° (c 1.33, CHCl3); FTIR (thin film/KCl) 3091, 3007, 2996, 2983, 2970, 
2941, 2933, 2876, 2863, 2838, 1737, 1695, 1677, 1481, 1466, 1452, 1432, 1394, 1389, 
1370, 1364, 1353, 1345, 1332, 1316, 1302, 1287, 1272, 1255, 1247, 1207, 1167, 1117, 
1092, 1074, 1048, 1022, 1013, 966, 943, 934, 916, 879, 856, 841, 823, 808, 786, 758, 
743, 690, 653, 605, 580, 534, 516, 499, 480, 449, 441, 416 cm-1; 1H NMR (300 MHz, 
CDCl3) δ 5.27 (d, J = 1.7 Hz, 1H), 4.58 (bs, 1H), 4.55 – 4.46 (m, 1H), 2.49 (d, J = 
12.1 Hz, 2H), 2.10 – 1.96 (m, 1H), 1.83 – 1.73 (m, 2H), 1.44 (s, 9H), 1.40 (s, 9H), 
1.35 – 1.11 (m, 3H); 13C NMR (75 MHz, CDCl3) δ 171.0, 145.7, 115.1, 81.4, 70.6, 
66.6, 61.4, 36.1, 28.5, 27.9, 25.8, 25.0, 23.6; HRMS (ESI) m/z  344.1899 [calcd for 






(+)-Dehydroproline 3.25k: Aziridine 3.24k (43.6 mg, 0.132 mmol, 1 equiv) was taken 
in a 5 mM solution of Cu(hfacac)2.H2O in toluene (1.32 mL, 6.6 X 10-3 mmol, 0.05 
equiv). The mixture was stirred in a sealed tube at 150 ºC for 5 h and then it was 
allowed to cool to room temperature and concentrated in vacuo The resultant brown 
solid was chromatographed on silica gel employing 9:1 hexanes:EtOAc as eluent to 
furnish 3.25k (25.7 mg, 59% yield) as a colorless oil. Spectroscopic data for this 
material was identical to that for its enantiomer 3.25l but with opposite optical 
rotation: []D21 -156.28° (c 0.15, CHCl3); 1H NMR (300 MHz, CDCl3) δ 5.45 (s, 1H), 





      
 
(-)-Dehydroproline 3.25l: Azyridine 3.24l (59.6 mg, 0.181 mmol, 1 equiv) was taken 
in a 5 mM solution of Cu(hfacac)2.H2O in toluene (1.81 mL, 9.05 X 10-3 mmol, 0.05 
equiv). The mixture was stirred in a sealed tube at 150 ºC for 5 h and then it was 
allowed to cool to room temperature and concentrated in vacuo The resultant brown 
solid was chromatographed on silica gel employing 9:1 hexanes:EtOAc as eluent to 
furnish 3.25l (29.6 mg, 50% yield) as a brown oil.  
[]D21 -124.62° (c 0.69, CHCl3); FTIR (thin film/KCl) 2977, 2936, 2874, 1744, 1481, 
1457, 1394, 1368, 1346, 1322, 1314, 1285, 1245, 1209, 1155, 1140, 1128, 1089, 1050, 
1034, 1023, 1001, 981, 954, 913, 885, 850, 833, 808, 785, 742, 696, 670, 616, 581, 
516 cm-1; 1H NMR (300 MHz, CDCl3) δ 5.45 (s, 1H), 5.14 (s, 1H), 4.97 (s, 1H), 2.36 
– 2.12 (m, 2H), 2.12 – 1.83 (m, 4H), 1.46 (s, 9H), 1.41 (s, 9H); 13C NMR (75 MHz, 
CDCl3) δ 170.8, 150.4, 113.4, 81.9, 75.7, 73.5, 61.2, 31.8, 28.1, 24.7, 24.1, 21.3; 






General Procedure A: Isothiocineole12 (1 equiv.) was dissolved in dichloromethane (1 
mL for each 2.4 mmol of sulfide) and then the appropriate bromide (1.5 equiv) was 
added. Next, water (1 mL for each 5 mmol of LiOTf). and lithium triflate (5 eq.) were 
added. The biphasic mixture was stirred for 16 hours at room temperature. The 
reaction was diluted with more water and then extracted with CH2Cl2. The organic 
layer was dried with NaSO4 and then concentrated. The crude product was dissolved 
in a minimum amount of dichloromethane and added dropwise to rapidly stirred 







trifluoromethanesulfonate (3.29a): Synthesized according to general procedure A. 
Isothiocineole (0.500g) and 1-(bromomethyl)-4-chlorobenzene (1.246 g) yield sulfide 
3.29a (0.786 g, 60%). 
1H NMR (400 MHz, CDCl3) δ 7.48 (d, J = 8.4, 2H), 7.21 (d, J = 8.4, 2H), 4.84 (d, J = 
12.5, 1H), 4.46 (d, J = 12.6, 1H), 3.68 (s, 1H), 2.67 (d, J = 14.1, 1H), 2.34 – 2.21 (m, 
2H), 1.98 (d, J = 3.2, 1H), 1.73 (s, 3H), 1.68 (s, 3H), 1.66 – 1.37 (m, 4H), 1.01 (d, J = 
7.1, 3H). 13C NMR (101 MHz, CDCl3) δ 136.0, 132.2, 129.9, 127.8, 120.9 (q, J = 
320.3), 72.9, 63.8, 50.5, 41.2, 32.2, 31.7, 25.4, 25.3, 23.1, 22.3, 17.9. IR (neat) 2940, 
1493, 1467, 1259, 1156, 1030, 732, 637, 517 cm-1. HRMS (ESI) m/z 295.1283 















trifluoromethanesulfonate (19b): Synthesized according to general procedure A. 
Isothiocineole (0.500g) and 1-(bromomethyl)-4-fluorobenzene (1.111 g) yield sulfide 
3.29b (0.925 g, 74%). 
1H NMR (400 MHz, CDCl3) δ 7.59 (dd, J = 8.6, 5.2, 2H), 6.99 (t, J = 8.6, 2H), 4.90 
(d, J = 12.5, 1H), 4.52 (d, J = 12.6, 1H), 3.75 (s, 1H), 2.73 (d, J = 14.2, 1H), 2.39 – 
2.28 (m, 2H), 2.03 (d, J = 3.3, 1H), 1.78 (s, 3H), 1.73 (s, 3H), 1.70 – 1.41 (m, 4H), 
1.06 (d, J = 7.1, 3H). 13C NMR (101 MHz, CDCl3) δ 163.5 (d, J = 250.4), 132.9 (d, J 
= 8.5), 125.1, 116.8 (d, J = 21.8), 72.8, 63.9, 50.6, 41.4, 32.2, 31.8, 25.5, 25.3, 23.2, 
22.3, 17.9. 19F NMR (376.135 MHz, CDCl3, C6F6) δ -81.31, -113.84. IR (neat) 2945, 
1601, 1511, 1463, 1263, 1160, 1030, 856, 638, 517 cm-1. HRMS (ESI) m/z 279.1573 







trifluoromethanesulfonate (3.29c): Synthesized according to general procedure A. 
Isothiocineole (0.500g) and 1-bromo-4-(bromomethyl)benzene (1.471 g) yield sulfide 
3.29c (0.918 g, 64%). 
1H NMR (400 MHz, CDCl3) δ 7.43 (q, J = 8.6, 4H), 4.87 (d, J = 12.5, 1H), 4.51 (d, J 
= 12.6, 1H), 3.72 (s, 1H), 2.72 (d, J = 14.2, 1H), 2.37 – 2.27 (m, 2H), 2.03 (s, 1H), 
1.78 (s, 3H), 1.73 (s, 3H), 1.70 – 1.43 (m, 4H), 1.06 (d, J = 7.1, 3H). 13C NMR (101 
MHz, CDCl3) δ 132.9, 132.4, 128.3, 124.4, 120.9 (q, J = 320.1), 73.02, 63.9, 50.5, 
41.3, 32.2, 31.8, 25.4, 25.3, 23.2, 22.3, 17.9. IR (neat) 2936, 1488, 1467, 1259, 1156, 
















trifluoromethanesulfonate (3.29d): Synthesized according to general procedure A. 
Isothiocineole (0.500g) and 1-(bromomethyl)-4-iodobenzene (1.379 g) yield sulfide 
3.29d (0.860 g, 55%). 
1H NMR (400 MHz, CDCl3) δ 7.63 (d, J = 8.4, 2H), 7.29 (d, J = 8.4, 2H), 4.87 (d, J = 
12.5, 1H), 4.51 (d, J = 12.6, 1H), 3.73 (s, 1H), 2.73 (d, J = 13.7, 1H), 2.33 (t, J = 9.7, 
2H), 2.06 (d, J = 3.4, 1H), 1.78 (s, 3H), 1.74 (s, 3H), 1.71 – 1.45 (m, 4H), 1.08 (d, J = 
7.1, 3H). 13C NMR (101 MHz, CDCl3) δ 138.9, 132.5, 128.9, 96.5, 73.0, 64.0, 50.6, 
41.5, 32.2, 31.8, 25.5, 25.3, 23.3, 22.4, 18.0. IR (neat) 2916, 1257, 1155, 1028, 637 







trifluoromethanesulfonate (3.29e): Synthesized according to general procedure A. 
Isothiocineole (0.500g) and 1-(bromomethyl)-3-methoxybenzene (1.183 g) yield 
sulfide 3.29e (0.937 g, 72%).. 
1H NMR (400 MHz, CDCl3) δ 7.25 – 7.16 (m, 2H), 7.07 (d, J = 7.7, 1H), 6.87 – 6.78 
(m, 1H), 4.89 (d, J = 12.5, 1H), 4.47 (d, J = 12.5, 1H), 3.80 (s, 4H), 2.76 – 2.68 (m, 
1H), 2.34 (t, J = 10.1, 2H), 2.06 (s, 1H), 1.80 (s, 3H), 1.75 (s, 3H), 1.73 – 1.42 (m, 
4H), 1.07 (d, J = 7.1, 3H). 13C NMR (101 MHz, CDCl3) δ 160.5, 130.7, 130.5, 122.7, 
116.7, 114.9, 72.6, 63.9, 55.7, 50.6, 42.3, 32.2, 31.8, 25.5, 25.4, 23.3, 22.4, 18.0. IR 
(neat) 2931, 1600, 1467, 1260, 1154, 1030, 647 cm-1. HRMS (ESI) m/z 291.1776 






trifluoromethanesulfonate (3.29f): Synthesized according to general procedure A. 
Isothiocineole (0.485 g) and 1-bromo-2-(bromomethyl)benzene (1.07 g) yield sulfide 
3.29f (0.863 g, 62%).  
1H NMR (500 MHz, CDCl3) δ 8.00 (d, J = 6.7, 1H), 7.64 (d, J = 7.9, 1H), 7.45 (t, J = 
7.2, 1H), 7.33 (td, J = 7.9, 1.3, 1H), 4.99 (d, J = 13.0, 1H), 4.70 (d, J = 13.0, 1H), 4.18 
(s, 1H), 2.92 (d, J = 14.9, 1H), 2.50 (s, 1H), 2.12 (d, J = 3.8, 1H), 1.89 (s, 3H), 1.88 (s, 
3H), 1.85 – 1.53 (m, 5H), 1.17 (d, J = 7.1, 3H). 13C NMR (126 MHz, CDCl3) δ 133.9, 
133.6, 132.2, 129.7, 128.7, 125.3, 73.3, 65.1, 50.4, 42.9, 32.8, 32.6, 26.6, 25.3, 23.6, 






trifluoromethanesulfonate (3.29g): Synthesized according to general procedure A. 
Isothiocineole (1.000 g) and benzyl bromide (2.012 g) yield sulfide 19g (01.875 g, 
78%). Compound matches existing literature data.13 
 214 
1H NMR (400 MHz, CDCl3) δ 7.56 (dd, J = 7.2, 2.2, 2H), 7.44 – 7.38 (m, 2H), 4.89 
(d, J = 12.6, 1H), 4.58 (d, J = 12.9, 1H), 3.95 (s, 1H), 2.72 (s, 1H), 2.43 (d, J = 13.5, 






thiabicyclo[3.2.1]octane trifluoromethanesulfonate (19h): Synthesized according to 
general procedure A. Isothiocineole (0.500 g) and 1-(bromomethyl)-4-
(trifluoromethyl)benzene (1.07 g) yield sulfide 19h (0.869 g, 62%). 
1H NMR (400 MHz, CDC3) δ 7.72 (d, J = 8.1, 2H), 7.60 (d, J = 7.9, 2H), 5.00 (d, J = 
12.9, 1H), 4.71 (d, J = 12.8, 1H), 3.86 (s, 1H), 2.77 (d, J = 14.1, 1H), 2.40 (d, J = 13.7, 
2H), 2.14 (s, 1H), 1.82 (s, 3H), 1.78 (s, 3H), 1.75 – 1.48 (m, 4H), 1.12 (d, J = 7.1, 3H). 
13C NMR (126 MHz, CDCl3) δ 133.7, 131.9 (q, J = 32.8), 131.2, 126.6 (q, J = 3.6), 
123,7 (q, J = 272.5), 120.9 (q, J = 320.1), 73.4, 64.4, 50.6, 41.2, 32.2, 31.9, 25.5, 25.3, 
23.3, 22.3, 17.9. IR (neat) 2946, 1462, 1420, 1352, 1253, 1159, 1134, 1111, 1067, 
1028, 855, 638 cm-1. 19F NMR (376.135 MHz, CDCl3, C6F6) δ -81.47, -66.21. HRMS 





trifluoromethanesulfonate (19i): Synthesized according to general procedure A. 
Isothiocineole (0.500 g) and 1-(bromomethyl)-4-nitrobenzene (0.953 g) yield sulfide 
3.29i (0.852 g, 64%). 
1H NMR (400 MHz, CDCl3) δ 8.17 (d, J = 8.7, 2H), 7.82 (d, J = 8.8, 2H), 5.07 (d, J = 
13.0, 1H), 4.78 (d, J = 13.0, 1H), 3.85 (s, 1H), 2.77 (d, J = 14.6, 1H), 2.45 – 2.34 (m, 
2H), 2.14 (s, 1H), 1.83 (s, 3H), 1.78 (s, 3H), 1.76 – 1.50 (m, 4H), 1.11 (d, J = 7.1, 3H). 
13C NMR (101 MHz, CDCl3) δ 148.6, 136.9, 132.0, 124.7, 120.8 (q, J = 320.2), 74.0, 
64.7, 50.6, 40.8, 32.2, 32.0, 25.6, 25.3, 23.3, 22.3, 17.9. IR (neat) 2994, 2944, 1605, 
1527, 1464, 1350, 1254, 1226, 1162, 1028, 860, 717, 639 cm-1. HRMS (ESI) m/z 






General Procedure B: In a typical experimental procedure sulfonium salt (~0.1 mmol, 
1 eq.) was dissolved in acetonitrile (0.1 M). Then the imine (1.0 eq.) was added and 
placed in a 0 °C bath. Next, K2CO3 (2.0 eq.) was added and the solution was stirred 
for 12-36 hours at room temperature. The reaction was quenched by addition of water 
and then extracted with CH2Cl3. The organic layer was dried with Na2SO4 and then 





N-Benzylidene-4-methylbenzenesulfonamide (3.28a): Prepared according to known 





N-Cyclohexenylmethylen-4-methylbenzenesulfonamide (3.28f): A mixture of 1-
Cyclohexene-1-carboxaldehyde (0.10g, 0.91 mmol, 1 equiv.), p-Toluenesulfonamide 
(0.155g, 0.91 mmol, 1 equiv.), activated MS 4A and catalytic amount of Amberlyst-15 
in dry toluene (5 mL) was heated in a sealed tube for 12 h. The mixture was filtered 
through Celite and concentrated. The resulting yellow oil was used in the next reaction 
(mostly pure) or can be purified by silica gel flash chromatography (slightly unstable). 
Yield 215 mg  (90%).  
1H NMR (500 MHz, CDCl3 )  ppm 8.40 (s, 1H), 7.72 (d, J = 8.2 Hz, 2H), 7.22 (d, J 
= 8.2 Hz, 2H), 6.75-6.71 (m, 1H), 2.33 (s, 3H), 2.29-2.20 (m, 2H), 2.19-2.13 (m, 2H), 
1.59-1.50 (m, 4H). 13C NMR (125 MHz, CDCl3)  ppm 172.3, 153.8, 144.1, 137.2, 
135.6, 129.6, 127.8, 27.3, 22.7, 21.6, 21.5, 21.2. IR (neat) 2934, 2863, 1628, 1567, 
1319, 1158, 1090, 930, 807, 777, 696, 655, 568 cm-1. ESMS m/z 264.1 ([M+H]+); 






(2R,3R)-2-(4-Chlorophenyl)-3-((E)-styryl)-1-tosylaziridine 3.30): Synthesized 
according to general procedure B. 4-methyl-N-((E)-3-
phenylallylidene)benzenesulfonamide (0.100 g) and sulfide salt 3.29a (0.156 g) yield 
aziridine 3.30a (0.055 g, 38%, d.r.=  >20:1). 
1H NMR (500 MHz, CDCl3) δ 7.75 (d, J = 8.3, 2H), 7.36 (d, J = 7.1, 2H), 7.28 (dd, J 
= 8.1, 6.7, 2H), 7.24 – 7.18 (m, 5H), 7.08 (d, J = 8.5, 2H), 6.73 (d, J = 15.8, 1H), 6.56 
(dd, J = 15.8, 9.6, 1H), 4.04 (d, J = 4.0, 1H), 3.33 (dd, J = 9.6, 4.0, 1H), 2.33 (s, 3H). 
13C NMR (126 MHz, CDCl3) δ 144.6, 137.9, 136.9, 136.0, 134.4, 133.8, 129.9, 129.1, 
128.9, 128.7, 127.9, 127.8, 127.0, 122.0, 55.5, 48.2, 21.9. IR (neat) 1597, 1493, 1326, 
1159, 1088, 900, 694 cm-1. HRMS (ESI) m/z 410.0971 [calculated mass for 





(2R,3R)-2-(4-Fluorophenyl)-3-((E)-styryl)-1-tosylaziridine (3.30b): Synthesized 
according to general procedure B. 4-methyl-N-((E)-3-
phenylallylidene)benzenesulfonamide (0.100 g) and sulfide salt 3.29b (0.150 g) yield 
aziridine 3.30b (0.097 g, 70%, d.r.=  >20:1). 
1H NMR (400 MHz, CDCl3) δ 7.75 (d, J = 8.3, 2H), 7.35 (d, J = 7.2, 2H), 7.27 (t, J = 
7.3, 2H), 7.24 – 7.15 (m, 2H), 7.14 – 7.08 (m, 3H), 6.90 (t, J = 8.6, 2H), 6.71 (d, J = 
15.8, 1H), 6.56 (dd, J = 15.8, 9.6, 1H), 4.06 (d, J = 4.1, 1H), 3.33 (dd, J = 9.6, 4.1, 
1H), 2.31 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 162.8 (d, J = 246.9), 144.6, 137.8, 
136.9, 136.0, 131.0, 129.8, 128.9, 128.6, 128.2 (d, J = 8.3), 127.7, 126.9, 122.0, 115.8 
(d, J = 21.8), 55.4, 48.2, 21.8. 19F NMR (376.135 MHz, CDCl3, C6F6) δ -116.61. IR 
(neat) 3056, 1599, 1494, 1327, 1231, 1160, 901, 837, 694 cm-1. HRMS (ESI) m/z 







Synthesized according to general procedure B. 4-methyl-N-((E)-3-
phenylallylidene)benzenesulfonamide (0.100 g) and sulfide salt 3.29c (0.188g) yield 
aziridine 3.30c (0.057 g, 38%, d.r.=  >20:1). 
1H NMR (400 MHz, CDCl3) δ 7.75 (d, J = 8.3, 2H), 7.35 (t, J = 7.7, 4H), 7.28 (dd, J = 
8.1, 6.5, 2H), 7.25 – 7.17 (m, 3H), 7.02 (d, J = 8.5, 2H), 6.72 (d, J = 15.8, 1H), 6.56 
(dd, J = 15.8, 9.6, 1H), 4.03 (d, J = 4.0, 1H), 3.33 (dd, J = 9.6, 4.1, 1H), 2.32 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ 144.6, 137.9, 136.8, 136.0, 134.4, 132.0, 129.9, 128.9, 
128.7, 128.1, 127.7, 127.0, 122.5, 121.9, 55.5, 48.2, 21.9. IR (neat) 3028, 1652, 1489, 
1301, 1156, 1085, 968, 902, 817, 745, 649, 536 cm-1. HRMS (ESI) m/z 454.0479 





(2R,3R)-2-(4-Iodophenyl)-3-((E)-styryl)-1-tosylaziridine (3.30d): Synthesized 
according to general procedure B. 4-methyl-N-((E)-3-
phenylallylidene)benzenesulfonamide (0.100 g) and sulfide salt 3.29d (0.188g) yield 
aziridine 3.30d (0.047 g, 28%, d.r.=  >20:1). 
1H NMR (400 MHz, CDCl3) δ 7.83 (d, J = 8.3, 2H), 7.61 (d, J = 8.4, 2H), 7.43 (d, J = 
7.0, 2H), 7.35 (t, J = 7.3, 2H), 7.31 – 7.23 (m, 3H), 7.02 – 6.90 (m, 2H), 6.80 (d, J = 
15.8, 1H), 6.64 (dd, J = 15.8, 9.6, 1H), 4.09 (s, 1H), 3.40 (dd, J = 9.6, 4.0, 1H), 2.40 
(s, 3H). 13C NMR (101 MHz, CDCl3) δ 144.6, 137.9(1), 137.9(0), 136.8, 136.0, 135.0, 
129.8, 128.9, 128.6, 128.3, 127.7, 126.9, 121.9, 94.0, 55.5, 48.3, 21.8. IR (neat) 1597, 
1485, 1327, 1159, 1092, 1006, 911, 813, 748, 694 cm-1. HRMS (ESI) m/z 502.0349 






(2R,3R)-2-((E)-3-Methoxystyryl)-3-phenyl-1-tosylaziridine (3.30e): Synthesized 
according to general procedure B. 4-methyl-N-((E)-3-
phenylallylidene)benzenesulfonamide (0.183 g) and sulfide salt 3.29e (0.283 g) yield 
aziridine 3.30e (0.093 g, 36%, d.r.=  >20:1). 
1H NMR (400 MHz, CDCl3) δ 7.85 (d, J = 8.3, 2H), 7.44 (d, J = 7.0, 2H), 7.35 (dd, J 
= 8.1, 6.6, 2H), 7.31 – 7.25 (m, 3H), 7.20 (t, J = 7.9, 1H), 6.85 – 6.77 (m, 3H), 6.72 – 
6.70 (m, 1H), 6.66 (dd, J = 15.8, 9.6, 1H), 4.13 (d, J = 4.1, 1H), 3.74 (s, 3H), 3.44 (dd, 
J = 9.6, 4.1, 1H), 2.39 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 160.0, 144.5, 137.7, 
137.1, 136.9, 136.1, 129.9, 129.8, 128.9, 128.6, 127.8, 127.0, 122.3, 118.9, 114.2, 
111.6, 55.5, 55.4, 48.9, 21.8. IR (neat) 3059, 2961, 1599, 1493, 1325, 1060, 1088, 

















Synthesized according to general procedure B. N-(cyclohex-1-en-1-ylmethylene)-4-
methylbenzenesulfonamide (0.155 g) and sulfide salt 3.29f (0.289 g) yield aziridine 
3.30f (0.163 g, 64%, d.r.= ~10:1 trans:cis). 
1H NMR (400 MHz, CDCl3) δ 7.77 (d, J = 8.3, 2H), 7.51 (dd, J = 7.7, 1.1, 1H), 7.27 
(d, J = 9.1, 2H), 7.21 – 7.09 (m, 3H), 6.09 (s, 1H), 4.37 (d, J = 4.9, 1H), 3.36 (d, J = 
4.7, 1H), 2.42 (s, 3H), 2.32 – 2.17 (m, 2H), 2.10 (d, J = 2.5, 2H), 1.76 – 1.58 (m, 4H). 
13C NMR (101 MHz, CDCl3) δ 144.1, 137.5, 134.7, 132.6, 130.9, 129.8, 129.6, 129.5, 
128.5, 127.8, 127.6, 124.2, 55.8, 47.0, 27.2, 25.7, 22.7, 22.1, 21.8. IR (neat) 2929, 






(2R,3R)-2-(Cyclohex-1-en-1-yl)-3-phenyl-1-tosylaziridine (3.30g): Synthesized 
according to general procedure B. N-(cyclohex-1-en-1-ylmethylene)-4-
methylbenzenesulfonamide (0.250 g) and sulfide salt 3.29g (0.195 g) yield aziridine 
3.30g (0.163 g, 79%, d.r.=  ~6:1 trans:cis). 
1H NMR (400 MHz, CDCl3) δ 7.69 (d, J = 8.3, 2H), 7.30 – 7.25 (m, 5H), 7.23 (d, J = 
8.0, 2H), 5.95 (d, J = 1.1, 1H), 4.08 (d, J = 4.9, 1H), 3.62 (d, J = 4.3, 1H), 2.39 (s, 3H), 
2.17 – 2.03 (m, 4H), 1.77 – 1.54 (m, 4H). 13C NMR (101 MHz, CDCl3) δ 143.9, 
137.7, 133.8, 130.5, 129.5(4), 129.5(3), 128.6, 128.5 128.2, 127.6, 53.9, 48.0, 26.6, 
25.5, 22.6, 22.2, 21.8. IR (neat) 2928, 1597, 1453, 1325, 1160, 1086, 935, 902, 813, 






Synthesized according to general procedure B. N-(cyclohex-1-en-1-ylmethylene)-4-
methylbenzenesulfonamide (0.300 g) and sulfide salt 3.29h (0.545 g) yield aziridine 







1H NMR (400 MHz, CDCl3) δ 7.72 (d, J = 8.3, 2H), 7.54 (d, J = 8.1, 2H), 7.39 (d, J = 
8.5, 2H), 7.25 (dd, J = 8.5, 0.6, 2H), 6.00 – 5.94 (m, 1H), 4.12 (d, J = 4.7, 1H), 3.56 
(d, J = 4.0, 1H), 2.41 (s, 3H), 2.16 – 2.06 (m, 4H), 1.74 – 1.55 (m, 4H). 13C NMR 
(101 MHz, CDCl3) δ 144.2, 138.2, 137.4, 130.5 (q, J = 32.5), 130.0(2), 129.9(6) 
 220 
129.6, 128.4, 127.5, 125.4 (q, J = 3.8), 121.4 (q, J = 272.1), 54.6, 46.7, 26.6, 25.5, 
22.5, 22.0, 21.7. IR (neat) 2930, 1920, 1804, 1620, 1598, 1434, 1404, 1323, 1162, 
912, 813, 693, 535 cm-1. 19F NMR (376.135 MHz, CDCl3, C6F6) δ -65.78. HRMS 






1H NMR (400 MHz, CDCl3) δ 7.89 (d, J = 8.3, 2H), 7.48 (d, J = 8.1, 2H), 7.35 (dd, J 
= 8.5, 0.6, 2H), 7.28 (d, J = 8.6, 2H), 5.72 – 5.56 (m, 1H), 3.99 (d, J = 7.3, 1H), 3.57 
(dd, J = 7.3, 1.3, 1H), 2.45 (s, 3H), 1.91 – 1.75 (m, 2H), 1.72 – 1.61 (m, 1H), 1.44 – 
1.31 (m, 3H), 1.28 – 1.18 (m, 2H). 13C NMR (101 MHz, CDCl3) δ 145.0, 137.2, 
135.0, 130.1 (q, J = 32.4), 130.0, 128.2, 128.1, 127.9(2), 127.8(9), 124.9 (q, J = 3.8), 
124.3 (q, J = 272.1), 49.5, 45.7, 26.4, 24.8, 22.2, 22.1, 21.9. IR (neat) 2928, 1621, 
1324, 1161, 1124, 1066, 1017, 900, 846, 677, 564 cm-1.  19F NMR (376.135 MHz, 
CDCl3, C6F6) δ -65.70. HRMS (ESI) m/z 422.1396 [calculated mass for 





Synthesized according to general procedure B. N-(cyclohex-1-en-1-ylmethylene)-4-
methylbenzenesulfonamide (0.300 g) and sulfide salt 3.29i (0.519 g) yield aziridine 






1H NMR (400 MHz, CDCl 3) δ 8.15 (d, J = 8.8, 2H), 7.74 (d, J = 8.3, 2H), 7.45 (d, J = 
8.7, 2H), 7.28 (d, J = 8.2, 2H), 5.98 (d, J = 1.0, 1H), 4.16 (d, J = 4.7, 1H), 3.56 (d, J = 
4.0, 1H), 2.42 (s, 3H), 2.17 – 2.05 (m, 4H), 1.71 – 1.57 (m, 4H). 13C NMR (101 MHz, 
CDCl 3) δ 149.0, 144.5, 141.8, 137.4, 130.5, 129.8, 129.7, 128.9, 127.6, 123.8, 55.3, 
 221 
46.3, 26.7, 25.6, 22.5, 22.0, 21.8. IR (neat) 2930, 1659, 1599, 1519, 1345, 1159, 667 







1H NMR (400 MHz, CDCl 3) δ 8.10 (d, J = 8.6, 2H), 7.89 (d, J = 8.2, 2H), 7.36 (d, J = 
6.1, 2H), 7.34 (d, J = 7.0, 2H), 5.63 (s, 1H), 4.02 (d, J = 7.3, 1H), 3.60 (d, J = 7.1, 1H), 
2.46 (s, 3H), 1.91 – 1.77 (m, 2H), 1.74 – 1.62 (m, 1H), 1.45 – 1.16 (m, 5H). 13C NMR 
(101 MHz, CDCl3) δ 147.7, 145.2, 140.6, 134.8, 130.1, 128.6, 128.21(9), 128.1(6), 
127.6, 123.2, 49.8, 45.3, 26.4, 24.8, 22.1(3), 22.0(7), 21.9. IR (neat) 2927, 1600, 





General Procedure C:  To a flame dried 13x100 mm threaded culture tube was added 
Cu(hfacac)2 (1.3 mg, 0.00246 mmol, 0.05 equiv.) and then evacuated and filled with 
nitrogen. Then a solution of the vinylazirdine 3.30 (0.025 g, 0.045 mmol) in dry 
toluene (0.5 mL)  is added. The vial was fitted with a teflon cap and submerged in an 
oil bath at 150ºC until reaction was complete by TLC. The reaction was concentrated 
and purified by silica gel chromatography to yield 3.31 (71-97% yield, diastereomeric 






Synthesized according to general procedure C to yield pyrroline 3.31a (84%, d.r.=  
>20:1). 
1H NMR (400 MHz, CDCl3) δ 7.31 – 7.17 (m, 13H), 5.72 (d, J = 6.0, 1H), 5.67 (d, J = 
6.0, 1H), 5.63 (d, J = 2.1, 1H), 5.60 (d, J = 2.0, 1H), 2.28 (s, 3H). 13C NMR (126 
MHz, CDCl3) δ 143.6, 140.1, 138.9, 135.9, 133.9, 130.0 129.5, 129.3, 129.0, 128.8, 
128.7, 128.1, 127.9, 127.7, 71.0 70.3, 21.7. IR (neat) 3063, 2927, 1597, 1491, 1349, 
 222 
1163, 1090, 1046, 817, 664, 598, 547 cm-1. HRMS (ESI) m/z 410.0990 [calculated 
















Synthesized according to general procedure C to yield pyrroline 3.31b (91%, d.r.=  
>20:1). 
1H NMR (400 MHz, CDCl3) δ 7.35 – 7.27 (m, 13H), 5.80 (d, J = 6.0, 1H), 5.75 (d, J = 
6.0, 1H), 5.71 (s, 2H), 2.35 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 162.6 (d, J = 
246.3), 143.5, 140.2, 136.2, 136.0, 129.8, 129.7 (d, J = 8.3), 129.5, 129.2, 128.7, 
128.1, 127.9, 127.6, 115.4 (d, J = 21.6), 70.9, 70.2, 21.7. 19F NMR (376.135 MHz, 
CDCl3, C6F6) δ-117.80. IR (neat) 3065, 2924, 1676, 1601, 1508, 1349, 1224, 1163, 
1091, 1046, 828, 665, 599 cm-1. HRMS (ESI) m/z 394.1269 [calculated mass for 






Synthesized according to general procedure C to yield pyrroline 3.31c (92%, d.r.=  
>20:1). 
1H NMR (400 MHz, CDCl3) δ 7.42 (d, J = 8.5, 2H), 7.35 (d, J = 8.3, 2H), 7.34 – 7.25 
(m, 5H), 7.22 (d, J = 8.4, 2H), 7.10 (d, J = 8.0, 2H), 5.79 (dt, J = 6.0, 2.0, 1H), 5.74 
(dt, J = 6.0, 2.1, 1H), 5.70 (dd, J = 4.6, 2.2, 1H), 5.66 (dd, J = 4.3, 2.1, 1H), 2.36 (s, 
3H). 13C NMR (126 MHz, CDCl3) δ 143.6, 140.1, 139.5, 135.9, 131.7, 130.0, 129.7, 
129.5, 129.0, 128.7, 128.2, 127.9, 127.7, 122.0, 71.0, 70.3, 21.7. IR (neat) 1596, 1484, 
1348, 1162, 1093, 1010, 816, 662, 596, 546 cm-1. HRMS (ESI) m/z 454.0465 







Synthesized according to general procedure C to yield pyrroline 3.31d (87%, d.r.=  
>20:1. 
1H NMR (400 MHz, CDCl3) δ 7.62 (d, J = 8.2, 2H), 7.38 – 7.27 (m, 7H), 7.12 – 7.07 
(m, 4H), 5.79 (dt, J = 5.8, 2.0, 1H), 5.76 – 5.72 (m, 1H), 5.70 (d, J = 2.2, 1H), 5.63 (d, 
J = 2.1, 1H), 2.36 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 143.6, 140.1(3), 140.1(1), 
137.7, 135.9, 130.0, 129.9, 129.5, 129.0, 128.7, 128.2, 127.9, 127.7, 93.7, 71.0, 70.4, 
21.7. IR (neat) 2921, 1674, 1597, 1482, 1349, 1163, 1091, 1048, 1006, 815, 697, 667, 







Synthesized according to general procedure C to yield pyrroline 3.31e (81%, d.r.=  
>20:1). 
1H NMR (400 MHz, CDCl3) δ 7.41 (dd, J = 7.9, 1.6, 2H), 7.38 – 7.28 (m, 5H), 7.21 
(td, J = 7.5, 1.2, 1H), 7.08 (d, J = 8.0, 2H), 6.94 (dd, J = 4.9, 3.8, 1H), 6.83 – 6.75 (m, 
2H), 5.80 – 5.75 (m, 3H), 5.69 (d, J = 1.7, 1H), 3.65 (s, 3H), 2.34 (s, 3H). 13C NMR 
(101 MHz, CDCl3) δ 159.8, 143.3, 141.8, 140.4, 136.2, 129.8, 129.6, 129.4, 129.1, 
128.6, 128.2, 128.1, 127.7, 120.1, 114.2, 112.6, 71.0, 70.8, 55.2, 21.7. IR (neat) 2918, 
1599, 1492, 1452, 1162, 1090, 1042, 761, 693, 665, 594, 545 cm-1. HRMS (ESI) m/z 






Synthesized according to general procedure C to yield pyrroline 3.31f (97%, d.r.=  
>20:1). 
1H NMR (400 MHz, CDCl3) δ 7.75 (d, J = 8.2, 2H), 7.62 (dd, J = 7.8, 1.7, 1H), 7.49 
(dd, J = 8.0, 1.1, 1H), 7.35 – 7.28 (m, 3H), 7.10 (td, J = 7.7, 1.7, 1H), 5.75 (bs, 1H), 
5.22 (d, J = 1.8, 1H), 4.14 (dd, J = 10.8, 5.3, 1H), 2.69 – 2.61 (m, 1H), 2.42 (s, 3H), 
2.39 – 2.31 (m, 1H), 1.94 – 1.82 (m, 2H), 1.78 (d, J = 13.0, 1H), 1.66 – 1.56 (m, 1H), 
1.50 – 1.37 (m, 1H), 1.34 – 1.12 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 143.8, 
141.0, 140.8, 134.4, 132.6, 129.9, 129.2, 128.9, 128.1(4), 128.0(9), 122.0, 119.2, 70.1, 
 224 
67.8, 37.6, 28.3, 26.5, 24.2, 21.8. IR (neat) 2931, 1683, 1506, 1348, 1164, 1094, 1062, 






5 mol. % Cu(hfacac)2
0.1M Toluene
150oC, 2h N
Ts 3.31g  
 
(2S,7aS)-2-Phenyl-1-tosyl-2,4,5,6,7,7a-hexahydro-1H-indole (3.31g): Synthesized 
according to general procedure C to yield pyrroline 3.31g (92%, d.r.=  >20:1). 
1H NMR (400 MHz, CDCl3) δ 7.59 (d, J = 8.2, 2H), 7.34 – 7.19 (m, 7H), 5.41 (d, J = 
2.1, 1H), 5.12 (d, J = 1.6, 1H), 4.22 (dd, J = 9.5, 5.2, 1H), 2.53 – 2.46 (m, 1H), 2.45 – 
2.42 (m, 1H), 2.39 (s, 3H), 1.94 (t, J = 13.4, 1H), 1.82 (dd, J = 16.7, 6.9, 2H), 1.58 – 
1.36 (m, 2H), 1.33 – 1.18 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 143.3, 141.9, 
140.9, 136.0, 129.7, 128.6, 127.7(3), 127.6(8), 127.4, 120.1, 70.6, 67.4, 37.3, 28.4, 
26.8, 24.2, 21.7. IR (neat) 2932, 1455, 1348, 1163, 1096, 1038, 757, 660, 589, 566 
















(3.31h): Synthesized according to general procedure C to yield pyrroline 3.31h (93%, 
d.r.=  >20:1). 
1H NMR (400 MHz, CDCl3) δ 7.59 (d, J = 8.3, 2H), 7.54 (d, J = 8.2, 2H), 7.42 (d, J = 
8.1, 2H), 7.22 (d, J = 8.0, 2H), 5.44 (d, J = 1.9, 1H), 5.11 (d, J = 1.7, 1H), 4.24 (dd, J 
= 8.2, 6.1, 1H), 2.60 – 2.53 (m, 1H), 2.43 (dd, J = 8.0, 6.0, 1H), 2.39 (s, 3H), 1.96 (t, J 
= 13.4, 1H), 1.85 (t, J = 12.4, 2H), 1.55 – 1.36 (m, 2H), 1.33 – 1.18 (m, 1H). 13C 
NMR (101 MHz, CDCl3) δ 145.9, 143.7, 141.8, 135.6, 129.84 (q, J = 32.3), 129.8, 
127.8, 127.7, 125.6 (q, J = 3.7), 124.4 (q, J = 272.1), 119.39, 70.1, 67.5, 37.4, 28.4, 
26.7, 24.1, 21.7. IR (neat)  2936, 1618, 1448,, 1420, 1324, 1162, 1122, 1066, 1017, 
827, 666, 591 cm-1. 19F NMR (376.135 MHz, CDCl3, C6F6) δ -65.64. HRMS (ESI) 







Synthesized according to general procedure C to yield pyrroline 3.31i (96%, d.r.=  
>20:1). 
1H NMR (400 MHz, CDCl3) δ 8.17 (d, J = 8.8, 2H), 7.64 (d, J = 8.3, 2H), 7.51 (d, J = 
8.7, 2H), 7.28 (d, J = 8.9, 2H), 5.46 (d, J = 2.3, 1H), 5.10 (d, J = 1.8, 1H), 4.19 (dd, J 
= 9.8, 5.0, 1H), 2.62 – 2.53 (m, 1H), 2.46 – 2.42 (m, 1H), 2.42 (s, 3H), 2.03 – 1.79 (m, 
3H), 1.56 – 1.37 (m, 2H), 1.31 – 1.18 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 149.4, 
147.4, 144.0, 142.5, 135.0, 129.9, 128.1, 127.8, 124.0, 118.8, 69.9, 67.6, 37.5, 28.3, 
26.6, 24.1, 21.8. IR (neat) 2934, 1683, 1520, 1456, 1344, 1161, 1096, 772, 676, 658 







(3.31j): Synthesized according to general procedure C to yield pyrroline 3.31j (92%, 
d.r.=  >20:1). 
1H NMR (400 MHz, CDCl3) δ 7.32 (d, J = 8.0, 2H), 7.12 – 7.08 (m, 4H), 6.96 (d, J = 
7.9, 2H), 5.54 (dt, J = 5.0, 1.9, 1H), 5.23 (q, J = 1.9, 1H), 4.32 (dt, J = 10.2, 4.9, 1H), 
2.93 – 2.84 (m, 1H), 2.57 – 2.49 (m, 1H), 2.31 (s, 3H), 2.16 – 2.01 (m, 1H), 1.91 – 
1.79 (m, 2H), 1.55 – 1.32 (m, 2H), 1.25 (ddq, J = 12.2, 6.8, 4.1, 1H). 13C NMR (101 
MHz, CDCl3) δ 143.5, 142.6, 142.5, 138.4, 130.00 (q, J = 32.2), 129.1, 128.9, 126.6, 
125.1 (q, J = 3.8), 124.3 (q, J = 272.1), 119.6, 69.9, 67.1, 36.6, 28.7, 26.6, 24.0, 21.5. 
IR (neat) 2931, 1652, 1421, 1343, 1325, 1160, 1122, 1108, 1065, 1017, 837, 812, 660, 
592 cm-1. 19F NMR (376.135 MHz, CDCl3, C6F6) δ -65.70. HRMS (ESI) m/z 






Synthesized according to general procedure C to yield pyrroline 3.31k (71%, d.r.=  
>20:1). 
1H NMR (400 MHz, CDCl3) δ 7.98 (d, J = 8.8, 2H), 7.24 (d, J = 8.3, 2H), 7.21 (d, J = 
8.8, 2H), 7.04 (d, J = 7.9, 2H), 5.57 (dt, J = 4.9, 1.8, 1H), 5.23 (d, J = 1.9, 1H), 4.38 
(dd, J = 9.3, 4.9, 1H), 2.88 – 2.80 (m, 1H), 2.55 – 2.47 (m, 1H), 2.34 (s, 3H), 2.08 (td, 
J = 12.9, 3.9, 1H), 1.91 – 1.80 (m, 2H), 1.44 – 1.34 (m, 2H), 1.32 – 1.16 (m, 1H). 13C 
 226 
NMR (101 MHz, CDCl3) δ 147.6, 147.5, 143.1(2), 143.0(7), 138.5, 129.3, 129.1, 
126.8, 123.5, 119.2, 69.7, 67.3, 36.2, 28.6, 26.6, 23.9, 21.6. IR (neat) 2932, 1520, 




















































H1 (ppm)  
-100102030405060708090100110120130140150160170180190














































































































































































































































































































































































































































































H1 (ppm)  
0102030405060708090100110120130140150160170180190
















































































H1 (ppm)  
-100102030405060708090100110120130140150160170180190200
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A4.1 Experimental Procedures for Chapter 4  
General Information:  Commercial reagents were purchased and used without 
further purification.  All glassware was flame dried and reactions were performed 
under a nitrogen atmosphere, unless otherwise stated.  Toluene, benzene, 
dichloromethane, diethyl ether, and THF were dried over a column of alumina.  Flash 
chromatography was done with Silicycle SiliaFlash® F60 silica, and thin layer 
chromatography (TLC) was performed with EMD 250 μm silica gel 60-F254 plates.  1H 
and 13C NMR data was acquired on a Varian Inova 400, 500, or 600 (400, 500 or 600 
MHz) spectrometer and referenced to residual protic solvent.  IR was taken on a 
Mattson Instruments Research Series FTIR spectrometer.  High-resolution mass 
spectrometry was performed at the University of Illinois at Urbana-Champaign 
facility.  Enantiomeric ratios were determined on an HP 1100 Series HPLC with a 
Daicel Chiracel® OD-H (0.46 cm x 25 cm) column.  GC/MS analysis was performed 
on an Agilent Technologies 6890N GC with a JW Scientific DB-5ms Column (30 m, 
0.25mm thickness, 0.25 m film thickness) and a JEOL JMS-GCmate II GCMS 
System. Measurements of optical rotation were done on a Rudolph Research Analytic 
Autopol III Automatic Polarimeter. 
 
 




Representative procedure for Vinyl Oxirane Rearrangements:  Stock solutions of 
the epoxide and catalyst in toluene were prepared. To a flame dried 13x100 mm 
threaded culture tube was added 0.50 mL of the substrate solution (0.144 mmol 
substrate), followed by 0.50 mL of Cu(hfacac)2 solution (0.0072 mmol catalyst, 5 mol 
%).  The septum was replaced with a cap, and the seal was reinforced with Teflon 
tape.  The tube was put in a 150ºC oil bath.  At the end of the reaction, the tube was 
cooled to room temperature the reaction mixture was filtered through neutral alumina 
(activity grade 1) washing with EtOAc to remove the copper catalyst. The solvent was 
removed in vacuo and flash chromatography with silica was performed. Note: the 
reaction is highly dependent on catalyst loading and the concentration of starting 
material. 
 
Reaction Analysis:  The dihydrofuran:ketone ratio was first determined by NMR 
analysis on the crude reaction mixture.  The diastereoselectivity was then assessed by 






(7E)-trans-5,6-Epoxydodecene (4.7):  To a 50 mL RBF equipped with a stir bar was 
added methylene chloride (30 mL), (5E,7E)-5,7-dodecadiene1,2 (0.50 g, 3.01 mmol), 
Na2HPO4 (0.742 g, equal mass with m-CPBA), and m-CPBA (77%, 0.742 g, 3.31 
mmol).  After 1 hour, the reaction was cooled to 0°C and filtered through celite.  It 
was then diluted with additional methylene chloride and washed with a saturated 
NaHCO3 solution (3x), water, and dried over Na2SO4.  The solvent was removed in 
vacuo, and the product was purified by chromatography (5% Et2O : 95% pentane) 
(0.384 g, 67%). 
 1H NMR (500 MHz, C6D6 )  5.74 (td, J = 15.2, 6.8, 1H), 5.21 (tdd, J = 15.2, 7.9, 1.4, 
1H), 2.97 (dd, J = 7.9, 2.0, 1H), 2.65 (ddd, J = 6.0, 5.2, 2.1, 1H), 1.99 – 1.82 (m, 2H), 
1.48 – 1.09 (m, 10H), 0.89 – 0.72 (m, 6H).  13C NMR (125 MHz, C6D6 )  135.8, 
129.3, 60.4, 58.8, 32.7, 32.6, 31.8, 28.8, 23.2, 22.9, 14.5, 14.4.  IR (neat) 2958, 2929, 
2872, 2860, 1459, 1378, 965 cm-1. HRMS (EI+) m/z 182.1670 [calculated mass for 





(E)-2-Butyl-3-(hex-1-enyl)oxirane (4.10): To a 250 mL round bottom flask with a 
magnetic stir bar was added 0.530 g (3.2 mmol) of (5Z,7E)-5,7-dodecadiene and 31 ml 
of acetone. The reaction was cooled to -10oC and 32 mL of dimethyldioxirane33 (1.0 
equiv., ~0.1 M in acetone) was added in 5 mL portions. Reaction was monitored by 
TLC (5% Et2O : 95% pentane, KMnO4) until complete and then solvent was 
evaporated and the product was purified by silica gel chromatography (5% Et2O : 95% 
pentane). The products are somewhat unstable to silica gel and separation was tedious 




(E, cis)-2-Butyl-3-(hex-1-enyl)oxirane (4.10): 1H NMR (400 MHz, CDCl3) δ 5.93 (dt, 
J = 15.4, 7.1, 1H), 5.39 – 5.20 (m, 1H), 3.37 (dd, J = 8.1, 4.3, 1H), 3.05 (ddd, J = 6.6, 
5.6, 4.4, 1H), 2.09 (dt, J = 8.2, 4.1, 2H), 1.66 – 1.53 (m, 2H), 1.53 – 1.44 (m, 2H), 
1.44 – 1.26 (m, 6H), 0.98 – 0.83 (m, 6H). 13C NMR (126 MHz, CDCl3) δ 138.3, 
124.3, 59.1, 57.4, 32.5, 31.4, 28.7, 27.9, 22.8, 22.4, 14.2, 14.1. IR (neat) 2955, 2926, 
2868, 1464, 1326, 1280, 1152, 752 cm-1. HRMS (EI+) m/z 182.16692 [calculated 





(Z, trans)-2-Butyl-3-(hex-1-enyl)oxirane (4.11): Previously synthesized but not 
characterized4. 1H NMR (400 MHz, CDCl3) δ 5.70 (dt, J = 11.0, 7.7, 1H), 5.14 – 4.95 
(m, 1H), 3.35 (dd, J = 8.9, 2.3, 1H), 2.82 (td, J = 5.7, 2.3, 1H), 2.32 – 2.10 (m, 2H), 
1.67 – 1.52 (m, 2H), 1.52 – 1.24 (m, 8H), 0.95 – 0.88 (m, 6H). 13C NMR (126 MHz, 
CDCl3) δ 136.4, 127.1, 60.2, 54.5, 31.7(7), 31.7(9), 28.1, 27.4, 22.5, 22.2, 14.0, 13.9. 
IR neat 2958, 2930, 2860, 1459, 1379, 1304, 929, 872 cm-1. HRMS (EI+) m/z 





(Z,Z)-Dodeca-5,7-diene (4.36): Method adapted from known protocol.5 To a 25 mL 
flame dried flask was added a stir bar and 8 g of Zn dust. Under N2 atmosphere was 
added 6 mL of H2O followed by 0.8 g Cu(OAc)2.H2O (4.0 mmol, 1.6 equiv.). After 15 
minutes of stirring 0.8 g of AgNO3 (4.7 mmol, 1.9 equiv.) was added. The solution 
was stirred for 30 minutes and then filtered under vacuum and the solid was washed 
with water (2 x 20 mL), methanol (2 x 20 mL), acetone (2 x 20 mL), and finally Et2O 
(2 x 20 mL). The solid Zn was transferred into a 50 mL round bottom flask under N2. 
To this flask were added 10 mL of MeOH and 10 mL of H2O. Then dodeca-5,7-diyne6 
0.413 g ( 2.5 mmol) was added in a solution of methanol and heterogeneous reaction 
was stirred for 7 days at room temperature. Then the solution was filtered through 
celite and washed with MeOH. The filtrate was extracted with hexanes and the organic 
layer dried with Na2SO4. The solvent was removed to yield pure product 0.340 g 
80%). Previously characterized.16  
1H NMR (600 MHz, CDCl3) δ 6.27 – 6.23 (m, 2H), 5.48 – 5.41 (m, 2H), 2.17 (q, J = 





(Z, cis)-2-Butyl-3-(hex-1-enyl)oxirane (4.8): To a 20 mL round bottom flask with a 
magnetic stir bar was added 0.200 g (1.2 mmol) of (Z,Z)-dodeca-5,7-diene and 4 ml of 
acetone. The reaction was cooled to 0oC and 15 mL of dimethyldioxirane3 (1.2 equiv., 
~0.1 M in acetone) was added in 5 mL portions. Reaction was monitored by TLC 
(2.5% Et2O : 97.5% pentane, KMnO4) until complete and then solvent was evaporated 
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and the product was purified by silica gel chromatography (2.5% Et2O : 97.5% 
pentane) to yield 193 mg (1.06 mmol, 88%).  
1H NMR (500 MHz, CDCl3) δ 5.76 (dtd, J = 11.1, 7.6, 0.9, 1H), 5.21 (ddt, J = 11.4, 
8.4, 1.5, 1H), 3.64 (ddd, J = 8.4, 4.3, 1.0, 1H), 3.07 (ddd, J = 6.3, 5.7, 4.4, 1H), 2.31 – 
2.13 (m, 2H), 1.64 – 1.54 (m, 2H), 1.54 – 1.44 (m, 3H), 1.44 – 1.30 (m, 9H), 0.91 (t, J 
= 7.1, 6H). 13C NMR (126 MHz, CDCl3) δ 137.4, 123.8, 58.6, 52.8, 31.7, 28.5, 28.0, 
27.5, 22.5, 22.3, 14.0, 13.9. IR (neat) 2954, 2862, 1558, 1521, 1311, 1150, 1062, 955 





cis-2,5-Dibutyl-2,5-dihydrofuran (4.9): To a flame dried 13x100 mm threaded culture 
tube was added 24 mg of substrate (4.7) (0.13 mmol) in 1 mL of dry toluene. The 
culture tube was fitted with a threaded septum cap and then submerged in an oil bath 
at 150ºC. A syringe pump was used to add 0.5 mL of toluene over 4 hours (1.25 
mol%/hour) which contained 3.3 mg of Cu(hfacac)2 (0.0066 mmol, 0.05 equiv.). The 
solution was heated for a total of 8 hours and then cooled to room temperature. The 
reaction mixture was filtered through neutral alumina (activity grade 1) washing with 
EtOAc and then purified by flash chromatography on silica gel (5% ether : 95% 
pentane, KMnO4) to yield 19.0 mg (79%, 0.10 mmol). (Crude diastereomeric ratio 
15:1, purified >20:1 cis:trans).  
1H NMR (500 MHz, C6D6 )  5.54 (d, J = 0.6, 2H), 4.86 – 4.70 (m, 2H), 1.69-0.99 (m, 
12H), 0.86 (t, J = 7.3, 6H).  13C NMR (125 MHz, C6D6 )  130.9, 86.3, 37.7, 28.6, 
23.5, 14.7. IR (neat) 2957, 2927, 2859, 1749, 1717, 1684, 1672, 1522, 1458, 1321 cm-






















Figure A4.1: NMR Experiment of 4.7 
 

















1 Toluene 150 3  :  1 17 
2 Toluene 125 1  :  4 10 
3 Toluene 100 1  :  >20 3 
5 Benzene 125 6  :  1 27 
6 Benzene 100 1.5   :   1 17 
7 Benzene 75 1  :  >20 8 
9 Xylene 225 3  :  1 45 
10 Xylene 150 1  :  1 10 
11 Xylene 100 1  :  5 5 
Conditions: 5 mol% Cu(hfacac)2, 0.15M and 15 hours.  a) All reactions were run to full conversion, b) These numbers were






trans-2,5-Dibutyl-2,5-dihydrofuran (4.12): To a flame dried 13 x 100 mm culture tube 
was added 3.4 mg of Cu(hfacac)2 (0.0069 mmol, 0.05 equiv). To this vial was added 
25 mg of vinyloxirane (4.10) (0.14 mmol) dissolved in 1.1 ml (0.125 M) benzene. The 
tube was sealed and reinforced with Teflon tape. The solution was submersed in an oil 
bath at 150ºC for 3 hours and then cooled to room temperature. The solution was 
filtered through neutral alumina (activity grade 1) washing with EtOAc. The solvent 
was removed in vacuo and flash chromatography (5% ether : 95% pentane, KMnO4) 
with silica was performed to yield 16.6 mg (66%, 0.91 mmol). (Crude diastereomeric 
ratio 1:18, purified >1:20 cis:trans).  
1H NMR (500 MHz, C6D6 )  5.53 (s, 2H), 4.88 – 4.78 (m, 2H), 1.72 – 1.03 (m, 12H), 
0.87 (t, J = 7.3, 6H).  13C NMR (125 MHz, C6D6 )  130.7, 86.1, 36.9, 28.4, 23.6, 
14.7.  IR (neat) 2957, 2929, 2859, 2360, 2341, 1458, 1377, 1108, 1079 cm-1. HRMS 

























Rearrangement of 4.11 according to general procedure. 
 
 
Rearrangement of 4.9 according to general procedure. 
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Rearrangements of 4.7, 4.10, 4.8, 4.11 produce 4.9, 4.37, and 4.38 as byproducts. 
They are observable in NMR tube experiments or observable in the crude NMR prior 
to removal of Cu(hfacac)2. Compound 4.1377 and 4.388 are isolable and spectral data 
matches existing information. Compound 4.379 was not isolable but assumed by it’s 
similarity to 4.13.    
 
                                                                  





(E,E)-1-Benzyloxy-2,4-hexadiene:  A 1L flask equipped with a stir bar containing 
DMF (500 mL) and sodium hydride (60% dispersion in mineral oil, 4.49 g, 112.24 
mmol) was cooled to 0°C in an ice bath, and then a solution of (2E, 4E)-2,4-hexadien-
1-ol (10.0 g, 102 mmol) in DMF was slowly added.  After 1 hour, sodium iodide (0.49 
g, 20.5 mmol) and benzyl chloride (11.8 mL, 13.0 g, 102 mmol) were added.  After 2 
hours, the reaction was quenched with water and diluted with diethyl ether.  The layers 
were separated, and the aqueous layer was extracted (2x) with diethyl ether.  The 
combined organic portions were then washed with brine, dried over MgSO4, and the 
solvent was removed in vacuo.  The crude product was purified by chromatography to 
give the product as colorless oil (16.26 g, 85%).   
1H NMR (500 MHz, CDCl3 )  7.39 – 7.26 (m, 5H), 6.23 (dd, J = 15.2, 10.5, 1H), 
6.13 – 6.03 (m, 1H), 5.71 – 5.60 (m, 2H), 4.51 (s, 2H), 4.05 (d, J = 6.3, 2H), 1.77 (d, J 
= 6.7, 3H).  13C NMR (125 MHz, CDCl3)   138.6, 133.6, 131.0 130.3, 128.6, 128.0, 
127.8, 126.8, 72.1, 70.8, 18.3.  IR (neat) 3062, 3026, 2932, 2910, 2853, 1496, 1453, 






2-((E)-3-(Benzyloxy)prop-1-en-1-yl)-3-methyloxirane (4.14a) and 2-
((benzyloxy)methyl)-3-((E)-prop-1-en-1-yl)oxirane (4.14b):  To a 500 mL RBF 
equipped with a stir bar was added methylene chloride (300 mL), (E,E)-1-benzyloxy-
2,4-hexadiene (5.9 g, 31.3 mmol), Na2HPO4 (7.73 g, equal mass with m-CPBA), and 
m-CPBA (77%, 7.73 g, 34.5 mmol).  After 1 hour, the reaction was cooled to 0°C and 
filtered through celite.  It was then diluted with additional diethyl ether and washed 
327 
with 1 M NaOH (1x), a saturated NaHCO3 solution (2x), water, and dried over 
MgSO4.  The solvent was removed in vacuo to give a clear oil (6.27 g, 98%) that was 
a 1.5:1 (4.14a:4.14b) mixture of regioisomers.  The regioisomeric vinyl oxiranes could 




2-((Benzyloxy)methyl)-3-((E)-prop-1-en-1-yl)oxirane (4.14b): 1H NMR (500 MHz, 
CDCl3 )  7.51-7.11 (m, 5H), 6.01 – 5.88 (m, 1H), 5.20 (dddd, J = 15.3, 8.3, 3.1, 1.5, 
1H), 4.67 – 4.49 (m, 2H), 3.74 (dd, J = 11.5, 3.2, 1H), 3.51 (dd, J = 11.5, 5.5, 1H), 
3.24 (dd, J = 8.3, 2.2, 1H), 3.13 – 3.07 (m, 1H), 1.74 (dd, J = 6.6, 1.6, 3H). 13C NMR 
(125 MHz, CDCl3)  138.1, 132.5, 128.6, 128.1, 128.0, 128.0, 73.5, 70.2, 58.8, 56.3, 
18.1. IR (neat) 3087, 3063, 3029, 2989, 2966, 2938, 2917, 2857, 1496, 1453, 1364, 
1239, 1206, 1105, 963, 874, 739, 699 cm-1. HRMS (EI+) m/z 204.11496 [calculated 




2-((E)-3-(Benzyloxy)prop-1-en-1-yl)-3-methyloxirane (4.14a) Characterization data 





(2E,4E)-Ethyl 5-(3-methyloxiran-2-yl)penta-2,4-dienoate (4.14c): To a 200 mL flame 
dried flask with magnetic stir bar was added 120 mL of methylene chloride. To this 
solution was added 2.00 g of (2E,4E,6E)-ethyl octa-2,4,6-trienoate11 (12.0 mmol, 1 
equiv.). Next, was added 2.7 g of Na2HPO4 followed by 2.7 g of m-CPBA (15.6 
mmol, 1.3 equiv.). The solution was stirred at room temperature until the starting 
material was consumed. The solution was cooled to 0oC and then filtered through 
celite. The organic filtrate was washed 3 times with sat. NaHCO3 and once with H2O. 
The solution was dried with Na2SO4 and the solvent removed in vacuo. The product 
was purified by silica gel chromatography (15% Et2O : 85% pentane) to yield 1.73 g 
of product (79%).  
 1H NMR (500 MHz, C6D6) δ 7.36 (ddd, J = 15.4, 11.2, 0.7, 1H), 6.07 (dd, J = 15.3, 
11.2, 1H), 5.87 (dd, J = 15.4, 0.6, 1H), 5.34 (dd, J = 15.3, 7.5, 1H), 4.05 (q, J = 7.1, 
2H), 2.62 (dd, J = 7.5, 1.8, 1H), 2.42 (qd, J = 5.1, 2.0, 1H), 0.99 (t, J = 7.1, 3H), 0.94 
(d, J = 5.1, 3H). 13C NMR (126 MHz, C6D6) δ 166.8, 143.5, 140.1, 131.1, 122.7, 60.6, 
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58.4, 57.1, 17.8, 14.7. IR (neat) 2984, 2932, 1713, 1644, 1619, 1305, 1231, 1145, 





(E)-Ethyl 3-((cis)-5-methyl-2,5-dihydrofuran-2-yl)acrylate (4.15c): To a flame dried 
13x100 mm threaded culture tube was added 25 mg of substrate (4.14c) (0.14 mmol) 
in 1 mL of dry toluene. The culture tube was fitted with a threaded septum cap and 
then submerged in an oil bath at 150ºC. A syringe pump was used to add 0.5 mL of 
toluene over 17 hours (0.12 mol%/hour) which contained 1.4 mg of Cu(hfacac)2 
(0.0027 mmol, 0.02 equiv.). The solution was heated for a total of 24 hours and then 
cooled to room temperature. The reaction mixture was filtered through neutral alumina 
(activity grade 1) washing with EtOAc and then purified by flash chromatography on 
silica gel (20% ether : 80% pentane, KMnO4) to yield 21.0 mg (84%, 0.12 mmol). 
(Crude diastereomeric ratio 8:1, purified >20:1 cis:trans).  
1H NMR (600 MHz, CDCl3) δ  6.83 (dd, J = 15.6, 5.3, 1H), 5.98 (d, J = 15.5, 1H), 
5.80 – 5.77 (m, 1H), 5.66 (d, J = 6.0, 1H), 5.31 – 5.22 (m, 1H), 4.98 – 4.89 (m, 1H), 
4.13 (q, J = 7.2, 2H), 1.25 (d, J = 6.4, 3H), 1.22 (t, J = 7.2, 3H). 13C NMR (126 MHz, 
CDCl3) δ 166.7, 147.9, 132.6, 127.1, 120.7, 85.0, 83.1, 60.7, 22.9, 14.5. IR neat 2981, 
2954, 2873, 1721, 1657, 1596, 1448, 1370, 1303, 1275, 1180, 1039, 981, 841 cm-1;. 





1-Phenyl-1,4-pentadien-3-ol:  To a 1L flask equipped with a stir bar was added THF 
(300 mL) and trans-cinnamaldehyde (8.4 g, 63.6 mmol).  The flask was then cooled in 
an ice bath, and a solution of vinyl magnesium bromide (0.7 M, 100 mL, 70 mmol) 
was added.  After 2 h, the reaction was quenched with water and HCl (1M).  The 
layers were separated, and the aqueous layer was extracted with diethyl ether.  The 
organic portions were combined and dried over MgSO4.  The solvent was removed in 
vacuo to leave the product as an orange oil (10.02 g, 99%).  The spectral data matched 






trans-1,2-Epoxy-1-phenyl-4-penten-3-ol:  To a 250 mL round bottom flask equipped 
with a stir bar was cooled in an ice bath. Then methylene chloride (180 mL), 1-phenyl-
1,4-pentadien-3-ol (3.00 g, 18.73 mmol), and Na2HPO4 (4.85 g, equal mass with m-
CPBA) were added.  After a few minutes, m-CPBA (77%, 4.83, 21.54 mmol) was 
added, and the reaction was allowed to stir at 0°C.  After about 2.5 hours, the reaction 
was filtered through celite and then washed with NaOH (1 M), sat. NaHCO3, sat. 
NaCl, and dried over Na2SO4  The solvent was removed in vacuo, and the product was 
obtained as a yellow oil (3.06 g, 94%) that did not require further purification and 





Methyl trans-6,7-epoxy-7-phenyl-4-heptenoate (4.14d): To a 25 mL RBF equipped 
with a stir bar was added toluene (8 mL), trans-1,2-epoxy-1-phenyl-4-penten-3-ol 
(1.03 g, 5.8 mmol), trimethyl orthoacetate (3.6 mL, 3.4 g, 28.3 mmol), and propionic 
acid (0.05 mL, 0.05 g, 0.67 mmol).  The reaction was allowed to reflux for 18 hours, 
and then the toluene was removed in vacuo and the crude product was purified by 
chromatography (5 – 30% Et2O : 95 – 70% pentane) to give a yellow oil (1.13 g, 
83%).  
1H NMR (500 MHz, CDCl3 )  7.34 – 7.19 (m, 5H), 5.98 – 5.85 (m, 1H), 5.35 (dd, J = 
15.5, 7.8, 1H), 3.71 (d, J = 2.0, 1H), 3.65 (s, 3H), 3.28 (dd, J = 7.8, 1.8, 1H), 2.40 (d, 
J = 2.7, 4H). 13C NMR (125 MHz, CDCl3 )  173.4, 137.3, 134.8, 128.7, 128.4, 128.4, 
125.6, 62.9, 60.4, 51.9, 33.5, 27.0. IR (neat) 3088, 3064, 3033, 2998, 2951, 2924, 
2846, 1737, 1458, 1437, 1363, 1249, 1199, 1170 cm-1. HRMS (EI+) m/z 232.1102 






(E)-1-(Benzyloxy)hex-4-ene-2,3-diol (4.44) and (E)-6-(benzyloxy)hex-4-ene-2,3-diol 
(4.45): To a 250 mL round bottom flask was added 2.00 g of (E,E)-1-benzyloxy-2,4-
hexadiene (0.011 mol) followed by 50 mL of acetone and 50 mL of distilled water. 
Next, 1.4 g of N-methylmorpholine-N-oxide (0.012 mol, 1.1 equiv.) followed by 1.3 
mL of 2.5% OsO4 solution in tBuOH (0.10 mmol, 0.01 equiv.) This solution was 
stirred vigorously at room temperature for 14 hours. The reaction was cooled to 0oC 
and quenched with a solution of sodium bisulfite and diluted with ethyl acetate.  The 
layers were separated, and the aqueous layer was extracted with ethyl acetate (3x).  
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The organic portions were combined and dried over Na2SO4.  The solvent was 
removed in vacuo and the product was purified by chromatography (80% ether : 20% 
pentane, anisaldehyde) to yield (E)-6-(benzyloxy)hex-4-ene-2,3-diol 1.08 g (46%, 4.9 
mmol); (E)-1-(benzyloxy)hex-4-ene-2,3-diol 0.20 g (9%, 0.91 mmol), starting material 




(E)-6-(Benzyloxy)hex-4-ene-2,3-diol (4.45): 1H NMR (300 MHz, CDCl3) δ 7.42 – 
7.21 (m, 5H), 6.01 – 5.86 (m, 1H), 5.81 – 5.63 (m, 1H), 4.52 (s, 2H), 4.04 (d, J = 5.5, 
2H), 3.86 (dd, J = 10.6, 6.5, 1H), 3.70 – 3.57 (m, 1H), 2.53 (dd, J = 6.9, 4.0, 2H), 1.17 
(d, J = 6.3, 3H); 13C NMR (75 MHz, CDCl3) δ 138.2, 132.1, 123.0, 128.6, 128.0, 
127.9, 77.1, 72.6, 70.8, 70.2, 19.1. IR (neat) 3387, 2971, 2860, 1453, 1362, 1264, 






(E)-1-(Benzyloxy)hex-4-ene-2,3-diol (4.44): 1H NMR (400 MHz, CDCl3) δ 7.39 – 
7.23 (m, 5H), 5.77 – 5.64 (m, 1H), 5.45 (ddd, J = 15.3, 7.2, 1.6, 1H), 4.55 (d, J = 11.9, 
1H), 4.49 (d, J = 11.9, 1H), 4.04 (t, J = 6.6, 1H), 3.67 – 3.59 (m, 1H), 3.56 (dd, J = 
9.8, 3.5, 1H), 3.47 (dd, J = 9.8, 6.0, 1H), 3.13 (bs, 1H), 3.02 (bs, 1H), 1.71 – 1.64 (m, 
3H). 13C NMR (101 MHz, CDCl3) δ 137.8, 129.9, 129.5, 128.5, 128.1, 127.9, 73.6, 
73.5, 73.4, 71.5, 18.0; IR (neat) 3443, 2931, 2856, 1671, 1605, 1451, 1206, 1116, 966, 






(E)-2-((Benzyloxy)methyl)-3-(prop-1-en-1-yl)oxirane (4.14e): Method adapted from 
known protocol.13 To a 25 mL round bottom flask was added 0.25 g of 
benzyltriethylammonium chloride (1.1 mmol, 1.2 equiv.) followed by 6 mL of 
dichloromethane and 6 mL of 25% NaOH(aq). The solution was cooled to 0oC and 
then 0.202 g of (E)-1-(benzyloxy)hex-4-ene-2,3-diol (0.91 mmol) was added. Lastly, 
0.250 g of 4-acetamidobenzenesulfonyl chloride (1.1 mmol, 1.2 eqiuv.) was added and 
the solution was warmed to room temperature slowly over 1 hour and stirred 
vigorously at room temperature overnight. The solution was diluted with water and 
extracted with CH2Cl2 twice. The solution was dried on Na2SO4 and the solvent 
removed in vacuo. Flash chromatography (10% ether : 90% pentane, anisaldehyde) 
with silica was performed to yield 0.108 g (0.53 mmol, 58%). 
 1H NMR (400 MHz, CDCl3) δ 7.40 – 7.28 (m, 5H), 5.96 (dq, J = 15.3, 6.6, 1H), 5.26 
(ddq, J = 15.4, 8.0, 1.7, 1H), 4.64 (d, J = 11.9, 1H), 4.54 (d, J = 11.9, 1H), 3.69 (dd, J 
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= 11.2, 4.4, 1H), 3.58 (dd, J = 11.2, 6.3, 1H), 3.45 (dd, J = 8.0, 4.4, 1H), 3.33 (dt, J = 
6.3, 4.4, 1H), 1.74 (dd, J = 6.6, 1.7, 3H). 13C NMR (101 MHz, CDCl3) δ 138.0, 133.5, 
128.6, 128.0, 127.9, 124.8, 73.3, 68.3, 57.0, 56.3, 18.2. IR (neat) 2938, 2858, 1453, 
1308, 1092, 962, 842, 736, 694 cm-1. HRMS (CI+) m/z 205.12268  [calculated mass 





(E)-2-(3-(Benzyloxy)prop-1-en-1-yl)-3-methyl-cis-oxirane (4.14f): Method adapted 
from known protocol.13 To a 13 x 100 mm culture tube was added 0.050 g of 
benzyltriethylammonium chloride (0.22 mmol, 1.9 equiv.) followed by 1 mL of 
dichloromethane and 1 mL of 25% NaOH(aq). The solution was cooled to 0oC and 
then 0.050 g of (E)-6-(benzyloxy)hex-4-ene-2,3-diol (0.11 mmol) was added. Lastly, 
31.6 mg of 4-acetamidobenzenesulfonyl chloride (0.14 mmol, 1.2 eqiuv.) was added 
and the solution was warmed to room temperature slowly over 1 hour and stirred 
vigorously at room temperature overnight. The solution was diluted with water and 
extracted with CH2Cl2 twice. The solution was dried on Na2SO4 and the solvent 
removed in vacuo. Flash chromatography (10% ether : 90% pentane, anisaldehyde) 
with silica was performed to yield: 0.012 g (0.059 mmol, 52%).  
1H NMR (400 MHz, CDCl3) δ 7.41 – 7.28 (m, 5H), 6.05 (ddd, J=15.6, 6.0, 5.3, 1H), 
5.70 – 5.58 (m, 1H), 4.54 (s, 2H), 4.08 (dd, J=5.6, 1.0, 2H), 3.43 (dd, J=7.7, 4.2, 1H), 
3.28 – 3.17 (m, 1H), 1.30 (dd, J=5.5, 0.7, 3H).  13C NMR (126 MHz, CDCl3) δ  138.3, 
133.3, 128.6, 128.0, 127.9, 127.2, 72.5, 70.1, 56.8, 54.8, 13.6. IR (neat) 2914, 2849, 
1451, 1276, 1057, 966, 738 cm-1. HRMS (CI+) m/z 205.12314 [calculated mass for 





1,6-bis(Benzyloxy)hex-4-ene-2,3-diol (4.45): To a 100 mL round bottom flask was 
added 1.67g of (2E,4E)-1,6-bis(benzyloxy)hexa-2,4-diene (5.68 mmol) followed by 25 
mL of acetone and 25 mL of distilled water. The solution was cooled to 0oC then 
0.732 g of N-methylmorpholine-N-oxide (6.25 mmol, 1.1 equiv.) followed by 0.7 mL 
of 2.5% OsO4 solution in tBuOH (0.057 mmol, 0.01 equiv.) This solution was stirred 
vigorously at room temperature for 14 hours. The reaction was cooled to 0oC and 
quenched with a solution of sodium bisulfite and diluted with ethyl acetate.  The layers 
were separated, and the aqueous layer was extracted with ethyl acetate (3x).  The 
organic portions were combined and dried over Na2SO4.  The solvent was removed in 
vacuo and the product was purified by chromatography (70% ether : 30% pentane, 
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anisaldehyde) to yield 1,6-bis(benzyloxy)hex-4-ene-2,3-diol  0.913g (49%, 2.7 mmol); 
staring material 0.45 g (27%, 1.5 mmol).  
1H NMR (300 MHz, CDCl3) δ 7.45 – 7.16 (m, 10H), 5.95 – 5.82 (m, 1H), 5.76 (dd, J 
= 15.6, 6.1, 1H), 4.57 (d, J = 11.9, 1H), 4.50 (s, 2H), 4.50 (d, J = 2.6, 1H), 4.19 (t, J = 
5.5, 1H), 4.02 (d, J = 5.4, 2H), 3.68 (dd, J = 8.8, 5.1, 1H), 3.61 (dd, J = 9.7, 3.6, 1H), 
3.53 (dd, J = 9.7, 5.7, 1H), 2.76 (s, 2H). 13C NMR (75 MHz, CDCl3) δ 138.3, 137.8, 
131.6, 129.8, 128.7, 128.6, 128.1, 128.0, 127.9, 127.8, 73.8, 73.1, 72.9, 72.5, 71.6, 






(E)-2-((Benzyloxy)methyl)-3-(3-(benzyloxy)prop-1-en-1-yl)oxirane (4.14g): Method 
adapted from known protocol.13 To a 100 mL round bottom flask was added 3.8 g of  
benzyltriethylammonium chloride (16.7 mmol, 7.2 equiv.) followed by 24 mL of 
dichloromethane and 24 mL of 25% NaOH(aq). The solution was cooled to 0oC and 
then 0.76 g of 1,6-bis(benzyloxy)hex-4-ene-2,3-diol (2.3 mmol) was added. Lastly, 
0.44 g of p-Toluenesulfonyl chloride (2.3 mmol, 1.0 eqiuv.) was added and the 
solution was warmed to room temperature slowly over 1 hour and stirred vigorously at 
room temperature overnight. The solution was diluted with water and extracted with 
CH2Cl2 twice. The solution was dried on Na2SO4 and the solvent removed in vacuo. 
Flash chromatography (20% ether : 80% pentane, anisaldehyde) with silica was 
performed to yield 0.483 g (1.6 mmol, 67%).   
1H NMR (400 MHz, CDCl3) δ 7.44 – 7.13 (m, 10H), 6.00 (dtd, J = 15.6, 5.4, 0.8, 1H), 
5.56 (ddt, J = 15.6, 7.5, 1.6, 1H), 4.58 (d, J = 12.0, 1H), 4.49 (d, J = 12.0, 1H), 4.47 (s, 
2H), 3.98 (dd, J = 5.5, 1.6, 2H), 3.65 (dd, J = 11.2, 4.3, 1H), 3.53 (dd, J = 11.2, 6.3, 
1H), 3.45 (ddd, J = 7.5, 4.4, 0.7, 1H), 3.31 (dt, J = 6.3, 4.4, 1H). 13C NMR (101 MHz, 
CDCl3) δ 138.0, 137.8, 133.4, 128.4, 127.7, 127.7, 126.0, 73.1, 72.2, 69.6, 68.0, 56.8, 
55.4.  IR (neat) 3031, 2855, 1698, 1507, 1373, 1091, 965, 736, 696 cm-1. HRMS (EI+) 





cis-2-Benzyloxymethyl-5-methyl-2,5-dihydrofuran (4.15a): To a flame dried 13x100 
mm threaded culture tube was added 25 mg of substrate (4.14a) (0.12 mmol) in 1 mL 
of dry toluene. The culture tube was fitted with a threaded septum cap and then 
submerged in an oil bath at 150ºC. A syringe pump was used to add 0.5 mL of toluene 
over 8 hours (0.63 mol%/hour) which contained 3.0 mg of Cu(hfacac)2 (0.0061 mmol, 
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0.05 equiv.). The solution was heated for a total of 12 hours and then cooled to room 
temperature. The reaction mixture was filtered through neutral alumina (activity grade 
1) washing with EtOAc and then purified by flash chromatography on silica gel (10% 
ether : 90% pentane, KMnO4) to yield 23.5 mg (94%, 0.12 mmol). (Crude 
diastereomeric ratio >20:1, purified >20:1 cis:trans).  
1H NMR (500 MHz, CDCl3 )  7.52 – 7.00 (m, 5H), 5.85 (d, J = 6.0, 1H), 5.78 (d, J = 
6.0, 1H), 4.99 – 4.90 (m, 2H), 4.66 – 4.54 (m, 2H), 3.54 – 3.47 (m, 2H), 1.29 (d, J = 
6.3, 3H). 13C NMR (125 MHz, CDCl3)  138.5, 133.1, 128.5, 127.8, 127.7, 127.1, 
85.5, 82.5, 74.1, 73.6, 23.0. IR (neat) 3312, 3089, 3064, 3031, 2971, 2924, 2859, 
1453, 1366, 1094 cm-1. HRMS (EI+) m/z 202.0996 [calculated mass for C13H14O2 (M-





cis-2-Benzyloxymethyl-5-methyl-2,5-dihydrofuran (4.15a): To a flame dried 13x100 
mm threaded culture tube was added 25 mg of substrate (4.14b) (0.12 mmol) in 1 mL 
of dry toluene. The culture tube was fitted with a threaded septum cap and then 
submerged in an oil bath at 150ºC. A syringe pump was used to add 0.5 mL of toluene 
over 8 hours (0.63 mol%/hour) which contained 3.0 mg of Cu(hfacac)2 (0.0061 mmol, 
0.05 equiv.). The solution was heated for a total of 12 hours and then cooled to room 
temperature. The reaction mixture was filtered through neutral alumina (activity grade 
1) washing with EtOAc and then purified by flash chromatography on silica gel (10% 
ether : 90% pentane, KMnO4) to yield 22.0 mg (88%, 0.11 mmol). (Crude 
diastereomeric ratio 13:1, purified >20:1 cis:trans). 
1H NMR (500 MHz, CDCl3 )  7.52 – 7.00 (m, 5H), 5.85 (d, J = 6.0, 1H), 5.78 (d, J = 
6.0, 1H), 4.99 – 4.90 (m, 2H), 4.66 – 4.54 (m, 2H), 3.54 – 3.47 (m, 2H), 1.29 (d, J = 
6.3, 3H). 13C NMR (125 MHz, CDCl3)  138.5, 133.1, 128.5, 127.8, 127.7, 127.1, 
85.5, 82.5, 74.1, 73.6, 23.0. IR (neat) 3312, 3089, 3064, 3031, 2971, 2924, 2859, 
1453, 1366, 1094 cm-1. HRMS (EI+) m/z 202.0996 [calculated mass for C13H14O2 (M-





Methyl 3-(cis-5-Phenyl-2,5-dihydrofuranyl)-propanoate (4.15d): To a flame dried 
13x100 mm threaded culture tube was added 25 mg of substrate (4.14d) (0.11 mmol) 
in 1 mL of dry toluene. The culture tube was fitted with a threaded septum cap and 
then submerged in an oil bath at 150ºC. A syringe pump was used to add 0.5 mL of 
toluene over 2 hours (0.12 mol%/hour) which contained 2.7 mg of Cu(hfacac)2 
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(0.0054 mmol, 0.05 equiv.). The solution was heated for a total of 6 hours and then 
cooled to room temperature. The reaction mixture was filtered through neutral alumina 
(activity grade 1) washing with EtOAc and then purified by flash chromatography on 
silica gel (20% ether : 80% pentane, KMnO4) to yield 17.5 mg (70%, 0.075 mmol). 
(Crude diastereomeric ratio 8:1, purified >20:1 cis:trans).  
1H NMR (500 MHz, CDCl3 )  ppm  7.39 – 7.27 (m, 5H), 5.94 – 5.88 (m, 2H), 5.76 
(d, J = 3.8, 1H), 4.98 – 4.90 (m, 1H), 3.65 (s, 3H), 2.56 – 2.37 (m, 2H), 2.11 – 2.02 
(m, 1H), 2.00 – 1.88 (m, 1H). 13C NMR (125 MHz, CDCl3)  ppm  174.2, 141.7, 
131.0, 130.2, 128.7, 128.1, 126.9, 87.9, 85.4, 51.8, 31.6, 30.3. IR (neat) 3083, 3063, 
3030, 2951, 2844, 2930, 2844, 1738, 1493, 1438, 1357, 1252, 1199, 1168, 1065 cm-1. 





2-((Benzyloxy)methyl)-5-methyl-2,5-dihydrofuran (4.15e): To a flame dried 13 x 100 
mm culture tube was added 3.0 mg of Cu(hfacac)2 (0.0061 mmol, 0.05 equiv). To this 
vial was added 25 mg of vinyloxirane (4.14f) (0.12 mmol) dissolved in 0.8 ml of 
benzene. The tube was sealed and reinforced with Teflon tape. The solution was 
submersed in an oil bath at 150ºC for 2 hours and then cooled to room temperature. 
The solution was filtered through neutral alumina (activity grade 1) washing with 
EtOAc. The solvent was removed in vacuo and flash chromatography (10% ether : 
90% pentane, anisaldehyde) with silica was performed to yield 24.0 mg (96%, 0.12 
mmol, diastereomeric ratio 1:8 cis:trans).   
1H NMR (500 MHz, CDCl3) δ 7.37 – 7.27 (m, 5H), 5.88 (dt, J=6.0, 1.2, 1H), 5.77 (d, 
J=6.2 1H), 5.07 – 4.98 (m, 2H), 4.62 (d, J=12.2, 1H), 4.56 (d, J=12.2, 1H), 3.49 (d, 
J=5.3, 2H), 1.27 (d, J=6.2, 3H). 13C NMR (126 MHz, CDCl3) δ 138.5, 133.3, 128.5, 
127.9, 127.8, 126.7, 85.0, 82.3, 73.6, 73.1, 21.9. IR (neat) 2969, 2958, 1496, 1453, 
1094, 1927, 736, 698 cm-1. LRMS m/z 204 [calculated mass for C13H16O2 (M+) 
204.1150]. Molecular ion too small for high resolution by electron impact, 
electrospray, and chemical ionization techniques. Structure confirmed by 2D analysis 
as well as by derivatization to (trans)-2-((4-methoxyphenoxy)methyl)-5-methyl-2,5-
dihydrofuran1414. This sequence was done by lithium naphthalenide reduction to 











Table A4.2: 2D-NMR analysis of 4.15e 
 
 C H COSY HMBC NOESY 
1 138.5 - - 7.34, 4.62, 4.56 - 
2 133.3 5.88 5.03 1.27, 5.77, 5.0 1.27 
3 128.5 7.34 7.27 7.34, 7.27 4.62, 4.56 
4 127.9 7.34 7.27 7.34, 7.27, 4.62, 4.56 4.62, 4.56 
5 127.8 7.27 7.34 7.34  
6 126.7 5.77 5.01 5.88, 5.0, 3.49 3.49 
7 85.0 5.03 3.49, 5.01, 5.88 5.88, 5.77, 3.49  
8 82.3 5.01 1.27, 5.03, 5.77 5.88, 5.77, 1.27  
9 73.6 4.56 4.62  7.34, 3.49 7.34, 3.49 
  4.62 4.56   7.34, 3.49 
10 73.1 3.49 5.03  4.62, 4.56, 5.88 4.62, 4.56, 5.77 







2-((Benzyloxy)methyl)-5-methyl-2,5-dihydrofuran (4.15e): To a flame dried 13 x 100 
mm culture tube was added 3.0 mg of Cu(hfacac)2 (0.0061 mmol, 0.05 equiv). To this 
vial was added 24.6 mg of vinyloxirane (4.14e) (0.12 mmol) dissolved in 0.8 ml of 
toluene. The tube was sealed and reinforced with Teflon tape. The solution was 
submersed in an oil bath at 100ºC for 13 hours and then cooled to room temperature. 
The solution was filtered through neutral alumina (activity grade 1) washing with 
EtOAc. The solvent was removed in vacuo and flash chromatography (10% ether : 
90% pentane, anisaldehyde) with silica was performed. Yield 22.6 mg (92%, 0.11 
mmol, diastereomeric ratio 1:6 cis:trans).   
1H NMR (500 MHz, CDCl3) δ 7.37 – 7.27 (m, 5H), 5.88 (dt, J=6.0, 1.2, 1H), 5.77 (d, 
J=6.2 1H), 5.07 – 4.98 (m, 2H), 4.62 (d, J=12.2, 1H), 4.56 (d, J=12.2, 1H), 3.49 (d, 
J=5.3, 2H), 1.27 (d, J=6.2, 3H). 13C NMR (126 MHz, CDCl3) δ = 138.5, 133.3, 128.5, 
127.9, 127.8, 126.7, 85.0, 82.3, 73.6, 73.1, 21.9. IR (neat) 2969, 2958, 1496, 1453, 
















2,5-bis((Benzyloxy)methyl)-2,5-dihydrofuran (4.15g): To a flame dried 13 x 100 mm 
culture tube was added 2.0 mg of Cu(hfacac)2 (0.0040 mmol, 0.05 equiv). To this vial 
was added 25 mg of vinyloxirane (4.14g) (0.081 mmol) dissolved in 0.54 ml of 
toluene. The tube was sealed and reinforced with Teflon tape. The solution was 
submersed in an oil bath at 150ºC for 2 hours and then cooled to room temperature. 
The solution was filtered through neutral alumina (activity grade 1) washing with 
EtOAc. The solvent was removed in vacuo and flash chromatography (20% ether : 
80% pentane, anisaldehyde) with silica was performed to yield 23.2 mg (93%, 0.074 
mmol, diastereomeric ratio 1:7 cis:trans).  
1H NMR (300 MHz, CDCl3) δ  7.42 – 7.18 (m, 10H), 5.92 (bs, 2H), 5.05 (t, J=3.4, 
2H), 4.58 (d, J=3.1, 4H), 3.53 (dd, J = 4.8, 3.3, 4H). 13C NMR (75 MHz, CDCl3) δ 
138.4, 129.0, 128.5, 127.8, 127.7, 85.7, 73.6, 72.9. IR (neat) 3028, 2849, 1603, 1451, 












1-((2R,3R)-3-Phenyloxiran-2-yl)prop-2-en-1-ol: To a flame dried 250 mL 
roundbottom flask was added 1.82g of aldehyde 4.17 (12.3 mmol), a magnetic stir bar, 
and 100 ml of dry THF. The solution was cooled to -78oC under an atmosphere of N2. 
Then 19.5 mL of vinyl magnesium bromide was added (0.7 M in THF (new bottle),  
13.7 mmol, 1.1 equiv.) in two portions. The solution was stirred for 1 h at -78oC and 
then 2 h at 0oC The solution was quenched with 20 mL of sat. NH4Cl and slowly 
warmed to room temperature. The solution was diluted with distilled water and then 
extracted with ethyl acetate. The solution was dried on Na2SO4 and then the solvent 
was removed in vacuo. Flash chromatography (30% ether : 70% pentane, 
anisaldehyde) with silica was performed to yield 1.01 g (47%, 5.7 mmol). The product 
was a 1.1 : 1 mixture of diastereomers with the (R,R,R)12 product as the major and was 
previously known.  
337 
The minor product: 1H NMR (400 MHz, CDCl3) δ 7.44 – 7.26 (m, 5H), 6.05-5.85 (m, 
1H), 5.41 (dd, J = 3.0, 1.5, 1H), 5.31 – 5.29 (m, 1H), 4.25 (dt, J = 8.8, 4.7, 1H), 3.92 





(E)-Methyl 5-((2R,3R)-3-phenyloxiran-2-yl)pent-4-enoate (4.18): Prepared identical to 
compound 4.14d.  
1H NMR (500 MHz, CDCl3 )  7.34 – 7.19 (m, 5H), 5.98 – 5.85 (m, 1H), 5.35 (dd, J = 
15.5, 7.8, 1H), 3.71 (d, J = 2.0, 1H), 3.65 (s, 3H), 3.28 (dd, J = 7.8, 1.8, 1H), 2.40 (d, 
J = 2.7, 4H).  13C NMR (125 MHz, CDCl3 )  173.4, 137.3, 134.8, 128.7, 128.4, 
128.4, 125.6, 62.9, 60.4, 51.9, 33.5, 27.0. IR (neat) 3088, 3064, 3033, 2998, 2951, 
2924, 2846, 1737, 1458, 1437, 1363, 1249, 1199, 1170 cm-1. HRMS (EI+) m/z 






Methyl 3-(cis-5-phenyl-2,5-dihydrofuranyl)-propanoate (4.19): To a flame dried 
13x100 mm threaded culture tube was added 25 mg of substrate (4.18) (0.11 mmol) in 
1 mL of dry toluene. The culture tube was fitted with a threaded septum cap and then 
submerged in an oil bath at 150ºC. A syringe pump was used to add 0.5 mL of toluene 
over 2 hours (0.12 mol%/hour) which contained 2.7 mg of Cu(hfacac)2 (0.0054 mmol, 
0.05 equiv.). The solution was heated for a total of 6 hours and then cooled to room 
temperature. The reaction mixture was filtered through neutral alumina (activity grade 
1) washing with EtOAc and then purified by flash chromatography on silica gel (20% 
ether : 80% pentane, KMnO4) to yield 17.5 mg (70%, 0.075 mmol). (Crude 
diastereomeric ratio 8:1, purified >20:1 cis:trans)  
1H NMR (500 MHz, CDCl3 )   7.39 – 7.27 (m, 5H), 5.94 – 5.88 (m, 2H), 5.76 (d, J = 
3.8, 1H), 4.98 – 4.90 (m, 1H), 3.65 (s, 3H), 2.56 – 2.37 (m, 2H), 2.11 – 2.02 (m, 1H), 
2.00 – 1.88 (m, 1H). 13C NMR (125 MHz, CDCl3)   174.2, 141.7, 131.0, 130.2, 
128.7, 128.1, 126.9, 87.9, 85.4, 51.8, 31.6, 30.3. IR (neat) 3083, 3063, 3030, 2951, 
2844, 2930, 2844, 1738, 1493, 1438, 1357, 1252, 1199, 1168, 1065 cm-1. HRMS (EI+) 
m/z 232.1100 [calculated mass for C14H16O3 (M+) 232.1100]. [α]D21 = - 81.6 ( c = 




The analysis of 4.19 was accomplished by eluting with a gradient of 2% iPrOH: 98% 
Hexanes going to 5% iPrOH: 95% hexanes over 30 minutes. 
 
                                                                            
 
 















4-epi-Goniothalesdiol:  To a stirred flask containing acetone (1 mL), water (1 mL), 
4.19 (0.208 g, 0.895 mmol), and 4-methylmorpholine N-oxide (0.1865 g, 1.59 mmol, 
1.78 equiv.) was added OsO4 (2.5% tBuOH, 0.07 mL).  After 15 hours, the reaction 
was quenched with a solution of sodium bisulfite and diluted with ethyl acetate.  The 
layers were separated, and the aqueous layer was extracted with ethyl acetate (3x).  
The combined organic portions were combined and dried over Na2SO4.  The solvent 
was removed in vacuo and the product was purified by chromatography (15-75% 
EtOAc/Hex) to yield 0.237 g (0.89 mmol, 99% yield).  
1H NMR (400 MHz, CDCl3) δ 7.41 – 7.28 (m, 5H), 4.72 (d, J = 5.6, 1H), 3.99 – 3.87 
(m, 3H), 3.70 (s, 3H), 2.70 – 2.49 (m, 2H), 2.20 – 2.08 (m, 1H), 2.08 – 1.96 (m, 1H). 
13C NMR (126 MHz, CDCl3) δ 174.3, 140.0, 128.7, 128.1, 126.1, 85.0, 82.9, 77.7, 






Cyclic sulfate 4.20: The cyclic sulfate of 4.48 was made using a literature procedure.16 
To a flame dried 4 mL threaded culture tube was added 47.9 mg of 4-epi-
goniothalesdiol (0.18 mmol) and was azeotroped with benzene. To this vial was added 
0.3 mL of CCl4, a stir bar was, and a reflux condenser was attached that was fitted 
with a drying tube containing CaCl2. The reaction was heated at reflux 25.7 mg (0.216 
mmol, 1.2 equiv.) of thionyl chloride was added slowly. The reaction was heated an 
additional 30 minutes to expel the HCl produced. The solution was then cooled to 0oC 
followed by addition of 0.22 mL of CH3CN. Then 57.8 mg (0.27 mmol, 1.5 equiv.) of 
NaIO4 was added followed by an aqueous solution RuCl3.H2O (0.1 mg of RuCl3.H2O 
[0.003 equiv.] in 0.30 mL of H2O). The solution was stirred at room temperature for 1 
hour and diluted with diethyl ether. The organic layer was washed with water, sat. 
NaHCO3 solution, and sat. NaCl solution. The organic layer was dried with Na2SO4 
and the solvent removed. The product can be isolated as a yellow-brown oil after 
filtration through a plug of silica to yield 51.9 mg (0.16 mmol, 88%). 
1H NMR (500 MHz, CDCl3 )  7.46 – 7.30 (m, 5H), 5.04 (d, J = 5.8, 1H), 4.97 – 4.91 
(m, 2H), 4.26 (dt, J = 8.0, 5.4, 1H), 3.70 (s, 3H), 2.66 – 2.48 (m, 2H), 2.33 – 2.20 (m, 
1H), 2.18 – 2.11 (m, 1H).  13C NMR (125 MHz, CDCl3) ppm 173.0, 136.2, 129.3, 





Lactone (4.21): To a 4 mL vial equipped with a stir bar and containing THF (0.5 mL) 
was added 4.20 (12.4 mg, 0.038 mmol) followed by a 15% H2SO4 aqueous solution 
(0.25 mL).  The vial was then capped and the seal was reinforced with Teflon tape. 
The vial was heated at 60° C for 14 hours.  After cooling to room temperature, the 
reaction mixture was diluted with ethyl acetate and water, and the layers were 
separated.  The aqueous layer was extracted with ethyl acetate (2x) and the combined 
organic fractions were dried over Na2SO4 and the solvent was removed in vacuo.  The 
compound was purified using column chromatography (EtOAc/Hex) and the 
characterization data was found to match that in the literature17 to yield 7.7 mg (0.033 
mmol, 87%).    
1H NMR (500 MHz, CDCl3 )  7.34 (m, 5H), 4.82 (dd, J = 5.3, 2.4, 1H), 4.65 (d, J = 
6.6, 1H), 4.49 (dd, J = 9.2, 4.4, 1H), 4.25 (dd, J = 6.4, 1.9, 1H), 2.73 (m, 1H), 2.51 
340 
(td, J = 17.1, 5.2, 1H), 2.21 (m, 1H).  13C NMR (125 MHz, CDCl3)   171.0, 138.4, 





(+)-Goniothalesdiol 4.22: To a 4 mL threaded culture tube was added 10 mg of 
lactone 4.21 (0.043 mmol) and 0.4 mL of dry methanol. Next, 3.5 mg of Amberlyst® 
15 (strongly acidic ion exchange resin, sulfonic acid functionality) was added and 
stirred vigorously with a large stir bar. The reaction was stirred for 10 hours at room 
temperature followed by quenching with a sat. NaHCO3 solution. The solution was 
extracted with ethyl acetate three times and then dried with NaSO4. The solvent was 
removed to yield pure 4.22 to yield 11.3 mg (0.042 mmol, 99%). The product was 
identical to literature spectra.18 
1H NMR (400 MHz, CDCl3) δ 7.46 – 7.37 (m, 2H), 7.38 – 7.30 (m, 2H), 7.27 (tt, J = 
5.8, 1.3, 1H), 4.59 (d, J = 4.6, 1H), 4.10 – 4.01 (m, 3H), 3.68 (s, 3H), 2.83 (bs, 1H), 
2.73 (bs, 1H), 2.61 (dt, J = 16.9, 6.9, 1H), 2.49 (dt, J = 16.9, 7.5, 1H), 2.15 – 1.99 (m, 
2H).  13C NMR (101 MHz, CDCl3) δ 174.9, 140.1, 128.7, 128.0, 126.3, 86.2, 85.4, 
80.8, 79.1 52.1, 30.8, 23.9. IR (neat)  3430, 2925, 1717, 1439, 1262, 1038, 759, 700 





Methyl 3-(5-phenylfuran-2-yl)propanoate:  A solution of DMDO (0.5mL, about 1.5 
eq) in acetone was added to dihydrofuran 4.19 (0.0075g, 0.3229 mmol).  Upon 
completion, the solvent was removed in vacuo.   
1H NMR (400 MHz, C6D6 )  ppm 7.63-7.58 (m, 2H), 7.21-6.89 (m, 3H), 6.34 (d, J = 
3.24, 1H), 5.89 (d, J = 3.27, 1H), 3.28 (s, 3H), 2.81 (t, J = 7.54, 2H), 2.36 (t, J = 7.53, 










(S,E)-2-(3-(Benzyloxy)prop-1-enyl)oxirane (4.32): Compound 4.32 was synthesized in 
enantiopure form from D-mannitol according to known procedures.19 Compound 
matched existing 1H NMR and [α]D20 data. 
 
The analysis of 4.32 was accomplished by eluting with a gradient of 2.5% iPrOH: 
97.5% Hexanes going to 5% iPrOH: 95% hexanes over 20 minutes.  
 





(S)-2-(benzyloxymethyl)-2,5-dihydrofuran (4.33): To a flame dried 13 x 45 mm culture 
tube was added 0.16 mg of Cu(hfacac)2 (0.00033 mmol, 0.005 equiv). To this vial was 
added 12.5 mg of vinyloxirane (4.32) (0.066 mmol) dissolved in 0.6 ml fluorobenzene. 
The tube was sealed and reinforced with Teflon tape. The solution was submersed in 
an oil bath at 175ºC for 24 hours and then cooled to room temperature. The solution 
was filtered through neutral alumina (activity grade 1) washing with EtOAc. The 
solvent was removed in vacuo and flash chromatography (40% ether : 60% pentane, 
KMnO4) with silica was performed to yield 7.5 mg (60%, 0.039 mmol). Spectral Data 
matched existing 1H NMR and [α]D25 data.21 
 
The analysis of 33 was accomplished by eluting with a gradient of 2.5% iPrOH: 97.5% 
hexanes going to 5% iPrOH: 95% hexanes over 20 minutes. The racemic compound 
was also made to assess enantioexcess.21 Product 33 does not racemize with heat or 
treatment with Cu(hfacac)2. 
342 
Racemic Product 33:            Enantioenriched 
Product 33: 
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(+) 4.21  
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0
H1 (ppm)  
-100102030405060708090100110120130140150160170180190200











































A4.3 Coordinates and Calculated Energies for Chapter 4  
DFT calculations were performed with the program Gaussian03[1] by using the 
WebMO interface (WebMO, version 9.1.002p; www.webmo.net) for importing and 
constructing models. 
 
[1] Gaussian 03, Revision C.02, M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. 
Scuseria, M. A. Robb, J. R. Cheeseman, J. A. Montgomery, Jr., T. Vreven, K. N. 
Kudin, J. C. Burant, J. M. Millam, S. S. Iyengar, J. Tomasi, V. Barone, B. Mennucci, 
M. Cossi, G. Scalmani, N. Rega, G. A. Petersson, H. Nakatsuji, M. Hada, M. Ehara, 
K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. 
Nakai, M. Klene, X. Li, J. E. Knox, H. P. Hratchian, J. B. Cross, C. Adamo, J. 
Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. 
Pomelli, J. W. Ochterski, P. Y. Ayala, K. Morokuma, G. A. Voth, P. Salvador, J. J. 
Dannenberg, V. G. Zakrzewski, S. Dapprich, A. D. Daniels, M. C. Strain, O. Farkas, 
D. K. Malick, A. D. Rabuck, K. Raghavachari, J. B. Foresman, J. V. Ortiz, Q. Cui, A. 
G. Baboul, S. Clifford,  J. Cioslowski, B. B. Stefanov, G. Liu, A. Liashenko, P. 
Piskorz, I. Komaromi, R. L. Martin, D. J. Fox, T. Keith, M. A. Al-Laham, C. Y. Peng, 
A. Nanayakkara, M. Challacombe, P. M. W. Gill, B. Johnson, W. Chen, M. W. Wong, 








































6-311+G(d,p) -545.6176 -0.02217 -13.91
(E)-dodec-7-en-5-one (4.13) 
B3LYP 
6-311+G(d,p) -545.6386 -0.04312 -27.06
(Z)-dodec-7-en-5-one (4.37) 
B3LYP 
6-311+G(d,p) -545.6359 -0.04042 -25.37
(E)-dodec-6-en-5-one  (4.38) 
B3LYP 
6-311+G(d,p) -545.6408 -0.04537 -28.47
375 
 
C    0.00000000  0.00000000  0.00000000 
O    0.79798900  1.07275800 -0.51462100 
C    1.24526900 -0.28801000 -0.73800400 
C    2.49593300 -0.69222400 -0.06714300 
C    3.43410400 -1.45004000 -0.63923700 
C    4.71502200 -1.88813900  0.00930400 
C    5.96728700 -1.41892300 -0.75344700 
C    7.27773500 -1.89594200 -0.11786400 
C    8.52126100 -1.43495500 -0.88364000 
H    8.51625400 -1.81354100 -1.91068800 
H    8.57197700 -0.34285300 -0.93475300 
H    9.43870300 -1.78770700 -0.40442400 
H    7.33028700 -1.53302700  0.91578700 
H    7.27141200 -2.99107900 -0.05572300 
H    5.96246900 -0.32400600 -0.80927500 
H    5.91475600 -1.77798300 -1.78926800 
H    4.75028700 -1.52117400  1.04097800 
H    4.73329100 -2.98524300  0.06747400 
H    3.28085300 -1.78169700 -1.66681000 
H    2.62833300 -0.33138300  0.95113400 
H    1.14155000 -0.61231900 -1.77301600 
C   -1.36842500 -0.19276300 -0.60760700 
C   -1.99806300 -1.54475400 -0.24497100 
C   -3.39862600 -1.73565700 -0.83771100 
C   -4.03181100 -3.08052800 -0.46969800 
H   -5.02752800 -3.18612000 -0.90905400 
H   -3.42154100 -3.91650200 -0.82595600 
H   -4.13510000 -3.18598800  0.61493300 
H   -4.04779600 -0.92013700 -0.49699500 
H   -3.34315200 -1.64385100 -1.92911000 
H   -1.34422100 -2.35569400 -0.58907000 
H   -2.05371200 -1.64108400  0.84695700 
H   -2.01818900  0.62165900 -0.26351600 
H   -1.28916200 -0.08857000 -1.69510000 










C    0.00000000  0.00000000  0.00000000 
O   -0.90556600  0.87108000 -0.68692300 
C   -1.44360500 -0.01139100  0.32862700 
C   -2.39199600 -1.05304500 -0.11295700 
C   -3.48678500 -1.38367200  0.57652200 
C   -4.48404500 -2.43243600  0.17821700 
C   -5.90383800 -1.87032500 -0.01888700 
C   -6.93785200 -2.94697400 -0.36643800 
C   -8.34811600 -2.38481200 -0.56742700 
H   -9.06129600 -3.17543500 -0.81653800 
H   -8.70812600 -1.88588200  0.33789800 
H   -8.36879500 -1.65090500 -1.37911500 
H   -6.62111300 -3.47138300 -1.27622000 
H   -6.95411400 -3.70142200  0.42955900 
H   -6.21641600 -1.34888600  0.89486400 
H   -5.88129000 -1.11228400 -0.81051200 
H   -4.15183800 -2.92857300 -0.74025200 
H   -4.52128000 -3.20741500  0.95628400 
H   -3.69923300 -0.85173000  1.50458200 
H   -2.17308200 -1.55280400 -1.05269900 
H   -1.73904800  0.51070400  1.23823200 
C    0.71270300 -1.05978900 -0.80586000 
C    1.38438400 -2.11796300  0.08025100 
C    2.16565900 -3.16733900 -0.71926200 
C    2.84493700 -4.21659500  0.16533300 
H    3.39482400 -4.94783700 -0.43344400 
H    3.55533700 -3.75118600  0.85588000 
H    2.11101100 -4.76352100  0.76564100 
H    1.48598700 -3.66522800 -1.42115800 
H    2.92081700 -2.66237700 -1.33357800 
H    2.06473500 -1.62430500  0.78601900 
H    0.62230900 -2.61835900  0.69000000 
H    0.01399300 -1.53484000 -1.49956500 
H    1.46987600 -0.56188400 -1.42439100 









C    0.00000000  0.00000000  0.00000000 
O   -0.85422100 -0.75027600 -0.86899800 
C   -1.44278500  0.30905800 -0.07083900 
C   -2.38727600 -0.12032700  0.97988800 
C   -3.49761700  0.51730500  1.36772700 
C   -4.06610100  1.80317400  0.83516700 
C   -5.51446200  1.64994500  0.33607400 
C   -6.12895700  2.96700500 -0.15052200 
C   -7.57064900  2.81370700 -0.64355000 
H   -8.22246500  2.43681600  0.15089800 
H   -7.97992700  3.76928100 -0.98289400 
H   -7.63019300  2.11103500 -1.48052400 
H   -5.50950300  3.37822400 -0.95687500 
H   -6.09683700  3.70214100  0.66301400 
H   -6.13253300  1.23722600  1.14345100 
H   -5.53760600  0.91153600 -0.47397800 
H   -3.44505900  2.20779200  0.03109400 
H   -4.05216200  2.55363400  1.63770700 
H   -4.07914300  0.05802500  2.16558600 
H   -2.12424300 -1.05663700  1.46593900 
H   -1.72131700  1.17811800 -0.66140000 
C    1.04845600  0.87614200 -0.64255000 
C    1.63995400  1.90247700  0.33289600 
C    2.72509700  2.78297100 -0.29804000 
C    3.30917500  3.81051600  0.67531600 
H    4.07807000  4.42194900  0.19519900 
H    2.53366100  4.48604000  1.04994100 
H    3.76683600  3.32094000  1.54071500 
H    3.52939100  2.14414900 -0.68223100 
H    2.30651700  3.30136000 -1.16914100 
H    0.83598600  2.54006400  0.72112600 
H    2.06050400  1.38047600  1.20190800 
H    1.84705000  0.23388400 -1.03433300 
H    0.60445100  1.38239100 -1.50641000 









C    0.00000000  0.00000000  0.00000000 
O    0.76169700  1.06079300  0.58406200 
C    1.41911600 -0.21291600  0.37303300 
C    1.84661200 -0.94079600  1.58606500 
C    2.89608200 -1.76485900  1.68858500 
C    3.88254900 -2.15754400  0.62434000 
C    5.33997400 -1.87607300  1.03213600 
C    6.36173800 -2.34512000 -0.00943300 
C    7.81065600 -2.06492400  0.39932600 
H    8.06173300 -2.57023500  1.33724200 
H    8.51427200 -2.41110400 -0.36279300 
H    7.98019700 -0.99362800  0.54575000 
H    6.15186500 -1.85493000 -0.96796300 
H    6.23195500 -3.42043900 -0.18303500 
H    5.54718500 -2.36772500  1.99117200 
H    5.46154400 -0.80077100  1.20850600 
H    3.66499800 -1.65777800 -0.32380100 
H    3.77726400 -3.23412500  0.43028100 
H    3.07585300 -2.21621700  2.66316200 
H    1.24234400 -0.76063700  2.46961800 
H    2.13416300 -0.18771600 -0.44537000 
C   -1.18275200 -0.54029400  0.76781300 
C   -1.66499200 -1.88943000  0.21718900 
C   -2.90185300 -2.43221000  0.94240700 
C   -3.37889400 -3.77975800  0.39376200 
H   -4.26046300 -4.13948000  0.93138600 
H   -3.64386400 -3.70438100 -0.66561000 
H   -2.59946400 -4.54269800  0.48586400 
H   -2.67789300 -2.53165400  2.01134500 
H   -3.71392600 -1.69878300  0.86885100 
H   -1.89103000 -1.78793400 -0.85221100 
H   -0.85087500 -2.62075500  0.28965000 
H   -0.92912500 -0.63372500  1.82679000 
H   -1.99379800  0.19594600  0.70676000 








C    0.00000000  0.00000000  0.00000000 
C   -0.52378800 -0.29743500  1.38073200 
C   -1.85241200 -0.29745200  1.38072100 
C   -2.37619100 -0.00002300 -0.00001600 
O   -1.18809100  0.24134300 -0.77684500 
C   -3.31848600  1.20382400 -0.11029900 
C   -4.69865000  0.97116800  0.51491400 
C   -5.64154200  2.17024700  0.35769600 
C   -7.02448200  1.93626100  0.97244600 
H   -7.67282700  2.80684000  0.84017700 
H   -7.52294400  1.07813600  0.51047100 
H   -6.95200900  1.73688600  2.04644900 
H   -5.18112100  3.05250000  0.81826800 
H   -5.74963400  2.40538100 -0.70782900 
H   -5.16246300  0.08760200  0.05703600 
H   -4.59350800  0.74157600  1.58271100 
H   -2.83203300  2.07111100  0.34999900 
H   -3.43037500  1.43270700 -1.17577900 
H   -2.88971100 -0.88329800 -0.41398600 
H   -2.49418900 -0.49383300  2.22990100 
H    0.11798000 -0.49380400  2.22992000 
C    0.94228700  1.20385100 -0.11029400 
C    2.32210000  0.97157400  0.51583900 
C    3.26563400  2.16993800  0.35702200 
C    4.64832900  1.93616700  0.97240600 
H    5.29713300  2.80623000  0.83899500 
H    4.57553800  1.73840400  2.04668500 
H    5.14645400  1.07711800  0.51178900 
H    3.37406100  2.40342300 -0.70883100 
H    2.80557400  3.05311500  0.81618300 
H    2.21640600  0.74382000  1.58397200 
H    2.78568200  0.08702500  0.05962300 
H    1.05480000  1.43225000 -1.17581400 
H    0.45548900  2.07130900  0.34931000 










C    0.00000000  0.00000000  0.00000000 
C    0.85311300  1.18732600 -0.35762300 
C    1.98686300  0.79016900 -0.92427300 
C    2.04146000 -0.71420300 -0.98748300 
O    0.79394800 -1.13375900 -0.40075600 
C    3.21278200 -1.36329200 -0.23904100 
C    4.57626000 -1.12868200 -0.89893700 
C    5.72419600 -1.85353400 -0.18566400 
C    7.08732100 -1.62164400 -0.84385900 
H    7.88216700 -2.15376900 -0.31388600 
H    7.08970400 -1.96965100 -1.88171200 
H    7.34804300 -0.55848200 -0.85142700 
H    5.76221900 -1.52589300  0.86010300 
H    5.50870800 -2.92838700 -0.15961600 
H    4.53776800 -1.46119000 -1.94473700 
H    4.79876300 -0.05465600 -0.92805100 
H    3.21888600 -0.99139600  0.79176600 
H    3.00856300 -2.43830000 -0.18669600 
H    2.06404900 -1.05973900 -2.03281400 
H    2.77606800  1.42902100 -1.29879200 
H    0.54741400  2.20930500 -0.17112000 
C   -1.36967500 -0.02609300 -0.68804300 
C   -2.21151600 -1.25015800 -0.31515700 
C   -3.57075900 -1.29077300 -1.02254000 
C   -4.41106100 -2.51397100 -0.64426200 
H   -4.61403800 -2.53694200  0.43118100 
H   -5.37348500 -2.51442400 -1.16381100 
H   -3.89363100 -3.44339700 -0.90188600 
H   -3.41242100 -1.27927000 -2.10789200 
H   -4.13081900 -0.37680200 -0.78802000 
H   -2.36835900 -1.26227600  0.77172200 
H   -1.64471000 -2.15598900 -0.55398300 
H   -1.21200700  0.00822700 -1.77237300 
H   -1.90771000  0.89143400 -0.41475900 








C    0.00000000  0.00000000  0.00000000 
C   -1.25205100  0.40873500  0.78150300 
C   -2.00275500  1.58100700  0.13959500 
C   -3.24854900  1.99150500  0.92187500 
C   -4.00059600  3.17926600  0.34616100 
C   -5.35042200  3.51223100  0.99172800 
C   -6.47067400  2.85425600  0.22479300 
C   -7.30756300  1.94334000  0.72303900 
C   -8.42962200  1.28936800 -0.03252900 
C   -9.81308400  1.55779200  0.58685500 
C   -10.9546690  0.84607200 -0.14750700 
C   -12.3297630  1.11724000  0.46959000 
H   -13.1216010  0.59601700 -0.07544400 
H   -12.3687300  0.78371700  1.51144100 
H   -12.5656570  2.18593700  0.45606300 
H   -10.9579980  1.15914300 -1.19861600 
H   -10.7624680 -0.23383100 -0.15258000 
H   -9.80629800  1.24245400  1.63816700 
H   -9.99793500  2.63860600  0.59357100 
H   -8.41906800  1.62796100 -1.07427200 
H   -8.26296000  0.20356200 -0.05524300 
H   -7.19998800  1.64732500  1.76738600 
H   -6.56833000  3.16196400 -0.81477100 
H   -5.46133200  4.60053700  0.95705300 
H   -5.36889800  3.18736000  2.03584000 
O   -3.58381500  3.82749600 -0.58892000 
H   -2.98858900  2.25247000  1.95819100 
H   -3.95817200  1.15826300  1.00933200 
H   -2.29148200  1.31974300 -0.88420000 
H   -1.33629500  2.44447400  0.04819900 
H   -0.96908400  0.67629300  1.80731000 
H   -1.92515700 -0.45334300  0.86760500 
H    0.51556800 -0.83600600  0.48073900 
H   -0.25317100 -0.30714500 -1.01948500 










C    0.00000000  0.00000000  0.00000000 
C    1.45712200  0.23906600 -0.40614900 
C    1.84945500  1.72080200 -0.38451400 
C    3.30410600  1.95702800 -0.78598500 
C    3.72732600  3.41616000 -0.82251700 
C    5.22286300  3.68668100 -1.02648400 
C    5.92114500  3.75663700  0.31061300 
C    6.86102600  2.93293800  0.78484700 
C    7.48818900  1.74266600  0.11478500 
C    9.01280400  1.88625500 -0.04951600 
C    9.67416900  0.64939900 -0.66743100 
C    11.1903890  0.79339600 -0.82704500 
H    11.6322520 -0.10413600 -1.26847500 
H    11.4416510  1.63981200 -1.47386300 
H    11.6754860  0.96137700  0.13964000 
H    9.45339700 -0.22624300 -0.04477400 
H    9.22146200  0.44853400 -1.64612500 
H    9.22463600  2.76555200 -0.66941900 
H    9.46368000  2.08827400  0.93015600 
H    7.28781800  0.85019200  0.72358400 
H    7.03438800  1.55295400 -0.86227700 
H    7.24698000  3.14964200  1.78011400 
H    5.59221700  4.57695600  0.94380500 
H    5.66092100  2.91598600 -1.66404300 
H    5.30633800  4.65200400 -1.53410900 
O    2.94326900  4.32857400 -0.68017500 
H    3.50158100  1.54494000 -1.78645700 
H    3.99327400  1.42458900 -0.11795900 
H    1.68149000  2.13324500  0.61620900 
H    1.19547400  2.28924400 -1.05321200 
H    1.62631500 -0.16716000 -1.41120700 
H    2.11883700 -0.32385700  0.26390500 
H   -0.25193000 -1.06384600 -0.02321400 
H   -0.19199900  0.36569200  1.01350200 








C    0.00000000  0.00000000  0.00000000 
C    1.34537500 -0.53124500  0.50316400 
C    2.49995600  0.45152800  0.27775400 
C    3.83887800 -0.07540900  0.78745900 
C    5.01823800  0.86227300  0.57040800 
C    6.32971800  0.37857700  1.08720000 
C    7.45373300  1.09143800  0.95265600 
C    8.81109700  0.68447900  1.43223700 
C    9.84178800  0.57922100  0.29079600 
C    11.2473300  0.21935200  0.78396200 
C    12.2777930  0.09950300 -0.34463800 
C    13.6808680 -0.25920300  0.15338800 
H    14.3909890 -0.33276600 -0.67481300 
H    14.0593810  0.49658800  0.84881900 
H    13.6817620 -1.22014500  0.67751100 
H    11.9400320 -0.65814900 -1.06198700 
H    12.3178260  1.04542800 -0.89824200 
H    11.5845530  0.97736100  1.50283700 
H    11.2066800 -0.72779500  1.33750000 
H    9.50042800 -0.17261600 -0.43009000 
H    9.87717500  1.53129400 -0.25239100 
H    9.16693200  1.43479700  2.15179000 
H    8.75217700 -0.26731200  1.97072200 
H    7.37595400  2.04981800  0.44077000 
H    6.34497100 -0.58755800  1.58640700 
O    4.89447700  1.93593200  0.00913500 
H    4.08991600 -1.03335600  0.30998100 
H    3.78823800 -0.30073800  1.86199800 
H    2.27820400  1.40404900  0.77035100 
H    2.58766000  0.68406900 -0.78850100 
H    1.57203600 -1.48069200  0.00213200 
H    1.26753800 -0.76385600  1.57263300 
H   -0.80400700 -0.72104500  0.17200400 
H   -0.27218400  0.92990200  0.50884500 
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A5.1 Experimental Procedures for Chapter 5  
General Information:  Commercial reagents were purchased and used without further 
purification.  All glassware was flame dried and reactions were performed under a 
nitrogen atmosphere, unless otherwise stated.  Toluene, benzene, dichloromethane, 
diethyl ether, and THF were dried over a column of alumina.  Flash chromatography 
was done with Silicycle SiliaFlash® F60 silica, and thin layer chromatography (TLC) 
was performed with EMD 250 μm silica gel 60-F254 plates.  1H and 13C NMR data was 
acquired on a Varian Inova 400, 500, or 600 (400, 500 or 600 MHz) spectrometer and 
referenced to residual protic solvent.  IR was taken on a Mattson Instruments Research 
Series FTIR spectrometer.  High-resolution mass spectrometry was performed at the 





Benzyl ether 5.7.  A 1L flask equipped with a stir bar containing DMF (500 mL) and 
sodium hydride (60% dispersion in mineral oil, 4.49 g, 112.24 mmol) was cooled to 
0°C in an ice bath, and then a solution of (2E, 4E)-2,4-hexadien-1-ol (5.6) (10.0 g, 102 
mmol) in DMF (10 mL) was slowly added.  After 1 hour, sodium iodide (0.49 g, 20.5 
mmol) and benzyl chloride (11.8 mL, 13.0 g, 102 mmol) were added.  After 2 hours, 
the reaction was quenched with water and diluted with diethyl ether.  The layers were 
separated, and the aqueous layer was extracted (2x) with diethyl ether.  The combined 
organic portions were then washed with brine, dried over MgSO4, and the solvent was 
removed in vacuo.  The crude product was purified by chromatography to give benzyl 
ether 5.7 as a colorless oil (16.26 g, 85%).   
1H NMR (500 MHz, CDCl3) δ 7.39 – 7.26 (m, 5H), 6.23 (dd, J = 15.2, 10.5, 1H), 6.13 
– 6.03 (m, 1H), 5.71 – 5.60 (m, 2H), 4.51 (s, 2H), 4.05 (d, J = 6.3, 2H), 1.77 (d, J = 
6.7, 3H).  13C NMR (125 MHz, CDCl3)  δ 138.6, 133.6, 131.0 130.3, 128.6, 128.0, 
127.8, 126.8, 72.1, 70.8, 18.3.  IR (neat) 3062, 3026, 2932, 2910, 2853, 1496, 1453, 






Vinyl oxiranes 5.8 and 5.9:  To a 500 mL flask equipped with a stir bar was added 
methylene chloride (300 mL), (E,E)-1-benzyloxy-2,4-hexadiene (5.9 g, 31.3 mmol), 
Na2HPO4 (7.73 g, equal mass with m-CPBA), and m-CPBA (77%, 7.73 g, 34.5 
mmol).  After 1 hour, the reaction was cooled to 0°C and filtered through celite.  It 
387 
was then diluted with additional diethyl ether and washed with 1 M NaOH, a saturated 
NaHCO3 solution (2x), water, and dried over MgSO4.  The solvent was removed in 
vacuo to give a clear oil (6.27 g, 98%) that was a 1.5:1 (5.8:5.9) mixture of 
regioisomers.  The regioisomeric vinyl oxirane products could be separated by column 
chromatography (10-20% ether : 90-80% pentane). For compound 5 characterization 
data matched previously reported in the literature.1  
(5.9) 1H NMR (500 MHz, CDCl3)  7.51 – 7.11 (m, 5H), 6.01 – 5.88 (m, 1H), 5.20 
(dddd, J = 15.3, 8.3, 3.1, 1.5, 1H), 4.67 – 4.49 (m, 2H), 3.74 (dd, J = 11.5, 3.2, 1H), 
3.51 (dd, J = 11.5, 5.5, 1H), 3.24 (dd, J = 8.3, 2.2, 1H), 3.13 – 3.07 (m, 1H), 1.74 (dd, 
J = 6.6, 1.6, 3H). 13C NMR (125 MHz, CDCl3)  138.1, 132.5, 128.6, 128.1, 128.0, 
128.0, 73.5, 70.2, 58.8, 56.3, 18.1. IR (neat) 3087, 3063, 3029, 2989, 2966, 2938, 
2917, 2857, 1496, 1453, 1364, 1239, 1206, 1105, 963, 874, 739, 699 cm-1. HRMS 











2,5-Dihydrofuran 5.10 (obtained from 5.9): To a flame dried 13x100 mm threaded 
culture tube was added vinyl oxirane 5.9 (25 mg, 0.12 mmol) in dry toluene (1 mL). 
The culture tube was fitted with a threaded septum cap and then submerged in an oil 
bath at 150ºC. A syringe pump was used to add toluene over 8 hours (0.5 mL, 0.63 
mol%/hour) which contained Cu(hfacac)2 (3.0 mg, 0.0061 mmol, 0.05 equiv.). The 
solution was heated for a total of 12 hours and then cooled to room temperature. The 
reaction mixture was filtered through neutral alumina (activity grade 1) washing with 
ethyl acetate and then purified by flash chromatography on silica gel (10% ether : 90% 
pentane, KMnO4) to yield of 2,5-dihydrofuran 5.10 (23.5 mg, 94%, 0.12 mmol), 
(Crude diastereomeric ratio >20:1, purified >20:1 cis:trans).  
1H NMR (500 MHz, CDCl3)  7.52 – 7.00 (m, 5H), 5.85 (d, J = 6.0, 1H), 5.78 (d, J = 
6.0, 1H), 4.99 – 4.90 (m, 2H), 4.66 – 4.54 (m, 2H), 3.54 – 3.47 (m, 2H), 1.29 (d, J = 
6.3, 3H). 13C NMR (125 MHz, CDCl3)  138.5, 133.1, 128.5, 127.8, 127.7, 127.1, 
85.5, 82.5, 74.1, 73.6, 23.0. IR (neat) 3312, 3089, 3064, 3031, 2971, 2924, 2859, 







2,5-Dihydrofuran 5.10 (obtained from 5.9): To a flame dried 13x100 mm threaded 
culture tube was added vinyl oxirane 5.9 (25 mg, 0.12 mmol) in dry toluene (1 mL). 
The culture tube was fitted with a threaded septum cap and then submerged in an oil 
bath at 150ºC. A syringe pump was used to add toluene over 8 hours (0.5 mL, 0.63 
mol%/hour) which contained Cu(hfacac)2 (3.0 mg, 0.0061 mmol, 0.05 equiv.). The 
solution was heated for a total of 12 hours and then cooled to room temperature. The 
reaction mixture was filtered through neutral alumina (activity grade 1) washing with 
ethyl acetate and then purified by flash chromatography on silica gel (10% ether : 90% 
pentane, KMnO4) to yield  of 2,5-dihydrofuran 5.10 (22.0 mg, 88%, 0.11 mmol), 
(Crude diastereomeric ratio 13:1, purified >20:1 cis:trans). 
1H NMR (500 MHz, CDCl3)  7.52 – 7.00 (m, 5H), 5.85 (d, J = 6.0, 1H), 5.78 (d, J = 
6.0, 1H), 4.99 – 4.90 (m, 2H), 4.66 – 4.54 (m, 2H), 3.54 – 3.47 (m, 2H), 1.29 (d, J = 
6.3, 3H). 13C NMR (125 MHz, CDCl3)  138.5, 133.1, 128.5, 127.8, 127.7, 127.1, 
85.5, 82.5, 74.1, 73.6, 23.0. IR (neat) 3312, 3089, 3064, 3031, 2971, 2924, 2859, 






Diol 5.11: To a stirred flask containing acetone (5.6 mL), water (5.6 mL), 
dihydrofuran 5.10 (1.00 g, 4.93 mmol), and 4-methylmorpholine N-oxide (1.01 g, 8.63 
mmol) was added OsO4 (2.5% in tBuOH, 0.25 mL).  After 24 hours, the reaction was 
quenched with a solution of sodium bisulfite and diluted with ethyl acetate.  The layers 
were separated, and the aqueous layer was extracted with ethyl acetate (3x).  The 
combined organic portions were dried over Na2SO4.  The solvent was removed in 
vacuo and was purified by chromatography (30-70% ethyl acetate : 70-30 % hexanes)  
to give diol 5.11 (1.03 g, 88%). 
1H NMR (400 MHz, CDCl3) δ 7.38 – 7.26 (m, 5H), 4.56 (d, J = 1.1, 2H), 3.96 (t, J = 
5.5, 1H), 3.91 (q, J = 4.8, 1H), 3.81 (ap, J = 6.2, 1H), 3.66 (ddd, J = 14.4, 8.5, 4.6, 
1H), 3.59 (dd, J = 4.7, 0.9, 2H), 3.15 (bs, 1H), 3.04 (bs, 1H), 1.28 (d, J = 6.3, 3H). 13C 
NMR (126 MHz, CDCl3) δ 138.1, 128.6, 127.9(7), 127.9(6), 82.8, 79.6, 76.4, 73.8, 
72.8, 71.0, 19.0. IR (neat) 3388, 2906, 1496, 1452, 1094, 1019, 738, 696 cm-1. HRMS 






Acetonide 5.12: To a 100 mL flask equipped with a stir bar was added methylene 
chloride (40 mL), diol 5.11 (1.03 g, 4.32 mmol), pyridinium p-toluenesulfonate (0.22 
g, 0.86 mmol), and 2,2-dimethoxypropane (4.5 g, 43.2 mmol).  The reaction was left 
to stir for 3 hours.  It was diluted with methylene chloride and washed with NaHCO3 
and brine.  The solution was dried over Na2SO4 and purified by chromatography (10-
30% ether : 90-70% pentane) to give acetonide 5.12 (0.88 g, 67%).   
1H NMR (500 MHz, CDCl3)  7.40 – 7.26 (m, 5H), 4.59 (s, 2H), 4.55 (dd, J = 6.96, 
4.47, 1H), 4.25 (dd, J = 6.94, 5.05, 1H), 4.06 (dd, J = 9.55, 4.40, 1H), 4.03 – 3.91 (m, 
1H), 3.64 – 3.52 (m, 2H), 1.53 (s, 3H), 1.33 (s, 3H), 1.31 (d, J = 6.3, 3H).  13C NMR 
(125 MHz, CDCl3)  138.2, 128.6, 128.0, 127.9, 114.9, 86.2, 83.2, 82.6, 80.9, 73.8, 
70.7, 27.6, 25.7, 19.2. IR (neat) 3088, 3062, 3031, 2982, 2932, 2870, 1497, 1454, 
1372, 1253, 1240, 1211, 1158, 1118, 1076 cm-1. HRMS (EI+) m/z 278.1515 





Primary alcohol 5.13: To a 50 mL flask equipped with a stir bar was added methanol 
(25 mL), acetonide 5.12 (0.80 g, 2.87 mmol), and 10% Pd/C (0.029 g).  A balloon of 
hydrogen gas was then added.  After 18 hours, the reaction was filtered through celite 
with ethyl acetate.  The solvent was removed in vacuo to afford primary alcohol 5.13 
(0.50 g, 93%).   
1H NMR (500 MHz, CDCl3) δ 4.61 (dd, J = 6.99, 4.51, 1H), 4.23 (dd, J = 6.96, 5.23, 
1H), 4.12 – 3.88 (m, 2H), 3.82 (ddd, J = 11.93, 4.90, 3.37, 1H), 3.67 (ddd, J = 12.00, 
7.63, 4.45, 1H), 2.00 (dd, J = 7.62, 5.03, 1H), 1.53 (s, 3H), 1.33 (s, 3H), 1.31 (d, J = 
6.35, 3H).  13C NMR (125 MHz, CDCl3)  δ 115.0, 86.3, 84.3, 81.8, 80.7, 63.0, 27.6, 
25.6, 19.1. IR (neat) 3466, 2982, 2934, 2878, 1456, 1382, 1263, 1241, 1212, 1158, 






Vinyl Tetrahydrofuran 5.14. Stock solutions of all reagents were prepared.  To a 5 mL 
flask equipped with a stir bar was added CH2Cl2 (1 mL) and a solution of oxalyl 
chloride (0.0210g, 0.166 mmol).  The solution was cooled to -78°C and DMSO was 
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added (0.0259 g, 0.332 mmol).  After 15 minutes, primary alcohol 5.13 (0.0260 g, 
0.138 mmol) was added, and the reaction was left to stir for 40 minutes at -78°C.  
After 40 minutes, triethyl amine was added (0.0699 g, 0.691 mmol), and after an 
additional 20 minutes, the reaction was warmed to 0°C in an ice bath.  After 30 
minutes, the reaction was filtered through a plug of celite with 50% diethyl 
ether/pentane.  The solvent was removed in vacuo, 0.5 mL of diethyl ether was added, 
and the solution was cooled to 0°C.   In the meantime, methyl triphenylphosphonium 
bromide (0.247 g, 0.691 mmol) was added to a 10 mL flask containing diethyl ether 
(3.5 mL), cooled to 0°C, and equipped with a stir bar.  Potassium t-butoxide (0.0814 g, 
0.725 mmol) was added to the solution.  After 1 hour, 1.5 mL of this solution (2 eq) 
was added to the crude aldehyde solution.  Upon completion, the reaction was 
quenched with ammonium chloride and diluted with diethyl ether.  The layers were 
separated, and the organic layer was washed with saturated NaCl and dried over 
MgSO4.  The solvent was removed in vacuo.  The product was purified by 
chromatography (5% ethyl acetate : 95% hexanes) to give vinyl tetrahydrofuran 5.14 
(0.0047 g, 18%).  The NMR data matched that previously published in the literature.2   
1H NMR (600 MHz, CDCl3 5.90 (ddd, J = 17.08, 10.50, 6.43, 1H), 5.39 (td, J = 
17.23, 1.35, 1H), 5.23 (td, J = 10.50, 1.28, 1H), 4.45 (dd, J = 6.99, 4.95, 1H), 4.28 
(ddd, J = 17.44, 6.60, 4.89, 2H), 4.07 – 3.89 (m, 1H), 1.55 (s, 3H), 1.34 (s, 3H), 1.33 





Silyl Ether 5.15: To a 250 mL flask was added 2,4-hexadien-1-ol (3.4 g, 34.6 mmol, 1 
equiv.) and CH2Cl2 (100 mL). A stir bar was added followed by imidazole (4.2 g, 61.7 
mmol, 1.8 equiv.). Lastly, tert-butylchlorodiphenylsilane (12.6 g, 45.8 mmol, 1.3 
equiv.) was added and the reaction was stirred for 10 hours at room temperature. The 
reaction was diluted with diethyl ether and washed with 1 M HCl. The solvent was 
removed in vacuo and then purified by column chromatography (2.5% ether: 97.5% 
pentane, anisaldehyde) to yield 11.5 g of product (34.2 mmol, 99%).  
1H NMR (400 MHz, CDCl3) δ 7.87 – 7.74 (m, 4H), 7.55 – 7.38 (m, 6H), 6.33 (dd, J = 
15.0, 10.7, 1H), 6.23 – 6.06 (m, 1H), 5.83 – 5.66 (m, 2H), 4.32 (d, J = 3.8, 2H), 1.83 
(d, J = 6.6, 3H), 1.16 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 135.7, 133.9, 131.3, 
130.4, 129.8, 129.6, 129.1, 127.8, 64.5, 27.0, 19.5, 18.3. IR (neat) 3023, 2932, 1959, 
1824, 1472, 1427, 1380, 1112, 1050, 988, 823, 702, 606, 491 cm-1. HRMS (EI+) m/z 






Vinyl Oxiranes 5.16 and 5.17: To a 500 mL flask equipped with a stir bar was added 
methylene chloride (320 mL), silyl ether 5.15 (12.2 g, 36.3 mmol), Na2HPO4 (9.81 g, 
equal mass with m-CPBA), and m-CPBA (70%, 9.81 g, 39.8 mmol, 1.1 equiv.). After 
1 hour, the reaction was cooled to 0°C and filtered through celite washing with diethyl 
ether.  It was then diluted with additional diethyl ether and washed with 1 M NaOH, a 
saturated NaHCO3 solution, water, and dried over MgSO4.  The solvent was removed 
in vacuo to give a clear oil that was purified by column chromatography (2.5% ether: 
97.5 % pentane, anisaldehyde).  The regioisomeric vinyl oxirane products are readily 
separable and yielded 7.2 g of 5.16 and 5.5 g of 5.17 (1.3:1 ratio, 36.0 mmol, 99%).  
Vinyl Oxirane 5.16. 1H NMR (400 MHz, CDCl3) δ 7.69 – 7.64 (m, 4H), 7.43 – 7.33 
(m, 6H), 5.97 (ddd, J = 15.5, 4.6, 4.1, 1H), 5.54 (ddt, J = 15.4, 7.9, 1.9, 1H), 4.21 (dd, 
J = 4.3, 1.8, 2H), 3.08 (dd, J = 7.9, 2.1, 1H), 2.89 (qd, J = 5.2, 2.2, 1H), 1.33 (d, J = 
5.2, 3H), 1.06 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 135.6, 135.6, 134.1, 133.6, 
133.5, 129.9, 127.9, 127.3, 63.7, 59.3, 56.6, 27.0, 19.4, 17.8. IR (neat) 2960, 2857, 
1428, 1112, 963, 823, 703, 491 cm-1. HRMS (EI+) m/z 295.11565 [calculated mass for 
C18H19O2Si (M-tBu+) 295.11544].  
Vinyl Oxirane 5.17. 1H NMR (400 MHz, CDCl3) δ 7.77 – 7.63 (m, 4H), 7.49 – 7.29 
(m, 6H), 5.98 – 5.82 (m, 1H), 5.20 (ddq, J = 15.3, 8.2, 1.6, 1H), 3.83 (dd, J = 11.8, 
3.5, 1H), 3.75 (dd, J = 11.8, 4.5, 1H), 3.21 (dd, J = 8.2, 2.1, 1H), 3.04 (ddd, J = 4.5, 
3.5, 2.2, 1H), 1.72 (dd, J = 6.6, 1.6, 3H), 1.06 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 
135.8, 135.7, 133.4(4), 133.3(8), 132.0, 129.9, 128.3, 127.9(0), 127.8(9), 64.0, 60.1, 
56.4, 26.9, 19.4, 18.1. HRMS (EI+) m/z 295.11522 [calculated mass for C18H19O2Si 





2,5-Dihydrofuran 5.18 from 5.16: To a flame dried 13x100 mm threaded culture tube 
was added vinyl oxirane 5.16 (25 mg, 0.071 mmol) in dry toluene (0.6 mL). The 
culture tube was fitted with a threaded septum cap and then submerged in an oil bath 
at 150ºC. A syringe pump was used to add toluene over 10 hours (0.1 mL, 0.50 
mol%/hour) which contained Cu(hfacac)2 (1.76 mg, 0.0035 mmol, 0.05 equiv.). The 
solution was heated for a total of 12 hours and then cooled to room temperature. The 
reaction mixture was filtered through neutral alumina (activity grade 1) washing with 
ethyl acetate and then purified by flash chromatography on silica gel (2.5% ether : 
97.5% pentane, anisaldehyde) to yield  of 2,5-dihydrofuran 5.18 (21 mg, 84%, 0.060 
mmol), (Crude diastereomeric ratio >20:1, purified >20:1 cis:trans). 
1H NMR (400 MHz, CDCl3) δ 7.73 – 7.66 (m, 4H), 7.45 – 7.32 (m, 6H), 5.82 (s, 2H), 
4.98 – 4.89 (m, 1H), 4.89 – 4.83 (m, 1H), 3.71 (dd, J = 10.3, 4.9, 1H), 3.63 (dd, J = 
10.3, 5.4, 1H), 1.25 (d, J = 6.4, 3H), 1.05 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 
135.9, 135.8, 133.9, 133.7, 132.7, 129.8(2), 129.7(8), 127.8, 127.5, 87.0, 82.5, 77.6, 
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77.2, 76.9, 67.7, 27.0, 23.0, 19.5. IR (neat) 2922, 2854, 1783, 1532, 1450, 1426, 1363, 
1112, 1091, 912, 741, 701 cm-1. HRMS (EI+) m/z 295.11644 [calculated mass for 





2,5-Dihydrofuran 5.18 from 5.17: To a flame dried 13x100 mm threaded culture tube 
was added vinyl oxirane 5.17 (25 mg, 0.071 mmol) in dry toluene (0.6 mL). The 
culture tube was fitted with a threaded septum cap and then submerged in an oil bath 
at 150ºC. A syringe pump was used to add toluene over 10 hours (0.1 mL, 0.50 
mol%/hour) which contained Cu(hfacac)2 (1.76 mg, 0.0035 mmol, 0.05 equiv.). The 
solution was heated for a total of 12 hours and then cooled to room temperature. The 
reaction mixture was filtered through neutral alumina (activity grade 1) washing with 
ethyl acetate and then purified by flash chromatography on silica gel (2.5% ether : 
97.5% pentane, anisaldehyde) to yield 2,5-dihydrofuran 5.18 (20 mg, 80%, 0.057 
mmol), (Crude diastereomeric ratio >20:1, purified >20:1 cis:trans).  
1H NMR (400 MHz, CDCl3) δ 7.73 – 7.66 (m, 4H), 7.45 – 7.32 (m, 6H), 5.82 (s, 2H), 
4.98 – 4.89 (m, 1H), 4.89 – 4.83 (m, 1H), 3.71 (dd, J = 10.3, 4.9, 1H), 3.63 (dd, J = 
10.3, 5.4, 1H), 1.25 (d, J = 6.4, 3H), 1.05 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 
135.9, 135.8, 133.9, 133.7, 132.7, 129.8(2), 129.7(8), 127.8, 127.5, 87.0, 82.5, 77.6, 
77.2, 76.9, 67.7, 27.0, 23.0, 19.5. IR (neat) 2922, 2854, 1783, 1532, 1450, 1426, 1363, 
1112, 1091, 912, 741, 701 cm-1. HRMS (EI+) m/z 295.11644 [calculated mass for 





Diol 5.19: To a stirred flask containing acetone (4.5 mL), water (4.5 mL), 
dihydrofuran 5.18 (0.31 g, 0.88 mmol), and 4-methylmorpholine N-oxide (0.31 g, 2.64 
mmol, 3 equiv.) was added OsO4 (2.5% in tBuOH, 1.0 mL, 0.1 equiv.).  After 12 
hours, the reaction was quenched with a solution of sodium bisulfite and diluted with 
ethyl acetate. The reaction was stirred vigorously for 16 hours and then the layers were 
separated. The aqueous layer was extracted with ethyl acetate three additional times. 
The combined organic portions were dried over Na2SO4.  The solvent was removed in 
vacuo and purified by chromatography (60% ether : 40% pentane, anisaldehyde) to 
yield diol 5.19 (0.34 g 0.88 mmol, 99% yield).  
1H NMR (400 MHz, CDCl3) δ 7.77 – 7.60 (m, 4H), 7.53 – 7.30 (m, 6H), 4.20 (bs, 
1H), 3.97 – 3.81 (m, 2H), 3.81 – 3.69 (m, 3H), 2.70 (bd, J = 5.4, 1H), 2.63 (bd, J = 
3.1, 1H), 1.31 (d, J = 6.2, 3H), 1.05 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 135.8(4), 
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135.7(7), 133.4, 133.2, 130.0(2), 129.9(7), 127.9(7), 127.9(3), 84.2, 79.1, 76.9, 72.8, 
64.5, 27.0, 19.4, 18.9. IR (neat) 3404, 2931, 2858, 1472, 1427, 1112, 1008, 938, 823, 






Vinyl Oxirane 5.21: To a 250 mL flask was added ethyl sorbate (1.0 g, 7.1 mmol, 1 
equiv.) and CH2Cl2 (50 mL). The solution was cooled to 0oC and then (6.7 g, 71.1 
mmol, 10 equiv.) H2O2:Urea was added. Next, Na2HPO4 (9.1 g, 64 mmol, 9 equiv.) 
was added followed by a slow addition of trifluoroacetic anhydride (2.5 mL, 3.75 g, 
17.9 mmol, 2.5 equiv.) The solution was vigorously stirred at 0oC for 4 hours. The 
reaction was decanted from the solid that aggregates during the course of the reaction. 
The solid was washed with CH2Cl2 and the organic washings are quenched with sat. 
NaHCO3. The organic layer was dried with Na2SO4 and the solvent removed in vacuo. 
The product was clean enough for further reaction but can be purified by silica gel 
chromatography (20% ether: 80% pentane) to yield epoxide that was slightly volatile 





Vinyl Oxiranes 5.24 and 5.25: To a tall threaded culture tube was added a stir bar, dry 
THF (1 mL), and LiHMDS (1.24 mL, 1.0 M in THF, 1.24 mmol, 1.02 equiv.) The 
reaction was cooled to -78oC and a solution of benzyl-2-bromoacetate (0.19 mL, 278 
mg, 1.2 mmol, 1 equiv.) in THF (0.5 mL) was added. The solution was stirred for 30 
minutes at -78oC and then crotonaldehyde (0.10 mL, 0.085 g, 1.2 mmol, 1 equiv.) was 
added. The solution was stirred for 1 hour at -78oC and then the cooling bath was 
removed for 15 minutes before it was quenched with sat. NH4Cl. The reaction was 
extracted with CH2Cl2 and dried with Na2SO4. The product was purified by silica gel 
chromatography (10% ether : 90% pentane, anisaldehyde) to yield of a 1.2:1 mixture 
of diasteriomers (5.25 cis : 5.24 trans), (204 mg, 0.94 mmol, 77%). The products are 
separable by column chromatography to yield 60 mg of 5.24 and 132 mg of 5.25.  
Vinyl Oxirane 5.24 1H NMR (400 MHz, CDCl3) δ 7.40 – 7.31 (m, 5H), 6.03 (dq, J = 
15.4, 6.6, 1H), 5.34 – 5.08 (m, 3H), 3.56 (dd, J = 8.2, 1.8, 1H), 3.40 (d, J = 1.9, 1H), 
1.75 (dd, J = 6.6, 1.7, 3H). 13C NMR (101 MHz, CDCl3) δ 168.8, 135.2, 134.5, 128.8, 
128.7(4), 128.6(5), 126.3, 67.4, 58.4, 54.8, 18.1. IR (neat) 3032, 2962, 1748, 1763, 
1454, 1424, 1278, 1186, 962, 763 cm-1. HRMS (EI+) m/z 218.09465 [calculated mass 
for C13H14O3 (M+) 218.09430].  
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Vinyl Oxirane 5.25 1H NMR (400 MHz, CDCl3) δ 7.44 – 7.30 (m, 5H), 6.07 (dq, J = 
15.5, 6.6, 1H), 5.37 (ddq, J = 15.5, 8.8, 1.7, 1H), 5.29 (d, J = 12.1, 1H), 5.19 (d, J = 
12.2, 1H), 3.70 (d, J = 4.5, 1H), 3.60 (dd, J = 8.8, 4.5, 1H), 1.72 (dd, J = 6.6, 1.7, 3H). 
13C NMR (101 MHz, CDCl3) δ 168.1, 136.1, 135.4, 128.8(4), 128.7(8), 128.7(5), 
123.6, 67.36, 58.0, 54.5, 18.3. IR (neat) 3053, 2970, 1750, 1497, 1454, 1283, 1186, 






2,5-Dihydrofuran 5.26 (trans): To a flame dried 13x100 mm threaded culture tube was 
added vinyl oxiranes 5.24 and 5.25 (100 mg, 1:1.2, 0.45 mmol) in dry toluene (4.5 
mL). Then, Cu(hfacac)2 (23 mg, 0.046 mmol, 0.1 equiv.) was added. The culture tube 
was fitted with a teflon cap and submerged in an oil bath at 150ºC. After 2 hours the 
reaction was concentrated and silica gel chromatography was performed (10% ether : 
90% pentane, anisaldehyde) to yield 5.26 (97 mg, 0.44 mmol, 97%, crude 
diastereomeric ratio 1:9, purified 1:9 cis:trans).   
1H NMR (400 MHz, CDCl3) δ 7.41 – 7.28 (m, 5H), 5.97 – 5.90 (m, 1H), 5.84 (dt, J = 
6.0, 2.1, 1H), 5.34 (dt, J = 5.7, 2.1, 1H), 5.24 – 5.14 (m, 3H), 1.31 (d, J = 6.4, 3H). 13C 
NMR (101 MHz, CDCl3) δ 171.3, 135.7, 134.4, 128.7, 128.4, 128.3, 124.4, 84.1, 83.7, 
66.8, 21.5. IR (neat) 2972, 2875, 1752, 1455, 1372, 1347, 1314, 1180, 1104, 1015, 






Vinyl Oxirane 5.28: To a 200 mL flame dried flask with magnetic stir bar was added 
methylene chloride (120 mL). To this solution was added (2E,4E,6E)-ethyl octa-2,4,6-
trienoate4 (2.00 g, 12.0 mmol, 1 equiv.). Next, was added Na2HPO4 (2.7 g ) followed 
by m-CPBA (2.7 g, 15.6 mmol, 1.3 equiv.). The solution was stirred at room 
temperature until the starting material was consumed. The solution was cooled to 0oC 
and then filtered through celite. The organic filtrate was washed 3 times with sat. 
NaHCO3 and once with H2O. The solution was dried with Na2SO4 and the solvent 
removed in vacuo. The product was purified by silica gel chromatography (15% ether 
: 85% pentane) to yield vinyl oxirane 5.28 (1.73 g, 79%).  
1H NMR (500 MHz, C6D6) δ 7.36 (ddd, J = 15.4, 11.2, 0.7, 1H), 6.07 (dd, J = 15.3, 
11.2, 1H), 5.87 (dd, J = 15.4, 0.6, 1H), 5.34 (dd, J = 15.3, 7.5, 1H), 4.05 (q, J = 7.1, 
2H), 2.62 (dd, J = 7.5, 1.8, 1H), 2.42 (qd, J = 5.1, 2.0, 1H), 0.99 (t, J = 7.1, 3H), 0.94 
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(d, J = 5.1, 3H). 13C NMR (126 MHz, C6D6) δ 166.8, 143.5, 140.1, 131.1, 122.7, 60.6, 
58.4, 57.1, 17.8, 14.7. IR (neat) 2984, 2932, 1713, 1644, 1619, 1305, 1231, 1145, 






2,5-Dihydrofuran 5.29: To a flame dried 13x100 mm threaded culture tube was added 
vinyl oxirane 5.28 (25 mg, 0.14 mmol) in dry toluene (1 mL). The culture tube was 
fitted with a threaded septum cap and then submerged in an oil bath at 150ºC. A 
syringe pump was used to add toluene over 17 hours (0.5 mL, 0.12 mol%/hour) which 
contained Cu(hfacac)2 (1.4 mg, 0.0027 mmol, 0.02 equiv.). The solution was heated 
for a total of 24 hours and then cooled to room temperature. The reaction mixture was 
filtered through neutral alumina (activity grade 1) washing with ethyl acetate and then 
purified by flash chromatography on silica gel (20% ether : 80% pentane, KMnO4) to 
yield  of 2,5-dihydrofuran 5.29 (21.0 mg, 84%, 0.12 mmol), (Crude diastereomeric 
ratio 8:1, purified >20:1 cis:trans).  
1H NMR (600 MHz, CDCl3) δ 6.83 (dd, J = 15.6, 5.3, 1H), 5.98 (d, J = 15.5, 1H), 
5.80 – 5.77 (m, 1H), 5.66 (d, J = 6.0, 1H), 5.31 – 5.22 (m, 1H), 4.98 – 4.89 (m, 1H), 
4.13 (q, J = 7.2, 2H), 1.25 (d, J = 6.4, 3H), 1.22 (t, J = 7.2, 3H). 13C NMR (126 MHz, 
CDCl3) δ 166.7, 147.9, 132.6, 127.1, 120.7, 85.0, 83.1, 60.7, 22.9, 14.5. IR neat 2981, 
2954, 2873, 1721, 1657, 1596, 1448, 1370, 1303, 1275, 1180, 1039, 981, 841 cm-1. 





Acetonide 5.30: To a stirred flask containing acetone (0.5 mL), water (0.5 mL), 
dihydrofuran 5.29 (0.014 g, 0.077 mmol), and 4-methylmorpholine N-oxide (9 mg, 
0.077 mmol, 1 equiv.) was added OsO4 (2.5% in tBuOH, 0.01 mL, cat.). After 24 
hours, the reaction was quenched with a solution of sodium bisulfite and diluted with 
ethyl acetate. The reaction was stirred vigorously for several hours and then the layers 
were then separated. The aqueous layer was extracted with ethyl acetate three 
additional times. The combined organic portions were dried over Na2SO4. The solvent 
was removed in vacuo and the diol was purified by chromatography (70% ether : 30% 
pentane, KMnO4), (9.5 mg, 0.043 mmol, 57%).   
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1H NMR (400 MHz, CDCl3) δ 6.96 (dd, J = 15.7, 4.8, 1H), 6.09 (dd, J = 15.6, 1.7, 
1H), 4.34 – 4.22 (m, 2H), 4.17 (q, J = 7.1, 2H), 3.94 – 3.88 (m, 1H), 3.72 (at, J = 5.2, 
1H). 2.68 (bd, J = 5.8, 1H), 2.47 (bd, J = 5.5, 1H), 1.30 (d, J = 6.3, 3H), 1.26 (t, J = 
7.1, 3H).  
 
The diol was prone to epimerization and retro Aldol reactions and therefore it was 
protected immediately after purification. To a 4 mL reaction vial equipped with a stir 
bar was added the diol (34 mg, 0.16 mmol), methylene chloride (0.5 mL), pyridinium 
p-toluenesulfonate (0.01 g, 0.04 mmol, 0.25 equiv.), and 2,2-dimethoxypropane (0.5 
mL).  The reaction was stirred for 12 hours.  It was diluted with methylene chloride 
and washed with NaHCO3 and brine.  The solution was dried over Na2SO4 and 
purified by chromatography (30% ether : 70% pentane, KMnO4) to give acetonide 
5.30 (0.017 g, 0.066 mmol, 42% yield).  
1H NMR (500 MHz, CDCl3) δ 6.99 (dd, J = 15.7, 5.0, 1H), 6.11 (dd, J = 15.7, 1.7, 
1H), 4.49 (dd, J = 6.8, 4.9, 1H), 4.44 (td, J = 4.9, 1.7, 1H), 4.31 (dd, J = 6.8, 4.4, 1H), 
4.20 (q, J = 6.5, 2H), 4.07 (qd, J = 6.4, 4.5, 1H), 1.55 (s, 3H), 1.33 (s, 3H), 1.33 (d, J = 
6.5, 3H), 1.29 (t, J = 7.1, 3H). 13C NMR (126 MHz, CDCl3) δ 166.3, 144.9, 122.2, 
115.3, 86.3, 85.1, 83.2, 80.9, 60.7, 27.6, 25.7, 19.3, 14.4. HRMS (EI+) m/z 256.1302 





Vinyl Oxirane 5.35: To a 10 mL flask with a magnetic stir bar was added L-Proline (13 
mg, 0.11mmol, 0.2 equiv.) followed by aldehyde 5.32 (0.1 g, 0.56 mmol, 1 equiv.) in 
1 mL of CH2Cl2. The solution was cooled to 0oC and after 15 minutes N-
chlorosuccinimide (0.097 g, 0.73 mmol, 1.3 equiv.) was added. The solution was 
stirred for 2 hours at 0oC and then 1 hour at room temperature, at which point it was 
quenched by the addition of pentane (5 mL) and filtered through a sintered glass 
funnel. The solvent was removed in vacuo and then resulting crude dissolved in 
pentane, filtered, and dried with Na2SO4. The solvent was removed once again to yield 
labile aldehyde 5.33.  
1H NMR (400 MHz, CDCl3) δ 9.53 (d, J = 1.9, 1H), 7.40 – 7.28 (m, 5H), 4.50 (s, 2H), 
4.45 (ddd, J = 7.3, 5.3, 1.9, 1H), 3.75 – 3.58 (m, 2H), 2.37 – 2.28 (m, 1H), 2.13 (dddd, 
J = 14.8, 7.5, 6.1, 4.3, 1H), 1.35 – 1.20 (m, 2H). 13C NMR (101 MHz, CDCl3) δ 
195.2, 138.0, 128.7, 128.0, 127.9, 73.4, 65.4, 61.7, 33.1.   
 
Aldehyde 5.33 was used without further purification. To another 10 mL round bottom 
flask was added THF (5 mL) and E-1-iodopropene (94 mg, 0.56 mmol, 1 equiv.). The 
solution was cooled to -78oC and then n-butyl-lithium (0.35 mL, 1.6 M in hexanes, 
0.56 mmol, 1 equiv.) was added drop wise. The solution was stirred for 10 minutes at -
397 
78oC and then aldehyde 5.33 dissolved in THF (0.1 mL) was added. The solution was 
stirred for 15 minutes at -78oC and then quenched with saturated NH4Cl and diethyl 
ether. The solution was warmed to room temperature over 3 hours. The solution was 
extracted with diethyl ether three times and then dried with Na2SO4. The solvent was 
removed to yield a mixture of epoxide and chloro-alcohol. This crude mixture was 
dissolved in absolute ethanol (5.6 mL). Then KOH (94 mg, 1.68 mmol, 3 equiv.) was 
added and the solution was stirred for 30 minutes. The solution was quenched with 
brine and extracted with pentane. The organic layer was dried with Na2SO4 and the 
solvent removed. The epoxide was purified using silica gel chromatography (20% 
ether : 80% pentane, anisaldehyde) to yield vinyl oxirane 5.35 (62 mg, 0.28 mmol, 
51%).   
1H NMR (400 MHz, CDCl3) δ 7.39 – 7.23 (m, 5H), 5.97 – 5.85 (m, 1H), 5.19 (ddd, J 
= 15.4, 8.2, 1.7, 1H), 4.51 (s, 2H), 3.60 (dd, J = 6.7, 5.8, 2H), 3.12 (dd, J = 8.2, 2.2, 
1H), 2.97 (ddd, J = 6.8, 4.8, 2.2, 1H), 1.93 (dtd, J = 11.7, 6.7, 4.8, 1H), 1.80 (ddd, J = 
11.9, 7.2, 4.0, 1H), 1.73 (dd, J = 6.6, 1.7, 3H). 13C NMR (101 MHz, CDCl3) δ 138.4, 
131.7, 128.8, 128.5, 127.7, 127.7, 73.2, 67.0, 58.8, 58.0, 32.7, 18.1. IR (neat) 2918, 
2857, 1496, 1463, 1362, 1207, 1099, 963, 879, 734, 698 cm-1. HRMS (EI+) m/z 





2,5-Dihydrofuran 5.36: To a flame dried 13x100 mm threaded culture tube was added 
vinyl oxirane 5.35 (10 mg, 0.046 mmol) in dry toluene (0.35 mL). The culture tube 
was fitted with a threaded septum cap and then submerged in an oil bath at 150ºC. A 
syringe pump was used to add toluene over 10 hours (0.1 mL, 0.1 mol%/hour) which 
contained Cu(hfacac)2 (1.1 mg, 0.0022 mmol, 0.05 equiv.). The solution was heated 
for a total of 13 hours and then cooled to room temperature. The reaction mixture was 
filtered through neutral alumina (activity grade 1) washing with ethyl acetate and then 
purified by flash chromatography on silica gel (10% ether : 90% pentane, 
anisaldehyde) to yield 2,5-dihydrofuran 5.36 (7.0 mg, 70%, 0.032 mmol), (Crude 
diastereomeric ratio 10:1, purified >20:1 cis:trans).  
1H NMR (400 MHz, CDCl3) δ 7.38 – 7.24 (m, 5H), 5.81 – 5.78 (m, 1H), 5.77 – 5.73 
(m, 1H), 4.95 – 4.84 (m, 2H), 4.53 (d, J = 11.8, 1H), 4.49 (d, J = 11.8, 1H), 3.62 (dd, J 
= 6.9, 6.0, 2H), 1.93 (dtd, J = 12.0, 7.1, 4.9, 1H), 1.88 – 1.79 (m, 1H), 1.26 (d, J = 6.3, 
3H). 13C NMR (126 MHz, CDCl3) δ 138.7, 131.6, 130.0, 128.6, 127.9, 127.7, 83.7, 
81.9, 73.3, 67.4, 37.6, 23.2. HRMS (EI+) m/z 218.13063 [calculated mass for 






Diol 5.37: To a scintillation vial containing acetone (0.2 mL), water (0.2 mL), 
dihydrofuran 5.36 (0.005 g, 0.023 mmol), and 4-methylmorpholine N-oxide (8.1 mg, 
0.069 mmol, 3 equiv.) was added OsO4 (2.5% in tBuOH, 0.1 mL, 0.3 equiv.).  After 
12 hours, the reaction was quenched with a solution of sodium bisulfite and diluted 
with ethyl acetate. The reaction was stirred vigorously for several hours and then the 
layers were separated. The aqueous layer was extracted with ethyl acetate three 
additional times. The combined organic portions were dried over Na2SO4.  The solvent 
was removed in vacuo and purified by chromatography (80% ether: 20% pentane, 
anisaldehyde) to yield diol 5.37 (4.0 mg, 0.016 mmol, 69% yield). 
1H NMR (400 MHz, CDCl3) δ 7.43 – 7.28 (m, 5H), 4.54 (d, J = 1.1, 2H), 3.92 – 3.84 
(m, 2H), 3.78 – 3.62 (m, 4H), 2.90 (bd, J = 6.0, 1H), 2.76 (bs, 1H), 2.06 – 1.86 (m, 
2H), 1.27 (d, J = 6.5, 3H). 13C NMR (101 MHz, CDCl3) δ 137.4, 128.9, 128.3, 128.1, 
82.1, 80.7, 76.7, 75.6, 73.8, 68.2, 34.1, 19.8. IR (neat) 3374, 2905, 2865, 1453, 1363, 
1311, 1205, 1073, 1027, 882, 735, 697 cm-1. HRMS (ESI) m/z 275.1251 [calculated 
mass for C14H20O4 (M+Na+) 275.1259].  
 
 
   
 
Acetonide 5.43: To a scintillation vial was added diol 5.37 (4 mg, 0.016 mmol, 1 
equiv.) and CH2Cl2 (0.3 mL). Then pyridinium p-toluenesulfonate (0.8 mg, 0.0032 
mmol, 0.2 equiv.) and 2,2-dimethoxypropane (16.5 mg, 0.158 mmol, 10 equiv.) were 
added to the vial. The reaction was stirred for 12 hours.  It was diluted with methylene 
chloride and washed with NaHCO3 and brine.  The solution was dried over Na2SO4 
and purified by chromatography (30% ether : 70% pentane, anisaldehyde) to give the 
expected acetonide (2.0 mg, 0.0068 mmol, 43% yield).  
1H NMR (500 MHz, CDCl3) δ 7.38 – 7.27 (m, 5H), 4.56 – 4.47 (m, 2H), 4.43 (dd, J = 
7.0, 4.9, 1H), 4.23 (dd, J = 7.0, 5.2, 1H), 3.96 – 3.86 (m, 2H), 3.67 – 3.56 (m, 2H), 
1.94 (qd, J = 13.8, 7.1, 2H), 1.53 (s, 3H), 1.33 (s, 3H), 1.29 (d, J = 6.4, 3H). 13C NMR 
(126 MHz, CDCl3) δ 138.7, 128.5, 127.8, 127.7, 115.0, 86.4, 85.6, 81.7, 80.2, 73.2, 
67.2, 34.2, 27.6, 25.7, 19.2. HRMS (EI+) m/z 292.16637 [calculated mass for 






Primary Alcohol 5.38: To a small vial with a septum cap was added acetonide (0.8 
mg, 0.0027 mmol). Then Pd/C (0.8 mg, 10%) was added along with methanol (0.5 
mL). A balloon of hydrogen was attached to the vial and it was stirred at room 
temperature for 15 hours. The solution was filtered through celite and the solvent 
removed in vacuo to yield the primary alcohol 5.38 in quantitative yield (0.5 mg).  
1H NMR (500 MHz, CDCl3) δ 4.44 – 4.37 (m, 1H), 4.28 (dd, J = 7.1, 4.9, 1H), 3.99 – 
3.90 (m, 2H), 3.84 – 3.78 (m, 2H), 2.33 – 2.27 (m, 1H), 1.99 – 1.90 (m, 1H), 1.90 – 
1.79 (m, 1H), 1.54 (s, 3H), 1.34 (s, 3H), 1.32 (d, J = 6.4, 3H). 13C NMR (101 MHz, 





Cyclopropylidene  5.44: To a 25 mL flask equipped with a stir bar was added 
methylene chloride (9 mL), diol 5.19 (0.340 g, 0.88 mmol), pyridinium p-
toluenesulfonate (0.040 g, 0.16 mmol, 0.2 equiv.), and dimethoxylcyclopentane (1.1 g, 
8.5 mmol, 10 equiv.).  The reaction was stirred for 12 hours at room temperature. It 
was diluted with methylene chloride and washed with NaHCO3 and brine.  The 
solution was dried over Na2SO4 and purified by chromatography (20% ether : 80% 
pentane) to give cyclopentylacetal (0.297 g, 0.66 mmol, 75% yield). 
1H NMR (400 MHz, CDCl3) δ 7.76 – 7.65 (m, 4H), 7.44 – 7.33 (m, 6H), 4.67 (dd, J = 
6.8, 3.7, 1H), 4.21 (dd, J = 6.7, 5.1, 1H), 4.06 – 3.96 (m, 2H), 3.79 (d, J = 3.9, 2H), 
1.96 (t, J = 7.6, 2H), 1.78 – 1.61 (m, 6H), 1.31 (d, J = 6.3, 1H), 1.07 (s, 9H). 13C NMR 
(101 MHz, CDCl3) δ 135.8(3), 135.7(6), 133.5, 133.3, 129.9, 129.8, 127.8(4), 
127.7(9), 123.6, 86.1, 84.0, 82.4, 80.2, 64.4, 37.0, 36.9, 27.0, 23.7, 23.3, 19.4, 19.3. IR 





Primary alcohol 5.39: To a 25 mL flask equipped with a stir bar was added 
cyclopentylacetal (0.297 g, 0.66 mmol) and tetrahydrofuran (6.5 mL). The solution 
400 
was cooled to 0oC and tetrabutylammonium fluoride (0.79 mL, 1 M in THF, 0.79 
mmol, 1.2 equiv.) was added dropwise. The reaction was stirred for 1 hour at 0oC and 
then 1 hour at room temperature. The reaction was quenched with water and extracted 
with CH2Cl2. The solution was dried over Na2SO4 and purified by chromatography 
(50% ether : 50% pentane) to give 5.39 (0.140 g, 0.65 mmol, 99% yield). 
1H NMR (400 MHz, CDCl3) δ 4.53 (dd, J = 7.1, 4.5, 1H), 4.18 (dd, J = 7.1, 5.2, 1H), 
4.04 – 3.94 (m, 2H), 3.79 (dd, J = 11.9, 3.4, 1H), 3.66 (dd, J = 12.0, 4.7, 1H), 2.80 (bs, 
1H), 1.96 (dd, J = 11.1, 4.3, 2H), 1.76 – 1.62 (m, 6H), 1.31 (d, J = 6.4, 3H). 13C NMR 
(101 MHz, CDCl3) δ 124.2, 86.0, 84.0, 81.6, 80.1, 62.7, 36.7(7), 36.7(5), 23.6, 23.2, 





Sulfone 5.40: To a 4 mL reaction vial containing dry methylene chloride (0.42 mL) 
and 1-phenyl-1H-tetrazole-5-thiol (0.045 g, 0.252 mmol) was added 
triphenylphosphine (0.066 g, 0.252 mmol) at 0oC. Primary alcohol 5.39 (0.036 g, 
0.168 mmol) was then dissolved in dry methylene chloride (0.23 mL) and added drop-
wise to the above solution over 2 minutes. After complete addition, diisopropyl 
azodicarboxylate (DIAD) (0.05 mL, 0.252 mmol) was added slowly over 30 minutes 
by syringe and the reaction was allowed to stir an additional 90 minutes to consume all 
starting alcohol.  The reaction was then concentrated to an oil and subsequently 
dissolved in ethanol (1.08 mL). To a 4 mL reaction vial containing ammonium 
molybdate (0.041 g, 0.033 mmol) was added 30% hydrogen peroxide solution (0.15 
mL, 1.68 mmol) at 0oC which immediately turns yellow in color. The crude reaction 
mixture in ethanol was then added to the molybdate solution, the bath was removed 
and the reaction was allowed to stir 14 hours at room temperature.  The reaction was 
then quenched by adding saturated sodium sulfite solution (2 mL), extracted with 
dichloromethane and dried over anhydrous NaSO4. The organics were concentrated 
and purified by flash chromatography (30% ethyl acetate : 70% hexanes, 
anisaldehyde) to give sulfone 5.40 (0.055 g, 81%).  
1H NMR (400 MHz, CDCl3) δ 7.69 – 7.55 (m, 5H), 4.47 (dd, J = 6.8, 5.4, 1H), 4.27 
(dd, J = 12.3, 5.4, 1H), 4.19 (dd, J = 6.8, 4.4, 1H), 3.94 – 3.88 (m, 3H), 1.95 – 1.87 
(m, 2H), 1.73 – 1.60 (m, 6H), 1.13 (d, J = 6.4, 3H).  13C NMR (101 MHz, CDCl3) δ 
153.8, 133.0, 131.4, 129.5, 125.6, 125.0, 85.4, 83.6, 80.6, 77.5, 58.9, 36.6, 36.6, 23.5, 
23.0, 18.7. IR (neat) 2973, 2941, 1498, 1353, 1154, 1106, 1054, 915, 764 cm-1. 






Aldehyde 5.41:  To a 50 mL flask was added the tribromide product derived from 
dimethyl anisole5 (1.0 g, 2.68 mmol) and glacial acetic acid (16.0 mL) with a reflux 
condenser attached.  To this was added sodium acetate (4.01 g, 29.49 mmol) and water 
(4.29 mL) and the reaction was refluxed at 110oC for 7 hours.  After cooling to room 
temperature, the reaction was diluted with diethyl ether and washed with water, 
saturated bicarbonate, and sodium carbonate.  The organics were dried over NaSO4, 
concentrated, and purified using flash chromatography (30% ethyl acetate : 70% 
hexanes, anisaldehyde) to give 5.41 (0.498g, 90%).   
1H NMR (400 MHz, CDCl3) δ 10.29 (s, 1H), 7.56 – 7.45 (m, 2H), 7.21 – 7.15 (m, 
1H), 5.56 (s, 2H), 3.90 (s, 3H), 2.06 (s, 3H).  13C NMR (101 MHz, CDCl3) δ 191.9, 
170.9, 158.6, 136.1, 130.4, 125.1, 122.9, 116.4, 56.3, 56.0, 21.0.  IR (neat) 2975, 
2942, 2843, 1736, 1697, 1587, 1472, 1381, 1270, 1241, 1026.  HRMS (EI+) m/z 





Protected Varitriol. A fresh stock solution of potassium bis-(trimethylsilyl) amide 
(KHMDS) was prepared by mixing hexa-methyldisilazane (0.051 mL, 0.24 mmol), 
dry tetrahydrofuran (5 mL), and 30% potassium hydride suspension (0.032g, 0.24 
mmol) at room temperature.  To a 4 mL reaction vial was added sulfone 5.40 (0.020 g, 
0.050 mmol) dissolved in a 4:1 mixture of dimethylformamide (DMF) and 
hexamethylphosphoramide (HMPA) (0.2 mL) at -78oC.  The freshly prepared 
KHMDS (1.0 mL, 0.048 mmol) was added and the reaction was allowed to stir 10 
minutes.  Aldehyde 5.41 (0.012 g, 0.055 mmol) was dissolved in the DMF:HMPA 
solvent mixture (0.2 mL) and subsequently added to the reaction.  The reaction was 
allowed to slowly warm to room temperature and then stirred 12 hours.  The reaction 
was quenched by adding water (1 mL), extracted with diethyl ether, dried over NaSO4, 
and purified by flash chromatography (30% ethyl acetate : 70% hexanes, 
anisaldehyde) to give protected varitriol (0.018 g, 94%).    
1H NMR (400 MHz, CDCl3) δ 7.30 (t, J = 8.0, 1H), 7.13 (d, J = 8.0, 1H), 6.95 (d, J = 
15.7, 1H), 6.84 (d, J = 8.0, 1H), 6.16 (dd, J = 15.7, 6.4, 1H), 5.27 (s, 2H), 4.51 – 4.41 
(m, 2H), 4.28 (dd, J = 6.5, 4.6, 1H), 4.10 – 4.02 (m, 1H), 3.83 (s, 3H), 2.06 (s, 3H), 
2.05 – 1.97 (m, 2H), 1.78 – 1.63 (m, 6H), 1.36 (d, J = 6.4, 3H).  13C NMR (126 MHz, 
402 
CDCl3) δ 171.4, 158.6, 138.9, 131.0, 130.1, 129.6, 124.6, 121.5, 119.0, 110.3, 86.5, 
85.8, 84.6, 80.2, 57.9, 56.1, 37.1, 37.0, 23.8, 23.4, 21.3, 19.4. IR (neat) 2970, 2943, 
1735, 1580, 1473, 1379, 1242, 1102, 1054 cm-1.  HRMS (ESI) m/z 411.1770 





Varitriol. To a 4 mL reaction vial was added protected varitriol (0.015 g, 0.039 mmol) 
and methanol (0.8 mL) at room temperature.  To this was added solid sodium 
methoxide (0.010 g, 0.195 mmol) and the reaction was stirred for 1 hour until starting 
material was consumed.  At this time the reaction was filtered through a plug of silica 
gel with ethyl acetate to give crude primary alcohol.  The crude primary alcohol was 
dissolved in methanol (0.6 mL) and Amberlyst 15 (5 mg) was added and the reaction 
was allowed to stir 1 hour until starting material was consumed.  The reaction was 
concentrated and filtered through a plug of silica gel with ethyl acetate to give varitriol 
(0.008 g, 74%) which matched all known spectral data in (CD3)2CO.   
1H NMR (400 MHz, CDCl3) δ 7.31 – 7.20 (m, 1H), 7.14 – 7.02 (m, 2H), 6.83 (d, J = 
8.0, 1H), 6.13 (dd, J = 15.7, 6.9, 1H), 4.87 – 4.72 (m, 2H), 4.34 (t, J = 6.1, 1H), 3.99 – 
3.89 (m, 2H), 3.87 (s, 3H), 3.83 – 3.75 (m, 1H), 2.58 (d, J = 5.8, 1H), 2.43 (d, J = 5.6, 
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A5.3 Coordinates and Calculated Energies for Chapter 5  
DFT calculations were performed with the program Gaussian03[1] by using the 
WebMO interface (WebMO, version 9.1.002p; www.webmo.net) for importing and 
constructing models. Transition states were verified by following the reaction 
coordinate forward and reverse (IRC).  
 
[1] Gaussian 03, Revision E.01,  M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. 
Scuseria,  M. A. Robb, J. R. Cheeseman, J. A. Montgomery, Jr., T. Vreven,  K. N. 
Kudin, J. C. Burant, J. M. Millam, S. S. Iyengar, J. Tomasi, V. Barone, B. Mennucci, 
M. Cossi, G. Scalmani, N. Rega, G. A. Petersson, H. Nakatsuji, M. Hada, M. Ehara, 
K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. 
Nakai, M. Klene, X. Li, J. E. Knox, H. P. Hratchian, J. B. Cross,  V. Bakken, C. 
Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. 
Cammi, C. Pomelli, J. W. Ochterski, P. Y. Ayala, K. Morokuma, G. A. Voth, P. 
Salvador, J. J. Dannenberg, V. G. Zakrzewski, S. Dapprich, A. D. Daniels, M. C. 
Strain, O. Farkas, D. K. Malick, A. D. Rabuck, K. Raghavachari,  J. B. Foresman, J. 
V. Ortiz, Q. Cui, A. G. Baboul, S. Clifford, J. Cioslowski, B. B. Stefanov, G. Liu, A. 
Liashenko, P. Piskorz, I. Komaromi, R. L. Martin, D. J. Fox, T. Keith, M. A. Al-
Laham, C. Y. Peng, A. Nanayakkara, M. Challacombe, P. M. W. Gill, B. Johnson, W. 
Chen, M. W. Wong, C. Gonzalez, and J. A. Pople, Gaussian, Inc., Wallingford CT, 
2004. 
 









5.24 B3LYP 6-311+G(d,p) -729.430 -459540.92 0.0
5.25 B3LYP 6-311+G(d,p) -729.429 -459540.33 0.6
5.22 B3LYP  6-311+G(d,p) -729.451 -459554.46 -13.5






















C    0.00000000  0.00000000  0.00000000 
C    0.74557900  1.12625200 -0.59213800 
C    1.39584300  2.03481500  0.13815900 
C    2.16277600  3.19852600 -0.41042700 
H    3.21007900  3.15910700 -0.09196200 
H    2.13758200  3.22117400 -1.50206900 
H    1.75774800  4.14579100 -0.03772400 
H    1.38037200  1.93607500  1.22292100 
H    0.75283400  1.18106100 -1.67872700 
O    0.04079800 -1.25985100 -0.68265600 
C   -1.20370000 -0.58269500 -0.65832900 
C   -2.27509100 -1.19194800  0.21597500 
O   -3.53354100 -0.69506200  0.09988800 
C   -3.85085300  0.41343800 -0.78594000 
C   -5.27058800  0.82781600 -0.51608900 
C   -5.55230800  1.82204400  0.42446900 
C   -6.86888900  2.18949800  0.69260400 
C   -7.91754900  1.56334200  0.02071200 
C   -7.64537100  0.57024800 -0.91919000 
C   -6.32787500  0.20600700 -1.18590100 
H   -6.11861000 -0.56983100 -1.91507200 
H   -8.45798900  0.08091000 -1.44395400 
H   -8.94270000  1.84902900  0.22764900 
H   -7.07602900  2.96264700  1.42373300 
H   -4.73784900  2.30826600  0.95161700 
H   -3.73898700  0.08649700 -1.82357300 
H   -3.16595400  1.24329500 -0.59418000 
O   -2.05170100 -2.06180600  1.01091100 
H   -1.50785500 -0.17151600 -1.61624300 















    
C    0.00000000  0.00000000  0.00000000 
C    0.41257800  1.15207200  0.82416200 
C    0.85994800  2.29163300  0.29177500 
C    1.28960900  3.49648400  1.07101400 
H    2.33137100  3.75251400  0.84913700 
H    0.68762200  4.37170500  0.80282900 
H    1.19767900  3.33402800  2.14675100 
H    0.92866300  2.37067000 -0.79303700 
H    0.34579300  1.02359100  1.90063700 
O    0.30510800 -1.31283700  0.49427700 
C   -1.06298800 -0.96459300  0.41283400 
C   -1.80014700 -0.79400800  1.71919200 
O   -3.12925900 -0.52287400  1.63469900 
C   -3.77074700 -0.22585100  0.38028600 
C   -5.12889200  0.38056500  0.64454500 
C   -6.11053900  0.29928300 -0.34756800 
C   -7.35617900  0.89382000 -0.16164300 
C   -7.63660500  1.56812600  1.02590500 
C   -6.66431700  1.64320700  2.02108200 
C   -5.41462100  1.05406300  1.83360900 
H   -4.66491200  1.10138400  2.61307800 
H   -6.87820600  2.15865500  2.95070800 
H   -8.60795900  2.02536600  1.17634400 
H   -8.10915500  0.82149100 -0.93831500 
H   -5.90393600 -0.23446700 -1.27049000 
H   -3.88222400 -1.14461700 -0.20465500 
H   -3.15254300  0.47563700 -0.19030900 
O   -1.28335900 -0.88925800  2.79660900 
H   -1.61191500 -1.47330500 -0.37694000 














   
C    0.00000000  0.00000000  0.00000000 
C    0.70435600 -0.48239300  1.23866700 
C    2.01861900 -0.50979900  1.05271000 
C    2.33168900 -0.02820300 -0.34904900 
O    1.07060500  0.15985700 -0.96116500 
C    3.11881900  1.30384800 -0.30033800 
O    4.47665700  1.23984200 -0.22923400 
C    5.21338200  0.00976000 -0.31807200 
C    6.68268400  0.28932000 -0.09285100 
C    7.60702600 -0.71947000 -0.38434500 
C    8.96627100 -0.51959000 -0.16097800 
C    9.41798700  0.69685000  0.35103000 
C    8.50137900  1.70560400  0.63573800 
C    7.13789100  1.50574600  0.41638600 
H    6.42710200  2.29336200  0.62891200 
H    8.84495800  2.65625200  1.02805300 
H    10.4766270  0.85651100  0.52134000 
H    9.67214700 -1.30928000 -0.39256700 
H    7.26462200 -1.66689500 -0.79059800 
H    4.85562700 -0.69953000  0.43607400 
H    5.06937200 -0.43846200 -1.30665600 
O    2.58626600  2.37573400 -0.28280000 
H    2.89067500 -0.76877500 -0.93157200 
H    2.77257400 -0.79073900  1.77590400 
H    0.18206800 -0.74917100  2.14844100 
C   -0.77522600  1.30383200  0.17322100 
H   -1.19861500  1.61319100 -0.78472400 
H   -1.59615600  1.16606500  0.88417100 
H   -0.11351900  2.09394700  0.53133400 










   
C    0.00000000  0.00000000  0.00000000 
C    0.88248300 -1.08346200  0.55535400 
C    0.19230600 -1.89655100  1.34428800 
C   -1.24053600 -1.44544300  1.40973000 
O   -1.28381100 -0.24006600  0.63085200 
C   -2.21807700 -2.50123400  0.84637400 
O   -3.53320500 -2.19745100  0.81017100 
C   -4.06539500 -0.96331400  1.33236600 
C   -5.53033000 -0.85934400  0.97472500 
C   -6.22643700  0.29097700  1.36339100 
C   -7.57767700  0.43646200  1.06447700 
C   -8.25154400 -0.56824200  0.36928600 
C   -7.56250100 -1.71341100 -0.02029300 
C   -6.20760700 -1.86217700  0.28068500 
H   -5.67389500 -2.75303700 -0.02274800 
H   -8.07795300 -2.49901100 -0.56164300 
H   -9.30387500 -0.45650900  0.13383400 
H   -8.10376200  1.33347400  1.37163300 
H   -5.70842200  1.07944700  1.90180100 
H   -3.95018700 -0.96195700  2.42265100 
H   -3.50799500 -0.12028900  0.92287300 
O   -1.85334900 -3.58002800  0.45940100 
H   -1.55040000 -1.21123600  2.43882000 
H    0.55416600 -2.77279200  1.86217700 
H    1.93262900 -1.16745300  0.30738500 
C    0.45325000  1.42565800  0.29368200 
H   -0.28860400  2.14051600 -0.06910300 
H    1.40167800  1.63207500 -0.21115200 
H    0.58808700  1.57311000  1.36784500 
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